[
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease cGVHD",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2019",
    "created_at": "2018-01-11T042314.961196",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-09",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395340",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Study of Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease cGVHD",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2019",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.961196",
    "verification_date": "2017-12-18",
    "verification_month_year": "December 18 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mechanism of Non-invasive Magnetic Stimulation",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2018-01-11T042334.934819",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-06",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394066",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Mechanism of Non-invasive Magnetic Stimulation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042334.934819",
    "verification_date": "2017-12-27",
    "verification_month_year": "December 27 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bisphosphonates for Prevention of Post-Denosumab Bone Loss",
    "completion_date": "2024-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2024",
    "created_at": "2018-01-11T042302.701210",
    "enrollment": 34,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396315",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Bisphosphonates for Prevention of Post-Denosumab Bone Loss in Premenopausal Women With Idiopathic Osteoporosis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2023",
    "received_results_disposit_date": "",
    "source": "Columbia University",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042302.701210",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Mechanistic Biology of Primary Immunodeficiency Disorders",
    "completion_date": "2030-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2030",
    "created_at": "2018-01-11T042335.130641",
    "enrollment": 1100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394053",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "The Mechanistic Biology of Primary Immunodeficiency Disorders",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2030-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2030",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042335.130641",
    "verification_date": "2017-12-26",
    "verification_month_year": "December 26 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The FVCDLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease",
    "completion_date": "2017-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2017",
    "created_at": "2018-01-11T042304.928356",
    "enrollment": 95,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396120",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The FVCDLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 1 2017",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-02-02",
    "start_date_type": "Actual",
    "start_month_year": "February 2 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042304.928356",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects",
    "completion_date": "2018-08-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 21 2018",
    "created_at": "2018-01-11T042303.444078",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396250",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open Label Crossover Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fasted Conditions",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 21 2018",
    "received_results_disposit_date": "",
    "source": "Bayer",
    "start_date": "2018-02-11",
    "start_date_type": "Anticipated",
    "start_month_year": "February 11 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.444078",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Infertility",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Vitamin D Deficiency Among Women With Unexplained Infertility",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2018",
    "created_at": "2018-01-11T042303.602826",
    "enrollment": 108,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396237",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Vitamin D Deficiency Among Women With Unexplained Infertility",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams Maternity Hospital",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.602826",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ONC201 in RecurrentRefractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma",
    "completion_date": "2027-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2027",
    "created_at": "2018-01-11T042335.530697",
    "enrollment": 94,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394027",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "ONC201 in RecurrentRefractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 1 2022",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042335.530697",
    "verification_date": "2017-12-15",
    "verification_month_year": "December 15 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Point-of-Use Pathogen Identification Tool for Diarrhea",
    "completion_date": "2025-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2025",
    "created_at": "2018-01-11T042335.332823",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394040",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Point-of-Use Pathogen Identification Tool for Diarrhea",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2025-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2025",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042335.332823",
    "verification_date": "2017-12-22",
    "verification_month_year": "December 22 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "saliva sample",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Responses to Genetic Risk Modifier Testing Among Women With BRCA12 Mutations",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-11T042302.380736",
    "enrollment": 195,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396341",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Responses to Genetic Risk Modifier Testing Among Women With BRCA12 Mutations",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "Memorial Sloan Kettering Cancer Center",
    "start_date": "2018-01-04",
    "start_date_type": "Actual",
    "start_month_year": "January 4 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042302.380736",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Lifestyle On-line Intervention in Patients With Obesity and Hypertension",
    "completion_date": "2018-05-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 14 2018",
    "created_at": "2018-01-11T042302.864981",
    "enrollment": 105,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396302",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of An Exercise and Nutritional Education Based Intervention Through New Technologies on Body Composition and Blood Pressure in Hypertensive People With Overweight and Obesity",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-07",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 7 2018",
    "received_results_disposit_date": "",
    "source": "Cardenal Herrera University",
    "start_date": "2018-01-22",
    "start_date_type": "Anticipated",
    "start_month_year": "January 22 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042302.864981",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Antenatal Corticosteroid in Elective Cesarean Section",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2018-01-11T042305.075127",
    "enrollment": 2000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396107",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Role of Antenatal Corticosteroid Use in Elective Term Cesarean Section",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042305.075127",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of Balance and Respiratory Muscle Training on Functional Capacity Balance Respiratory Function and Respiratory Muscle Strength in Children With Cerebral Palsy",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2018-01-11T042303.009651",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-05",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396289",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Balance and Respiratory Muscle Training on Functional Capacity Balance Respiratory Function and Respiratory Muscle Strength in Children With Cerebral Palsy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Bezmialem Vakif University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.009651",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus",
    "completion_date": "2021-03-17",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 17 2021",
    "created_at": "2018-01-11T042314.135900",
    "enrollment": 160,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395405",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase II Multi-Center Prospective Randomized Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-03-17",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 17 2021",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-01-18",
    "start_date_type": "Anticipated",
    "start_month_year": "January 18 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.135900",
    "verification_date": "2017-12-14",
    "verification_month_year": "December 14 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Depot Medroxyprogesterone Acetate as Emergency Contraception",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2018-01-11T042309.574526",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395756",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Investigation of the Potential for Intramuscular Depot Medroxyprogesterone Acetate as Emergency Contraception",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2019",
    "received_results_disposit_date": "",
    "source": "University of Southern California",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042309.574526",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "MBD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "NRX101 for Moderate Bipolar Depression and Suicidal Ideation",
    "completion_date": "2019-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2019",
    "created_at": "2018-01-11T042314.315047",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395392",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "NRX-101 for Treatment of Moderate Bipolar Depression and Suicidal Ideation The MBD Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2019",
    "received_results_disposit_date": "",
    "source": "NeuroRx Inc.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.315047",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "HEROES",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Houston Emergency Opioid Engagement System",
    "completion_date": "2018-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2018",
    "created_at": "2018-01-11T042303.148189",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396276",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Houston Emergency Opioid Engagement System HEROES",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2018",
    "received_results_disposit_date": "",
    "source": "The University of Texas Health Science Center Houston",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.148189",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2018-01-11T042302.556352",
    "enrollment": 176,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396328",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042302.556352",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ARGOS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of the Right Use of Inhaled Therapeutics",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-11T042313.978751",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395418",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of the Right Use of Inhaled Therapeutics Prescribed in Asthma and COPD in Adults",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Association Nationale pour les Traitements A Domicile les Innovations et la Recherche",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042313.978751",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Estradiol Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer",
    "completion_date": "2018-01-01",
    "completion_date_type": "Actual",
    "completion_month_year": "January 2018",
    "created_at": "2018-01-11T042310.756402",
    "enrollment": 299,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395665",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Estradiol Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2017",
    "received_results_disposit_date": "",
    "source": "Institut Universitari Dexeus",
    "start_date": "2014-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.756402",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prospective Comparison of Surgical Outcomes With Using Integrated Robotic Technology Versus Conventional Laparoscopy for Gastric Cancer Surgery",
    "completion_date": "2024-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2024",
    "created_at": "2018-01-11T042302.221760",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396354",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prospective Comparison of Surgical Outcomes With Using Integrated Robotic Technology Versus Conventional Laparoscopy for Gastric Cancer Surgery",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2024-01-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2 2024",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2018-01-02",
    "start_date_type": "Actual",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042302.221760",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Acne Scarring in Skin of Color Laser vs Microneedling",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-11T042310.580916",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395678",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Fractionated 1540nm Nonablative Laser and Microneedling in the Treatment of Atrophic Acne Scarring in Skin of Color A Randomized Controlled Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Boston University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.580916",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "EatWellQ8",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Online vs. Face-to-face Nutritional Advice in Kuwait EatWellQ8",
    "completion_date": "2018-12-24",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 24 2018",
    "created_at": "2018-01-11T042303.294538",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396263",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Randomized Control Trial to Evaluate the Effectiveness of Online Versus Face-to-face Nutrition Advice in Kuwait The EatWellQ8 Study",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Reading",
    "start_date": "2017-12-24",
    "start_date_type": "Actual",
    "start_month_year": "December 24 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.294538",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of the Proximal Approach and Distal Approach of Axillary Vein Catheterization Under Ultrasound Guidance",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-11T042310.403773",
    "enrollment": 194,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395691",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of the Proximal Approach and Distal Approach of Axillary Vein Catheterization Under Ultrasound Guidance in Cardiac Surgical Patients a Prospective Randomized Controlled Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Shanghai Zhongshan Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.403773",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ID-JPL934 for Abnormal Bowel Movement",
    "completion_date": "2018-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2018",
    "created_at": "2018-01-11T042311.208844",
    "enrollment": 112,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395626",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Validity and Safety of Symptom Improvement of ID-JPL934 for Abnormal Bowel Movement Such as Constipation Diarrhea Abdominal Pain Randomized Double-blind Placebo-controlled Parallel-group Study",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-02",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 2 2017",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2017-07-12",
    "start_date_type": "Actual",
    "start_month_year": "July 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042311.208844",
    "verification_date": "2017-08-01",
    "verification_month_year": "August 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Arteriell blood-gases.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Factors Determining Oxygen Wash in During Pre-oxygenation",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042309.270409",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395782",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Factors Determining End-tidal O2 Concentration in During Pre-oxygenation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Region Vstmanland",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Day",
    "updated_at": "2018-01-11T042309.270409",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma",
    "completion_date": "2016-05-15",
    "completion_date_type": "Actual",
    "completion_month_year": "May 15 2016",
    "created_at": "2018-01-11T042314.482585",
    "enrollment": 90,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395379",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-03-15",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 15 2016",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Nice",
    "start_date": "2012-01-11",
    "start_date_type": "Actual",
    "start_month_year": "January 11 2012",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.482585",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer",
    "completion_date": "2018-09-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 15 2018",
    "created_at": "2018-01-11T042315.138521",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395327",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 15 2018",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Departemental Vendee",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042315.138521",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Edoxaban for Prevention of Blood Vessels Being Blocked by Clots Thrombolytic Events in Children at Risk Because of Cardiac Disease",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2021",
    "created_at": "2018-01-11T042311.053285",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395639",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open-label Randomised Parallel-group Multicentre Observational Trial to Evaluate Safety and Efficacy of Edoxaban Tosylate in Children From 38 Weeks Gestational Age to Less Than 18 Years of Age With Cardiac Diseases at Risk of Thromboembolic Events",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2021",
    "received_results_disposit_date": "",
    "source": "Daiichi Sankyo Inc.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042311.053285",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Duloxetine LY248686 in the Treatment of Japanese Children and Adolescents With Depressive Disorder",
    "completion_date": "2021-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2021",
    "created_at": "2018-01-11T042314.800819",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395353",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2021",
    "received_results_disposit_date": "",
    "source": "Eli Lilly and Company",
    "start_date": "2018-01-30",
    "start_date_type": "Anticipated",
    "start_month_year": "January 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.800819",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Maternal Physical Activity and Pregnancy Outcome",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2018-01-11T042310.904594",
    "enrollment": 350,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395652",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Maternal Physical Activity and Pregnancy Outcome",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.904594",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Onset of Labour Epidural Analgesia With Different Concentration Bupivacaine and Different Doses of Sufentanyl",
    "completion_date": "2018-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2018",
    "created_at": "2018-01-11T042311.534703",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395600",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Onset of Labour Epidural Analgesia With Different Concentration Bupivacaine and Different Doses of Sufentanyl",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2018",
    "received_results_disposit_date": "",
    "source": "Fudan University",
    "start_date": "2018-02-10",
    "start_date_type": "Anticipated",
    "start_month_year": "February 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042311.534703",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Improving Outcomes for Hemodialysis Patients",
    "completion_date": "2019-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2019",
    "created_at": "2018-01-11T042314.637892",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-04",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395366",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Improving Outcomes for Hemodialysis Patients by Addressing Poor Health Related Quality of Life With Cognitive Behavioral Strategies",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2019",
    "received_results_disposit_date": "",
    "source": "Columbia University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042314.637892",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Anterior Wedge in Patients With Osteoarthritis Hip",
    "completion_date": "2018-12-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 10 2018",
    "created_at": "2018-01-11T042337.166176",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393923",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Anterior Wedge Use in Patients With Osteoarthritis Hip",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 1 2018",
    "received_results_disposit_date": "",
    "source": "Faculdade de Cincias Mdicas da Santa Casa de So Paulo",
    "start_date": "2017-07-10",
    "start_date_type": "Actual",
    "start_month_year": "July 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042337.166176",
    "verification_date": "2017-01-01",
    "verification_month_year": "January 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Serum Concentration of lgG in Patient With Acute Coronary Syndrome",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2018-01-11T042334.535469",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394092",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Changes in Glycopeptides of Serum Immunoglobulin G in Patients With Acute Myocardial Infarction and the Relationships Between Its Change and Prognosis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 15 2018",
    "received_results_disposit_date": "",
    "source": "The First Affiliated Hospital of Dalian Medical University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042334.535469",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery",
    "completion_date": "2016-04-06",
    "completion_date_type": "Actual",
    "completion_month_year": "April 6 2016",
    "created_at": "2018-01-11T042338.851983",
    "enrollment": 105,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393819",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-01-07",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 7 2016",
    "received_results_disposit_date": "",
    "source": "Lakehead University",
    "start_date": "2014-10-29",
    "start_date_type": "Actual",
    "start_month_year": "October 29 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042338.851983",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "HEARTS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "HEart trAnsplantation Registry of piTie-Salpetriere University Hospital",
    "completion_date": "2017-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2017",
    "created_at": "2018-01-11T042319.786922",
    "enrollment": 566,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393793",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Heart Transplantation Registry of Piti-Salptrire University Hospital",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2015",
    "received_results_disposit_date": "",
    "source": "Groupe Hospitalier Pitie-Salpetriere",
    "start_date": "2009-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2009",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042319.786922",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis",
    "completion_date": "2017-12-15",
    "completion_date_type": "Actual",
    "completion_month_year": "December 15 2017",
    "created_at": "2018-01-11T042330.039263",
    "enrollment": 1662,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394378",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-03",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 3 2017",
    "received_results_disposit_date": "",
    "source": "Ningbo No. 1 Hospital",
    "start_date": "2017-11-06",
    "start_date_type": "Actual",
    "start_month_year": "November 6 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042330.039263",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis PSC",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-11T042323.665182",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394781",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Open-label Phase 2 Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis PSC",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Durect",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042323.665182",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Maxillo-facial Treatment on Cleft Lip and Palate Patients Faces Aesthetic Considerations",
    "completion_date": "2017-12-22",
    "completion_date_type": "Actual",
    "completion_month_year": "December 22 2017",
    "created_at": "2018-01-11T042320.146342",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395015",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Efficacia Del Trattamento Chirurgico Maxillo-facciale Sul Volto Dei Bambini Con Labiopalatoschisi Valutazioni Estetiche ed Ortodontiche",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-20",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 20 2017",
    "received_results_disposit_date": "",
    "source": "Policlinico Universitario Agostino Gemelli",
    "start_date": "2017-06-05",
    "start_date_type": "Actual",
    "start_month_year": "June 5 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042320.146342",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Meta-analysis of Fruit and Vegetable Sources and Cardiovascular Outcomes",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-11T042330.639727",
    "enrollment": 1,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394339",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Relation of Fruit and Vegetable Sources With Cardiovascular Outcomes A Systematic Review and Meta-analysis of Prospective Cohort Studies.",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Toronto",
    "start_date": "2017-04-01",
    "start_date_type": "Actual",
    "start_month_year": "April 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042330.639727",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Preoperative Budesonide Inhalation on Arterial Blood Oxygenation and Intrapulmonary Shunt During OLV",
    "completion_date": "2017-04-01",
    "completion_date_type": "Actual",
    "completion_month_year": "April 2017",
    "created_at": "2018-01-11T042332.470341",
    "enrollment": 50,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394222",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Preoperative Budesonide Inhalation on Arterial Blood Oxygenation and Intrapulmonary Shunt in Patients Received One-lung Ventilation",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-03-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 2017",
    "received_results_disposit_date": "",
    "source": "Fujian Medical University Union Hospital",
    "start_date": "2016-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042332.470341",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Wound Infiltration With Ketorolac Versus Lidocaine for Postoperative Analgesia After Total Abdominal Hysterectomy",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042335.919226",
    "enrollment": 80,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394001",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Wound Infiltration With Ketorolac Versus Lidocaine for Postoperative Analgesia After Total Abdominal Hysterectomy a Prospective Randomized Double-blind Study.",
    "overall_status": "Active not recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2018-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042335.919226",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "RGD PETMRI in Sporadic Vestibular Schwannoma",
    "completion_date": "2021-01-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2 2021",
    "created_at": "2018-01-11T042341.089818",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393689",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Kan tumorvkst Forudsiges Ved RGD-PETMR af Vestibularis Schwannomer",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2 2021",
    "received_results_disposit_date": "",
    "source": "Rigshospitalet Denmark",
    "start_date": "2018-01-02",
    "start_date_type": "Actual",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042341.089818",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2018",
    "created_at": "2018-01-11T042345.098004",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393442",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 15 2018",
    "received_results_disposit_date": "",
    "source": "Medical University of Vienna",
    "start_date": "2017-11-25",
    "start_date_type": "Actual",
    "start_month_year": "November 25 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042345.098004",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Influence of Sleep Quality in Patients With Periorbicular Hyperchromia a Case Control Study",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042342.098134",
    "enrollment": 280,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393624",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Influence of Sleep Quality in Patients With Periorbicular Hyperchromia a Case Control Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2018",
    "received_results_disposit_date": "",
    "source": "Hospital de Clinicas de Porto Alegre",
    "start_date": "2017-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042342.098134",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2020",
    "created_at": "2018-01-11T042323.844098",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394768",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "An Observational Study Comparing NICOM-Cheetah Versus Flotrac-Vigileo for Cardiac Output Monitoring in the Surgical Intensive Care Unit.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Changi General Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "2 Years",
    "updated_at": "2018-01-11T042323.844098",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Oral Care in Infants With Gastroschisis",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2019",
    "created_at": "2018-01-11T042338.635865",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393832",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Oral Care An Important Adjunctive Therapy in Infants With Gastroschisis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "Baylor College of Medicine",
    "start_date": "2017-10-14",
    "start_date_type": "Actual",
    "start_month_year": "October 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042338.635865",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety of Fucicort Lipid Cream Compared to Combination Treatment With Fucidin Cream Followed by Betamethasone Lianbang Beisong Cream and Fucicort Lipid Cream Vehicle in Clinically Infected Atopic DermatitisEczema",
    "completion_date": "2019-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2019",
    "created_at": "2018-01-11T042317.935985",
    "enrollment": 550,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395132",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety of Fucicort Lipid Cream Compared to Combination Treatment With Fucidin Cream Followed by Betamethasone Lianbang Beisong Cream and Fucicort Lipid Cream Vehicle in Clinically Infected Atopic DermatitisEczema",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "LEO Pharma",
    "start_date": "2018-03-20",
    "start_date_type": "Anticipated",
    "start_month_year": "March 20 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042317.935985",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Thrombosomes in Bleeding Thrombocytopenic Patients",
    "completion_date": "2018-12-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 18 2018",
    "created_at": "2018-01-11T042324.025168",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394755",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase I Multi-Center Open-Label Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 18 2018",
    "received_results_disposit_date": "",
    "source": "Cellphire Inc.",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042324.025168",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-11T042338.209475",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393858",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Prospective Study of Combination of Anti-PD-1 Plus Autologous DC-CIK Cell Immunotherapy and Hyperthermia for Patients With Advanced Malignant Mesothelioma",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Capital Medical University",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042338.209475",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Exercise Activity-Based Bolus Decisions in Type 1 Diabetes",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-11T042330.440160",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394352",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Pilot Study of Activity-Based Bolus Decisions in Type 1 Diabetes",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Virginia",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042330.440160",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "OVATION II",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of GEN-1 With NACT for Treatment of Ovarian Cancer OVATION II",
    "completion_date": "2021-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2021",
    "created_at": "2018-01-11T042337.806935",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393884",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase III Study Evaluating the Dosing Safety Efficacy and Biological Activity of Intraperitoneal GEN-1 IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer Administered in Combination With Neoadjuvant Chemotherapy NACT in Patients Newly Diagnosed With Advanced Epithelial Ovarian Fallopian Tube or Primary Peritoneal Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Celsion",
    "start_date": "2018-04-30",
    "start_date_type": "Anticipated",
    "start_month_year": "April 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042337.806935",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prevention of Thromboembolic Events in Total Knee Replacement Patients",
    "completion_date": "2019-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2019",
    "created_at": "2018-01-11T042344.386017",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393481",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Multicenter Randomized Open-label Blinded Endpoint Evaluation Active-controlled Phase 2 Study to Compare the Efficacy and Safety of s.c. MAA868 Versus s.c. Enoxaparin in Adult Patients Undergoing Unilateral Total Knee Arthroplasty",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2019",
    "received_results_disposit_date": "",
    "source": "Novartis",
    "start_date": "2018-01-26",
    "start_date_type": "Anticipated",
    "start_month_year": "January 26 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042344.386017",
    "verification_date": "2017-08-01",
    "verification_month_year": "August 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bioequivalence Study of Lu AF35700",
    "completion_date": "2018-07-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 13 2018",
    "created_at": "2018-01-11T042328.456277",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394482",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "Interventional Randomized Open-label Three-group Two-sequence Crossover Single-dose Bioequivalence Study of Lu AF35700 in Healthy Subjects Comparing the 5 10 and 20 mg Commercial Tablet Test to the 5 10 and 20 mg Clinical Tablet Reference",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 20 2018",
    "received_results_disposit_date": "",
    "source": "H. Lundbeck AS",
    "start_date": "2018-01-03",
    "start_date_type": "Actual",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042328.456277",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2018-01-11T042344.186446",
    "enrollment": 825,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393494",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Multi-Center Double-Blind Randomized Vehicle-Controlled Parallel-Group Study to Compare Perrigos AdapaleneBP Gel to Galdermas Epiduo AdapaleneBP Gel and Both Treatments to a Vehicle Control in the Treatment of Acne Vulgaris",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "Perrigo Company",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042344.186446",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Improvement Of Pelvic Exams for Patients With Chronic Vulvovaginal Conditions",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042337.379303",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393910",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Improvement Of Pelvic Exams for Patients With Chronic Vulvovaginal Conditions",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Drexel University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042337.379303",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease AFAD",
    "completion_date": "2019-05-08",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 8 2019",
    "created_at": "2018-01-11T042339.064988",
    "enrollment": 46,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393806",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Double Blind Sponsor Open Placebo-controlled Stratified Parallel Group Study to Evaluate the Efficacy and Safety of Repeat Doses of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease AFAD",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 13 2019",
    "received_results_disposit_date": "",
    "source": "GlaxoSmithKline",
    "start_date": "2018-02-23",
    "start_date_type": "Anticipated",
    "start_month_year": "February 23 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042339.064988",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assessment of the Efficacy Safety and Tolerability of AVP-786 Deudextromethorphan Hydrobromide d6 DMQuinidine Sulfate Q for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type",
    "completion_date": "2020-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2020",
    "created_at": "2018-01-11T042343.757759",
    "enrollment": 412,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393520",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 3 Multicenter Randomized Double-blind Placebo-controlled Parallel-design Study to Assess the Efficacy Safety and Tolerability of AVP-786 Deudextromethorphan Hydrobromide d6 DMQuinidine Sulfate Q for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2020",
    "received_results_disposit_date": "",
    "source": "Avanir Pharmaceuticals",
    "start_date": "2017-10-13",
    "start_date_type": "Actual",
    "start_month_year": "October 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042343.757759",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Qualitative Study of Black-White Sleep Disparities",
    "completion_date": "2019-04-27",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 27 2019",
    "created_at": "2018-01-11T042407.819010",
    "enrollment": 408,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389828",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Qualitative Study of Black-White Sleep Disparities",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 27 2019",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042407.819010",
    "verification_date": "2017-11-29",
    "verification_month_year": "November 29 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-11T042342.930384",
    "enrollment": 80,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393572",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intraperitoneal Instillation of Bupivacaine With Either Magnesium Sulphate or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy a Prospective Randomized Double-blinded Trial.",
    "overall_status": "Active not recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2018-01-03",
    "start_date_type": "Actual",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042342.930384",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tertiary Care With or Without Manual Therapy for Chronic Migraine",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-11T042313.386104",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395457",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Two-centre Pragmatic Randomised Controlled Trial on the Effectiveness of Manual Therapy as an Adjunct to Tertiary Management of Chronic Migraine",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Bournemouth University",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042313.386104",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pathogen Screening in OA and Non-OA Orthopaedic Surgical Patients",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042333.301177",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394170",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Pathogen Screening in OA and Non-OA Orthopaedic Surgical Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "The Foundation for Sports Medicine and Arthritis Research",
    "start_date": "2017-05-01",
    "start_date_type": "Actual",
    "start_month_year": "May 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042333.301177",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Eat Healthy for Families",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2018-01-11T042330.831350",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394326",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Implementing a Dietary Energy Density Intervention in Preschool Children",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "University of Delaware",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042330.831350",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Respiratory Variations of the Diameter of Superior Vena Cava for Predicting Fluid Responsiveness After Cardiac Surgery",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042337.592096",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393897",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Respiratory Variations of the Diameter of Superior Vena Cava for Predicting Fluid Responsiveness After Cardiac Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Saint Etienne",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042337.592096",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke",
    "completion_date": "2019-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2019",
    "created_at": "2018-01-11T042321.081125",
    "enrollment": 980,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394950",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke BRAISa Pilot Prospective Random and Open Label Multi-center Study",
    "overall_status": "Active not recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "General Hospital of Shenyang Military Region",
    "start_date": "2017-12-30",
    "start_date_type": "Actual",
    "start_month_year": "December 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042321.081125",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Training Therapy for the Prevention of Back Pain",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2019",
    "created_at": "2018-01-11T042345.305992",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393429",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Training Therapy for the Secondary and Tertiary Prevention of Backache and Low Back Pain A Randomized Controlled Pilot Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "Medical University of Vienna",
    "start_date": "2017-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042345.305992",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ATHERODENT",
    "baseline_population": "",
    "biospec_description": "Blood samples will be collected for determination of miRNA fractions associated with coronary\n      plaque vulnerability",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Periodontal Disease Inflammation and Acute Coronary Syndromes",
    "completion_date": "2021-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2021",
    "created_at": "2018-01-11T042313.209625",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395041",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Periodontal Disease Inflammation and Atherosclerosis Progression in Patients With Acute Coronary Syndromes - the ATHERODENT Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2021",
    "received_results_disposit_date": "",
    "source": "Cardio Med Medical Center",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042313.209625",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "OMEGOZ",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects",
    "completion_date": "2020-12-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 18 2020",
    "created_at": "2018-01-11T042318.129317",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395119",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 18 2020",
    "received_results_disposit_date": "",
    "source": "University of North Carolina Chapel Hill",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042318.129317",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Body Mass Index and Eating Behaviour Changes in Female Patients With Fibromyalgia Under Medical Treatment",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-11T042321.851026",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394898",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prospective Observational Study of Evaluation of Body Mass Index and Eating Behaviour Changes in Female Patients With Fibromyalgia Under Medical Treatment",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "Gaziosmanpasa Taksim Research and Education Hospital",
    "start_date": "2018-01-03",
    "start_date_type": "Actual",
    "start_month_year": "January 3 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "4 Weeks",
    "updated_at": "2018-01-11T042321.851026",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PtDA-MAT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pilot Test of Patient Decision Aid for Opioid Use Disorder",
    "completion_date": "2018-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2018",
    "created_at": "2018-01-11T042331.901186",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394261",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pilot Test of Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2018",
    "received_results_disposit_date": "",
    "source": "University of California Los Angeles",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042331.901186",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients",
    "completion_date": "2020-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2020",
    "created_at": "2018-01-11T042329.427961",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-03",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394417",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Patients Receiving Concurrent Chemoradiation for Head and Neck Cancers",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "National University Hospital Singapore",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042329.427961",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube in Patients With Semi-regid Neck Collar.",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042356.464878",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392766",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Fiberoptic Intubation Between Double Lumen Tube and Single Lumen Tube in Patients With Semi-rigid Neck Collar Immobilization of the Cervical Spine.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Ajou University School of Medicine",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042356.464878",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Internet-based Metacognitive Therapy for Excessive Worry",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2018-01-11T042349.815674",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393156",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Internet-based Metacognitive Therapy for Excessive Worry A Randomized Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042349.815674",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Whole blood serum",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors",
    "completion_date": "2047-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2047",
    "created_at": "2018-01-09T041345.830086",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391791",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Long Term Follow-up of Subjects Exposed to Genetically Engineered Tumor Antigen Specific T Cell Receptors",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2047-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2047",
    "received_results_disposit_date": "",
    "source": "Adaptimmune",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041345.830086",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial of SHR-1210 an Anti-PD-1 Inhibitor in Combination With Apatinib in Patients With Advanced TNBC",
    "completion_date": "2020-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2020",
    "created_at": "2018-01-11T042331.408633",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394287",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase IbIIOpen-labeled Investigator-initiated Clinical Trial of SHR-1210 Anti-PD-1 Antibody in Combination With Apatinib in Subjects With Advanced Triple Negative Breast Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2019",
    "received_results_disposit_date": "",
    "source": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
    "start_date": "2018-01-07",
    "start_date_type": "Anticipated",
    "start_month_year": "January 7 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042331.408633",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "CALYPSO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adapting Sleep and Yoga Interventions for Maximal Effectiveness in Low Income Populations",
    "completion_date": "2018-07-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 30 2018",
    "created_at": "2018-01-11T042404.268975",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392194",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Adapting Sleep and Yoga Interventions for Maximal Effectiveness in Low Income Populations",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "Brigham and Womens Hospital",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042404.268975",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041345.621904",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391804",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Pilot Study of ALLN-177 in Adult and Pediatric Subjects Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Allena Pharmaceuticals",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041345.621904",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase 1 Study Evaluating the Safety Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC",
    "completion_date": "2020-03-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 22 2020",
    "created_at": "2018-01-09T041341.770368",
    "enrollment": 41,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392064",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Study Evaluating the Safety Tolerability and Efficacy of AMG 119 in Subjects With RelapsedRefractory Small Cell Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 22 2020",
    "received_results_disposit_date": "",
    "source": "Amgen",
    "start_date": "2018-04-02",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041341.770368",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TraP-AF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-11T042339.474204",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392649",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery The TraP-AF Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "University of Chicago",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042339.474204",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ThyroPred-1",
    "baseline_population": "",
    "biospec_description": "Fine needle aspiration biopsy FNAB material and washout will be diluted in dedicated buffer\n      and frozen in -80C. RNA and DNA will be isolated by commercial kits.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-11T042402.927884",
    "enrollment": 433,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392402",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prospective Validation of the Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2019",
    "received_results_disposit_date": "",
    "source": "Maria Sklodowska-Curie Memorial Cancer Center Institute of Oncology",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042402.927884",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety Reactogenicity and Immunogenicity of mRNA-1653 in Healthy Adults",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042358.577189",
    "enrollment": 119,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392389",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 1 Randomized Observer-Blind Placebo-Controlled Dose-Ranging Study to Evaluate the Safety Reactogenicity and Immunogenicity of mRNA-1653 a Combined Human Metapneumovirus and Human Parainfluenza Virus Type 3 Vaccine When Administered to Healthy Adults",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2019",
    "received_results_disposit_date": "",
    "source": "Moderna Therapeutics",
    "start_date": "2017-12-04",
    "start_date_type": "Actual",
    "start_month_year": "December 4 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042358.577189",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2018-01-11T042353.606786",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392935",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "University of Utah",
    "start_date": "2017-11-30",
    "start_date_type": "Actual",
    "start_month_year": "November 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042353.606786",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Two Silicone Hydrogel Toric Contact Lenses",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2018",
    "created_at": "2018-01-11T042403.150944",
    "enrollment": 35,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392532",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Axis Orientation Comparison of Two Silicone Hydrogel Toric Contact Lenses",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Alcon Research",
    "start_date": "2018-01-04",
    "start_date_type": "Actual",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042403.150944",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor nave Advanced EGFR Mutant Lung Cancer",
    "completion_date": "2025-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2025",
    "created_at": "2018-01-09T041338.508672",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392246",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor nave Advanced EGFR Mutant Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2021",
    "received_results_disposit_date": "",
    "source": "Dana-Farber Cancer Institute",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041338.508672",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparing the Quality of Life Between LADG and TLDG for Gastric Cancer_KLASS07 CKLASS01.",
    "completion_date": "2019-10-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2 2019",
    "created_at": "2018-01-11T042349.400040",
    "enrollment": 442,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393182",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multicenter Randomized Controlled Trial Comparing the Quality of Life Between Laparoscopy-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric cancer_KLASS 07 CKLASS01Korea-China Collaborated Study",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2 2019",
    "received_results_disposit_date": "",
    "source": "Korea University Anam Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042349.400040",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study in Chinese Healthy Adults to Evaluate the Safety Tolerability and Pharmacokinetics on ZSP1601 and the Effect of Food on ZSP1601 Pharmacokinetics",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-11T042356.211804",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392779",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 9,
    "number_of_groups": "",
    "official_title": "A Phase 1 Randomized Double-Blind Parallel-Group Placebo-Controlled Study to Evaluate the Safety Tolerability and Pharmacokinetics of ZSP1601 and the Effect of Food on ZSP1601 Pharmacokinetics in Chinese Healthy Subjects.",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2019",
    "received_results_disposit_date": "",
    "source": "Guangdong Zhongsheng Pharmaceutical Co. Ltd.",
    "start_date": "2018-01-05",
    "start_date_type": "Actual",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042356.211804",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa RDEB",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-11T042354.048928",
    "enrollment": 9,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392909",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Restoration of Full-Length Type VII Collagen in RDEB Patients With Nonsense Mutations After Intravenous Gentamicin Treatment",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "University of Southern California",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042354.048928",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of Local Consolidation Therapy LCT After Nivolumab and Ipilimumab LONESTAR",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2022",
    "created_at": "2018-01-11T042405.121680",
    "enrollment": 270,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391869",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Phase III Trial of Local Consolidation Therapy LCT After Nivolumab and Ipilimumab for Immunotherapy-Naive Patients With Metastatic Non-Small Cell Lung Cancer LONESTAR -Strategic Alliance BMS",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2022",
    "received_results_disposit_date": "",
    "source": "M.D. Anderson Cancer Center",
    "start_date": "2017-12-29",
    "start_date_type": "Actual",
    "start_month_year": "December 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042405.121680",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study on the Mechanism of Colla Corri Asini in the Treatment of Thalassemia Patients With Pregnancy Anemia",
    "completion_date": "2019-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2019",
    "created_at": "2018-01-09T041337.795075",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392298",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Investigation of Signal Pathway Induced by Colla Corri Asini Regulating Globin Level in Beta Thalassemia Patients With Pregnancy Anemia",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "The First Affiliated Hospital Guangzhou University of Traditional Chinese Medicine",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041337.795075",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "FLU-06-IB",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine 2018 Produced at Butantan Institute",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2018-01-09T041339.442596",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392207",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine 2018 Southern Hemisphere Season Produced at Butantan Institute",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 15 2018",
    "received_results_disposit_date": "",
    "source": "Butantan Institute",
    "start_date": "2018-03-15",
    "start_date_type": "Anticipated",
    "start_month_year": "March 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041339.442596",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-11T042344.701451",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393468",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open Label Randomized Phase 1 Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042344.701451",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PETMRI for the Staging of Newly Diagnosed Prostate Cancer",
    "completion_date": "2023-02-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 20 2023",
    "created_at": "2018-01-11T042404.487353",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392181",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "PETMRI for the Staging of Newly Diagnosed Prostate Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-01-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 20 2023",
    "received_results_disposit_date": "",
    "source": "Northwestern University",
    "start_date": "2018-01-20",
    "start_date_type": "Anticipated",
    "start_month_year": "January 20 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042404.487353",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prolonged Isolated Thrombocytopenia After Allo-SCT  N-acetyl-L-cysteine NAC Versus Best Supportive Therapy",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-09T041344.821377",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391856",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Prospective Randomized Controlled Study for Intervention of Prolonged Isolated Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation N-acetyl-L-cysteine NAC Versus Best Supportive Therapy",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "Peking University Peoples Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041344.821377",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PRIMO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Infectious Diseases and Movement Program Study of the Effects of Physical Activity on HIV Infection",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-11T042355.777582",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392805",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Infectious Diseases and Movement Program Study of the Effects of Physical Activity on HIV Infection",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Roma La Sapienza",
    "start_date": "2016-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042355.777582",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Apatinib Treatment in for Advanced Ovarian Cancer",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2019",
    "created_at": "2018-01-11T042343.965993",
    "enrollment": 34,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393507",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Study of Apatinib in Combination With Chemotherapy Versus Chemotherapy Alone for Advanced Ovarian Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "The Peoples Hospital of Leshan",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042343.965993",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of an Investigational Drug to See How it Affects the People With Parkinsons Disease Complicated by Motor Fluctuations OFF Episodes Compared to an Approved Drug Used to Treat People With Parkinsons Disease Complicated by Motor Fluctuations OFF Episodes",
    "completion_date": "2019-05-24",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 24 2019",
    "created_at": "2018-01-09T041344.407017",
    "enrollment": 85,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391882",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open-Label Randomized Crossover Trial Utilizing a Single-Blinded Rater to Evaluate APL-130277 Compared to Subcutaneous Apomorphine in Levodopa Responsive Subjects With Parkinsons Disease Complicated by Motor Fluctuations",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-24",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 24 2019",
    "received_results_disposit_date": "",
    "source": "Sunovion",
    "start_date": "2018-01-03",
    "start_date_type": "Anticipated",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041344.407017",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "DNA Methylation in Malar Melasma and Its Change by Sunscreen Retinoic Acid and Niacinamide.",
    "completion_date": "2016-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 1 2016",
    "created_at": "2018-01-11T042359.008378",
    "enrollment": 28,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": true,
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392623",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "DNA Methylation in Malar Melasma and Its Change by Sunscreen Retinoic Acid and Niacinamide.",
    "overall_status": "Completed",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-01-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 1 2016",
    "received_results_disposit_date": "",
    "source": "Universidad Autonoma de San Luis Potos",
    "start_date": "2015-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042359.008378",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Optimizing Parameters for Long-pulsed NdYAG Laser for Reducing Hair Shaft Diameter",
    "completion_date": "2019-09-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 15 2019",
    "created_at": "2018-01-11T042332.278054",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394235",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Optimizing Parameters for Long-pulsed NdYAG Laser for Reducing Hair Shaft Diameter at the Donor Area for Hair Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "Institute of Dermatology Thailand",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042332.278054",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive HER-2 Negative AdvancedMetastatic Breast Cancer Patients",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2018-01-11T042338.412119",
    "enrollment": 47,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393845",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive HER-2 Negative AdvancedMetastatic Breast Cancer Patients Big Ten Cancer Research Consortium BTCRC-BRE16-042",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2021",
    "received_results_disposit_date": "",
    "source": "Big Ten Cancer Research Consortium",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042338.412119",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Health-Related Quality of Life in Upper Secondary Schools in Denmark",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2018-01-11T042404.686033",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391999",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Danish Sundhed Trivsel og Lring p HHX og HTX Erhvervsskolerne i Aars",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-07-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 30 2020",
    "received_results_disposit_date": "",
    "source": "Aalborg University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042404.686033",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer",
    "completion_date": "2027-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2027",
    "created_at": "2018-01-09T041345.054561",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391843",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "FOLFOXIRI Combined With Cetuximab as a Neoadjuvant Chemotherapy for EGFR Wild Type Locally Advanced Rectal CancerA Phase II Study",
    "overall_status": "Active not recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2027-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2027",
    "received_results_disposit_date": "",
    "source": "RenJi Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041345.054561",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Multicenter Randomized Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer",
    "completion_date": "2022-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2022",
    "created_at": "2018-01-11T042403.375277",
    "enrollment": 308,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392220",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multicenter Randomized Case-control Study of Unilateral vs Bilateral Selective Neck Dissection for Clinically Negative Neck of Supraglottic Laryngeal Carcinoma",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2020",
    "received_results_disposit_date": "",
    "source": "Cancer Institute and Hospital Chinese Academy of Medical Sciences",
    "start_date": "2016-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042403.375277",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "REVOR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of the Systematic Use of the Criteria STOPPSTART in Short Stay Geriatric.",
    "completion_date": "2018-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2018",
    "created_at": "2018-01-11T042347.446928",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393299",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of the Systematic Use of the Criteria STOPPSTART in Short Stay Geriatric Study of Superiority Randomized Controlled Prospective Single Blind",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "Lille Catholic University",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042347.446928",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prophylactic Linisopril to Prevent Anthracycline Induced Cardiotoxicity",
    "completion_date": "2019-12-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 15 2019",
    "created_at": "2018-01-11T042356.917287",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392740",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prophylactic Lisinopril to Prevent Anthracycline Induced Left Ventricular Systolic Dysfunction Using Strain Echocardiography for Surveillance.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "Genesys Regional Medical Center",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042356.917287",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-09T041359.139480",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392051",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Drug-Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of ISIS 681257 40 mg Subcutaneous Injections On The Pharmacokinetics And Pharmacodynamics Of Clopidogrel In Healthy Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Akcea Therapeutics",
    "start_date": "2017-12-28",
    "start_date_type": "Actual",
    "start_month_year": "December 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041359.139480",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "BSM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Breastfeeding Self-Management for Nipple and Breast Pain",
    "completion_date": "2017-11-07",
    "completion_date_type": "Actual",
    "completion_month_year": "November 7 2017",
    "created_at": "2018-01-11T042358.125233",
    "enrollment": 65,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392675",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Promoting Self-Management of Breast and Nipple Pain in Breastfeeding Women",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-06",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 6 2017",
    "received_results_disposit_date": "",
    "source": "University of Connecticut",
    "start_date": "2017-04-24",
    "start_date_type": "Actual",
    "start_month_year": "April 24 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042358.125233",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042403.609007",
    "enrollment": 5,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392311",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 15 2018",
    "received_results_disposit_date": "",
    "source": "Guangdong Provincial Hospital of Traditional Chinese Medicine",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042403.609007",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Whole blood serum",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Long Term Follow up of Subjects Exposed to NY-ESO-1T",
    "completion_date": "2047-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2047",
    "created_at": "2018-01-09T041346.013330",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391778",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Long Term Follow Up Of Subjects Exposed To NY-ESO-1T A Genetically Engineered NY-ESO-1 Specific T Cell Receptor",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2047-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2047",
    "received_results_disposit_date": "",
    "source": "Adaptimmune",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041346.013330",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PrInCESS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PIcc Cost EffectiveneSS and Safety of Infusional Therapy",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2018-01-11T042355.349642",
    "enrollment": 624,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392831",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparative Cost-Effectiveness and Safety of Infusional Therapy With Central Venous Catheters Versus Peripherally Inserted Central Catheters a Randomized Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Hospital de Clinicas de Porto Alegre",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042355.349642",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "P204",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer",
    "completion_date": "2020-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2020",
    "created_at": "2018-01-11T042319.208767",
    "enrollment": 94,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395080",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Leap Therapeutics Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042319.208767",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Safe Sleep for Babies a Bassinet Distribution and Education Program",
    "completion_date": "2019-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2019",
    "created_at": "2018-01-11T042357.137872",
    "enrollment": 440,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392727",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Safe Sleep for Babies a Bassinet Distribution and Education Program",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Manitoba",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042357.137872",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Digital Cervical and Cesarean Section",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-09T041341.598526",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392077",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Role of Digital Cervical Opening in Elective Cesarean Section",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041341.598526",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy PSP",
    "completion_date": "2024-09-12",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 12 2024",
    "created_at": "2018-01-09T041346.220336",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-02",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391765",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy PSP",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2024-09-12",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 12 2024",
    "received_results_disposit_date": "",
    "source": "AbbVie",
    "start_date": "2018-01-24",
    "start_date_type": "Anticipated",
    "start_month_year": "January 24 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041346.220336",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Qatar Cardiometabolic Registry",
    "completion_date": "2027-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2027",
    "created_at": "2018-01-11T042331.032475",
    "enrollment": 50000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394313",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Qatar Cardiometabolic Registry",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2027-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2027",
    "received_results_disposit_date": "",
    "source": "Hamad Medical Corporation",
    "start_date": "2017-09-15",
    "start_date_type": "Actual",
    "start_month_year": "September 15 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042331.032475",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients",
    "completion_date": "2015-01-31",
    "completion_date_type": "Actual",
    "completion_month_year": "January 31 2015",
    "created_at": "2018-01-11T042306.963610",
    "enrollment": 18,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395951",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Clinical Observation of Mean Systemic Filling Pressure in Critical Care Patients With Continuous Diuretics Administration",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-10-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 1 2014",
    "received_results_disposit_date": "",
    "source": "Catharina Ziekenhuis Eindhoven",
    "start_date": "2014-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042306.963610",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "More-2-Eat Phase 2 Scaling and Spread of the Integrated Nutrition Pathway for Acute Care",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-11T042405.582281",
    "enrollment": 4000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391752",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 10,
    "official_title": "More-2-Eat Phase 2 SpreadScaling up Improved Nutrition Care to Detect and Treat Hospital Malnutrition.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2019",
    "received_results_disposit_date": "",
    "source": "University of Waterloo",
    "start_date": "2018-05-01",
    "start_date_type": "Anticipated",
    "start_month_year": "May 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042405.582281",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Pre-AeRATE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pre- and Apnoeic Oxygenation for RSI in ED",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2019",
    "created_at": "2018-01-11T042305.214055",
    "enrollment": 184,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396094",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pre- and Apnoeic High Flow Oxygenation for RApid Sequence Intubation in The Emergency Department Pre-AeRATE a Multicentre Randomised Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2019",
    "received_results_disposit_date": "",
    "source": "National University Hospital Singapore",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042305.214055",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "UNFNF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Undisplaced Femoral Neck Fractures",
    "completion_date": "2017-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2017",
    "created_at": "2018-01-09T041337.982031",
    "enrollment": 235,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392285",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Undisplaced Femoral Neck Fractures Treatment With Internal Fixation or Hip Arthroplasty",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-05-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 31 2015",
    "received_results_disposit_date": "",
    "source": "Sundsvall Hospital",
    "start_date": "2013-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2013",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041337.982031",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bone Volume Changes After Socket Preservation Using Geistlich Bio-Oss Collagen and Mucograft Seal",
    "completion_date": "2020-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2020",
    "created_at": "2018-01-11T042317.773029",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395145",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Valuation of Bone Volume Changes After Socket Preservation Using Geistlich Bio-Oss Collagen and Geistlich Mucograft Seal Compared to Natural Healing After Tooth Extraction",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Rambam Health Care Campus",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042317.773029",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "IDAVON",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2018-01-11T042348.531420",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393234",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Study of Safety and Feasibility of the Intersphincteric Resection With or Without Intraoperative Radiation in Low Rectal Cancer",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2022",
    "received_results_disposit_date": "",
    "source": "Second Hospital of Jilin University",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042348.531420",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Usefulness of Cardiovascular Disease CVD Management Solution",
    "completion_date": "2019-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2019",
    "created_at": "2018-01-11T042403.833419",
    "enrollment": 666,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2018-01-01",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392259",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prospective Validation of Usefulness in Cardiovascular Disease CVD Management With CVD Management Solution Based on Interconnection to Hospital Examination",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042403.833419",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ADM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Thick vs. Thin Acellular Dermal Matrix ADM",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-09T041342.135287",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392038",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Root Coverage Using the Coronally Positioned Tunnel Technique Comparing Thick Versus Thin Acellular Dermal Matrix",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Louisville",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041342.135287",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab Produced by CinnaGen and FOLFIRI Compared With Erbitux Cetuximab Produced by Merck Company and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Patients",
    "completion_date": "2018-11-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 22 2018",
    "created_at": "2018-01-09T041343.620217",
    "enrollment": 234,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391934",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase III Randomized Two Armed Parallel Double-blind Active-controlled Equivalency Clinical Trial to Determine the Therapeutic Efficacy and Safety Between Cetuximab Produced by CinnaGen and FOLFIRI Compared With Erbitux Cetuximab the Reference Drug Produced by Merck Company and FOLFIRI for RAS Wild-type Metastatic Colorectal Cancer Patients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 22 2018",
    "received_results_disposit_date": "",
    "source": "Cinnagen",
    "start_date": "2018-01-03",
    "start_date_type": "Anticipated",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041343.620217",
    "verification_date": "2017-02-01",
    "verification_month_year": "February 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Semilunar and Conventional Coronally Positioned Flap for the Treatment Gingival Recession",
    "completion_date": "2018-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2018",
    "created_at": "2018-01-09T041343.420956",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391947",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of a Semilunar Coronally Positioned Flap and Conventional Coronally Advanced Flap for the Treatment of Gingival Recession- A Split-mouth Randomized Prospective Comparative Controlled Clinical Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 1 2018",
    "received_results_disposit_date": "",
    "source": "Damascus University",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041343.420956",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors",
    "completion_date": "2027-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2027",
    "created_at": "2018-01-09T041338.708135",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392233",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase II Study to Evaluated the Long-term of Safety and Efficacy of Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2027-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2027",
    "received_results_disposit_date": "",
    "source": "RenJi Hospital",
    "start_date": "2017-08-18",
    "start_date_type": "Actual",
    "start_month_year": "August 18 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041338.708135",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DM I-TEAM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Diabetes Interprofessional Team to Enhance Adherence to Medical Care",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-11T042346.828106",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393338",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Diabetes Interprofessional Team to Enhance Adherence to Medical Care",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Thomas Jefferson University",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042346.828106",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "MultiPlaque",
    "baseline_population": "",
    "biospec_description": "Blood samples will be collected for determination of miRNA fractions associated with coronary\n      plaque vulnerability",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-09T041344.012174",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391908",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "A Prospective Monocentric Clinical Study for Multiomics and Imaging-based Assessment of the Vulnerable Coronary Plaques and Associated Risk in Patients Who Presented an Acute Coronary Syndrome",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Cardio Med Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041344.012174",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "L-RECORD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Left Radial comparEd to Femoral Approach for CORonary Angiography in Patients With Previous CABG StuDy",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-11T042351.548576",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-31",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393052",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Left Radial comparEd to Femoral Approach for CORonary Angiography in Patients With Previous CABG StuDy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital of Patras",
    "start_date": "2017-01-20",
    "start_date_type": "Actual",
    "start_month_year": "January 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042351.548576",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "CCFRRBA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CART-19 Cells For RR B-ALL",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041346.597995",
    "enrollment": 20,
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391739",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "CART-19 Cells For Patients With RelapsedRefractory B-cell Acute Lymphoblastic Leukemia",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Fujian Medical University",
    "start_date": "2016-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041346.597995",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Incidence of Anesthesia-related Adverse Events and Obstetric Complications After Cesarean Delivery",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-09T041348.089412",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391648",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Incidence of Anesthesia-related Adverse Events and Obstetric Complications After Cesarean Delivery a Retrospective Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Far Eastern Memorial Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041348.089412",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Characterization and Treatment of Adolescent Depression",
    "completion_date": "2020-08-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 20 2020",
    "created_at": "2018-01-07T041905.585786",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388606",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Characterization and Treatment of Adolescent Depression",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 20 2020",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2017-12-28",
    "start_date_type": "Actual",
    "start_month_year": "December 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041905.585786",
    "verification_date": "2017-12-19",
    "verification_month_year": "December 19 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "FAECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF MORBID OBESITY",
    "completion_date": "2020-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2020",
    "created_at": "2018-01-09T041345.433860",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391817",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "FAECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF MORBID OBESITY",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2020",
    "received_results_disposit_date": "",
    "source": "Joint Authority for Pijt-Hme Social and Health Care",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041345.433860",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2018-01-11T042405.359216",
    "enrollment": 452,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391830",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042405.359216",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PBMT for the Prevention of CIPN",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-09T041353.620662",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391271",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Use of Photobiomodulation Therapy for the Prevention of Chemotherapy-induced Peripheral Neuropathy a Pilot Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2018",
    "received_results_disposit_date": "",
    "source": "Hasselt University",
    "start_date": "2017-11-13",
    "start_date_type": "Actual",
    "start_month_year": "November 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041353.620662",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy",
    "completion_date": "2018-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2018",
    "created_at": "2018-01-09T041350.031984",
    "enrollment": 18,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391518",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy in Patients With Normal Tension Glaucoma and Healthy Individuals.",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-04",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 4 2017",
    "received_results_disposit_date": "",
    "source": "Augenabteilung Allgemeines Krankenhaus Linz",
    "start_date": "2017-02-05",
    "start_date_type": "Actual",
    "start_month_year": "February 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041350.031984",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Challenge Infection of Healthy Adult Volunteers With RSV A2",
    "completion_date": "2020-11-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 15 2020",
    "created_at": "2018-01-11T042412.019252",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388645",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Challenge Infection of Healthy Adult Volunteers With RSV A2",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 15 2019",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042412.019252",
    "verification_date": "2017-12-22",
    "verification_month_year": "December 22 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Highly Conformal Hypofractionated Focally Dose Escalated Post-Prostatectomy Radiotherapy",
    "completion_date": "2021-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2021",
    "created_at": "2018-01-11T042412.505314",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388619",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Highly Conformal Hypofractionated Focally Dose Escalated Post-Prostatectomy Radiotherapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 1 2021",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042412.505314",
    "verification_date": "2017-12-07",
    "verification_month_year": "December 7 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CCFRRBL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CART-19 Cells for RR B-cell Lymphoma",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-09T041346.782005",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391726",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "CART-19 Cells For Patients With Relapsed or Refractory B-cell Lymphoma",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Fujian Medical University",
    "start_date": "2016-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041346.782005",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ATGPTCy",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT",
    "completion_date": "2018-12-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 20 2018",
    "created_at": "2018-01-11T042308.211883",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395860",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Low Dose Rabbit Antithymocyte Globulin Plus Low-dose Post-transplantation Cyclophosphamide as GVHD in Hapl-HSCT for Patients With Hematologic Malignancies a Phase II Trial",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 20 2018",
    "received_results_disposit_date": "",
    "source": "Shanghai General Hospital Shanghai Jiao Tong University School of Medicine",
    "start_date": "2017-05-30",
    "start_date_type": "Actual",
    "start_month_year": "May 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042308.211883",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers",
    "completion_date": "2019-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2019",
    "created_at": "2018-01-11T042412.263060",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388632",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Phase I Study of Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 1 2019",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042412.263060",
    "verification_date": "2017-12-21",
    "verification_month_year": "December 21 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Shortened Prolonged Exposure Therapy for Chronic PTSD in Taiwanese Adults",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2018-01-11T042406.706896",
    "enrollment": 8,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-30",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391297",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Shortened Prolonged Exposure Therapy for Chronic PTSD A Systematic Case Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Chang Gung University",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042406.706896",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison Study of Sleeve Gastrectomy Versus MGB and SASI Bypass  Retrospective Study",
    "completion_date": "2017-12-02",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2 2017",
    "created_at": "2018-01-11T042333.507843",
    "enrollment": 800,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394157",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Efficacy of Sleeve Gastrectomy  MGB  SASI Bypass in Type 2 Diabetes Obese Patients  Comparative Retrospective Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 1 2017",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2011-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2011",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042333.507843",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Physiological Predictors of Clinical Outcomes After Anti-reflux Surgery",
    "completion_date": "2018-09-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 15 2018",
    "created_at": "2018-01-11T042409.176577",
    "enrollment": 350,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390634",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Oesophageal Manometry and Ambulatory Reflux Monitoring Predictors of Clinical Outcomes After Anti-reflux Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 15 2018",
    "received_results_disposit_date": "",
    "source": "Guys and St Thomas NHS Foundation Trust",
    "start_date": "2018-03-15",
    "start_date_type": "Anticipated",
    "start_month_year": "March 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042409.176577",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hybrid APC Assisted EMR for Large Colon Polyps",
    "completion_date": "2020-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2020",
    "created_at": "2018-01-09T041359.534730",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390907",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Hybrid APC Assisted EMR for Large Colon Polyps to Reduce Local Recurrence  a Pilot Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2019",
    "received_results_disposit_date": "",
    "source": "Milton S. Hershey Medical Center",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041359.534730",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "SMARTCOUGH-C-2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Diagnosing Respiratory Disease in Children Using Cough Sounds 2",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-09T041336.912898",
    "enrollment": 1667,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392363",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds 2",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "ResApp Health Limited",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041336.912898",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes",
    "completion_date": "2015-11-20",
    "completion_date_type": "Actual",
    "completion_month_year": "November 20 2015",
    "created_at": "2018-01-09T041337.091159",
    "enrollment": 267,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392350",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-09-15",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 15 2015",
    "received_results_disposit_date": "",
    "source": "Reengineering Healthcare Inc.",
    "start_date": "2012-06-15",
    "start_date_type": "Actual",
    "start_month_year": "June 15 2012",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041337.091159",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MINDGAIT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Promoting Independent Living in Frail Older Adults by Improving Cognition and Gait Ability and Using Assistive Products",
    "completion_date": "2018-10-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 22 2018",
    "created_at": "2018-01-09T041401.101262",
    "enrollment": 62,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390478",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "MINDGAIT - Promoting Independent Living in Frail Older Adults by Improving Cognition and Gait Ability and Using Assistive Products",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-23",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 23 2018",
    "received_results_disposit_date": "",
    "source": "Escola Superior de Enfermagem de Coimbra",
    "start_date": "2018-04-23",
    "start_date_type": "Anticipated",
    "start_month_year": "April 23 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041401.101262",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Drug Interaction Study of FimasartanAmlodipineHydrochlorothiazide in Healthy Male Subjects",
    "completion_date": "2018-01-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 30 2018",
    "created_at": "2018-01-08T041349.836414",
    "enrollment": 36,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390465",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "An Open-label Randomized Single Dose 6-Sequence 3-Period Cross-over Study to Evaluate a Drug Interaction Between Fixed-dose Combination of FimasartanAmlodipine and Hydrochlorothiazide in Healthy Male Subjects",
    "overall_status": "Active not recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-16",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 16 2018",
    "received_results_disposit_date": "",
    "source": "Boryung Pharmaceutical Co. Ltd",
    "start_date": "2017-12-15",
    "start_date_type": "Actual",
    "start_month_year": "December 15 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041349.836414",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ALLELE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ATA129 for Solid Organ Transplant Subjects With EBV-PTLD After Failure of Rituximab or Rituximab and Chemotherapy",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2020",
    "created_at": "2018-01-11T042330.224979",
    "enrollment": 66,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394365",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Multicenter Open Label Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy ALLELE Study",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2020",
    "received_results_disposit_date": "",
    "source": "Atara Biotherapeutics",
    "start_date": "2017-12-29",
    "start_date_type": "Actual",
    "start_month_year": "December 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042330.224979",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Long-Term Follow-up Study",
    "completion_date": "2048-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2048",
    "created_at": "2018-01-08T041341.297364",
    "enrollment": 8000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390894",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2047-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2047",
    "received_results_disposit_date": "",
    "source": "Spanish Breast Cancer Research Group",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041341.297364",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PRIMA-FS-US",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PRIMA US-Feasibility Study in Atrophic Dry AMD",
    "completion_date": "2022-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2022",
    "created_at": "2018-01-09T041337.428250",
    "enrollment": 5,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392324",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2020",
    "received_results_disposit_date": "",
    "source": "Pixium Vision SA",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041337.428250",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of a Web-based Training Programme Focusing on Challenging Behaviour",
    "completion_date": "2018-11-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 15 2018",
    "created_at": "2018-01-08T041341.825121",
    "enrollment": 221,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390868",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects of a Web-based Training Programme for Professional Carers Working With People With Learning Disabilities Who Exhibit Challenging Behaviour",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 15 2018",
    "received_results_disposit_date": "",
    "source": "Ume University",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041341.825121",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of the Inspiratory Muscle Training on Respiratory Parameters and Functional Capacity in Idiopathic Scoliosis",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042404.902196",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391895",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of the Inspiratory Muscle Training on Respiratory Muscle Strength Respiratory Function and Functional Capacity in Adolescents With Idiopathic Scoliosis",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Bezmialem Vakif University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042404.902196",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tailored Written Lifestyle Feedback in Colorectal Cancer Screening",
    "completion_date": "2018-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2018",
    "created_at": "2018-01-11T042306.028618",
    "enrollment": 3642,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396029",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Randomized Trial of Tailored Written Lifestyle Feedback in Colorectal Cancer Screening",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-10-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 30 2016",
    "received_results_disposit_date": "",
    "source": "Oslo University Hospital",
    "start_date": "2014-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042306.028618",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Uric Acid Effects on Endothelium and Oxydative Stress",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-11T042306.606019",
    "enrollment": 42,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395977",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Differential Effects of Uric Acid and Xanthine Oxidoreductase on Endothelial Function and Oxydative Stress",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Fonds National de la Recherche Scientifique",
    "start_date": "2018-01-03",
    "start_date_type": "Actual",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042306.606019",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Accuracy of Intraocular Lens Power in High Myopia",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2019",
    "created_at": "2018-01-11T042331.226857",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394300",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Accuracy of Intraocular Lens Power in High Myopia",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2018-01-11T042331.226857",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Chewing Efficiency of Conventional Complete Denture in Comparison to Reinforced Poly Amide Denture",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-09T041357.301034",
    "enrollment": 38,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391063",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation Of Chewing Efficiency Of Metal-Reinforced PolyAmide Denture Base In Comparison To Conventional Heat Cured Acrylic Resin Denture Base For Mandibular Complete Denture A Randomized Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041357.301034",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Proton Beam Radiation Therapy in Treating Patients With Breast Cancer After Surgery",
    "completion_date": "2022-05-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 15 2022",
    "created_at": "2018-01-08T041332.430297",
    "enrollment": 82,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391453",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-05-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 15 2022",
    "received_results_disposit_date": "",
    "source": "Mayo Clinic",
    "start_date": "2016-05-10",
    "start_date_type": "Actual",
    "start_month_year": "May 10 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041332.430297",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "AGE-ZT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Preventive Arterial Wall Phenotype and Low-dose FluvastatinValsartan Combination",
    "completion_date": "2017-06-01",
    "completion_date_type": "Actual",
    "completion_month_year": "June 2017",
    "created_at": "2018-01-11T042346.155071",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393377",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Preventive Arterial Wall Phenotype in Subjects at Moderate Cardiovascular Risk Induced by Very Low-dose FluvastatinValsartan Combination a Pilot Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-06-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 2015",
    "received_results_disposit_date": "",
    "source": "University Medical Centre Ljubljana",
    "start_date": "2014-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042346.155071",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Analgesic Effect of TAP Block After Laparoscopic Cholecystectomy",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-09T041349.829053",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391531",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Placebo-controlled Randomized Double-blind Trial of Transversus Abdominis Plane Block on Pain After Laparoscopic Cholecystectomy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital of Liege",
    "start_date": "2017-12-27",
    "start_date_type": "Actual",
    "start_month_year": "December 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041349.829053",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Open-Label Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2018-01-09T041337.259565",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392337",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open-Label Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "Psoriasis Treatment Center of Central New Jersey",
    "start_date": "2017-11-07",
    "start_date_type": "Actual",
    "start_month_year": "November 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041337.259565",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "FB4 Framingham Boston Bloomington Birmingham and Baylor",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2018-01-11T042325.372570",
    "enrollment": 125,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394664",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Macronutrients and Body Fat Accumulation A Mechanistic Feeding Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2021",
    "received_results_disposit_date": "",
    "source": "Boston Childrens Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042325.372570",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-09T041339.946321",
    "enrollment": 92,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392168",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Phase 12a Single Dose and 28-day Parallel Group Double Blind Vehicle-Controlled Study of the Safety Pharmacokinetics and Efficacy of ARQ-151 Cream 0.5 and 0.15 in Adults With Mild to Moderate Chronic Plaque Psoriasis",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Arcutis Inc.",
    "start_date": "2017-12-11",
    "start_date_type": "Actual",
    "start_month_year": "December 11 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041339.946321",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "3D-CRT Proton or Brachytherapy APBI in Treating Patients With Invasive and Non-invasive Breast Cancer",
    "completion_date": "2020-06-08",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 8 2020",
    "created_at": "2018-01-09T041351.835776",
    "enrollment": 168,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391388",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase II Study of Accelerated 3 Fraction Photon and Proton Partial Breast External Beam Radiotherapy and Partial Breast Brachytherapy for Early Invasive and Noninvasive Breast Cancer",
    "overall_status": "Active not recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-08",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 8 2020",
    "received_results_disposit_date": "",
    "source": "Mayo Clinic",
    "start_date": "2015-06-16",
    "start_date_type": "Actual",
    "start_month_year": "June 16 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041351.835776",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MATCH",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ATA129 for Allogeneic Hematopoietic Cell Transplant Subjects With EBV-PTLD After Failure of Rituximab",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2020",
    "created_at": "2018-01-09T041340.645510",
    "enrollment": 33,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392142",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Multicenter Open-Label Phase 3 Trial of ATA129 for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab MATCH Study",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2020",
    "received_results_disposit_date": "",
    "source": "Atara Biotherapeutics",
    "start_date": "2017-12-29",
    "start_date_type": "Actual",
    "start_month_year": "December 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041340.645510",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy",
    "completion_date": "2022-02-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2 2022",
    "created_at": "2018-01-11T042404.056796",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-29",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391479",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 2 Multi-centre Open-label Study of Avelumab MSB0010718C in Locally Advanced or Metastatic Penile Cancer Patients Unfit for Platinum-based Chemotherapy or Progressed On or After Platinum-based Chemotherapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2021",
    "received_results_disposit_date": "",
    "source": "University Health Network Toronto",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042404.056796",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "OCT Angiography in Vitreo and Chorioretinal Pathologies",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-08T041354.021206",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390205",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Optical Coherence Tomography Angiography in Vitreo and Chorioretinal Pathologies Under the Influence of Dark and Light Adaptation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "CRG UZ Brussel",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041354.021206",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "WIC breastfeed",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trends in Breastfeeding Disparity in U.S. Infants by WIC Eligibility and Participation",
    "completion_date": "2014-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2014",
    "created_at": "2018-01-08T041345.658505",
    "enrollment": 13771,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390660",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Trends in Breastfeeding Disparity in U.S. Infants by WIC Eligibility and Participation Evidence From NHANES 1999-2014",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2014",
    "received_results_disposit_date": "",
    "source": "Old Dominion University",
    "start_date": "1999-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 1999",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041345.658505",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ai Chi Method for Children With Asthma",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-09T041340.838015",
    "enrollment": 42,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392129",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Ai Chi Method for Children With Asthma A Single-blinded Randomized Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Federal do Rio Grande do Norte",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041340.838015",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pain Management in Outpatient Urologic Procedures",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2018-01-11T042346.381339",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393364",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pain Management in Outpatient Urologic Procedures",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "University Hospitals Cleveland Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042346.381339",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Rein4CeTo1",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hernia After Colorectal Cancer Surgery an RCT Comparing 41-technique With or Without a Reinforced Tension Line Suture",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2022",
    "created_at": "2018-01-08T041343.307800",
    "enrollment": 338,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390764",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Rein4CeTo1 Incisional Hernia After Colorectal Cancer Surgery - a Randomized Controlled Multicentre Trial Comparing Small Stitch 41-technique With Respectively Without a Reinforced Tension-line Suture for Abdominal Closure",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "Skane University Hospital",
    "start_date": "2017-10-16",
    "start_date_type": "Actual",
    "start_month_year": "October 16 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041343.307800",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MyoMass",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2018-01-11T042338.014059",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393871",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Myocardial Mass Determination of the Different Coronary Territories by FFRct and Invasive Measurement of Absolute Coronary Blood Flow. A Clinical Registry",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Catharina Ziekenhuis Eindhoven",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042338.014059",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Risk-score Based ICU Triage",
    "completion_date": "2018-08-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 14 2018",
    "created_at": "2018-01-08T041353.035577",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390270",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Rational Coronary Care Unit Triage for Stable Patients With NSTEMI Evaluating the Safety and Costs of a Risk Score-based Triaging System",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-14",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 14 2018",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-02-14",
    "start_date_type": "Anticipated",
    "start_month_year": "February 14 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041353.035577",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DexGlySurg",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hyperglycemic Response and Steroid Administration After Surgery DexGlySurgery",
    "completion_date": "2018-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2018",
    "created_at": "2018-01-08T041354.978520",
    "enrollment": 250,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390179",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Hyperglycemic Response to Steroid Administration After Noncardiac Surgery in Patients With and Without Diabetes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2018",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Nmes",
    "start_date": "2017-11-26",
    "start_date_type": "Actual",
    "start_month_year": "November 26 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "2 Months",
    "updated_at": "2018-01-08T041354.978520",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "STARTA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria",
    "completion_date": "2019-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2019",
    "created_at": "2018-01-11T042329.823858",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394391",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Single-blind Randomized Parallel Design Study to Assess the Effectiveness of SMS Reminders in Improving ART Adherence Among Adolescents Living With HIV in Nigeria STARTA Trial-Adolescents",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2019",
    "received_results_disposit_date": "",
    "source": "Babcock University",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042329.823858",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-08T041356.117265",
    "enrollment": 32,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390114",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Internet-Based Cognitive Behavioral Therapy to Treat Insomnia in HIV A Pilot Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Indiana University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041356.117265",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-11T042321.660173",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394911",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Nicholson Science Pheromone Trial at Tampa General Hospital Emergency Room",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Nicholson Science",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042321.660173",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Long-term Safety Extension to Study TRCA-301",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-08T041342.185439",
    "enrollment": 210,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390842",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Blinded Placebo-Controlled Extension to Study TRCA-301 to Evaluate the Long-term Safety and Durability of Effect of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "Tricida Inc.",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041342.185439",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Safety Tolerability and Pharmacokinetics in Healthy Adult Male Participants",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-08T041345.824369",
    "enrollment": 44,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390647",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 1 Clinical Study of E6130 - Clinical Pharmacology Study in Healthy Adult Male Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2019",
    "received_results_disposit_date": "",
    "source": "Eisai Inc.",
    "start_date": "2017-12-21",
    "start_date_type": "Actual",
    "start_month_year": "December 21 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041345.824369",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Negative Affect in Individuals With Binge Eating Episodes",
    "completion_date": "2022-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2022",
    "created_at": "2018-01-11T042351.768579",
    "enrollment": 410,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393039",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Neural Effects of Negative Affect on Food Choices and Reward In Individuals With Binge Eating Episodes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-10-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 31 2022",
    "received_results_disposit_date": "",
    "source": "University of Colorado Denver",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042351.768579",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042326.836831",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394586",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Zurich",
    "start_date": "2018-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2018-01-11T042326.836831",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Femto-PG",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Changes in Prostaglandin Levels in Laser Cataract Surgery LCS Subject to Laser Prevalence",
    "completion_date": "2018-03-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2 2018",
    "created_at": "2018-01-09T041401.327472",
    "enrollment": 70,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390400",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intraindividual Comparison of Prostaglandin E2 PGE2 and Total-prostaglandin PG Following Femtosecond Laser-assisted Cataract Surgery Using a Low-energy High-frequency Femtosecond Laser-Device in Regard to the Sequence of Anterior Capsulotomy and Lens Fragmentation",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 9 2018",
    "received_results_disposit_date": "",
    "source": "Medical University of Vienna",
    "start_date": "2017-05-29",
    "start_date_type": "Actual",
    "start_month_year": "May 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041401.327472",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PrmaSoin",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Which Needs for Premature New-born Babies Parents Facing Environmental and Social Difficulties",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-11T042329.044298",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394443",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Which Needs for Premature New-born Babies Parents Facing Environmental and Social Difficulties  A Qualitative Study in Besancon University Hospital.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Besancon",
    "start_date": "2017-12-28",
    "start_date_type": "Actual",
    "start_month_year": "December 28 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042329.044298",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Perioperative Anaphylaxis in Egyptian Population.",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2018-01-11T042350.918100",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393091",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Perioperative Anaphylaxis in Egypt In Assiut University Hospitals.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042350.918100",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Blood sample for measurement of serum P3NP concentration.",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Circulating P3NP and Cardiovascular Events in Hemodialysis Patients",
    "completion_date": "2005-01-31",
    "completion_date_type": "Actual",
    "completion_month_year": "January 31 2005",
    "created_at": "2018-01-11T042407.384208",
    "enrollment": 244,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391128",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Involvement of Circulating Aminoterminal Propeptide of Type 3 Procollagen in Cardiovascular Events in Patients on Hemodialysis",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2005-01-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 31 2005",
    "received_results_disposit_date": "",
    "source": "Toujinkai Hospital",
    "start_date": "2005-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2005",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042407.384208",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor",
    "completion_date": "2018-01-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 30 2018",
    "created_at": "2018-01-11T042309.875012",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395730",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Intraumbilical Oxytocin Compared to Placental Cord Drainage in the Management of Third Stage of Labor A Randomized Controlled Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2017-09-30",
    "start_date_type": "Actual",
    "start_month_year": "September 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042309.875012",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pain Control in Children and Adolescent After Thoracic Surgery The Effect of Gabapentin",
    "completion_date": "2020-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2020",
    "created_at": "2018-01-11T042340.863746",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393702",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of Gabapentin as Adjuvant for Postoperative Pain in Pediatric Thoracic Surgery - a Randomized Triple Blind Study",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2019",
    "received_results_disposit_date": "",
    "source": "National Institute for Tuberculosis and Lung Diseases Poland",
    "start_date": "2017-05-09",
    "start_date_type": "Actual",
    "start_month_year": "May 9 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042340.863746",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ACEX",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Use of Breath Acetone aa a Marker of Energy Balance",
    "completion_date": "2017-06-01",
    "completion_date_type": "Actual",
    "completion_month_year": "June 2017",
    "created_at": "2018-01-08T041341.482479",
    "enrollment": 8,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390881",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Assessment of the Validity of Breath Acetone Concentration as a Bio-marker of Instantaneous Energy Balance in Healthy Subjects",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 2017",
    "received_results_disposit_date": "",
    "source": "University of Lausanne",
    "start_date": "2016-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041341.482479",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-11T042336.556083",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393962",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Interventional Treatment of Ovarian Cancer With Cancer Antigen-specific Engineered Immune Effector T Lymphocytes OC-EIEs",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Shenzhen Geno-Immune Medical Institute",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042336.556083",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Decompression Tables for Diving at Altitude",
    "completion_date": "2020-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2020",
    "created_at": "2018-01-08T041352.008610",
    "enrollment": 72,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390335",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Development of Decompression Tables for Diving at Altitude",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2020",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041352.008610",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Misoprostol Versus Active Management of Labour in CS",
    "completion_date": "2018-03-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 6 2018",
    "created_at": "2018-01-08T041357.718633",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390010",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intrauterine Misoprostol With Active Management of Labour Versus Active Management of Labour for Prevebtion of Postpartum Hemorage in Cesarean Section Randomized Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 27 2018",
    "received_results_disposit_date": "",
    "source": "Aljazeera Hospital",
    "start_date": "2017-10-05",
    "start_date_type": "Actual",
    "start_month_year": "October 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041357.718633",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nutraceutical Efficacy for rUTI",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042315.782290",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395288",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Randomized Controlled Trial to Determine the Efficacy of Nutraceutical vs Control as Non-antibiotic Prophylaxis for Recurrent Urinary Tract Infection in Postmenopausal Women Using Vaginal Estrogen Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Washington University School of Medicine",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042315.782290",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Repetitive Transcranial Magnetic Stimulation rTMS Treatment for Obsessive Compulsive Disease",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-11T042351.117906",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393078",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Study of Brain Network Mechanism for Individualized Accurate Target Positioning rTMS Treatment on Obsessive Compulsive Disorder",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Anhui Medical University",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042351.117906",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Avelumab With Decitabine as First Line for AML Treatment of Patients With AML Who Are Unfit for Intensive Chemotherapy",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-11T042308.048268",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395873",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase I Study of Avelumab in Combination With Decitabine as First Line Treatment of Patients With AML Who Are Unfit for Intensive Chemotherapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Milton S. Hershey Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042308.048268",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial to Demonstrate the Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab Avastin in Healthy Male Subjects",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-08T041345.472034",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390673",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase I Double-blind Randomised Single-dose Parallel Group Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD204 and Bevacizumab Avastin in Healthy Male Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Prestige Biopharma Pte Ltd",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041345.472034",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SPROUTvsFAT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of the Consumption of Broccoli Sprouts in Overweight Subjects",
    "completion_date": "2017-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 2017",
    "created_at": "2018-01-08T041342.005122",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390855",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Effects of the Consumption of Broccoli Sprouts in Overweight Subjects",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 2016",
    "received_results_disposit_date": "",
    "source": "Universidad Catlica San Antonio de Murcia",
    "start_date": "2015-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041342.005122",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Release of Proinflammatory Cytokines IL-1 IL-6 and Total-prostaglandin PG Following Femtosecond Laser-assisted Cataract Surgery Compared to Manual Cataract Surgery",
    "completion_date": "2016-11-25",
    "completion_date_type": "Actual",
    "completion_month_year": "November 25 2016",
    "created_at": "2018-01-09T041401.531996",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390361",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intraindividual Comparison of Proinflammatory Cytokines IL-1 IL-6 and Total-prostaglandin PG Following Femtosecond Laser-assisted Cataract Surgery Using a Low-energy High-frequency Femtosecond Laser-Device Compared to Manual Cataract Surgery",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-08-09",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 9 2016",
    "received_results_disposit_date": "",
    "source": "Medical University of Vienna",
    "start_date": "2016-04-05",
    "start_date_type": "Actual",
    "start_month_year": "April 5 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041401.531996",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pfizer Immunotherapy Combinations for Acute Myeloid Leukemia AML Multi-Arm Study 1",
    "completion_date": "2023-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2023",
    "created_at": "2018-01-08T041352.592557",
    "enrollment": 138,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390296",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 8,
    "number_of_groups": "",
    "official_title": "An Open-label Phase IBII Multi-Arm Study of OX40 Agonist Monoclonal Antibody mAb Anti-41BB mAb Anti-PDL1 mAb Smoothened Inhibitor Anti-CD33 mAb and Azacitidine as Single-Agents andor Combinations for the Treatment of Patients With Acute Myeloid Leukemia AML",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2023",
    "received_results_disposit_date": "",
    "source": "M.D. Anderson Cancer Center",
    "start_date": "2017-12-27",
    "start_date_type": "Actual",
    "start_month_year": "December 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041352.592557",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer",
    "completion_date": "2023-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2023",
    "created_at": "2018-01-11T042304.170153",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396185",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Icotinib as Consolidation Therapy After Synchronous or Sequential Chemoradiotherapy in Stage IIIA-IIIB Non-small Cell Lung Cancer With EGFR Sensitive Mutation A Single Center Single Arm Open Label and Prospective Clinical Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2022",
    "received_results_disposit_date": "",
    "source": "Betta Pharmaceuticals Co.Ltd.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042304.170153",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Survey of ParentCaregiver Practices on the Storage Use and Disposal of Opioids in a Comprehensive Cancer Center",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-08T041352.833775",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390283",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "A Survey of ParentCaregiver Practices on the Storage Use and Disposal of Opioids in a Comprehensive Cancer Center",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "M.D. Anderson Cancer Center",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041352.833775",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-08T041344.842155",
    "enrollment": 328,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390712",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Mirror-image Study Exploring Relapse and Resource Utilization of Paliperidone Palmitate and Risperidone Long-acting Injection in Vitalit Health Network Patients",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "Rseau de Sant Vitalit Health Network",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041344.842155",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial to Compare the Efficacy Safety Pharmacokinetics and Immunogenecity of HD204 to Avastin in Advanced Non-squamous Non-small Cell Lung Cancer Patients",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-08T041345.284957",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390686",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomised Double-blind Parallel Group Equivalence Multicentre Phase III Trial to Compare the Efficacy Safety Pharmacokinetics and Immunogenicity of HD204 to Avastin in Patients With Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Prestige Biopharma Pte Ltd",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041345.284957",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Cingal17-02",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-08T041357.321672",
    "enrollment": 576,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390036",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Extension Study to Cingal 16-02 Trial Extension to 39 Week Follow Up in the Randomized Double-Blind Active Comparator Controlled Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide Cingal to Provide Symptomatic Relief of Osteoarthritis of the Knee",
    "overall_status": "Enrolling by invitation",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Anika Therapeutics Inc.",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041357.321672",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Microbial Profile Among Patients Before and After Partial Maxillectomy",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-08T041345.073880",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390699",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Microbial Profile Among Patients Before and After Partial Maxillectomy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "Rambam Health Care Campus",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041345.073880",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 1 2018",
    "created_at": "2018-01-08T041350.448268",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390426",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 1 2018",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041350.448268",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of Proprioceptive Training on Plantar Pressure Balance Posture and Gait in Individuals With Diabetes Mellitus Type 2",
    "completion_date": "2018-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2018",
    "created_at": "2018-01-09T041358.930583",
    "enrollment": 14,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390959",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of Proprioceptive Training on Plantar Pressure Postural Balance Posture and Gait in Individuals With Diabetes Mellitus Type 2",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Federal de Pernambuco",
    "start_date": "2017-05-10",
    "start_date_type": "Actual",
    "start_month_year": "May 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041358.930583",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "BCD-085-7",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An International Multicenter Randomized Double-blind Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 JSC BIOCAD Russia in Patients With Moderate to Severe Plaque Psoriasis",
    "completion_date": "2019-07-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 20 2019",
    "created_at": "2018-01-08T041356.321533",
    "enrollment": 213,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390101",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An International Multicenter Randomized Double-blind Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 JSC BIOCAD Russia in Patients With Moderate to Severe Plaque Psoriasis",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 20 2018",
    "received_results_disposit_date": "",
    "source": "Biocad",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041356.321533",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NutriAgeCancer",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nutritional Status Assessment in the Elderly Suffering From Cancer  a National Cross-UCOG Survey",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-08T041342.565498",
    "enrollment": 1886,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-28",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390816",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Nutritional Status Assessment in the Elderly Suffering From Cancer NutriAgeCancer  a National Cross-UCOG Survey",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-14",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 14 2017",
    "received_results_disposit_date": "",
    "source": "Socit Francophone dOnco-Griatrie",
    "start_date": "2017-11-02",
    "start_date_type": "Actual",
    "start_month_year": "November 2 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041342.565498",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice",
    "completion_date": "2021-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2021",
    "created_at": "2018-01-08T041406.941013",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389529",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Study on the Relationship Between the Change of Cholesterol Efflux Capacity and the Prognosis of Coronary Artery Disease in Real Clinical Practice",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "Luan Municipal Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041406.941013",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Back on Track",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PCORI-1609-36568 A Naturalistic Experiment to Evaluate the Impact of Changes to Oregon Medicaid Treatment Reimbursement for Back Pain on Opioid Prescribing and Patient Outcomes",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2018-01-11T042350.031842",
    "enrollment": 4425,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393143",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "A Naturalistic Experiment Evaluating the Impact of Medicaid Treatment Reimbursement Changes on Opioid Prescribing and Patient Outcomes Among Patients With Back Pain",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "Kaiser Permanente",
    "start_date": "2018-03-31",
    "start_date_type": "Anticipated",
    "start_month_year": "March 31 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042350.031842",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2018-01-08T041359.149009",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389919",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "EFFECTIVENESS AND SAFETY OF INTRAOSSEOUS ADMINISTRATION OF MESENCHYMAL STORMAL CELLS FOR PRIMARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "National Research Center for Hematology Russia",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041359.149009",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Healing Nipple Wounds Comparison Between 2 Treatment Modalities",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-07T041849.301581",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389516",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Healing Nipple Wounds Comparison Between 2 Treatment Modalities Lanolin Ointmentnad Nursicare Therapeutic Breast Pads Among Postpartum Mothers Dealing With Sore Nipples",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Laniado Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041849.301581",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma",
    "completion_date": "2021-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2021",
    "created_at": "2018-01-07T041854.011950",
    "enrollment": 81,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389230",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Phase I Study of Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a HER2-Specific Hinge-optimized 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Patients With RecurrentRefractory Malignant Glioma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2021",
    "received_results_disposit_date": "",
    "source": "City of Hope Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041854.011950",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-07T041850.563003",
    "enrollment": 56,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389438",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Single-center Randomized Controlled Trial of Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma Treated With First-line Gemcitabine Plus Cisplatin",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Beijing Huanxing Cancer Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041850.563003",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Dupilumab Anti-IL4R on the Host-Microbe Interface in Atopic Dermatitis",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041402.536826",
    "enrollment": 99,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389893",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Dupilumab Anti-IL4R on the Host-Microbe Interface in Atopic Dermatitis Dupilumab Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-02-12",
    "start_date_type": "Anticipated",
    "start_month_year": "February 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041402.536826",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC",
    "completion_date": "2019-08-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 30 2019",
    "created_at": "2018-01-07T041851.289857",
    "enrollment": 43,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389399",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Pulmonary Physiology and Systemic Inflammatory Signature Investigations in Early Onset Pulmonary Events Associated With Brigatinib Use in Non-Small Cell Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 30 2019",
    "received_results_disposit_date": "",
    "source": "University of Colorado Denver",
    "start_date": "2018-01-30",
    "start_date_type": "Anticipated",
    "start_month_year": "January 30 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041851.289857",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PMSPIVRS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Paracetamol and Metamizole With SPI-guided Anaesthesia for VRS",
    "completion_date": "2020-01-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 10 2020",
    "created_at": "2018-01-07T041853.802969",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389243",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Influence of SPI-guided Analgesia With Preemptive Analgesia Using Either Paracetamol or Metamizole on the Presence of Oculocardiac Reflex Postoperative Pain Postoperative Nausea and Vomiting in Patients Undergoing VRS Under General Anaesthesia a Randomised Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-10",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 10 2020",
    "received_results_disposit_date": "",
    "source": "Medical University of Silesia",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041853.802969",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-11T042400.111002",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392558",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Burts Bees Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042400.111002",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "COMPARE-Rad",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Left and Right Transradial Approach for CAG and PCI",
    "completion_date": "2017-09-07",
    "completion_date_type": "Actual",
    "completion_month_year": "September 7 2017",
    "created_at": "2018-01-07T041849.512087",
    "enrollment": 322,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389503",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison Between Left and Right Transradial Approach During Coronary Angiography and Percutaneous Coronary Intervention",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-07",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 7 2017",
    "received_results_disposit_date": "",
    "source": "Wonju Severance Christian Hospital",
    "start_date": "2017-03-08",
    "start_date_type": "Actual",
    "start_month_year": "March 8 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041849.512087",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Whole-body Vibration Exercise in Brain Injury Patients With Minimally Conscious State",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-08T041408.037438",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389113",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects of Whole-body Vibration Exercise on Cortical Activity and Consciousness Level in Brain Injury Patients With Minimally Conscious State Pilot Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2017-01-02",
    "start_date_type": "Actual",
    "start_month_year": "January 2 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041408.037438",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DRYCHILD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.",
    "completion_date": "2021-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2021",
    "created_at": "2018-01-07T041851.073897",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389412",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "The Effect of Clinical Characterization of Children With Monosymptomatic Nocturnal Enuresis on the Efficacy of Desmopressin and Alarm Therapy.",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 1 2021",
    "received_results_disposit_date": "",
    "source": "University of Aarhus",
    "start_date": "2017-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041851.073897",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser",
    "completion_date": "2018-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2018",
    "created_at": "2018-01-08T041350.235205",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390439",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser a Randomized Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2 2018",
    "received_results_disposit_date": "",
    "source": "Hospital de Clinicas de Porto Alegre",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041350.235205",
    "verification_date": "2017-06-01",
    "verification_month_year": "June 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics",
    "completion_date": "2018-02-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2 2018",
    "created_at": "2018-01-11T042411.760037",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389321",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-center Open-label One-sequence Two-treatment Study to Investigate the Effect of Macitentan at Steady State on the Pharmacokinetics of Riociguat in Healthy Male Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2 2018",
    "received_results_disposit_date": "",
    "source": "Actelion",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042411.760037",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Home Care for the Patient With Heart Failure Can Caregiver Education Prevent Hospital Admissions",
    "completion_date": "2016-04-10",
    "completion_date_type": "Actual",
    "completion_month_year": "April 10 2016",
    "created_at": "2018-01-09T041359.334715",
    "enrollment": 434,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389841",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Home Care for the Patient With Heart Failure Can Caregiver Education Prevent Hospital Admissions A Clinical Randomized Trial.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-04-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "April 10 2016",
    "received_results_disposit_date": "",
    "source": "Italian College of General Practitioners",
    "start_date": "2013-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041359.334715",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Los Tres Paso Neoadjuvant Palbociclib Monotherapy Concurrent Chemoradiation Therapy Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative HPV-Unrelated Head and Neck Squamous Cell Carcinoma",
    "completion_date": "2026-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2026",
    "created_at": "2018-01-07T041849.920261",
    "enrollment": 29,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389477",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Los Tres Paso Trial Step One - Neoadjuvant Palbociclib Monotherapy Step Two - Concurrent Chemoradiation Therapy and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative HPV-Unrelated Head and Neck Squamous Cell Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "Washington University School of Medicine",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041849.920261",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EKSOGAIT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stroke Rehabilitation With Exoskeleton-assisted Gait.",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-11T042310.051712",
    "enrollment": 162,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395717",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Stroke Rehabilitation With Exoskeleton-assisted Gait Clinical and Neuromuscular Outcomes.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 11 2018",
    "received_results_disposit_date": "",
    "source": "IRCCS San Raffaele",
    "start_date": "2016-01-11",
    "start_date_type": "Actual",
    "start_month_year": "January 11 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.051712",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Perfusion of Colorectal Anastomosis Using Fluorescence Angiography",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-08T041349.089089",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390517",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Study of Perfusion of Colorectal Anastomosis Using Fluorescence Angiography",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 31 2019",
    "received_results_disposit_date": "",
    "source": "State Scientific Centre of Coloproctology Russian Federation",
    "start_date": "2017-11-09",
    "start_date_type": "Actual",
    "start_month_year": "November 9 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041349.089089",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation",
    "completion_date": "2020-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2020",
    "created_at": "2018-01-11T042306.167271",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396016",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "University Health Network Toronto",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042306.167271",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluate Marginal B. Loss in Immediate Implant Placement in Maxillary Esthetic Zone Using Socket Shield Versus Xenograft",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2018",
    "created_at": "2018-01-11T042326.251604",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394625",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Marginal Bone Loss in Immediate Implant Placement in Maxillary Esthetic Zone Using Socket Shield Technique Versus Xenogenous Bone Substitute Material",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042326.251604",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Inflammation Impact on Pain in Knee Osteoarthritis",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-08T041359.338829",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389906",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Inflammation Impact on Pain in Patients With Knee Osteoarthritis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Northern Orthopaedic Division Denmark",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041359.338829",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Newborn Cortical Response to Pain and Non Pharmacological Analgesia",
    "completion_date": "2017-05-31",
    "completion_date_type": "Actual",
    "completion_month_year": "May 31 2017",
    "created_at": "2018-01-09T041402.994498",
    "enrollment": 80,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389789",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Cortical Pain Processing in Full Term Infants After Giving Different Non-pharmacological Analgesia",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-05-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 31 2017",
    "received_results_disposit_date": "",
    "source": "IRCCS Burlo Garofolo",
    "start_date": "2016-11-02",
    "start_date_type": "Actual",
    "start_month_year": "November 2 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041402.994498",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Metabolic Resuscitation in Sepsis A Randomized Clinical Trial",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-07T041845.089288",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389555",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Vitamin C Steroids and Thiamine in Severe Sepsis and Septic Shock",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Beth Israel Deaconess Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041845.089288",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ALL-MB 2015",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 ALL-MB 2015",
    "completion_date": "2025-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2025",
    "created_at": "2018-01-11T042410.555088",
    "enrollment": 4000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390387",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 10,
    "number_of_groups": "",
    "official_title": "Moscow-Berlin 2015 Multicenter Randomized Study for Treatment of Acute Lymphoblastic Leukemia in Children Adolescents and Young Adults",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2020",
    "received_results_disposit_date": "",
    "source": "Federal Research Institute of Pediatric Hematology Oncology and Immunology",
    "start_date": "2015-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042410.555088",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ReInventing Yourself After SCI an Intervention to Improve Outcomes After Spinal Cord Injury",
    "completion_date": "2022-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2022",
    "created_at": "2018-01-08T041355.702686",
    "enrollment": 252,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390140",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "ReInventing Yourself After SCI A Multi-site Randomized Controlled Trial of an Intervention to Improve Outcomes After Spinal Cord Injury",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2022",
    "received_results_disposit_date": "",
    "source": "Craig Hospital",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041355.702686",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "SIMUTEC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Traditional Versus Virtual Reality for Surgical Skills for ObGyn Residents",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2018-01-11T042308.710046",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395821",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison Between Exclusive Surgical Training Versus Virtual Reality Plus Traditional Training in Surgical Skills of Residents of Obstetrics and Gynecology",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "Hospital de Clinicas de Porto Alegre",
    "start_date": "2017-12-22",
    "start_date_type": "Actual",
    "start_month_year": "December 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042308.710046",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Trial of Acyclovir for Viral Uveitis",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-07T041854.633934",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389191",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Clinical Trial of Oral Acyclovir in Viral Uveitis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Tianjin Medical University",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041854.633934",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LENUS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An In-home Observational Study to Compare Infant Crying and Fussing Parameters Documented by the LENA Recorder With Those Documented Via Parental E-diaries",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-08T041351.794149",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390348",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "An In-home Observational Study to Compare Infant Crying and Fussing Parameters Documented by the LENA Recorder With Those Documented Via Parental E-diaries",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Danone Asia Pacific Holdings Pte Ltd.",
    "start_date": "2017-11-22",
    "start_date_type": "Actual",
    "start_month_year": "November 22 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041351.794149",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Vitamin D Level and Risk of Infections in Cirrhotic Patients",
    "completion_date": "2018-02-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 15 2018",
    "created_at": "2018-01-11T042406.937068",
    "enrollment": 87,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391245",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Vitamin D Level and Risk of Infections in Cirrhotic Patients Does it Have a Role",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042406.937068",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Negative Pressure Incision Management System in Infrainguinal Vascular Surgery",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2018-01-11T042311.365968",
    "enrollment": 118,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395613",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prophylactic Use of a Negative Pressure Incision Management System in Infrainguinal Vascular Surgery - A Multicentre Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Karolinska University Hospital",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042311.365968",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants",
    "completion_date": "2013-01-01",
    "completion_date_type": "Actual",
    "completion_month_year": "January 2013",
    "created_at": "2018-01-08T041351.405056",
    "enrollment": 95,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390374",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants a Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2012-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 2012",
    "received_results_disposit_date": "",
    "source": "Dr Cipto Mangunkusumo General Hospital",
    "start_date": "2010-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 2010",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041351.405056",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Gastric Cancer",
    "completion_date": "2020-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2020",
    "created_at": "2018-01-11T042345.528338",
    "enrollment": 28,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393416",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single Center Phase I Clinical Study to Evaluate the Safety of MASCT-I Combined With PD1 Antibody in Vivo for the Advanced Patients With Gastric Cancer Who Failed First Line Chemotherapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "SYZ Cell Therapy Co..",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042345.528338",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "NOMEM-Tau",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.",
    "completion_date": "2021-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2021",
    "created_at": "2018-01-07T041856.670537",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389100",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Tau Positron Emission Tomography PET Imaging in the Northern Manhattan Study of Metabolism and Mind NOMEM With 18F-MK6240.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "Columbia University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041856.670537",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer Surgery",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-11T042345.729369",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393403",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Comparison of the Effect of Intravenous Continuous Dexmedetomidine Infusion and Dexmedetomidine as a Local Anesthetic Adjuvant in Subcostal Transverse Abdominis Plane Block in Patients Undergoing Gastric Cancer Surgery",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Kaohsiung Medical University Chung-Ho Memorial Hospital",
    "start_date": "2017-12-23",
    "start_date_type": "Actual",
    "start_month_year": "December 23 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042345.729369",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Avelumab HCC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment",
    "completion_date": "2020-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2020",
    "created_at": "2018-01-07T041856.258748",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-27",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389126",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041856.258748",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Role of SCUBE-1 in Ischemia-reperfusion Injury",
    "completion_date": "2018-02-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 20 2018",
    "created_at": "2018-01-08T041406.544481",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389607",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Role of SCUBE-1 in Ischemia-reperfusion Injury in Patients With Knee Prosthesis",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Diskapi Yildirim Beyazit Education and Research Hospital",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041406.544481",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2020",
    "created_at": "2018-01-07T041841.262519",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389685",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Can Platelet Rich Plasma Reduce the Level of Pro-Inflammatory Synovial Fluid Biomarkers Following an Anterior Cruciate Ligament Tear",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2020",
    "received_results_disposit_date": "",
    "source": "New York University School of Medicine",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041841.262519",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of a Wearable Hip Assist Robot on Cardiopulmonary Metabolic Efficiency During Stair Ascent in Elderly Adults",
    "completion_date": "2017-11-10",
    "completion_date_type": "Actual",
    "completion_month_year": "November 10 2017",
    "created_at": "2018-01-07T041855.656700",
    "enrollment": 15,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389165",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Effect of a Wearable Hip Assist Robot on Cardiopulmonary Metabolic Efficiency During Stair Ascent in Elderly Adults",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 10 2017",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2017-10-16",
    "start_date_type": "Actual",
    "start_month_year": "October 16 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041855.656700",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC",
    "completion_date": "2022-08-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 30 2022",
    "created_at": "2018-01-07T041853.585409",
    "enrollment": 144,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389256",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Controlled Phase II Clinical Trial of Apatinib in Combination With EGFR-TKI Versus EGFR-TKI for Non-squamous Non-small Cell Lung CancerNSCLC With T790M-negative After the Failure of EGFR-TKI Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2020",
    "received_results_disposit_date": "",
    "source": "Sichuan Cancer Hospital and Research Institute",
    "start_date": "2018-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041853.585409",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Preoperative Pain on POCD in Elderly Patients",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042341.302168",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393676",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Effect of Preoperative Pain on Postoperative Cognitive Dysfunction in Elderly Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "RenJi Hospital",
    "start_date": "2016-12-01",
    "start_date_type": "",
    "start_month_year": "December 1 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042341.302168",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Upper Limb Function After Breast Cancer Surgery the Role of Post-operative Physical Therapy Intervention- Randomized Control Trial",
    "completion_date": "2019-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2019",
    "created_at": "2018-01-07T041854.433012",
    "enrollment": 1200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389204",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 6,
    "official_title": "Upper Limb Function After Breast Cancer Surgery the Role of Post-operative Physical Therapy Intervention- Randomized Control Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 1 2019",
    "received_results_disposit_date": "",
    "source": "Assuta Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "18 Months",
    "updated_at": "2018-01-07T041854.433012",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Green Coffee Extract Supplementation on Leptin Ghrelin AdiponectinAnthropometric Measurements Lipid Profile in Breast Cancer Survivors",
    "completion_date": "2019-08-12",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 12 2019",
    "created_at": "2018-01-11T042324.963459",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394690",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "the Evaluation of Green Coffee Extract Supplementation on Leptin Ghrelin AdiponectinAnthropometric Measurements Lipid Profile in Breast Cancer Survivors",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-12",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 12 2019",
    "received_results_disposit_date": "",
    "source": "National Nutrition and Food Technology Institute",
    "start_date": "2018-03-12",
    "start_date_type": "Anticipated",
    "start_month_year": "March 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042324.963459",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MT-06",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH",
    "completion_date": "2021-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2021",
    "created_at": "2018-01-11T042312.545001",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395522",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "One-arm Multi-center International Prospective Study to Assess the Efficacy of Medi-tate Temporary Implantable Nitinol Device iTind in Subjects With Symptomatic Benign Prostatic Hypertrophy BPH",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "Medi-Tate Ltd.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042312.545001",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042343.133725",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393559",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of Leg Elevation on the Prevention of Intraoperative Hypotension During Shoulder Surgery in the Beach Chair Position",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042343.133725",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme",
    "completion_date": "2019-01-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 5 2019",
    "created_at": "2018-01-11T042409.879473",
    "enrollment": 68,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390127",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Positive End-expiratory Pressure on Arterial Oxygen Partial Pressure in Elderly Patients Undergoing Urologic Surgery Using LMA Supreme in Lithotomy Position",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 5 2019",
    "received_results_disposit_date": "",
    "source": "Asan Medical Center",
    "start_date": "2018-01-05",
    "start_date_type": "Actual",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042409.879473",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Green Coffee Extract Supplementation on Adropin Irisin VaspineSystemic Inflammation and Oxidative Stress in Breast Cancer Survivors",
    "completion_date": "2019-10-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 11 2019",
    "created_at": "2018-01-11T042312.051709",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395561",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "the Evaluation of Green Coffee Extract Supplementation on Adropin Irisin VaspineSystemic Inflammation and Oxidative Stress in Breast Cancer Survivors",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 11 2019",
    "received_results_disposit_date": "",
    "source": "National Nutrition and Food Technology Institute",
    "start_date": "2018-02-11",
    "start_date_type": "Anticipated",
    "start_month_year": "February 11 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042312.051709",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Explore Transplant @Home Within Kaiser Permanente Southern California",
    "completion_date": "2019-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2019",
    "created_at": "2018-01-08T041358.958307",
    "enrollment": 1200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389932",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Working Within an Integrated Learning Healthcare System to Improve Living Kidney Donation Knowledge Across the CKD Continuum for All Racial Groups",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2019",
    "received_results_disposit_date": "",
    "source": "University of California Los Angeles",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041358.958307",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2022",
    "created_at": "2018-01-11T042408.278908",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390777",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw a Multicenter Randomized Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2021",
    "received_results_disposit_date": "",
    "source": "University of Roma La Sapienza",
    "start_date": "2018-09-01",
    "start_date_type": "Anticipated",
    "start_month_year": "September 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042408.278908",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-09T041355.022285",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391180",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances A Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Riyadh Colleges of Dentistry and Pharmacy",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041355.022285",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Investigation in Integrated Perspective of Radiculomyelopathy Patients",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-11T042305.717450",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396055",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Investigation of the Relationship Between Surgical Approaches Psychological Intervention Neuromuscular Control Rehabilitation Exercise and Biomechanical Characteristics in Radiculomyelopathy Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 1 2018",
    "received_results_disposit_date": "",
    "source": "National Taiwan University Hospital",
    "start_date": "2015-08-13",
    "start_date_type": "Actual",
    "start_month_year": "August 13 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042305.717450",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "INTACT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Efficacy Study of Trans Sodium Crocetinate TSC in Newly Diagnosed Glioblastoma GBM Biopsy-Only Subjects",
    "completion_date": "2022-06-23",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 23 2022",
    "created_at": "2018-01-11T042352.430225",
    "enrollment": 264,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393000",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Open-label Randomized Controlled Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma GBM Biopsy-Only Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 28 2021",
    "received_results_disposit_date": "",
    "source": "Diffusion Pharmaceuticals LLC",
    "start_date": "2018-01-05",
    "start_date_type": "Anticipated",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042352.430225",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "REVERSE-MR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Early Mitral ValvE Repair Versus Watchful Waiting for Asymptomatic SEvere Degenerative Mitral Regurgitation",
    "completion_date": "2026-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2026",
    "created_at": "2018-01-07T041848.916325",
    "enrollment": 424,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389542",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Comparison of Early Mitral ValvE Repair Versus Watchful Waiting for Asymptomatic SEvere Degenerative Mitral Regurgitation Due to Leaflet Prolapse",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2025-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2025",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire Amiens",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041848.916325",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of a Propolis Tablet on the Saliva and the Amount of Adolescent Dental Plaque Microbes",
    "completion_date": "2018-12-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 21 2018",
    "created_at": "2018-01-11T042324.397037",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394729",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of a Propolis-containing Tablet on the Acidity of Saliva and the Amount of Adolescent Dental Plaque Microbes a Randomized Clinical Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Federal do Rio de Janeiro",
    "start_date": "2017-09-29",
    "start_date_type": "Actual",
    "start_month_year": "September 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042324.397037",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Toujeo Versus NPH Self-titration Study",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-07T041849.711661",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389490",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Pilot Study to Describe the Glycaemic Variability of Insulin Glargine 300Uml Versus NPH Neutral Protamine Hagedorn in the Insulin-nave Type 2 Diabetes Patients Following a Patient-adjusted Insulin Algorithm in Hong Kong",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2019",
    "received_results_disposit_date": "",
    "source": "Chinese University of Hong Kong",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041849.711661",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CHF-AZ",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Heart Failure Management in Azerbaijan",
    "completion_date": "2019-01-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 14 2019",
    "created_at": "2018-01-11T042410.100066",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390088",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Clinical Profiles and Treatment Management of Chronic Heart Failure in Azerbaijan",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "World Heart Failure Society",
    "start_date": "2018-02-14",
    "start_date_type": "Anticipated",
    "start_month_year": "February 14 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042410.100066",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Modified Mllers Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2020",
    "created_at": "2018-01-09T041338.151120",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392272",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Modified Mllers Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2020",
    "received_results_disposit_date": "",
    "source": "Sheba Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041338.151120",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD",
    "completion_date": "2021-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2021",
    "created_at": "2018-01-07T041841.044203",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389698",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Developing Advanced Blood-Brain Barrier Permeability Imaging for Early Alzheimers Disease",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "New York University School of Medicine",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041841.044203",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up",
    "completion_date": "2016-05-30",
    "completion_date_type": "Actual",
    "completion_month_year": "May 30 2016",
    "created_at": "2018-01-11T042312.870186",
    "enrollment": 200,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395496",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up",
    "overall_status": "Completed",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-05-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 1 2016",
    "received_results_disposit_date": "",
    "source": "Istanbul University",
    "start_date": "2013-05-01",
    "start_date_type": "Actual",
    "start_month_year": "May 1 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042312.870186",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Randomized CO2 vs Sham Laser Treatment of Provoked Vestibulodynia",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2018-01-08T041357.094938",
    "enrollment": 21,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390049",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Controlled Trial of Fractional CO2 Laser vs Sham Laser for Women With Provoked Vestibulodynia Who Have Failed Conservative Management",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2019",
    "received_results_disposit_date": "",
    "source": "Wake Forest University Health Sciences",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041357.094938",
    "verification_date": "2017-06-01",
    "verification_month_year": "June 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Awareness on Preoperative Anxiety",
    "completion_date": "2018-02-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 20 2018",
    "created_at": "2018-01-08T041406.750220",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389581",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Effect of Awareness on Preoperative Anxiety Before Anesthesia",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Diskapi Yildirim Beyazit Education and Research Hospital",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041406.750220",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PRADO-IC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of PRADO Heart Failure in Occitania",
    "completion_date": "2021-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2021",
    "created_at": "2018-01-11T042305.388264",
    "enrollment": 404,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396081",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of PRADO Heart Failure in Occitania",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Montpellier",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042305.388264",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CERAMENTTMG and V in the Management of Hip and Knee Arthroplasty Revisions Revision Arthroplasty Italy",
    "completion_date": "2019-09-27",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 27 2019",
    "created_at": "2018-01-07T041842.101510",
    "enrollment": 135,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389646",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "CERAMENTTMG and V in the Management of Hip and Knee Arthroplasty Revisions Revision Arthroplasty Italy",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 27 2018",
    "received_results_disposit_date": "",
    "source": "Istituto Ortopedico Galeazzi",
    "start_date": "2017-09-27",
    "start_date_type": "Actual",
    "start_month_year": "September 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041842.101510",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042350.466213",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393117",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prospective Randomized Blinded Comparison of Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Unilateral Immediate Breast Reconstruction",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Case Comprehensive Cancer Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042350.466213",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Modified Paramedian Versus Conventional Technique in the Residency Training An Observational Study",
    "completion_date": "2012-09-30",
    "completion_date_type": "Actual",
    "completion_month_year": "September 30 2012",
    "created_at": "2018-01-07T041841.474558",
    "enrollment": 518,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389672",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "a Modified Method That Improved Residency Neuraxial Anesthesia Performance and Reduced Patient Complications",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2012-09-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 30 2012",
    "received_results_disposit_date": "",
    "source": "National Taiwan University Hospital",
    "start_date": "2011-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2011",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041841.474558",
    "verification_date": "2011-01-01",
    "verification_month_year": "January 2011",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Hemifacial Spasm on Intraocular Pressure Measurement",
    "completion_date": "2017-12-20",
    "completion_date_type": "Actual",
    "completion_month_year": "December 20 2017",
    "created_at": "2018-01-08T041342.754406",
    "enrollment": 49,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390803",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Effect of Hemifacial Spasm on Intraocular Pressure Measurement",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-20",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 20 2017",
    "received_results_disposit_date": "",
    "source": "Medipol University",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041342.754406",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ADORE FOCUS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Finding Opportunities for Clinical Care and Trial Participation Among Underrepresented Samples",
    "completion_date": "2019-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2019",
    "created_at": "2018-01-08T041357.523178",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390023",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Finding Opportunities for Clinical Care and Trial Participation Among Underrepresented Samples An Administrative Supplement to the ADORE Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "University of Kansas Medical Center",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041357.523178",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-08T041352.196586",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390322",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "DiaGone First in Human FIH Study - Safety and Performance of the DiaGone Device for the Treatment of Type 2 Diabetes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "Digma Medical Ltd.",
    "start_date": "2017-07-28",
    "start_date_type": "Actual",
    "start_month_year": "July 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041352.196586",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bioequivalence Study Comparing Fluticasone PropionateSalmeterol 10050 g Inhalation Powder With Advair Diskus 10050 g in Asthma Patients",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042320.522124",
    "enrollment": 1050,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394989",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Multicenter Randomized Parallel-group Placebo-controlled 4-week Clinical Endpoint Bioequivalence Study Comparing Fluticasone PropionateSalmeterol 10050 g Inhalation Powder With Advair Diskus 10050 g in Asthma Patients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Cipla Ltd.",
    "start_date": "2018-02-26",
    "start_date_type": "Anticipated",
    "start_month_year": "February 26 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042320.522124",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Transforaminal Versus Lateralized Interlaminar Cervical Epidurals",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2019",
    "created_at": "2018-01-07T041842.497475",
    "enrollment": 116,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389620",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Cervical Transforaminal Epidural Corticosteroid Injections With Lateralized Interlaminar Epidural Corticosteroid Injections for Treatment of Cervicogenic Upper Extremity Radiculopathy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041842.497475",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Performance and Nutrition Program for Athletes in Adaptive Sports",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-09T041340.157831",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-26",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392155",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Effectiveness of a Performance and Nutrition Program for Athletes in Adaptive Sports",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Mayo Clinic",
    "start_date": "2018-01-09",
    "start_date_type": "Anticipated",
    "start_month_year": "January 9 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041340.157831",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Stroke",
    "completion_date": "2020-01-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 13 2020",
    "created_at": "2018-01-08T041354.203165",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390192",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Investigation for Individualized Noninvasive Neuromodulation in Neurorehabilitation of Brain Disease Longitudinal Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 13 2020",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2015-01-13",
    "start_date_type": "Actual",
    "start_month_year": "January 13 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041354.203165",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "BIS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "BIS of Sedation Depth During Flexible Bronchoscopy.",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042319.027426",
    "enrollment": 500,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395093",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Bispectral Index Monitoring of Sedation Depth During Flexible Bronchoscopy With or Without Fentanyl .",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Nanjing First Hospital Nanjing Medical University",
    "start_date": "2016-07-21",
    "start_date_type": "Actual",
    "start_month_year": "July 21 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042319.027426",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Validity of Mini Fluid Challenge Post Liver Transplantation",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-11T042304.468840",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396159",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Validity of Mini Fluid Challenge to Assess Fluid Responsiveness Post Liver Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Kasr El Aini Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042304.468840",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "OCTIVUS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention",
    "completion_date": "2026-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2026",
    "created_at": "2018-01-11T042339.267309",
    "enrollment": 2000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394079",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Prospective Open Label Multi-center Dual Arm All-comer Randomized Pragmatic Trial  Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 15 2021",
    "received_results_disposit_date": "",
    "source": "Asan Medical Center",
    "start_date": "2018-02-15",
    "start_date_type": "Anticipated",
    "start_month_year": "February 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042339.267309",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-11T042311.885331",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395574",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Terlipressin on Cerebral Oxygen Saturation and Cerebral Blood Flow During Living Donor Liver Transplantation",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Kasr El Aini Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042311.885331",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "TAB",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-07T041904.354138",
    "enrollment": 44,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388671",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-12-25",
    "start_date_type": "Actual",
    "start_month_year": "December 25 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041904.354138",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Procalcitonin PCT as a Marker of Infection in Post-orthotopic Liver Transplant",
    "completion_date": "2018-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2018",
    "created_at": "2018-01-07T041851.909969",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389360",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of Procalcitonin PCT as a Marker of Infection in Post-orthotopic Liver Transplant",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "National Hepatology  Tropical Medicine Research Institute",
    "start_date": "2014-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041851.909969",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Metastatic Renal Cell Carcinoma",
    "completion_date": "2035-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2035",
    "created_at": "2018-01-11T042336.968773",
    "enrollment": 66,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393936",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Dose Escalation and Dose Expansion Trial to Assess the Safety Tolerability and Anti-tumor Activity of Autologous T Cell Modified Chimeric Antigen Receptor CAR CCT 301-38 or CCT 301-59 in Patients With Recurrent or Refractory Stage IV Metastatic Renal Cell Carcinoma",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 30 2021",
    "received_results_disposit_date": "",
    "source": "Shanghai Sinobioway Sunterra Biotech",
    "start_date": "2018-01-30",
    "start_date_type": "Anticipated",
    "start_month_year": "January 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042336.968773",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Laminaria and Misoprostol Before Operative Hysteroscopy",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-08T041406.339415",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388827",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Use of Laminaria Versus Laminaria Plus Misoprostol Before Operative Hysteroscopy in Nulliparous Women . A Double Blinded Randomized Trial.",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Zagazig University",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041406.339415",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Brain Imaging Study of Brain Plasticity in Chronic Stroke Patients",
    "completion_date": "2019-08-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 18 2019",
    "created_at": "2018-01-11T042400.849849",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392519",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Study About Reorganization and Recovery Mechanism of Brain Neural Network for Chronic Stroke Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 18 2019",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2015-08-18",
    "start_date_type": "Actual",
    "start_month_year": "August 18 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042400.849849",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hydro-dissection of Median Nerve in Rheumatoid Arthritis Patients",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2018",
    "created_at": "2018-01-11T042333.902841",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394131",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Treatment of Carpal Tunnel in Rheumatoid Arthritis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042333.902841",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza",
    "completion_date": "2018-08-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 10 2018",
    "created_at": "2018-01-11T042332.671660",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394209",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-10",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 10 2018",
    "received_results_disposit_date": "",
    "source": "Capital Medical University",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042332.671660",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia AML",
    "completion_date": "2019-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2019",
    "created_at": "2018-01-07T041902.530755",
    "enrollment": 57,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388749",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase 12 Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia AML That is Refractory to or Relapsed After Standard Induction Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2019",
    "received_results_disposit_date": "",
    "source": "Moleculin Biotech Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041902.530755",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Position of the Endotracheal Tube Cuff in Relation to Cricoid in Children.",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-07T041903.708666",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388710",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Consultant Anesthesiology",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "King Fahad Medical City",
    "start_date": "2017-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041903.708666",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Conjoined Twins a Report of Four Cases.",
    "completion_date": "2017-10-01",
    "completion_date_type": "Actual",
    "completion_month_year": "October 2017",
    "created_at": "2018-01-07T041904.145573",
    "enrollment": 4,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-25",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388684",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Conjoined Twins a Report of Four Cases.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 2017",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2000-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 2000",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041904.145573",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Innovative Approach for Uniblocker Intubation",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042355.568551",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392818",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An Innovative Approach for Accurately Predicting the Optimal Insertion Depth of Uniblocker Without Fiberoptic Bronchoscope Assistance",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "The First Hospital of Qinhuangdao",
    "start_date": "2018-01-07",
    "start_date_type": "Actual",
    "start_month_year": "January 7 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042355.568551",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "CSF analysis with culture sensitivity and gram stain .\n\n        -  CSF-CRP level measured by reagent nephelometric method by BN prospec seimense.\n\n        -  Serum procalcitonin level for all patient suspected with meningitis measured by\n           chemilumensce on cobas E411 or by ELISA enzyme linked immunoassay",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Role of CSF-CRPand Serum Procalcitonin in Differentiation Between Bacterial and Viral Meningitis in Children",
    "completion_date": "2020-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2020",
    "created_at": "2018-01-05T041715.015843",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387969",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Role of CSF-CRPand Serum Procalcitonin in Differentiation Between Bacterial and Viral Meningitis in Children",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041715.015843",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of tDCS on Auditory Hallucination Insight Neurocognitive Function and HRV in Patients With Schizophrenia",
    "completion_date": "2022-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2022",
    "created_at": "2018-01-11T042410.863766",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388554",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "To Investigate the Effects of Transcranial Direct Current Stimulation on Auditory Hallucination Insight Neurocognitive Function Heart Rate Variability Psychosocial Functioning and Quality of Life in Patients With Schizophrenia",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "Tri-Service General Hospital",
    "start_date": "2016-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042410.863766",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Predictors for Bronchoalveolar Lavage BAL Recovery Rate Derived From Quantified Computed Tomography qCT",
    "completion_date": "2017-09-01",
    "completion_date_type": "Actual",
    "completion_month_year": "September 2017",
    "created_at": "2018-01-08T041409.785951",
    "enrollment": 33,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388580",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Predictors for Bronchoalveolar Lavage Recovery Rate Derived From Quantified Computed Tomography",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 2017",
    "received_results_disposit_date": "",
    "source": "Universittsmedizin Mannheim",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041409.785951",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Beds for Kids Program on Child Sleep",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2019",
    "created_at": "2018-01-11T042355.130990",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392844",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Beds for Kids Program Impact on Child Sleep and Family Functioning in Young Children",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2019",
    "received_results_disposit_date": "",
    "source": "Childrens Hospital of Philadelphia",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042355.130990",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Change of Tissue Oxygenation During a Vascular Occlusion Test Using Two Different NIRS O3TM vs. INVOS",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042308.556100",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395834",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Comparison of Change of Tissue Oxygenation During a Vascular Occlusion Test Using Two Different Near-infrared Spectroscopy O3TM vs. INVOS",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042308.556100",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ultrasound-guided Sciatic Nerve Block in Below Knee Amputation Surgery",
    "completion_date": "2017-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 1 2017",
    "created_at": "2018-01-11T042335.735690",
    "enrollment": 56,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394014",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Ultrasound -Guided Sciatic Nerve Block in Below Knee Amputation Surgery Subgluteal Versus Popliteal",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 1 2017",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042335.735690",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.",
    "completion_date": "2017-09-17",
    "completion_date_type": "Actual",
    "completion_month_year": "September 17 2017",
    "created_at": "2018-01-07T041908.107073",
    "enrollment": 110,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388463",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effectiveness of Standard Single Dose Omeprazole Versus High Dose Continuous Infusion in High-risk Critically Ill Patients.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-14",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 14 2017",
    "received_results_disposit_date": "",
    "source": "Menoufia University",
    "start_date": "2016-05-11",
    "start_date_type": "Actual",
    "start_month_year": "May 11 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041908.107073",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CARCIK",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With rr ALL Post HSCT",
    "completion_date": "2020-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2020",
    "created_at": "2018-01-07T041857.728016",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389035",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase 1-2a Trial to Determine the Feasibility and Safety of a Single Dose of Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Adult and Pediatric Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia After Hematopoietic Stem Cell Transplantation",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2019",
    "received_results_disposit_date": "",
    "source": "Fondazione Matilde Tettamanti Menotti De Marchi Onlus",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041857.728016",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Omega-3 Fatty Acid for Critically Ill Patients.",
    "completion_date": "2017-11-30",
    "completion_date_type": "Actual",
    "completion_month_year": "November 30 2017",
    "created_at": "2018-01-07T041908.308694",
    "enrollment": 110,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388450",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Enteral Nutrition With Omega-3 Fatty Acid in Critically Ill Septic Patients.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-27",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 27 2017",
    "received_results_disposit_date": "",
    "source": "Menoufia University",
    "start_date": "2015-01-15",
    "start_date_type": "Actual",
    "start_month_year": "January 15 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041908.308694",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Novel Text-Messaging Bot in Patients Undergoing Joint Arthroplasty",
    "completion_date": "2017-10-01",
    "completion_date_type": "Actual",
    "completion_month_year": "October 1 2017",
    "created_at": "2018-01-07T041840.818576",
    "enrollment": 159,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-24",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388502",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of a Novel Text-Messaging Bot in Patients Undergoing Total Joint Arthroplasty A Prospective Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 1 2017",
    "received_results_disposit_date": "",
    "source": "Rush University Medical Center",
    "start_date": "2016-11-21",
    "start_date_type": "Actual",
    "start_month_year": "November 21 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041840.818576",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Significance of Ultrasound Elastography in Lymph Node",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-09T041349.450577",
    "enrollment": 42,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391557",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Significance of Endoscopic Ultrasonography Guided Transbronchial Lymph Node Biopsy TBNA and Ultrasound Elastography in Lymph Node",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-04-17",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "April 17 2017",
    "received_results_disposit_date": "",
    "source": "Nanjing First Hospital Nanjing Medical University",
    "start_date": "2016-06-21",
    "start_date_type": "Actual",
    "start_month_year": "June 21 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041349.450577",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ALTIC-2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-05T041720.709320",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387826",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Pharmacodynamic Comparison of Low Dose Ticagrelor 60mg Bid to Low Dose Prasugrel 5mg od in Patients With Prior Myocardial Infarction",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Attikon Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041720.709320",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Assess the Safety Tolerability Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-11T042321.448936",
    "enrollment": 119,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394924",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 2 Dose Ranging Randomized Double Blind Placebo-Controlled Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis PBC With or Without an Inadequate Response to Ursodeoxycholic Acid UDCA",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Enanta Pharmaceuticals",
    "start_date": "2017-12-27",
    "start_date_type": "Actual",
    "start_month_year": "December 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042321.448936",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain",
    "completion_date": "2021-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2021",
    "created_at": "2018-01-07T041912.986122",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387930",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "The Hong Kong Polytechnic University",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041912.986122",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Shockwave Lithotripsy SWL Versus Oral Dissolution Therapy ODT Versus Combined SWL And ODT For Radiolucent Renal Stone",
    "completion_date": "2018-01-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 30 2018",
    "created_at": "2018-01-05T041713.478128",
    "enrollment": 150,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388060",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Shockwave Lithotripsy SWL Versus Oral Dissolution Therapy ODT Versus Combined SWL And ODT For Radiolucent Renal Stone Non-randomised Controlled Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 30 2018",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2017-04-01",
    "start_date_type": "Actual",
    "start_month_year": "April 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041713.478128",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-07T041900.978067",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388840",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Comparison of the Effect of Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction Hair Transplantion in Male Androgenic Alopecia Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-24",
    "start_date_type": "Anticipated",
    "start_month_year": "January 24 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041900.978067",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of Prehabilitation for Patients Undergoing Lumbar Spinal Stenosis Surgery",
    "completion_date": "2021-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2021",
    "created_at": "2018-01-07T041858.535782",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388983",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effectiveness of Prehabilitation for Patients Undergoing Lumbar Spinal Stenosis A Randomized Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "The Hong Kong Polytechnic University",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041858.535782",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Techniques for Perioperative Analgesia for Live Liver Donors A Pilot Study",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-11T042336.118987",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393988",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Pilot Study for a Prospective Randomized Controlled Trial of Techniques for Perioperative Analgesia for Live Liver Donors",
    "overall_status": "Active not recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042336.118987",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Shanghai Infants Gut Microbiome Associated Study",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-05T041712.708300",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388112",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Effects of Probiotics on the Gut Microbiome of Infants Treated With Antibiotics",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2017",
    "received_results_disposit_date": "",
    "source": "Shanghai 10th Peoples Hospital",
    "start_date": "2017-02-20",
    "start_date_type": "Actual",
    "start_month_year": "February 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041712.708300",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041405.645213",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387904",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Eploratory Open Clinical Trial to Compare the Efficacy and Safety of Anlotinib Plus Irinotecan Versus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "The First Affiliated Hospital of Zhengzhou University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041405.645213",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy",
    "completion_date": "2022-12-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 11 2022",
    "created_at": "2018-01-05T041712.020898",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388151",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Use of Propofol Versus Use of Midazolam as Sedative Agent in Patients With Liver Cirrhosis Presented for Lower Gastrointestinal Endoscopy Randomised Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-11-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 11 2022",
    "received_results_disposit_date": "",
    "source": "Tanta University",
    "start_date": "2016-04-01",
    "start_date_type": "Actual",
    "start_month_year": "April 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041712.020898",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "RCT of a Polyherbal Dietary Supplement for Prediabetes",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2018-01-08T041408.914121",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388762",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Placebo-controlled Clinical Trial of a Polyherbal Dietary Supplement GlucoSupreme Herbal on Markers of Glycemic Control Among Prediabetic Adults",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "University of Maryland",
    "start_date": "2017-12-05",
    "start_date_type": "Actual",
    "start_month_year": "December 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041408.914121",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Median Nerve Injury in US-guided Carpal Tunnel Injections",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 1 2017",
    "created_at": "2018-01-09T041352.616169",
    "enrollment": 126,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391336",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Median Nerve Injury in US-guided Carpal Tunnel Injections",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 30 2017",
    "received_results_disposit_date": "",
    "source": "Tri-Service General Hospital",
    "start_date": "2017-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041352.616169",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2022",
    "created_at": "2018-01-05T041712.507987",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388125",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2022",
    "received_results_disposit_date": "",
    "source": "Tanta University",
    "start_date": "2016-04-01",
    "start_date_type": "Actual",
    "start_month_year": "April 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041712.507987",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Multi-Targeted Recombinant Ad5 CEAMUC1Brachyury Based Immunotherapy Vaccine Regimen in People With Advanced Cancer",
    "completion_date": "2020-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2020",
    "created_at": "2018-01-11T042418.579224",
    "enrollment": 32,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384316",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Multi-Targeted Recombinant Ad5 CEAMUC1Brachyury Based Immunotherapy Vaccine Regimen in People With Advanced Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042418.579224",
    "verification_date": "2017-12-15",
    "verification_month_year": "December 15 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial Comparing Routine Versus Selective Use of Completion Angiography After Surgical Thromboembolectomy in the Treatment of Acute Lower Limb Ischemia and Their Impacts on Limb Salvage Rates",
    "completion_date": "2018-02-04",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 4 2018",
    "created_at": "2018-01-05T041714.093373",
    "enrollment": 92,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388021",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Routine Versus Selective Completion Angiography After Thromboembolectomy in the Treatment of Acute Lower Limb Ischemia A Randomized Controlled Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-04",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 4 2018",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2015-03-02",
    "start_date_type": "Actual",
    "start_month_year": "March 2 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041714.093373",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Plant-based Nutritional Products on Stem Cells",
    "completion_date": "2018-05-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 31 2018",
    "created_at": "2018-01-05T041713.280755",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-23",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388073",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Evaluation of Plant-based Nutritional Products on Stem Cells",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Natural Immune Systems Inc",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041713.280755",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Vitamin D3 Supplementation and Stress Fracture Occurrence in High-Risk Collegiate Athletes",
    "completion_date": "2016-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 1 2016",
    "created_at": "2018-01-11T042317.434194",
    "enrollment": 118,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395171",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Vitamin D3 Supplementation and Stress Fracture Occurrence in High-Risk Collegiate Athletes",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 1 2016",
    "received_results_disposit_date": "",
    "source": "Palmetto Health",
    "start_date": "2015-11-30",
    "start_date_type": "Actual",
    "start_month_year": "November 30 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042317.434194",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "FELICITy",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fetal Biomarkers of Chronic Maternal Stress During Pregnancy",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2018-01-07T041855.450755",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389178",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Fetal Early Non-invasive Biomarkers of Chronic Maternal Stress During Pregnancy Resulting in Alterations of Infant Cognitive Development",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2020",
    "received_results_disposit_date": "",
    "source": "Technische Universitt Mnchen",
    "start_date": "2016-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2016",
    "study_type": "Observational Patient Registry",
    "target_duration": "18 Months",
    "updated_at": "2018-01-07T041855.450755",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ketamine in Borderline Personality Disorder",
    "completion_date": "2020-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2020",
    "created_at": "2018-01-11T042315.410382",
    "enrollment": 66,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395314",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2020",
    "received_results_disposit_date": "",
    "source": "Yale University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042315.410382",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adherence to Antidepressant Treatment in Subjects With Depression",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2021",
    "created_at": "2018-01-09T041405.863032",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388164",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Adherence to Antidepressant Treatment in Subjects With Depression",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2021",
    "received_results_disposit_date": "",
    "source": "Laureate Institute for Brain Research Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041405.863032",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ultrasound Guided Bilateral Erector Spinae Plane Block in Laparoscopic Cholecystectomy",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-11T042407.168070",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391167",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Laparoscopic Cholecystectomy Patients Randomised Controlled Prospective Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "Maltepe University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042407.168070",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of PRN1008 in Adult Patients With Immune Thrombocytopenic Purpura ITP",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-11T042316.894147",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395210",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Adaptive Open-Label Dose-Finding Phase 12 Study Investigating the Safety Pharmacokinetics and Clinical Activity of PRN1008 an Oral BTK Inhibitor in Patients With Relapsed Immune Thrombocytopenic Purpura",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Principia Biopharma Inc.",
    "start_date": "2017-12-05",
    "start_date_type": "Actual",
    "start_month_year": "December 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042316.894147",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "EARLIER",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2021",
    "created_at": "2018-01-08T041410.211776",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388476",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension in Patients With Suspicion of Pulmonary Hypertension",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "University of Giessen",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041410.211776",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "BMN270-302",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vgkg",
    "completion_date": "2023-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2023",
    "created_at": "2018-01-11T042352.885835",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392974",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase 3 Study To Evaluate EfficacySafety of Valoctocogene Roxaparvovec an AAV Vector-Mediated Gene Transfer of hFVIII at a Dose of 4E13vgkg in Hemophilia A Patients With Residual FVIII Levels 1IUdL Receiving Prophylactic FVIII Infusions",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2022",
    "received_results_disposit_date": "",
    "source": "BioMarin Pharmaceutical",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042352.885835",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Microbial Testing for Caries Risk Assessment and Use of Adjunctive Therapies",
    "completion_date": "2018-06-29",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 29 2018",
    "created_at": "2018-01-11T042411.507226",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389373",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Microbial Testing for Caries Risk Assessment and Use of Adjunctive Therapies",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Colorado Denver",
    "start_date": "2018-01-16",
    "start_date_type": "Anticipated",
    "start_month_year": "January 16 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042411.507226",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Using Addiction Comprehensive Health Enhancement Support System ACHESS in an Alcoholic Liver Disease Population",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2019",
    "created_at": "2018-01-09T041406.065794",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388320",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Using Addiction Comprehensive Health Enhancement Support System ACHESS in an Alcoholic Liver Disease Population",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "New York Presbyterian Hospital",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041406.065794",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "INCREASE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis RR-MS",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2018-01-02T182856.526775",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387046",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Evaluation of clINical reCovery After a Relapse a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW INCREASE",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "Merck KGaA",
    "start_date": "2018-01-05",
    "start_date_type": "Anticipated",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182856.526775",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tadalafil-Delivra and Raynauds Phenomenon",
    "completion_date": "2018-07-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 30 2018",
    "created_at": "2018-01-11T042347.037013",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393325",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "A Multicenter Observational Pilot Study on the Effect of Tadalafil Delivra Cream in the Treatment of Raynauds Phenomenon and Pain Associated With Digital Ulcers",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Lawson Health Research Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042347.037013",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "RAFALE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions",
    "completion_date": "2017-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2017",
    "created_at": "2018-01-07T041913.858744",
    "enrollment": 104,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387540",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions Using International Pharmacovigilance Database",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-04",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 4 2017",
    "received_results_disposit_date": "",
    "source": "Groupe Hospitalier Pitie-Salpetriere",
    "start_date": "2017-12-02",
    "start_date_type": "Actual",
    "start_month_year": "December 2 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "2 Days",
    "updated_at": "2018-01-07T041913.858744",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Glucophage Immediate Release GIR China Bioequivalence Study",
    "completion_date": "2018-01-27",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 27 2018",
    "created_at": "2018-01-11T042348.961044",
    "enrollment": 44,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393208",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Randomized Open-label 2-Way-Crossover Study Assessing the Bioequivalence Between Single Doses of 500 mg Glucophage Immediate Release GIR Tablets Sino-American Shanghai Squibb Pharmaceuticals Ltd. Manufactured in China and 500 mg GIR Tablets Merck Sant s.a.s. in Semoy Manufactured in France Under Fed and Fasted State in Two Groups of Healthy Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 27 2018",
    "received_results_disposit_date": "",
    "source": "Merck KGaA",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042348.961044",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ZIKAllianceCH",
    "baseline_population": "",
    "biospec_description": "Blood Hair Urine Vaginal fluids Saliva Semen",
    "biospec_retention": "Samples With DNA",
    "brief_title": "ZIKAlliance Children Cohort ZIKAllianceCH",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-11T042347.667824",
    "enrollment": 5000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393286",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Children CH Cohort for the Evaluation of Developmental and Neurological Abnormalities in Infants Born to Mothers Residing in Areas With Zika Virus Transmission During Pregnancy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "University of Heidelberg Medical Center",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042347.667824",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2018-01-09T041403.630958",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389451",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "University of Iowa",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041403.630958",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Internal Jugular Vein Distensibility in Assessment of Fluid Responsiveness in Donors of Living Donor Liver Transplantation",
    "completion_date": "2017-10-01",
    "completion_date_type": "Actual",
    "completion_month_year": "October 1 2017",
    "created_at": "2018-01-09T041357.726517",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391037",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Internal Jugular Vein Distensibility in Assessment of Fluid Responsiveness in Donors of Living Donor Liver Transplantation",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 10 2017",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2016-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041357.726517",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "University of Michigan  Wayne State Chronic Pain Study",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-09T041347.801741",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391661",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Openness to Cognitive Approach of Nonspecific Chronic Pain",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Wayne State University",
    "start_date": "2017-12-10",
    "start_date_type": "Actual",
    "start_month_year": "December 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041347.801741",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "APTE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-05T041726.409831",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387501",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety of the Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium in Patients Undergoing Transfer of Cryo-preserved Embryos Clinical Trial II.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Hospital San Carlos Madrid",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041726.409831",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Transcranial Direct Current Stimulation on Reward Learning in Subclinical Depression.",
    "completion_date": "2019-11-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 6 2019",
    "created_at": "2018-01-11T042347.241833",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393312",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An fMRI Investigation Into the Effects of Transcranial Direct Current Stimulation on Reward Learning in Subclinical Depression.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Oxford",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042347.241833",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery",
    "completion_date": "2019-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2019",
    "created_at": "2018-01-11T042308.867100",
    "enrollment": 250,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395808",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 3 Multicenter Single-Arm Open-Label Study to Evaluate the Safety of Tramadol Infusion AVE-901 in the Management of Post-Operative Pain Following Surgery",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Avenue Therapeutics Inc.",
    "start_date": "2017-12-22",
    "start_date_type": "Actual",
    "start_month_year": "December 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042308.867100",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "UW17104",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies",
    "completion_date": "2022-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2022",
    "created_at": "2018-01-05T041726.185996",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387514",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2021",
    "received_results_disposit_date": "",
    "source": "University of Wisconsin Madison",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041726.185996",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Evaluate the Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Advanced andor Metastatic Solid Tumors",
    "completion_date": "2021-01-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 5 2021",
    "created_at": "2018-01-11T042415.030559",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386721",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open-Label Multicenter Phase II Study to Evaluate the Therapeutic Activity of RO6874281 an Immunocytokine Consisting of Interleukin-2 Variant IL-2v Targeting Fibroblast Activation Protein- FAP in Combination With Atezolizumab Anti-PD-L1 Administered Intravenously in Participants With Advanced andor Metastatic Solid Tumors",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2019",
    "received_results_disposit_date": "",
    "source": "Hoffmann-La Roche",
    "start_date": "2018-01-30",
    "start_date_type": "Anticipated",
    "start_month_year": "January 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042415.030559",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Morbidity Mortality and Gender Differences in Patients With Pacemakers",
    "completion_date": "2016-03-31",
    "completion_date_type": "Actual",
    "completion_month_year": "March 31 2016",
    "created_at": "2018-01-05T041709.445795",
    "enrollment": 11444,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388281",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Morbidity Mortality and Gender Differences in Patients With Pacemakers a Large-scale Single-center Cohort Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-03-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 31 2016",
    "received_results_disposit_date": "",
    "source": "Medical University of Vienna",
    "start_date": "2015-07-28",
    "start_date_type": "Actual",
    "start_month_year": "July 28 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041709.445795",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adaptive Arm Training for Children With Hemiplegia",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-07T041909.877937",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387449",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Adaptive Arm Training for Children With Hemiplegia",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Blythedale Childrens Hospital",
    "start_date": "2017-11-07",
    "start_date_type": "Actual",
    "start_month_year": "November 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041909.877937",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LODEFI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluating Low-dose Deferasirox DFX in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-11T042413.812083",
    "enrollment": 39,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387475",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Trial Evaluating Low-dose Deferasirox DFX in Patients With Low-risk MDS Myelodysplastic Syndrome Resistant or Relapsing After ESA Agents LODEFI",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "University Hospital Grenoble",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042413.812083",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Low Dose Levothyroxine During Pregnancy",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-09T041355.417365",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391154",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of Low Dose Levothyroxine During Pregnancy",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2018",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2017-05-01",
    "start_date_type": "Actual",
    "start_month_year": "May 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041355.417365",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "BA_GCSF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "GCSF Adjunct Therapy for Biliary Atresia",
    "completion_date": "2019-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2019",
    "created_at": "2018-01-11T042319.955597",
    "enrollment": 6,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395028",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Holterman Ai-Xuan M.D.",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042319.955597",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line RecurrentMetastatic Squamous Cell Carcinoma of Head and Neck",
    "completion_date": "2024-07-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 28 2024",
    "created_at": "2018-01-02T182909.400448",
    "enrollment": 580,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386838",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Global Open-label Study of Nivolumab in Combination With BMS-986205 vs Standard of Care EXTREME Regimen in First-line RecurrentMetastatic Squamous Cell Carcinoma of Head and Neck",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-29",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 29 2021",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182909.400448",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Denosumab in Reducing Salpingo-oophorectomy Risk in Premenopausal BRCA12 Mutations Carriers",
    "completion_date": "2019-08-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 21 2019",
    "created_at": "2017-12-29T041551.199124",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382574",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pilot Study of Denosumab in BRCA12 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 21 2019",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute NCI",
    "start_date": "2018-06-03",
    "start_date_type": "Anticipated",
    "start_month_year": "June 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041551.199124",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Abilify Maintena PMS in Schizophrenia Patients",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2018-01-02T182908.935479",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386851",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Post-Marketing Surveillance of Safety and Effectiveness of Abilify Maintena Injections in Korean Patients With Schizophrenia Under the New Drug Re-Examination",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "Korea Otsuka Pharmaceutical Co. Ltd.",
    "start_date": "2016-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182908.935479",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "68Ga PSMA in Preprostatectomy Patients",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2018-01-09T041405.368347",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388346",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "68Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "University of Iowa",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041405.368347",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "GREPAMOR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-05T041712.909469",
    "enrollment": 296,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388099",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Instituto Valenciano de Infertilidad IVI VALENCIA",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041712.909469",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Guided Bone Regeneration With L-PRF in the Atrophic Maxilla - The GLAM Technique",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-09T041353.826213",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391258",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Guided Bone Regeneration With L-PRF in the Atrophic Maxilla - A Pilot Clinical Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2017",
    "received_results_disposit_date": "",
    "source": "Implantology Institute",
    "start_date": "2015-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041353.826213",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "rTMS and Body Weight-support Treadmill Training After Incomplete Spinal Cord Injury",
    "completion_date": "2019-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2019",
    "created_at": "2018-01-11T042327.227239",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394560",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Repetitive Transcranial Magnetic Stimulation Combined to Body Weight-support Treadmill Training in the Sensory-motor Recovery of Patients With Chronic Incomplete Spinal Cord Injury",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 30 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Federal de Pernambuco",
    "start_date": "2018-01-30",
    "start_date_type": "Anticipated",
    "start_month_year": "January 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042327.227239",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-05T041725.965963",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387527",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Case Comprehensive Cancer Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041725.965963",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "qMHD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Quantification of Microbiota in Health and Diseases",
    "completion_date": "2018-11-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 21 2018",
    "created_at": "2018-01-08T041408.696040",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388424",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 6,
    "official_title": "Quantification of Microbiota in Health and Diseases",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 21 2018",
    "received_results_disposit_date": "",
    "source": "University of Cantanzaro",
    "start_date": "2017-11-22",
    "start_date_type": "Actual",
    "start_month_year": "November 22 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041408.696040",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Feces and human breast milk",
    "biospec_retention": "Samples With DNA",
    "brief_title": "A Cohort Analysis Study of Intestinal Flora in Infants",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2021",
    "created_at": "2018-01-11T042304.034689",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396198",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "An Observational Study of Intestinal Flora in Infants",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2019",
    "received_results_disposit_date": "",
    "source": "Zhejiang University",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042304.034689",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-05T041712.206100",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388138",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "overall_status": "Withheld",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "Redacted",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "NA",
    "target_duration": "",
    "updated_at": "2018-01-05T041712.206100",
    "verification_date": "",
    "verification_month_year": "",
    "why_stopped": ""
  },
  {
    "acronym": "PERILIC-IC",
    "baseline_population": "",
    "biospec_description": "Nasopharyngeal sample Blood sample",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Pertussis Immunization Programs in Low Income Countries - Ivory Coast",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-05T041713.865380",
    "enrollment": 1150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388034",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Pertussis Immunization Programs in Low Income Countries - Ivory Coast",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Institut Pasteur",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041713.865380",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "COLONG",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib",
    "completion_date": "2018-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2018",
    "created_at": "2018-01-02T182910.042798",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386825",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "COLONG Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "Bayer",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182910.042798",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Electroacupuncture Versus Transcutaneous Electric Nerve Stimulation for Functional Constipation",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-09T041348.281245",
    "enrollment": 128,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391635",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of Electroacupuncture Versus Transcutaneous Electric Nerve Stimulation for Functional Constipationa Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Guanganmen Hospital of China Academy of Chinese Medical Sciences",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041348.281245",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ENDOMEDE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-02T182855.916454",
    "enrollment": 2156,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387059",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multicentre Prospective Randomised Controlled Interventional Clinical Investigation to Assess the Clinical Safety and Performance of Forielle a Medical Device for Endometrial Washing in Restoring Favorable Endometrial Condition to Implantation After COS During Assisted Reproductive Practice ENDOMEDE",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "Merck KGaA",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182855.916454",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MTBOD-1",
    "baseline_population": "",
    "biospec_description": "Dischargesflushing fluid from vagina faces and fimbria end of fallopian tube are going to\n      sent for analysis of 16s RNA.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Pelvic Microbiomes of Benign and Malignant Ovarian Diseases",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2021",
    "created_at": "2018-01-07T041858.328205",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388996",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Role of Pelvic Microbiomes During the Malignant Transformation of Benign Ovarian Diseases",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Peking Union Medical College Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041858.328205",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2018-01-07T041856.883935",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389087",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Single Arm Exploratory and Open Phase II Clinical Trial of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Henan Cancer Hospital",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041856.883935",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MaPS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mato Preventing Stroke MaPS a Stroke Register Study",
    "completion_date": "2025-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2025",
    "created_at": "2018-01-09T041356.175881",
    "enrollment": 840,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391102",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Mato Preventing Stroke MaPS Stroke Register in City of Mato Brazil",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Centro Neurolgico de Pesquisa e Reabiitao Brazil",
    "start_date": "2015-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 2015",
    "study_type": "Observational Patient Registry",
    "target_duration": "10 Years",
    "updated_at": "2018-01-09T041356.175881",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Blood plasma.",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Biomarkers in Patients Undergoing Atrial Fibrillation Ablation",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-05T041708.598371",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-22",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388333",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "A Single-center Observational Study to Find Biomarkers for the Outcome of Catheter Ablation in Patients With Atrial Fibrillation",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Universittsklinikum Hamburg-Eppendorf",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041708.598371",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Possible Links Between Inflammation and Lipid Metabolism",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042357.694657",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392701",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Possible Links Between Inflammation and Lipid Metabolism",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Barmherzige Brder Linz",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042357.694657",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Acute Effects of Physical Activity On Memory Cognitive Performance and Brain Activity",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-09T041350.270115",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391505",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Acute Effects of Physical Activity On Memory Cognitive Performance and Brain Activity",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Southern Denmark",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041350.270115",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Inspiratory Muscle Training in Pulmonary Hypertension",
    "completion_date": "2018-02-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 15 2018",
    "created_at": "2018-01-07T041917.640906",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385733",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Inspiratory Muscle Training on Exercise Capacity Physical Activity and Quality of Life in Pulmonary Hypertension",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 15 2018",
    "received_results_disposit_date": "",
    "source": "Istanbul University",
    "start_date": "2017-10-10",
    "start_date_type": "Actual",
    "start_month_year": "October 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041917.640906",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility",
    "completion_date": "2019-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2019",
    "created_at": "2018-01-02T182922.077732",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386552",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Double Blind Controlled Parallel Groups Multi-center Phase II Clinical Study of Lidocaine Pertubation as a Treatment for Couples With Unexplained Infertility",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2018",
    "received_results_disposit_date": "",
    "source": "Isifer AB",
    "start_date": "2017-06-20",
    "start_date_type": "Actual",
    "start_month_year": "June 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182922.077732",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Exploring ProQOL Health Status Job Involvement and Turnover in Medical Professionals",
    "completion_date": "2018-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2018",
    "created_at": "2018-01-02T182954.025283",
    "enrollment": 550,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385811",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Exploring the Correlation of ProQOL Health Status Job Involvement Intention to Stay and Turnover Behaviour in Medical Professionals",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2018",
    "received_results_disposit_date": "",
    "source": "China Medical University Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "3 Months",
    "updated_at": "2018-01-02T182954.025283",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ASTC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Antibacterial-coated Sutures at Time of Cesarean",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-02T182934.485045",
    "enrollment": 3374,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386240",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Antibacterial-coated Sutures at Time of Cesarean",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "The University of Texas Medical Branch Galveston",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182934.485045",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-6 Brain Metastases",
    "completion_date": "2025-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2025",
    "created_at": "2018-01-09T041352.229981",
    "enrollment": 111,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391362",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-6 Brain Metastases A Single Arm Phase II Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2021",
    "received_results_disposit_date": "",
    "source": "Dana-Farber Cancer Institute",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041352.229981",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CheckMate 9DX",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation",
    "completion_date": "2025-03-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 21 2025",
    "created_at": "2018-01-11T042419.896122",
    "enrollment": 530,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383458",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 3 Randomized Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-02-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 27 2022",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2017-12-18",
    "start_date_type": "Actual",
    "start_month_year": "December 18 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042419.896122",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Technology to Improve the Health of Resource-poor Hispanics With Diabetes",
    "completion_date": "2022-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2022",
    "created_at": "2018-01-11T042328.854111",
    "enrollment": 176,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394456",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Technology to Improve the Health of Resource-poor Hispanics With Diabetes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2020",
    "received_results_disposit_date": "",
    "source": "Baylor College of Medicine",
    "start_date": "2018-01-13",
    "start_date_type": "Anticipated",
    "start_month_year": "January 13 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042328.854111",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "QUILT-3.090 NANT Squamous Cell Carcinoma SCC Vaccine Molecularly Informed Integrated Immunotherapy in Subjects With SCC Who Have Progressed on or After Platinum-based Chemotherapy and Anti-programmed Cell Death Protein 1 PD-1Programmed Death-ligand 1 PD-L1 Therapy",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042414.270928",
    "enrollment": 65,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387111",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "NANT Squamous Cell Carcinoma SCC Vaccine Molecularly Informed Integrated Immunotherapy Combining Innate High-affinity Natural Killer haNK Cell Therapy With Adenoviral and Yeast-based Vaccines to Induce T-cell Responses in Subjects With SCC Who Have Progressed on or After Platinum-based Chemotherapy and Anti-programmed Cell Death Protein 1 PD-1Programmed Death-ligand 1 PD-L1 Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "NantKwest Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042414.270928",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "SOTA-BONE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Bone Safety of Sotagliflozin Dose 1 and Dose 2 Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2020",
    "created_at": "2018-01-02T182931.463376",
    "enrollment": 360,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386344",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A 26-week Randomized Double-blind Placebo-controlled Parallel-group Multicenter Phase 3 Study With a 78-week Extension Period to Evaluate the Efficacy and Bone Safety of Sotagliflozin in Patients 55 Years or Older With Type 2 Diabetes Mellitus and Inadequate Glycemic Control",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2020",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2018-02-05",
    "start_date_type": "Anticipated",
    "start_month_year": "February 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182931.463376",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of Unicompartmental Versus Total Knee Arthroplasty",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2017-12-31T041317.374944",
    "enrollment": 112,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385759",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Prospective Randomized Trial of Unicompartmental Versus Total Knee Arthroplasty for the Treatment of Medial Compartment Osteoarthritis",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Anderson Orthopaedic Research Institute",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041317.374944",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Interstitial fluid skin biopsies and blood serum plasma and whole blood",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Interstitial Fluid in the Development of Cardiovascular Disease",
    "completion_date": "2030-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2030",
    "created_at": "2018-01-11T042414.037912",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386097",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Studies of the Importance of Interstitial Fluid in the Development of Cardiovascular Disease an Expanded Study.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Karolinska University Hospital",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042414.037912",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis",
    "completion_date": "2018-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2018",
    "created_at": "2018-01-11T042325.165414",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394677",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Phase 2 Study to Evaluate the Efficacy Safety and Tolerabililty of RVT-501 Topical Ointment in Pediatric Patients With Mild to Moderate Atopic Dermatitis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Dermavant Sciences GmbH",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042325.165414",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042354.278796",
    "enrollment": 41,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392896",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Placebo-Controlled Single-Blind Single-Center Phase 1 Study in Normal Healthy Volunteers and Open-Label Multi-Center Study in Patients With Primary Hyperoxaluria to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DCR-PHXC Solution for Injection Subcutaneous Use",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "Dicerna Pharmaceuticals Inc.",
    "start_date": "2017-12-06",
    "start_date_type": "Actual",
    "start_month_year": "December 6 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042354.278796",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Firearm Storage Device Distribution to Families of Children With Mental Health Complaints",
    "completion_date": "2018-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2018",
    "created_at": "2018-01-05T041731.837512",
    "enrollment": 244,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386409",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Impact of Firearm Safety Device Distribution on Firearm Exposure in the Households of Patients With Mental Health Complaints",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2018",
    "received_results_disposit_date": "",
    "source": "Seattle Childrens Hospital",
    "start_date": "2016-02-12",
    "start_date_type": "Actual",
    "start_month_year": "February 12 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041731.837512",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Retention of Metal Reinforced Polyamide Denture Base and Heat Cured Acrylic Resin Denture Base in Complete Mandibular Denture",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2017-12-31T041317.557652",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385746",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Retention of Metal Reinforced Polyamide Denture Base Compared to Conventional Heat Cured Acrylic Resin Denture Base in Complete Mandibular Denture",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041317.557652",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of IMGN632 in Patients With RelapseRefractory AML BPDCN ALL Other CD123 Hem Malignancies",
    "completion_date": "2021-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2021",
    "created_at": "2018-01-11T042415.258360",
    "enrollment": 155,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386513",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Multi-center Open-label Study of IMGN632 Administered Intravenously in Patients With RelapsedRefractory CD123-positive Acute Myeloid Leukemia and Other CD123-positive Hematologic Malignancies",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2020",
    "received_results_disposit_date": "",
    "source": "ImmunoGen Inc.",
    "start_date": "2018-01-04",
    "start_date_type": "Actual",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042415.258360",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluating the Infectivity Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine RSV 6120NS21030s in RSV-Seropositive Children and RSV-Seronegative Infants and Children",
    "completion_date": "2021-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2021",
    "created_at": "2018-01-02T182851.168496",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387137",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Phase I Placebo-Controlled Study of the Infectivity Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV 6120NS21030s Lot RSV012A Delivered as Nose Drops to RSV-Seropositive Children 12 to 59 Months of Age and RSV-Seronegative Infants and Children 6 to 24 Months of Age",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-26",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 26 2019",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2017-10-13",
    "start_date_type": "Actual",
    "start_month_year": "October 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182851.168496",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Sphenopalatine Ganglion Block for Post-dural Puncture Headache",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-31T041317.215144",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385772",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Sphenopalatine Ganglion Block as a Treatment Modality for Post-dural Puncture Headache in the Post-partum Patient",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Brigham and Womens Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041317.215144",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "IQARE-SCD",
    "baseline_population": "",
    "biospec_description": "Blood sample 10mL  for adult patient and teenagers and salivary sample for minor patients\n      under 12 years of age",
    "biospec_retention": "Samples With DNA",
    "brief_title": "CIQTP Prolongation  Role and Mechanism in Sudden Cardiac Death",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2019",
    "created_at": "2018-01-02T182855.163133",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387072",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "CIQTP Prolongation  Role and Mechanism in Sudden Cardiac Death",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Nantes University Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182855.163133",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ADIFE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-07T041917.400860",
    "enrollment": 496,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385902",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact on Mortality of Timing of Dialysis Initiation in Patients With End-stage Renal Disease by a Novel Assessment Based on Fuzzy Mathematics",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "The First Affiliated Hospital of Dalian Medical University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041917.400860",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "ECG Identifying the Culprit Coronary Artery",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2018-01-05T041730.130071",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387280",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Electrocardigram Identifying the Culprit Site in Patients With Acute Inferior Myocardial Infarction",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Yuans General Hospital",
    "start_date": "2015-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041730.130071",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2018-01-09T041408.321796",
    "enrollment": 74,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386149",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Clinical Research on the Efficacy and Safety of Bosinji on LBP and Radiculopathy by HIVD of L-spine A Multicenter Randomized Controlled Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "Kyunghee University Medical Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041408.321796",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis",
    "completion_date": "2020-11-16",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 16 2020",
    "created_at": "2018-01-11T042416.742483",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385564",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Exploratory Maintenance Trial Evaluating the Effect of BI 655064 in Lupus Nephritis Patients Who Have Achieved a Meaningful Response Either at the End of 1293.10 or After an Induction Treatment Outside of 1293.10",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-16",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 16 2020",
    "received_results_disposit_date": "",
    "source": "Boehringer Ingelheim",
    "start_date": "2018-01-09",
    "start_date_type": "Anticipated",
    "start_month_year": "January 9 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042416.742483",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Oxycodone Concentration in the Blood After Oral Premedication",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2018-01-02T182932.115586",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386318",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Oxycodone Concentration in the Blood After Oral Premedication",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "Sahlgrenska University Hospital Sweden",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182932.115586",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PROVIDE-HF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto SacubitrilValsartan in Heart Failure",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-02T182850.125804",
    "enrollment": 1500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387163",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "PROVIDE-HF Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto SacubitrilValsartan in Heart Failure",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Novartis",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182850.125804",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Serum Bilirubin Levels in Normal-tension Glaucoma",
    "completion_date": "2017-04-01",
    "completion_date_type": "Actual",
    "completion_month_year": "April 2017",
    "created_at": "2018-01-05T041729.705261",
    "enrollment": 76,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387306",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Reduced Serum Bilirubin Levels in Patients With Normal-tension Glaucoma",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-03-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 2017",
    "received_results_disposit_date": "",
    "source": "Trakya University",
    "start_date": "2010-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041729.705261",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pulsed Shortwave Therapy Adjunct Pain and Recovery in Total Knee Replacement",
    "completion_date": "2019-03-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 15 2019",
    "created_at": "2018-01-11T042313.544822",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395444",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Double Blind Placebo-controlled Clinical Trial to Assess Pulsed Shortwave Therapy as an Adjunct Pain Therapy  Knee Recovery for Total Knee Arthroplasty",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 15 2018",
    "received_results_disposit_date": "",
    "source": "BioElectronics Corporation",
    "start_date": "2017-12-15",
    "start_date_type": "Actual",
    "start_month_year": "December 15 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042313.544822",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Rotational Stability of V4C Toric Implantable Contact Lenses After On Axis Implantation Measured With OPD Scan 3",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-11T042406.021512",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391544",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Rotational Stability of V4C Toric Implantable Contact Lenses After On Axis Implantation Measured With OPD Scan 3",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2017-04-28",
    "start_date_type": "Actual",
    "start_month_year": "April 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042406.021512",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Respiratory Rates - Accuracy of Contact-free Monitoring of Respiratory Rates",
    "completion_date": "2018-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2018",
    "created_at": "2018-01-11T042342.714514",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393585",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Respiratory Rates - Accuracy of Contact-free Monitoring of Respiratory Rates in the Triage Setting of an Emergency Department",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital Basel Switzerland",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042342.714514",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ONCOVIR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients",
    "completion_date": "2020-04-09",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 9 2020",
    "created_at": "2018-01-08T041357.930012",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389997",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 9 2020",
    "received_results_disposit_date": "",
    "source": "Poitiers University Hospital",
    "start_date": "2018-01-09",
    "start_date_type": "Anticipated",
    "start_month_year": "January 9 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041357.930012",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PAPET",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prophylactic Antibiotics Prior to Embryo Transfer PAPET RCT",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-02T182934.852772",
    "enrollment": 356,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386227",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prophylactic Antibiotics Prior to Embryo Transfer a Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2019",
    "received_results_disposit_date": "",
    "source": "Washington University School of Medicine",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182934.852772",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Psycho-social Support on Mental Health and Hope of Adolescents Affected by Earthquake in Nepal",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2017",
    "created_at": "2018-01-02T182859.596754",
    "enrollment": 1912,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387007",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Psycho-social Support Training by School Teachers on Improving Mental Health and Hope of School Going Adolescents in Earthquake Affected Districts in Nepal",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-03-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 2017",
    "received_results_disposit_date": "",
    "source": "Tokyo University",
    "start_date": "2016-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182859.596754",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis",
    "completion_date": "2021-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2021",
    "created_at": "2018-01-11T042415.841941",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386214",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2020",
    "received_results_disposit_date": "",
    "source": "Washington University School of Medicine",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042415.841941",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "QUILT-3.070 NANT Pancreatic Cancer Vaccine Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042416.089998",
    "enrollment": 173,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387098",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "NANT Pancreatic Cancer Vaccine Molecularly Informed Integrated Immunotherapy Combining Innate High-affinity Natural Killer haNK Cell Therapy With Adenoviral and Yeast-based Vaccines to Induce T-cell Responses in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "NantKwest Inc.",
    "start_date": "2018-01-02",
    "start_date_type": "Actual",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042416.089998",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody VRC-HIVMAB075-00-AB VRC07-523LS Administered in Multiple Doses Routes and Dosing Schedules to Healthy HIV-uninfected Adults",
    "completion_date": "2021-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2021",
    "created_at": "2018-01-02T182850.611406",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387150",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "A Multicenter Randomized Phase 1 Clinical Trial to Evaluate the Safety and Serum Concentrations of a Human Monoclonal Antibody VRC-HIVMAB075-00-AB VRC07-523LS Administered in Multiple Doses Routes and Dosing Schedules to Healthy HIV-uninfected Adults",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2021",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182850.611406",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2019",
    "created_at": "2018-01-02T182926.386394",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386448",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Safety and Efficacy of Naltrexone and Scopolamine Utilized in Combination in the Treatment of Major Depression A Double Blinded Randomized Controlled Pilot Study",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 15 2018",
    "received_results_disposit_date": "",
    "source": "The Taub Group",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182926.386394",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "REDNIVIN",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-11T042307.863689",
    "enrollment": 306,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395886",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance A Prospective Single-blinded Randomized Control Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Shanghai Zhongshan Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042307.863689",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "IVH-T4",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage",
    "completion_date": "2024-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2024",
    "created_at": "2018-01-08T041348.901310",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390530",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage Phase II Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2024-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2024",
    "received_results_disposit_date": "",
    "source": "Albert Einstein College of Medicine Inc.",
    "start_date": "2019-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2019",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041348.901310",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin",
    "completion_date": "2018-04-09",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 9 2018",
    "created_at": "2018-01-02T182933.226117",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386279",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "A Phase 1 Randomized Placebo-and Positive-controlled Crossover Study To Determine The Effect Of Single-dose Pf-04965842 On Qtc Interval In Healthy Volunteers",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 9 2018",
    "received_results_disposit_date": "",
    "source": "Pfizer",
    "start_date": "2018-01-19",
    "start_date_type": "Anticipated",
    "start_month_year": "January 19 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182933.226117",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis",
    "completion_date": "2020-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2020",
    "created_at": "2018-01-11T042352.204284",
    "enrollment": 72,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393013",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 1b2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2020",
    "received_results_disposit_date": "",
    "source": "Kezar Life Sciences Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042352.204284",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "TPN",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2019",
    "created_at": "2018-01-02T182936.863178",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386175",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Grenoble",
    "start_date": "2017-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182936.863178",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CHP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Couples Health Project Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk",
    "completion_date": "2022-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2022",
    "created_at": "2018-01-08T041412.095159",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386110",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Couples Health Project Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "Hunter College of City University of New York",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041412.095159",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "QUILT-3.067 NANT Triple Negative Breast Cancer TNBC Vaccine Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-11T042414.761518",
    "enrollment": 79,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387085",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "NANT Triple Negative Breast Cancer TNBC Vaccine Molecularly Informed Integrated Immunotherapy Combining Innate High-affinity Natural Killer haNK Cell Therapy With Adenoviral and Yeast-based Vaccines to Induce T-cell Responses in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "NantKwest Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042414.761518",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Compassionate Use Progressive Metastatic Castrate Resistant Prostate Cancer Monotherapy Treatment With Trametinib",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-08T041412.306268",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386071",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Individual Patient Program for Patient With Progressive Metastatic Castrate Resistant Prostate Cancer Monotherapy Treatment With Trametinib",
    "overall_status": "Available",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "Jonsson Comprehensive Cancer Center",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "Expanded Access",
    "target_duration": "",
    "updated_at": "2018-01-08T041412.306268",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety of PLACENTEX  i.m. in Patients With Scleroderma Diseases",
    "completion_date": "2018-09-08",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 8 2018",
    "created_at": "2018-01-07T041911.394503",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388255",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase IV Single-arm Open-label Clinical Trial to Evaluate the Efficacy and Safety of PLACENTEX  Polydeoxyribonucleotide i.m. in Patients With Fibrotic and Atrophic Cutaneous Lesions in Scleroderma Diseases",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-08",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 8 2018",
    "received_results_disposit_date": "",
    "source": "Mastelli S.r.l",
    "start_date": "2016-11-08",
    "start_date_type": "Actual",
    "start_month_year": "November 8 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041911.394503",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of a Distance Eduaction Course for Prevention in RSIWRMD",
    "completion_date": "2019-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2019",
    "created_at": "2018-01-07T041916.969173",
    "enrollment": 76,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385954",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of a Distance Eduaction Course for Prevention in RSIWRMD on Life Quality of a Nursing Group",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2019",
    "received_results_disposit_date": "",
    "source": "Hospital de Clinicas de Porto Alegre",
    "start_date": "2017-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041916.969173",
    "verification_date": "2017-10-01",
    "verification_month_year": "October 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EGIAES",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2021",
    "created_at": "2018-01-02T182849.068888",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385798",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Aarhus University Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182849.068888",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-07T041857.520966",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389048",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Performance Assessment of the PMD-200 Physiological Monitor Device a Novel Pain Monitor in Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2018",
    "received_results_disposit_date": "",
    "source": "Medasense Biometrics Ltd",
    "start_date": "2017-11-13",
    "start_date_type": "Actual",
    "start_month_year": "November 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041857.520966",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CisplatinCarboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Lung Cancer",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2017-12-29T041551.443685",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382561",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Phase II Clinical Trial of CisplatinCarboplatin and Etoposide CE Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer ED-SCLC",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute NCI",
    "start_date": "2018-05-12",
    "start_date_type": "Anticipated",
    "start_month_year": "May 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041551.443685",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Wound Infiltration With BupivacaineAdrenalin During Cesarean Section and Postoperative Pain.",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042307.452885",
    "enrollment": 286,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395912",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of a Single-shot Wound Infiltration With BupivacaineAdrenalin During Cesarean Section in Reducing Postoperative Pain. A Randomized Prospective Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "HaEmek Medical Center Israel",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042307.452885",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Auricular Point Acupressure to Manage Pain in Patients With Alzheimers Disease and Related Disorders",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042343.345059",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393546",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Auricular Point Acupressure to Manage Pain in Patients With Alzheimers Disease and Related Disorders",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Johns Hopkins University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042343.345059",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Breastfeeding Study",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-02T182852.026577",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387124",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Characterization of Stool Consistency and Fecal Microbiota of Breastfed Infants",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2018",
    "received_results_disposit_date": "",
    "source": "Nestl",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182852.026577",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-08T041347.721883",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390595",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Phase II Multicentre Randomized Open-label Study to Evaluate the Safety and Efficacy of Avelumab With GemcitabineCarboplatin Versus GemcitabineCarboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma UC Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Associaci per a la Recerca Oncologica Spain",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041347.721883",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction BASILICA Prospective Investigation",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2017-12-26T040711.180834",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381989",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Latrogenic Coronary Artery Obstruction BASILICA",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2017-12-25",
    "start_date_type": "Anticipated",
    "start_month_year": "December 25 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040711.180834",
    "verification_date": "2017-11-21",
    "verification_month_year": "November 21 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Application of the SIMPLE Program for Weight Loss at Pathways to Housing A Feasibility Study",
    "completion_date": "2015-10-08",
    "completion_date_type": "Actual",
    "completion_month_year": "October 8 2015",
    "created_at": "2018-01-07T041850.766519",
    "enrollment": 9,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389425",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Application of the Simplified Intervention to Modify Physical Activity Lifestyle and Eating Behavior From Dr. Cenk Tek and Colleagues of Yale University to a Sample of Obese Patients With Stable Schizophrenia or Schizoaffective Disorder on Antipsychotic Medications in the Pathways to Housing Multidisciplinary Care Setting A Feasibility Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-03-18",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 18 2015",
    "received_results_disposit_date": "",
    "source": "University of Calgary",
    "start_date": "2014-11-19",
    "start_date_type": "Actual",
    "start_month_year": "November 19 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041850.766519",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SAFIR PI3K",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase II Randomized Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy as Maintenance Therapy in Patients With PIK3CA Mutated Advanced Breast Cancer",
    "completion_date": "2023-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2023",
    "created_at": "2018-01-02T182937.267029",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386162",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase II Randomized Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy as Maintenance Therapy in Patients With PIK3CA Mutated Advanced Breast Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2022",
    "received_results_disposit_date": "",
    "source": "UNICANCER",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182937.267029",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Open-Labeled Phase 1 Study for Apatinib Plus Nivolumab in Patients With Unresectable or Metastatic Cancer",
    "completion_date": "2019-12-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 22 2019",
    "created_at": "2018-01-11T042303.888684",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396211",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open-Labeled Phase I Study to Evaluate the Safety and Tolerability of Apatinib and Nivolumab in Patients With Unresectable or Metastatic Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 22 2019",
    "received_results_disposit_date": "",
    "source": "LSK BioPartners Inc.",
    "start_date": "2017-12-22",
    "start_date_type": "Actual",
    "start_month_year": "December 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042303.888684",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "FAAH-I MULTI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fatty Acid Amide Hydrolase FAAH Inhibitor Treatment of Cannabis Use Disorder CUD",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2022",
    "created_at": "2018-01-02T182925.080865",
    "enrollment": 260,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386487",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 2 8-week Randomized Double-Blind Placebo-Controlled Parallel Study to Evaluate Efficacy Safety and Tolerability of the Fatty Acid Amide Hydrolase FAAH Inhibitor PF-04457845 in Adults With DSM5 Current Cannabis Use Disorder CUD",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2022",
    "received_results_disposit_date": "",
    "source": "Yale University",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182925.080865",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Heart Rate Variability and Hyperthyroidism Evaluation of the Short-term Effects of Propanolol",
    "completion_date": "2009-09-30",
    "completion_date_type": "Actual",
    "completion_month_year": "September 30 2009",
    "created_at": "2018-01-11T042340.441590",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393728",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Short Term Effects of Propanolol on Heart Rate Variability of Hyperthyroidism",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2008-12-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 30 2008",
    "received_results_disposit_date": "",
    "source": "Yaounde Central Hospital",
    "start_date": "2008-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2008",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042340.441590",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-09T041354.814801",
    "enrollment": 360,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391193",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine in Children Aged 6 Months to 17 Years",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041354.814801",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "CHRONIC1",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes",
    "completion_date": "2016-08-01",
    "completion_date_type": "Actual",
    "completion_month_year": "August 2016",
    "created_at": "2018-01-11T042340.649116",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393715",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 2016",
    "received_results_disposit_date": "",
    "source": "Yaounde Central Hospital",
    "start_date": "2016-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042340.649116",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Quantification of Proteomes L-plastin  Lipocalin and Adiponectin in Chronic Periodontitis and Diabetic Subjects",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 1 2017",
    "created_at": "2018-01-09T041352.427082",
    "enrollment": 70,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391349",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Quantification of Proteomes L-plastin  Lipocalin and Adiponectin in Subgingival Tissue Samples of Generalized Severe Chronic Periodontitis Patients With and Without Type II Diabetes Mellitus",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-22",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 22 2017",
    "received_results_disposit_date": "",
    "source": "Meenakshi Ammal Dental College and Hospital",
    "start_date": "2016-10-20",
    "start_date_type": "Actual",
    "start_month_year": "October 20 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041352.427082",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ZUMA-7",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study Evaluating the Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With RelapsedRefractory Diffuse Large B Cell Lymphoma",
    "completion_date": "2035-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2035",
    "created_at": "2018-01-11T042406.471238",
    "enrollment": 350,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391466",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 3 Randomized Open-Label Study Evaluating Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With RelapsedRefractory Diffuse Large B Cell Lymphoma",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2022",
    "received_results_disposit_date": "",
    "source": "Kite A Gilead Company",
    "start_date": "2017-12-14",
    "start_date_type": "Actual",
    "start_month_year": "December 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042406.471238",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2018",
    "created_at": "2018-01-02T182951.948973",
    "enrollment": 1500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385863",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "A Multicenter Clinical Study on the Comparison of the Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 30 2016",
    "received_results_disposit_date": "",
    "source": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University",
    "start_date": "2011-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2011",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182951.948973",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome Utility of Plasma Zonulin Levels as a Predictive Biomarker",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-02T182849.615507",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387176",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome Utility of Plasma Zonulin Levels as a Predictive Biomarker",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "New York University School of Medicine",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182849.615507",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Parental Feeding Styles and Child Dietary Quality",
    "completion_date": "2009-12-31",
    "completion_date_type": "Actual",
    "completion_month_year": "December 31 2009",
    "created_at": "2018-01-08T041346.292537",
    "enrollment": 177,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-21",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390621",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Parental Feeding Styles and Child Dietary Quality at Dinner Among Low-income Minority Families",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2009-02-28",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "February 28 2009",
    "received_results_disposit_date": "",
    "source": "Baylor College of Medicine",
    "start_date": "2007-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2007",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041346.292537",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Cervical Manual Therapy on Cervicogenic Headache",
    "completion_date": "2019-05-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 15 2019",
    "created_at": "2018-01-02T182950.179393",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385889",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Effects of Cervical Spine Manual Therapy on Range of Motion Joint Position Sense and Balance in Participants With Cervicogenic Headache",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 15 2018",
    "received_results_disposit_date": "",
    "source": "Shenandoah University",
    "start_date": "2018-02-15",
    "start_date_type": "Anticipated",
    "start_month_year": "February 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182950.179393",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "SHARE Sharing Goals and Preferences Study",
    "completion_date": "2024-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2024",
    "created_at": "2018-01-09T041341.396384",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392090",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "SHARE Sharing Goals and Preferences Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2021",
    "received_results_disposit_date": "",
    "source": "Dana-Farber Cancer Institute",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041341.396384",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "Aqueous-PREP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures",
    "completion_date": "2021-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2021",
    "created_at": "2018-01-09T041409.443326",
    "enrollment": 2000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385304",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Aqueous-PREP A Pragmatic Randomized Trial Evaluating Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2021",
    "received_results_disposit_date": "",
    "source": "University of Maryland",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041409.443326",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Evaluate the Safety and Initial Effectiveness of the Sinusway for Endoscopy of Sinuses in Conjunction With BSD",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-08T041353.232670",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390257",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Safety and Effectiveness Evaluation of the Sinusway Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses in Conjunction With Sinus Balloon Dilation",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "3NT Medical Ltd.",
    "start_date": "2017-04-25",
    "start_date_type": "Actual",
    "start_month_year": "April 25 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041353.232670",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "OPTO-MRI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of an MRI-compatible Vital Signs Sensor System",
    "completion_date": "2018-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2018",
    "created_at": "2018-01-09T041409.874352",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384849",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Clinical Evaluation of a Fiber-optic Sensor System for Monitoring Respiration Activity and Heart Work During MRI Examinations",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2018",
    "received_results_disposit_date": "",
    "source": "Military Institute of Aviation Medicine",
    "start_date": "2017-01-03",
    "start_date_type": "Actual",
    "start_month_year": "January 3 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041409.874352",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2018",
    "created_at": "2017-12-31T041331.092251",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385031",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "Maastricht Radiation Oncology",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041331.092251",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2018-01-11T042401.779579",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392467",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multi-center Randomized Double-blind Parallel Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of PNEUMOSTEM for the Prevention and Treatment of Severe Bronchopulmonary Dysplasia in Premature Infants",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2021",
    "received_results_disposit_date": "",
    "source": "Medipost Co Ltd.",
    "start_date": "2019-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2019",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042401.779579",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Endotracheal Intracuff Pressure Between Two Cuff Sealing Methods",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2017-12-31T041330.913847",
    "enrollment": 35,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385044",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Endotracheal Intracuff Pressure Between Two Cuff Sealing Methods",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "DongGuk University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041330.913847",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TRUST",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The TransEnterix European Patient Registry",
    "completion_date": "2025-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2025",
    "created_at": "2017-12-31T041329.822570",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385109",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The TransEnterix European Patient Registry for Robotic Assisted Laparoscopic Procedures in Urology Abdominal Surgery Thoracic and Gynecologic Surgery",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2025-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2025",
    "received_results_disposit_date": "",
    "source": "TransEnterix",
    "start_date": "2017-07-25",
    "start_date_type": "Actual",
    "start_month_year": "July 25 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "30 Days",
    "updated_at": "2017-12-31T041329.822570",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mel vs BUCYVP-16 Conditioning Regimen for MM Undergoing Auto-HSCT",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2017-12-31T041330.024242",
    "enrollment": 122,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385096",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Melphalan vs Busulfan Cyclophosphamide Etoposide Conditioning Regimen for Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "Nanfang Hospital of Southern Medical University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041330.024242",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Serum or plasma",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Association of Haptoglobin 2-2 With Postoperative Delirium",
    "completion_date": "2019-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2019",
    "created_at": "2018-01-11T042401.524584",
    "enrollment": 800,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392480",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Determination of the Association of Haptoglobin 2-2 With Delirium After Orthopedic Surgery",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2019",
    "received_results_disposit_date": "",
    "source": "Sun Yat-sen University",
    "start_date": "2017-12-20",
    "start_date_type": "Actual",
    "start_month_year": "December 20 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042401.524584",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of the Novel Step Up Your Game Program on Mens Lacrosse",
    "completion_date": "2017-05-31",
    "completion_date_type": "Actual",
    "completion_month_year": "May 31 2017",
    "created_at": "2018-01-08T041405.936442",
    "enrollment": 25,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389737",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of the Novel Step Up Your Game Program on Mens Collegiate Lacrosse Players A Comparative Study of a Comprehensive Osteopathic Approach on Performance",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-05-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 31 2017",
    "received_results_disposit_date": "",
    "source": "New York Institute of Technology",
    "start_date": "2017-03-07",
    "start_date_type": "Actual",
    "start_month_year": "March 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041405.936442",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting",
    "completion_date": "2017-03-10",
    "completion_date_type": "Actual",
    "completion_month_year": "March 10 2017",
    "created_at": "2018-01-09T041405.153498",
    "enrollment": 200,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387956",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intrathecal Atropine to Prevent Morphine Induced Postoperative Nausea and Vomiting in Patients Undergoing Laparotomy Under General Anesthesia",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-28",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 28 2016",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2016-06-20",
    "start_date_type": "Actual",
    "start_month_year": "June 20 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041405.153498",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia",
    "completion_date": "2017-06-01",
    "completion_date_type": "Actual",
    "completion_month_year": "June 2017",
    "created_at": "2017-12-31T041329.057148",
    "enrollment": 90,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385161",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia Refractory to Medical Treatment",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-06-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 2015",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2013-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041329.057148",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SWE Predict",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases",
    "completion_date": "2018-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2018",
    "created_at": "2018-01-07T041855.849290",
    "enrollment": 1500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389152",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of SWE as a Predictive Tool for Progression of Chronic Liver Diseases",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2018",
    "received_results_disposit_date": "",
    "source": "SuperSonic Imagine",
    "start_date": "2010-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 1 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041855.849290",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy",
    "completion_date": "2023-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2023",
    "created_at": "2018-01-11T042416.971488",
    "enrollment": 580,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385057",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2023",
    "received_results_disposit_date": "",
    "source": "Massachusetts Eye and Ear Infirmary",
    "start_date": "2018-09-01",
    "start_date_type": "Anticipated",
    "start_month_year": "September 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042416.971488",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brains Vessels and Blood Flow",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2018",
    "created_at": "2018-01-08T041415.729826",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385174",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brains Vessels and Blood Flow",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Danish Headache Center",
    "start_date": "2017-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041415.729826",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Lurasidone HCl in Subjects With Schizophrenia",
    "completion_date": "2019-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2019",
    "created_at": "2018-01-11T042351.997414",
    "enrollment": 62,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393026",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Multi-Center Open-Label Single Arm and Flexible Dose Study of the Effectiveness and Safety of Oral Use Lurasidone HCl Tablet LATUDA for 40-160 mgDay in Subjects With Schizophrenia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2019",
    "received_results_disposit_date": "",
    "source": "Standard Chem.  Pharm. Co. Ltd.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042351.997414",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "OPEN  ASK Cluster Randomized Controlled Trial",
    "completion_date": "2021-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 1 2021",
    "created_at": "2017-12-31T041321.255774",
    "enrollment": 5565,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385512",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Improving Patient-Centered Communication in Primary Care A Cluster Randomized Controlled Trial of the Comparative Effectiveness of Three Interventions",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 1 2020",
    "received_results_disposit_date": "",
    "source": "University of California San Diego",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041321.255774",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nutrition Arsenic and Cognitive Function in Children",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-08T041414.855072",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384862",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Nutrition Arsenic and Cognitive Function in Children",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Columbia University",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041414.855072",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Role of Pain-related Fear in Sexual Pain",
    "completion_date": "2018-07-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 30 2018",
    "created_at": "2017-12-31T041319.898274",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385603",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Role of Pain-related Fear in Sexual Pain",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041319.898274",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-11T042416.318960",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384875",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "overall_status": "Withheld",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "Redacted",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "NA",
    "target_duration": "",
    "updated_at": "2018-01-11T042416.318960",
    "verification_date": "",
    "verification_month_year": "",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Feasibility and Acceptability of a Yoga Intervention in Gynecologic Cancer",
    "completion_date": "2018-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2018",
    "created_at": "2018-01-09T041409.221976",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385577",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Feasibility and Acceptability of a Yoga Intervention for Distress in Women With Gynecologic Cancer",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2018",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041409.221976",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "NPO-NIV",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nutritional Practices and Outcomes in Non-Invasive Ventilation",
    "completion_date": "2018-07-09",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 9 2018",
    "created_at": "2018-01-02T182955.891072",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385421",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Nutritional Practices and Outcomes in Non-Invasive Ventilation",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 9 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital Grenoble",
    "start_date": "2017-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182955.891072",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "COMSE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Maternity Care and Contraception",
    "completion_date": "2017-04-01",
    "completion_date_type": "Actual",
    "completion_month_year": "April 1 2017",
    "created_at": "2018-01-08T041358.543250",
    "enrollment": 299,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389958",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Safe Maternity Care Through Immediate Provision of Highly-effective Postpartum Contraception",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 30 2016",
    "received_results_disposit_date": "",
    "source": "Oregon Health and Science University",
    "start_date": "2015-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041358.543250",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Metabol-T",
    "baseline_population": "",
    "biospec_description": "Tear fluid",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Metabolites of Tear Fluid",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2018",
    "created_at": "2018-01-07T041853.161727",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389282",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Metabolites of Tear Fluid - Evaluation in a Clinical Pilot Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 1 2016",
    "received_results_disposit_date": "",
    "source": "University Hospital Tuebingen",
    "start_date": "2013-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2013",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041853.161727",
    "verification_date": "2017-10-01",
    "verification_month_year": "October 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Healthy School Start Plus Intervention Study",
    "completion_date": "2020-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2020",
    "created_at": "2018-01-11T042408.947742",
    "enrollment": 350,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390725",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Healthy School Start Plus Intervention for Prevention of Childhood Overweight and Obesity in Disadvantaged Areas Through Parental Support in the School Setting - a Parallel Group Cluster Randomised Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 20 2019",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042408.947742",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of Subconcussive Events on Cognition",
    "completion_date": "2018-07-03",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 3 2018",
    "created_at": "2018-01-11T042332.095597",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394248",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Effects of Subconcussive Events on Cognition",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-03",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 3 2018",
    "received_results_disposit_date": "",
    "source": "New York Institute of Technology",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "6 Months",
    "updated_at": "2018-01-11T042332.095597",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stress and CKD Among African Americans",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-05T041729.493190",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387319",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Social Stress Inflammation and Chronic Kidney Disease Among African Americans",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Emory University",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041729.493190",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Obesity and Heart Health",
    "completion_date": "2021-05-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 31 2021",
    "created_at": "2018-01-07T041901.856508",
    "enrollment": 28,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388788",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Circadian Mechanisms of Cardiovascular Risk in Obesity",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2020",
    "received_results_disposit_date": "",
    "source": "Oregon Health and Science University",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041901.856508",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients",
    "completion_date": "2016-10-30",
    "completion_date_type": "Actual",
    "completion_month_year": "October 30 2016",
    "created_at": "2018-01-11T042324.211671",
    "enrollment": 260,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394742",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients - a Randomized Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-06-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 30 2015",
    "received_results_disposit_date": "",
    "source": "University of Jyvaskyla",
    "start_date": "2014-05-01",
    "start_date_type": "Actual",
    "start_month_year": "May 1 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042324.211671",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-09T041404.267638",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388931",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041404.267638",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of HILT in Shoulder Osteoarthritis",
    "completion_date": "2018-08-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 21 2018",
    "created_at": "2018-01-02T182956.680911",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385408",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of High-intensity Laser Therapy in Shoulder Osteoarthritis a Prospective Randomized Controlled Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 21 2018",
    "received_results_disposit_date": "",
    "source": "University of Rzeszow",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182956.680911",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CA_LBW",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Optimization of Contrast Agent Dose in CT With Lean Body Weight",
    "completion_date": "2018-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2018",
    "created_at": "2017-12-31T041335.156401",
    "enrollment": 274,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384979",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Controlled Trial of Optimization of Contrast Agent Dose in CT With Lean Body Weight",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2018",
    "received_results_disposit_date": "",
    "source": "IRCCS Policlinico S. Donato",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041335.156401",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to 1 and Less Than or Equal to  30 Years of Age With RelapsedRefractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma",
    "completion_date": "2021-06-17",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 17 2021",
    "created_at": "2017-12-31T041340.669351",
    "enrollment": 69,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384654",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Open-label Multicenter Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects 1 and 30 Years of Age With RelapsedRefractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 5 2020",
    "received_results_disposit_date": "",
    "source": "Janssen Research  Development LLC",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041340.669351",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-08T041349.269905",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390504",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "overall_status": "Withheld",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "Redacted",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "NA",
    "target_duration": "",
    "updated_at": "2018-01-08T041349.269905",
    "verification_date": "",
    "verification_month_year": "",
    "why_stopped": ""
  },
  {
    "acronym": "Endorings-2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Endorings-2-assisted Colonoscopy a New Accessory for Improvement of Adenoma Detection Rate",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2020",
    "created_at": "2017-12-31T041323.140610",
    "enrollment": 292,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385434",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Endorings-2-assisted Colonoscopy a New Accessory for Improvement of Adenoma Detection Rate",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Muenster",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041323.140610",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Time Difference Between Onsets of Lateral And Medial Hamstring Muscles During Gait in Patients With Patellofemoral Pain.",
    "completion_date": "2015-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 1 2015",
    "created_at": "2018-01-11T042357.913351",
    "enrollment": 30,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392688",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Is There a Time Difference Between Onsets of Lateral and Medial Hamstring Muscles During Gait in Patients With Patellofemoral Pain Comparing to Healthy Subjects",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-05-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 30 2015",
    "received_results_disposit_date": "",
    "source": "Baheehir University",
    "start_date": "2014-01-21",
    "start_date_type": "Actual",
    "start_month_year": "January 21 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042357.913351",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase 2b Study of the Efficacy Safety and Tolerability of M1095 in Subjects With Moderate to Severe Psoriasis",
    "completion_date": "2020-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2020",
    "created_at": "2018-01-11T042417.464476",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384745",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "A Phase 2b Randomized Double-blind Placebo Controlled Multi-center 12-week Study With an Additional 40-week Follow-up Assessment of Efficacy Safety and Tolerability of M1095 in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2019",
    "received_results_disposit_date": "",
    "source": "Bond Avillion 2 Development LP",
    "start_date": "2018-08-01",
    "start_date_type": "Anticipated",
    "start_month_year": "August 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042417.464476",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Blood Biomarker in Early Parkinsons Disease",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-31T041338.481507",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384797",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Blood Biomarker in Early Parkinsons Disease",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2019",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041338.481507",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of EDP-938 in Healthy Subjects",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2017-12-31T041338.091769",
    "enrollment": 82,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384823",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Randomized Double-Blind Placebo-Controlled First-In-Human Study of Orally Administered EDP-938 to Evaluate the Safety Tolerability and Pharmacokinetics of Single Ascending Doses SAD Multiple Ascending Doses MAD and the Effect of Food on EDP-938 Pharmacokinetics in Healthy Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Enanta Pharmaceuticals",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041338.091769",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PROGREDIR",
    "baseline_population": "",
    "biospec_description": "Urine midstream sample and 24h collection and blood fasting serum fasting plasma post\n      OGGT serum post OGGT plasma aliquots were prepared and stored at -180 C in nitrogen.\n\n      DNA extraction was performed stored at -80C.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Chronic Kidney Disease Determinants of Progression and Cardiovascular Risk",
    "completion_date": "2013-12-15",
    "completion_date_type": "Actual",
    "completion_month_year": "December 15 2013",
    "created_at": "2018-01-11T042341.510394",
    "enrollment": 454,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393663",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Chronic Kidney Disease Determinants of Progression and Cardiovascular Risk. A Cohort Study in a Brazilian Population",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2013-12-15",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 15 2013",
    "received_results_disposit_date": "",
    "source": "University of Sao Paulo",
    "start_date": "2012-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2012",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042341.510394",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Inhospital Resuscitation Incidence Causes and Outcome",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2017-12-31T041338.289121",
    "enrollment": 139,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384810",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Causes and Outcome of Cardiac Arrest In-a University Hospital",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Dokuz Eylul University",
    "start_date": "2014-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041338.289121",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of Singing-based Music Therapy Program on the Level of Psychoemotional Benefits in Caregivers of ICU Patients",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2018-01-07T041844.885919",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389568",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Effects of Singing-based Music Therapy Program on the Level of Psychoemotional Benefits in Caregivers of ICU Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041844.885919",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DIPPer Academy",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Iterative Beta Testing of Videos for the DIPPer Academy",
    "completion_date": "2019-09-19",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 19 2019",
    "created_at": "2018-01-09T041409.654643",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385265",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Interactive mHealth App for Better Glycemic Control in Families of Young Kids With T1D",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-19",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 19 2019",
    "received_results_disposit_date": "",
    "source": "University of Kansas Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041409.654643",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "EPICANCER",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2018",
    "created_at": "2018-01-11T042348.109286",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393260",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 9 2018",
    "received_results_disposit_date": "",
    "source": "Assistance Publique - Hpitaux de Paris",
    "start_date": "2018-02-06",
    "start_date_type": "Anticipated",
    "start_month_year": "February 6 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042348.109286",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PERSEO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-11T042353.388816",
    "enrollment": 1080,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392948",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Italian Society of Invasive Cardiology",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "13 Months",
    "updated_at": "2018-01-11T042353.388816",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DREAMS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Digital Rehabilitation Environment Augmenting Medical System",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-02T182945.002524",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385993",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Digital Rehabilitation Environment Augmenting Medical System",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182945.002524",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Motivating Videos to Encourage Cycling for Geriatric Rehabilitation",
    "completion_date": "2019-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2019",
    "created_at": "2018-01-11T042326.659232",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394599",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Motivating Engagement for Physical Activity in the Elderly - Day Program",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 28 2019",
    "received_results_disposit_date": "",
    "source": "Bruyere Research Institute",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042326.659232",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "LED",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema",
    "completion_date": "2017-06-27",
    "completion_date_type": "Actual",
    "completion_month_year": "June 27 2017",
    "created_at": "2018-01-05T041734.171402",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385382",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Macular Thickness and Vessel Density Changes After Dexamethasone Implant and Ranibizumab Intravitreal Injection in Diabetic Macular Edema 6-month Follow-up",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-27",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 27 2017",
    "received_results_disposit_date": "",
    "source": "G. dAnnunzio University",
    "start_date": "2016-12-06",
    "start_date_type": "Actual",
    "start_month_year": "December 6 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041734.171402",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reduced Target Delineation Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma",
    "completion_date": "2020-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2020",
    "created_at": "2018-01-07T041852.946784",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389295",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Sequential Chemoradiotherapy With Reduced Target Delineation During Radiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2020",
    "received_results_disposit_date": "",
    "source": "Fudan University",
    "start_date": "2014-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041852.946784",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NeuroFibro",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Neurostimulation Applied to Fibromyalgia",
    "completion_date": "2020-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2020",
    "created_at": "2017-12-31T041337.079725",
    "enrollment": 84,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384888",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Neurostimulation Applied to Fibromyalgia",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2019",
    "received_results_disposit_date": "",
    "source": "Federal University of Paraba",
    "start_date": "2017-05-15",
    "start_date_type": "Actual",
    "start_month_year": "May 15 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041337.079725",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Simple Needle Guide Device for Ultrasound-guided Internal Jugular Vein Catheterization in Cardiac Surgical Patients",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2018-01-08T041348.582952",
    "enrollment": 138,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390543",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of Simple Needle Guide Device for Ultrasound-guided Internal Jugular Vein Catheterization in Cardiac Surgical Patients a Randomized-controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2018-01-17",
    "start_date_type": "Anticipated",
    "start_month_year": "January 17 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041348.582952",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Salt Sensitivity Hypertension and Lens Opacities",
    "completion_date": "2017-12-07",
    "completion_date_type": "Actual",
    "completion_month_year": "December 7 2017",
    "created_at": "2018-01-02T183000.247895",
    "enrollment": 429,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385070",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Using Lens Opacities to Predict Salt Sensitivity Hypertension",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-07",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 7 2017",
    "received_results_disposit_date": "",
    "source": "Kecioren Education and Training Hospital",
    "start_date": "2017-03-15",
    "start_date_type": "Actual",
    "start_month_year": "March 15 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "6 Months",
    "updated_at": "2018-01-02T183000.247895",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ROAST",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer",
    "completion_date": "2028-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2028",
    "created_at": "2018-01-08T041350.667362",
    "enrollment": 190,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390413",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer - a Randomised Trial of Functional Oncological and Financial Aspects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2023",
    "received_results_disposit_date": "",
    "source": "Aarhus University Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041350.667362",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Efficacy and Safety of Bedaquiline TMC207 in Participants With Multibacillary Leprosy",
    "completion_date": "2020-11-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2 2020",
    "created_at": "2018-01-07T041921.036291",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384641",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open-Label Study to Evaluate the Efficacy and Safety of TMC207 in Subjects With Multibacillary Leprosy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-03",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 3 2019",
    "received_results_disposit_date": "",
    "source": "Janssen Research  Development LLC",
    "start_date": "2018-05-18",
    "start_date_type": "Anticipated",
    "start_month_year": "May 18 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041921.036291",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "DS-8201a in Human Epidermal Growth Factor Receptor2 HER2-Expressing Colorectal Cancer",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2017-12-31T041335.740414",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384940",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 2 Multicenter Open-label Study of DS-8201a in Subjects With HER2-expressing Advanced Colorectal Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Daiichi Sankyo Inc.",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041335.740414",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparative Study Between Patellar Denervation and Non-patellar Denervation in Total Knee Arthroplasty With Patellar Resurfacing",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-08T041359.794962",
    "enrollment": 210,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389880",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Patellar Denervation in Total Knee Arthroplasty With Patellar Resurfacing to Relieve Postoperative Anterior Knee Pain a Randomized Control Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2019",
    "received_results_disposit_date": "",
    "source": "Navamindradhiraj University",
    "start_date": "2017-12-18",
    "start_date_type": "Actual",
    "start_month_year": "December 18 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041359.794962",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TREAT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Time-restricted Eating on Weight Loss.",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2018",
    "created_at": "2018-01-11T042349.176923",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393195",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Study of Time-restricted Eating on Weight Loss. A Randomized Controlled Trial of the Effects of Time-restricted Eating on Weight Loss in Obese Subjects.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2018",
    "received_results_disposit_date": "",
    "source": "University of California San Francisco",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042349.176923",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Treatment Dairy for Spasticity",
    "completion_date": "2022-10-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 30 2022",
    "created_at": "2017-12-31T041335.927477",
    "enrollment": 96,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384927",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Effect of Treatment Dairy on Botulinum Toxin Treatment for Muscle Overactivity Spasticity. A Randomised Cross-over Study.",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 30 2019",
    "received_results_disposit_date": "",
    "source": "Rigshospitalet Denmark",
    "start_date": "2017-12-11",
    "start_date_type": "Actual",
    "start_month_year": "December 11 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041335.927477",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Symptom Collection of Lung Cancer Patients",
    "completion_date": "2018-05-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 31 2018",
    "created_at": "2018-01-11T042418.143638",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384680",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "A Study on Symptom Collection of Patients With Lung Cancer.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Kyunghee University Medical Center",
    "start_date": "2015-09-16",
    "start_date_type": "Actual",
    "start_month_year": "September 16 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042418.143638",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer",
    "completion_date": "2019-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2019",
    "created_at": "2018-01-11T042418.358057",
    "enrollment": 96,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384667",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety Evaluation of Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer -Randomized Double-blind Placebo-controlled Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Kyunghee University Medical Center",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042418.358057",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Mazira Project An Evaluation of Eggs During Complementary Feeding in Rural Malawi",
    "completion_date": "2018-10-19",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 19 2018",
    "created_at": "2018-01-02T182959.332579",
    "enrollment": 662,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385252",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Mazira Project An Evaluation of Eggs During Complementary Feeding in Rural Malawi",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-19",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 19 2018",
    "received_results_disposit_date": "",
    "source": "University of California Davis",
    "start_date": "2018-01-22",
    "start_date_type": "Anticipated",
    "start_month_year": "January 22 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182959.332579",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Chronic Pain Skills Study - Vanderbilt University Medical Center",
    "completion_date": "2019-06-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 22 2019",
    "created_at": "2017-12-31T041335.543465",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384953",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Chronic Pain Skills Study - Vanderbilt University Medical Center",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 22 2019",
    "received_results_disposit_date": "",
    "source": "Vanderbilt University Medical Center",
    "start_date": "2017-06-22",
    "start_date_type": "Actual",
    "start_month_year": "June 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041335.543465",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Does Cardiac Rehabilitation Reduce the Risk of Recurrence of Atrial Fibrillation Following the First Catheter Ablation",
    "completion_date": "2016-07-31",
    "completion_date_type": "Actual",
    "completion_month_year": "July 31 2016",
    "created_at": "2018-01-07T041842.304288",
    "enrollment": 462,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389633",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Does Cardiac Rehabilitation Reduce the Risk of Recurrence of Atrial Fibrillation Following the First Catheter Ablation",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 31 2016",
    "received_results_disposit_date": "",
    "source": "Hasselt University",
    "start_date": "2007-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2007",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041842.304288",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Feasibility and Acceptability of a Soy-fiber-maize Complementary Food in Malawi.",
    "completion_date": "2019-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2019",
    "created_at": "2017-12-31T041320.081878",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385590",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Feasibility and Acceptability of a Soy-fiber-maize Blend Complementary Food and Its Effects on Stool Frequency Stool Consistency Microbiota Composition Growth and Dietary Intake of Children Aged 6 to 36 Months in Malawi.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2019",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-09-01",
    "start_date_type": "Anticipated",
    "start_month_year": "September 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041320.081878",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer",
    "completion_date": "2023-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2023",
    "created_at": "2017-12-31T041336.112354",
    "enrollment": 110,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384914",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2022",
    "received_results_disposit_date": "",
    "source": "H. Lee Moffitt Cancer Center and Research Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041336.112354",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test",
    "completion_date": "2018-03-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 15 2018",
    "created_at": "2017-12-31T041328.372073",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385187",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 15 2018",
    "received_results_disposit_date": "",
    "source": "Ectosense NV",
    "start_date": "2017-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041328.372073",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer KLASS-06",
    "completion_date": "2027-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2027",
    "created_at": "2017-12-31T041331.282233",
    "enrollment": 772,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385018",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Multicenter Randomized Controlled Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer KLASS-06",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2022",
    "received_results_disposit_date": "",
    "source": "Yonsei University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041331.282233",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effectiveness of Waiting Room Posters for Stroke Education",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-09T041346.975685",
    "enrollment": 1096,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391713",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effectiveness of Waiting Room Posters in Improving Awareness and Knowledge of the Signs and Symptoms of Stroke",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "University of Malaya",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041346.975685",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Outcomes in Chronic Low Pain Back Utilizing Activity Trackers",
    "completion_date": "2018-05-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 11 2018",
    "created_at": "2017-12-31T041330.324338",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385083",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Clinical Outcomes in Chronic Low Pain Back Utilizing Activity Trackers",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2018",
    "received_results_disposit_date": "",
    "source": "New York Institute of Technology",
    "start_date": "2017-05-12",
    "start_date_type": "Actual",
    "start_month_year": "May 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041330.324338",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-05T041723.752345",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387657",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Single-Center Open-Label Two-Period Single-Sequence Multiple Dosing Drug-Drug Interaction Study of Sotagliflozin and Hydrochlorothiazide in Healthy Male and Female Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2017-12-08",
    "start_date_type": "Actual",
    "start_month_year": "December 8 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041723.752345",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-02T182958.706525",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385356",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "University Clinical Centre Maribor",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182958.706525",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease",
    "completion_date": "2018-09-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 22 2018",
    "created_at": "2017-12-31T041335.352967",
    "enrollment": 324,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384966",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Multi-center Double-blind Randomized Placebo-controlled Study to Assess the Pharmacodynamics Pharmacokinetics Tolerability and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 22 2018",
    "received_results_disposit_date": "",
    "source": "Idorsia Pharmaceuticals Ltd.",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041335.352967",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "FoRtitude",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2018-01-02T183001.142249",
    "enrollment": 215,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384992",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 16,
    "number_of_groups": "",
    "official_title": "Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors The FoRtitude Trial",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-12-05",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 5 2015",
    "received_results_disposit_date": "",
    "source": "Wake Forest University Health Sciences",
    "start_date": "2014-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T183001.142249",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Results of Pars Plana Vitrectomy in Diabetic Macular Edema",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2017-12-31T041336.307213",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384901",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Results of Pars Plana Vitrectomy in Diabetic Macular Edema",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Hillel Yaffe Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041336.307213",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Cognition and Control in Youths",
    "completion_date": "2022-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2022",
    "created_at": "2018-01-11T042345.948873",
    "enrollment": 270,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393390",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Study of Cognition and Control in Youths",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2021",
    "received_results_disposit_date": "",
    "source": "University of Michigan",
    "start_date": "2016-03-17",
    "start_date_type": "Actual",
    "start_month_year": "March 17 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042345.948873",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-02T182946.007765",
    "enrollment": 42,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-20",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385967",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Prospective Double Blind Clinical Trial to Investigate the Increase in Duration of Analgesia With Addition of 0.25mcgkg of Dexmedetomidine DEX to 25 ml of 0.5Ropivacaine in Supraclavicular Brachial Plexus Block.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182946.007765",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model",
    "completion_date": "2018-06-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 21 2018",
    "created_at": "2017-12-29T041529.614326",
    "enrollment": 34,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383783",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-12",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 12 2018",
    "received_results_disposit_date": "",
    "source": "Indiana University",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041529.614326",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Non Digestible Carbohydrate on Production of Phenolic Acids From Strawberry Juice",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2017-12-29T041529.230717",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383809",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Impact of Non Digestible Carbohydrate on Production of Phenolic Acids From Strawberry Juice",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Glasgow",
    "start_date": "2017-04-28",
    "start_date_type": "Actual",
    "start_month_year": "April 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041529.230717",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma",
    "completion_date": "2020-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2020",
    "created_at": "2017-12-29T041529.426205",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383796",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Clinical Trial Comparing Three Dimension Laparoscopic and Open Surgery for Perihiliar Cholangiocarcinoma",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2018",
    "received_results_disposit_date": "",
    "source": "Tongji Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041529.426205",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0D1 Radical Resection",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041341.213559",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392103",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0D1 Radical Resection",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Zhongnan Hospital",
    "start_date": "2017-01-01",
    "start_date_type": "",
    "start_month_year": "January 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041341.213559",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Medication Management Software for Infertility Patients",
    "completion_date": "2018-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2018",
    "created_at": "2018-01-09T041411.815382",
    "enrollment": 190,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383848",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Medication Management Software for Infertility Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "University of Michigan",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041411.815382",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body.",
    "completion_date": "2018-05-04",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 4 2018",
    "created_at": "2018-01-11T042419.258036",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382509",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase I Open-label Single and Multiple Dose Trial to Investigate Metabolism and Pharmacokinetics of 14CBI 1467335 Administered as Oral Solution in Healthy Male Volunteers",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-04",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 4 2018",
    "received_results_disposit_date": "",
    "source": "Boehringer Ingelheim",
    "start_date": "2018-01-12",
    "start_date_type": "Anticipated",
    "start_month_year": "January 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042419.258036",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Speeding Recovery From Pain and Opioid Use",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-07T041901.420016",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388814",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Speeding Recovery From Pain and Opioid Use After Mastectomy and Breast Reconstruction Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Wake Forest University Health Sciences",
    "start_date": "2018-07-01",
    "start_date_type": "Anticipated",
    "start_month_year": "July 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041901.420016",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NI EGP highBMI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 1 2017",
    "created_at": "2017-12-29T041528.640560",
    "enrollment": 7,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383822",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Egulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance",
    "overall_status": "Completed",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 31 2017",
    "received_results_disposit_date": "",
    "source": "University Health Network Toronto",
    "start_date": "2015-09-08",
    "start_date_type": "Actual",
    "start_month_year": "September 8 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041528.640560",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer",
    "completion_date": "2021-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2021",
    "created_at": "2017-12-29T041528.447498",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383835",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Feasibility Study of Moderate Dose Omega 3 Fatty Acid Supplementation in Premenopausal Women at High Risk for Breast Cancer Considering Future Pregnancy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2020",
    "received_results_disposit_date": "",
    "source": "University of Kansas Medical Center",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041528.447498",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Probiotic Intervention to Prevent Relapse Following Hospitalization for Mania",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2021",
    "created_at": "2017-12-29T041527.888090",
    "enrollment": 66,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383874",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Probiotic Intervention to Prevent Relapse Following Hospitalization for Mania",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2020",
    "received_results_disposit_date": "",
    "source": "University of Texas Southwestern Medical Center",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041527.888090",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nutrition Status BMD and SSRIs",
    "completion_date": "2014-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2014",
    "created_at": "2017-12-29T041528.067046",
    "enrollment": 13027,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383861",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Nutrition Status Bone Mass Density and Selective Serotonin Reuptake Inhibitors",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2014",
    "received_results_disposit_date": "",
    "source": "University of New Mexico",
    "start_date": "2005-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2005",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041528.067046",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "KVUS at Neoadjuvant CTx of Breast Cancer",
    "completion_date": "2019-12-12",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 12 2019",
    "created_at": "2017-12-31T041328.188957",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385200",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Contrast-enhanced Ultrasound in Neoadjuvant Chemotherapy of Breast Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-12",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 12 2019",
    "received_results_disposit_date": "",
    "source": "RWTH Aachen University",
    "start_date": "2016-12-12",
    "start_date_type": "Actual",
    "start_month_year": "December 12 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041328.188957",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients",
    "completion_date": "2019-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2019",
    "created_at": "2017-12-31T041329.259872",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385148",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Diagnostic Performance and Evaluation Efficacy of a Novel PTK7 PET Radiotracer 68Ga-SGC8",
    "overall_status": "Recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-15",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 15 2017",
    "received_results_disposit_date": "",
    "source": "Xijing Hospital",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041329.259872",
    "verification_date": "2017-01-01",
    "verification_month_year": "January 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Link Between Clinical and Physiological Sleep Data and Health-related Outcomes",
    "completion_date": "2022-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2022",
    "created_at": "2018-01-11T042420.132537",
    "enrollment": 5000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383354",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Examining the Link Between Clinical and Physiological Sleep Data and Health-related Outcomes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Sunnybrook Health Sciences Centre",
    "start_date": "2004-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2004",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042420.132537",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Long Term Open-label Study Evaluating Safety of Diacerein 1 Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex",
    "completion_date": "2019-12-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 15 2019",
    "created_at": "2018-01-07T041852.737252",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389308",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An International Multicenter Open-label Long Term Extension Study Evaluating the Safety of Diacerein 1 Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex EBS",
    "overall_status": "Enrolling by invitation",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 15 2019",
    "received_results_disposit_date": "",
    "source": "Castle Creek Pharmaceuticals LLC",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041852.737252",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2017-12-31T041347.395383",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384238",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase III Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Pancreas Cancer During Surgical Procedures",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Stanford University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041347.395383",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CATSTAT-HF",
    "baseline_population": "",
    "biospec_description": "Full blood obtained from the antecubital vein.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Plasma Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-07T041851.485515",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389386",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Plasma Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital of Split",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041851.485515",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of the Survival of Recombinant Human Neuregulin-1 in Chronic Heart Failure CHF Patients",
    "completion_date": "2023-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2023",
    "created_at": "2018-01-11T042412.758497",
    "enrollment": 1600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388593",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase III Multi-centerRandomized Double-blind Based on Standard Therapy Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1 in Patients With Chronic Systolic Heart Failure",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2022",
    "received_results_disposit_date": "",
    "source": "Zensun Sci.  Tech. Co. Ltd.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042412.758497",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Dosing Time and Meal on IN-105 Insulin Tregopil PK and PD",
    "completion_date": "2014-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 1 2014",
    "created_at": "2018-01-11T042353.142825",
    "enrollment": 51,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392961",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "To Assess the Pharmacokinetics and Pharmacodynamics of IN-105 in Relation to the Pre-meal Dosing Time Between-meal Interval and Type of Meal - A Phase 1 Three Cohort Randomized Placebo Controlled Crossover Trial in Type 2 Diabetes Patients",
    "overall_status": "Completed",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 1 2014",
    "received_results_disposit_date": "",
    "source": "Biocon Limited",
    "start_date": "2014-03-27",
    "start_date_type": "Actual",
    "start_month_year": "March 27 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042353.142825",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Whole blood serum stool",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Nutritional Intake and Gut Microbiome",
    "completion_date": "2018-10-12",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 12 2018",
    "created_at": "2018-01-07T041907.465563",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388411",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Nutritional Intake Metabolic Abnormalities and Gut Microbiome in Children",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-12",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 12 2018",
    "received_results_disposit_date": "",
    "source": "Hallym University Kangnam Sacred Heart Hospital",
    "start_date": "2017-10-18",
    "start_date_type": "Actual",
    "start_month_year": "October 18 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041907.465563",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "serum and plasma",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Protein and microRNA Markers for Early Detection of Alzheimers Disease",
    "completion_date": "2020-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2020",
    "created_at": "2018-01-05T041710.584378",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388242",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Screen and Verification of Biomarkers for Early Detection of Alzheimers Disease",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2020",
    "received_results_disposit_date": "",
    "source": "Sun Yat-sen University",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041710.584378",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Augmented Care at Worksite for Diabetes Prevention",
    "completion_date": "2023-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2023",
    "created_at": "2017-12-29T041545.653561",
    "enrollment": 236,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382873",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of Augmented Care at the Worksite for Diabetes Prevention",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2023",
    "received_results_disposit_date": "",
    "source": "Ohio State University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041545.653561",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Suspension Training in the Elderly",
    "completion_date": "2017-04-01",
    "completion_date_type": "Actual",
    "completion_month_year": "April 1 2017",
    "created_at": "2017-12-31T041347.017201",
    "enrollment": 30,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384264",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Changes in Phase Angle and Handgrip Strength Induced by Suspension Training in Older Women A Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-01-12",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 12 2017",
    "received_results_disposit_date": "",
    "source": "University of Bologna",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041347.017201",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "OnTrackAn Online Role-Playing Game for Young People With First Episode Psychosis",
    "completion_date": "2020-02-29",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 29 2020",
    "created_at": "2018-01-11T042409.400680",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390491",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "OnTrackAn Online Role-Playing Game for Young People With First Episode Psychosis",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-29",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 29 2020",
    "received_results_disposit_date": "",
    "source": "Center for Social Innovation Massachusetts",
    "start_date": "2018-04-17",
    "start_date_type": "Anticipated",
    "start_month_year": "April 17 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042409.400680",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Self-Advocacy for Independent Life SAIL After TBI",
    "completion_date": "2020-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2020",
    "created_at": "2018-01-05T041732.705603",
    "enrollment": 74,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385824",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Self-Advocacy for Independent Life SAIL After Traumatic Brain Injury",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2020",
    "received_results_disposit_date": "",
    "source": "Craig Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041732.705603",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Dental Hygiene and Peri-Implant Tissues Homeostasis",
    "completion_date": "2019-05-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 15 2019",
    "created_at": "2017-12-31T041344.127006",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384446",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Role of Dental Hygiene Procedures in Disruption of Healthy Homeostasis in Tissues Surrounding Dental Implants - Phase I",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 15 2018",
    "received_results_disposit_date": "",
    "source": "University of Washington",
    "start_date": "2017-11-22",
    "start_date_type": "Actual",
    "start_month_year": "November 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041344.127006",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EVIDENS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Observational Study for Lung Cancer Patients Treated With Nivolumab",
    "completion_date": "2020-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2020",
    "created_at": "2018-01-11T042420.856287",
    "enrollment": 1462,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382496",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "EVIDENS Lung Cancer Patients TrEated With NiVolumab A LongItuDinal ProspEctive ObservatioNal Multicentric Study",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2020",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2016-07-13",
    "start_date_type": "Actual",
    "start_month_year": "July 13 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042420.856287",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "K-LUCAS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Korean Lung Cancer Screening Project",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042324.770018",
    "enrollment": 8000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394703",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Korean Lung Cancer Screening Project for High-risk Smokers to Evaluate Effectiveness and Feasibility of Lung Cancer Screening With Low-dose Computed Tomography for Implementing National Cancer Screening Program",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2017",
    "received_results_disposit_date": "",
    "source": "National Cancer Center Korea",
    "start_date": "2017-04-10",
    "start_date_type": "Actual",
    "start_month_year": "April 10 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042324.770018",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pectoralis II Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-02T183007.693210",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383198",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pectoralis II Block With Liposomal Bupivacaine vs Bupivacaine Plus Dexamethasone for Mastectomy With Immediate Reconstruction",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 1 2018",
    "received_results_disposit_date": "",
    "source": "Greenville Health System",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T183007.693210",
    "verification_date": "2017-10-01",
    "verification_month_year": "October 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stent Placement and the Risk of New-onset AF in Patients With AMI",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2017-12-29T041543.774809",
    "enrollment": 40000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382990",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Impacts of Different Stent Types in Acute Myocardial Infarction on the Risk of Atrial Fibrillation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Mackay Memorial Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041543.774809",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.",
    "completion_date": "2020-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2020",
    "created_at": "2018-01-08T041405.725211",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389750",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "A Randomized Double-Blind Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists in Physically Dependent Opioid Users With Moderate-to-Severe Opioid Use Disorder",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2020",
    "received_results_disposit_date": "",
    "source": "New York State Psychiatric Institute",
    "start_date": "2018-02-15",
    "start_date_type": "Anticipated",
    "start_month_year": "February 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041405.725211",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "HCV Positive Heart Donors",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-29T041546.072007",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382847",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-center Pilot Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Heart Transplant Recipients With Post-transplant Treatment of Hepatitis C Viremia With Mavyret",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "New York University School of Medicine",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041546.072007",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "BIO-CR-RBC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Recovery and Lifespan of Red Blood Cells From Pathogen-reduced Stored Blood Units",
    "completion_date": "2019-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2019",
    "created_at": "2017-12-31T041344.684534",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384407",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Measurement of the Recovery and Lifespan of Red Blood Cells From Pathogen-Reduced Stored Blood Units Using Cellular Biotinylation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Cincinnati",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041344.684534",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-02T183002.251674",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384563",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 9,
    "number_of_groups": "",
    "official_title": "Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Baylor College of Medicine",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T183002.251674",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Individual Patient Expanded Access for AB-PA01 an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-11T042309.739957",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395743",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Expanded Access Program for AB-PA01 an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic for the Treatment of Individual Patients With Serious or Immediately Life-threatening Infections Caused by Pseudomonas Aeruginosa",
    "overall_status": "Available",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "AmpliPhi Biosciences Corporation",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "Expanded Access",
    "target_duration": "",
    "updated_at": "2018-01-11T042309.739957",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Draining Significant Effusion on Gas Exchange and Lung Mechanics in Patient Under Mechanical Ventilation",
    "completion_date": "2017-08-30",
    "completion_date_type": "Actual",
    "completion_month_year": "August 30 2017",
    "created_at": "2018-01-11T042322.251570",
    "enrollment": 27,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394872",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 30 2017",
    "received_results_disposit_date": "",
    "source": "Dokuz Eylul University",
    "start_date": "2016-05-01",
    "start_date_type": "Actual",
    "start_month_year": "May 1 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042322.251570",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-09T041357.513173",
    "enrollment": 31,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391050",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase IbII Study to Investigate the Safety and Clinical Activity of APR-246 in Combination With Dabrafenib in Patients With BRAF V600 Mutant Unresectable andor mEtastatic Cutaneous MElanoma Resistant to DabrafenibTrametinib Combination",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "Aprea Therapeutics AB",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041357.513173",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "PREPARED",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Implementation of Shared Decision-Making in Cancer Care",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-11T042346.587636",
    "enrollment": 1440,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393351",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of a Program for Routine Implementation of Shared Decision-Making in Cancer Care A Stepped Wedge Cluster Randomized Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Universittsklinikum Hamburg-Eppendorf",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042346.587636",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04",
    "completion_date": "2022-04-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 18 2022",
    "created_at": "2017-12-29T041540.852501",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383146",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A 52-week Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis",
    "overall_status": "Enrolling by invitation",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-04-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 18 2022",
    "received_results_disposit_date": "",
    "source": "Allergan",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041540.852501",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Individual Patient Expanded Access for AB-SA01 an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-11T042309.420457",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395769",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Expanded Access Program for AB-SA01 an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic for the Treatment of Serious Infections Caused by Staphylococcus Aureus.",
    "overall_status": "Available",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "AmpliPhi Biosciences Corporation",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "Expanded Access",
    "target_duration": "",
    "updated_at": "2018-01-11T042309.420457",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337",
    "completion_date": "2017-11-07",
    "completion_date_type": "Actual",
    "completion_month_year": "November 7 2017",
    "created_at": "2017-12-31T041355.036508",
    "enrollment": 16,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382756",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Cross-over Randomized and Open-label Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-337 After a Single Oral Dose in Healthy Male Subjects",
    "overall_status": "Completed",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-02",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 2 2017",
    "received_results_disposit_date": "",
    "source": "Chong Kun Dang Pharmaceutical",
    "start_date": "2017-10-12",
    "start_date_type": "Actual",
    "start_month_year": "October 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041355.036508",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-31T041354.799149",
    "enrollment": 270,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382782",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Illinois Institute of Technology",
    "start_date": "2017-12-12",
    "start_date_type": "Actual",
    "start_month_year": "December 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041354.799149",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Studies of Sulfur Metabolism in Humans",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2017-12-31T041354.381540",
    "enrollment": 1,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383133",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Allosteric Regulation of Cytosolic Sulfotransferases in Humans",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Albert Einstein College of Medicine Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041354.381540",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DSE-vs-FFR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "DSE vs. FFR in SCAD and BYSTANDER Lesions",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2017-12-31T041353.355483",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383718",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Comparison of Dobutamine Stress Echocardiography and Fractional Flow Reserve in Patients With Moderate Coronary Artery Disease Stable and Non-culprit Lesions Investigation",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 1 2016",
    "received_results_disposit_date": "",
    "source": "Bajcsy-Zsilinszky Hospital",
    "start_date": "2014-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041353.355483",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2017-12-31T041355.241307",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382743",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy - a Randomized Control Trial.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Kasr El Aini Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041355.241307",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "INTEVOPROSTATE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma",
    "completion_date": "2018-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2018",
    "created_at": "2017-12-31T041353.149192",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382522",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital Brest",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041353.149192",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study",
    "completion_date": "2024-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2024",
    "created_at": "2017-12-31T041355.455794",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382457",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2020",
    "received_results_disposit_date": "",
    "source": "Edwards Lifesciences",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041355.455794",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors",
    "completion_date": "2019-11-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 15 2019",
    "created_at": "2018-01-11T042420.626710",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382834",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 15 2019",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042420.626710",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Barley and Rice Mixture Effects on Blood Glucose",
    "completion_date": "2017-09-18",
    "completion_date_type": "Actual",
    "completion_month_year": "September 18 2017",
    "created_at": "2018-01-05T041729.057946",
    "enrollment": 39,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387345",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "-glucan Rich Barley and Rice Mixes and Post-prandial Glycemia - a Dose Response Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-04",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 4 2017",
    "received_results_disposit_date": "",
    "source": "Arizona State University",
    "start_date": "2017-02-13",
    "start_date_type": "Actual",
    "start_month_year": "February 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041729.057946",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Outcomes With Amniotic Fluid for Musculoskeletal Conditions Musculoskeletal Conditions",
    "completion_date": "2022-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2022",
    "created_at": "2018-01-08T041340.907672",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390920",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of Regenerative Medicine Treatment Outcomes With Amniotic Fluid for Musculoskeletal Conditions",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2020",
    "received_results_disposit_date": "",
    "source": "R3 Stem Cell",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041340.907672",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Unilateral Approach for Bilateral Decompression of Lumbar Canal Stenosis",
    "completion_date": "2018-11-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 15 2018",
    "created_at": "2018-01-07T041911.173573",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388307",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Unilateral Decompression Approach for Lumbar Canal Stenosis",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041911.173573",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CEGIR 7807 Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2020",
    "created_at": "2018-01-07T041922.415528",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382678",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "CEGIR 7807 Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Childrens Hospital Medical Center Cincinnati",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Day",
    "updated_at": "2018-01-07T041922.415528",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Mosey",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Immediate Versus Delayed Cochlear Implantation on Hearing Handicap",
    "completion_date": "2020-03-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2 2020",
    "created_at": "2018-01-11T042421.568062",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382769",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Controlled Trial of Immediate Versus Delayed Cochlear Implantation on Hearing Handicap",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2 2019",
    "received_results_disposit_date": "",
    "source": "Cochlear",
    "start_date": "2018-02-02",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042421.568062",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects",
    "completion_date": "2018-06-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 10 2018",
    "created_at": "2017-12-29T041538.814812",
    "enrollment": 34,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383276",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Dose Escalating Study of the Safety Tolerability and Pharmacokinetics of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-25",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 25 2018",
    "received_results_disposit_date": "",
    "source": "Beijing Tongren Hospital",
    "start_date": "2017-12-18",
    "start_date_type": "Actual",
    "start_month_year": "December 18 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041538.814812",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "BONES",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Observational Non-interventional Use of LIPUS to Mitigate Fracture Non-union in Patients at Risk",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-29T041552.743130",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382483",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "A Prospective Patient-centric Observational Consecutive Enrollment Non-interventional Study of Patients At Risk for Fracture Non-union Treated With EXOGEN Compared to a National Healthcare Claims Database Control",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Bioventus LLC",
    "start_date": "2017-10-13",
    "start_date_type": "Actual",
    "start_month_year": "October 13 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041552.743130",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PEARL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Antimicrobial Stewardship Programs in the Global Setting",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2018",
    "created_at": "2017-12-29T041552.937923",
    "enrollment": 3650,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382470",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Partnership to Enhance Antimicrobial Use in Resource-Limited Settings PEARL An Assessment of Need and Feasibility of Antimicrobial Stewardship Programs",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2018",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041552.937923",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Estimation of Intracranial Pressure Using Non-invasive Fundus Videos",
    "completion_date": "2022-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2022",
    "created_at": "2017-12-31T041354.591660",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382860",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Estimation of Intracranial Pressure Using Non-invasive Fundus Videos",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Odense University Hospital",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041354.591660",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Efficacy of Pembrolizumab MK-3475 in Combination With TS-1Cisplatin or TS-1Oxaliplatin as First Line Chemotherapy in Gastric Cancer MK-3475-659KEYNOTE-659",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-29T041550.780764",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382600",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase IIb Clinical Trial to Study the Safety and Efficacy of Pembrolizumab MK-3475 in Combination With TS-1Cisplatin or TS-1Oxaliplatin as a First Line Chemotherapy in Participants With Advanced or Recurrent Gastric Cancer KEYNOTE-659",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2020",
    "received_results_disposit_date": "",
    "source": "Merck Sharp  Dohme Corp.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041550.780764",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mental Health Prevention Among Preschool Children Using a Culturally Adapted Version of ICPS",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-07T041923.304894",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383172",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Mental Health Prevention Among Preschool Children a Pilot Study of the Adaptation of the I Can Problem Solve ICPS Program to Chile",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Fundacin San Carlos de Maipo",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041923.304894",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin Fab2 Fragment INM004 in Healthy Volunteers",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2018-01-07T041911.857933",
    "enrollment": 14,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388216",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "A Phase I Study to Evaluate the Safety Tolerance and Pharmacokinetics of the Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin Fab2 Fragment INM004 in Healthy Volunteers",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Inmunova S.A.",
    "start_date": "2017-12-16",
    "start_date_type": "Actual",
    "start_month_year": "December 16 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041911.857933",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "IMMUNEO",
    "baseline_population": "",
    "biospec_description": "RNA isolated from peripheral blood.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers",
    "completion_date": "2022-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2022",
    "created_at": "2017-12-29T041539.797442",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383211",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Transcriptomic Profile of the Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 1 2018",
    "received_results_disposit_date": "",
    "source": "George Washington University",
    "start_date": "2017-06-16",
    "start_date_type": "Actual",
    "start_month_year": "June 16 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041539.797442",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hemopatch Performance Evaluation A Prospective Observational Registry",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2018-01-11T042358.351232",
    "enrollment": 1194,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392662",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 6,
    "official_title": "Hemopatch Performance Evaluation A Prospective Observational Registry",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Baxter Healthcare Corporation",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "4 Weeks",
    "updated_at": "2018-01-11T042358.351232",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "NUANCE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma",
    "completion_date": "2023-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2023",
    "created_at": "2017-12-29T041545.448251",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382886",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase I Open Label Trial of a Combination of Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2023",
    "received_results_disposit_date": "",
    "source": "University of Utah",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041545.448251",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Continuum Metal Bearing System in Total Hip Arthroplasty",
    "completion_date": "2030-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2030",
    "created_at": "2017-12-29T041549.955357",
    "enrollment": 85,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382652",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Continuum Metal Bearing System in Total Hip Arthroplasty- A Multi-center Prospective Non-controlled Post Market Surveillance Study",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2025-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2025",
    "received_results_disposit_date": "",
    "source": "Zimmer Biomet",
    "start_date": "2011-02-09",
    "start_date_type": "Actual",
    "start_month_year": "February 9 2011",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041549.955357",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "OBERTO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer OBERTO",
    "completion_date": "2018-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2018",
    "created_at": "2018-01-09T041354.221708",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391232",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Single Dose Multi-center Study to Evaluate Safety Tolerability and Immunogenicity of Subcutaneous Injection of PolyPEPI1018 Vaccine as an Add-on Immunotherapy to the Standard-of-Care Maintenance Therapy in Subjects With Metastatic Colorectal Cancer CRC",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 1 2018",
    "received_results_disposit_date": "",
    "source": "Treos Bio Zrt",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041354.221708",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Metabolomic Response to Meal Ingestion",
    "completion_date": "2017-10-15",
    "completion_date_type": "Actual",
    "completion_month_year": "October 15 2017",
    "created_at": "2018-01-08T041418.414071",
    "enrollment": 32,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383250",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Factors to Determine the Responses to Meal Ingestion Circulating Metabolites",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 30 2017",
    "received_results_disposit_date": "",
    "source": "Hospital Universitari Vall dHebron Research Institute",
    "start_date": "2014-11-15",
    "start_date_type": "Actual",
    "start_month_year": "November 15 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041418.414071",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients",
    "completion_date": "2018-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2018",
    "created_at": "2018-01-09T041354.419684",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391219",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients.",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2018",
    "received_results_disposit_date": "",
    "source": "Shahid Beheshti University of Medical Sciences",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041354.419684",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate Efficacy Safety Tolerability and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Participants With Negative Symptoms of Schizophrenia",
    "completion_date": "2020-04-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 20 2020",
    "created_at": "2017-12-29T041550.164922",
    "enrollment": 315,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382639",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Phase 2 12-Week Randomized Double-Blind Placebo-Controlled Parallel Study to Evaluate Efficacy Safety Tolerability and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Subjects With Negative Symptoms of Schizophrenia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-04-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 20 2020",
    "received_results_disposit_date": "",
    "source": "Takeda",
    "start_date": "2017-12-21",
    "start_date_type": "Anticipated",
    "start_month_year": "December 21 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041550.164922",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Blood samples for PACAP stress peptide analysis",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Neuroeconomics of Social Behavior Following Trauma Exposure",
    "completion_date": "2022-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2022",
    "created_at": "2017-12-29T041533.378501",
    "enrollment": 168,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383536",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Social Withdrawal Following Trauma Exposure a Neuroeconomic Approach",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2022",
    "received_results_disposit_date": "",
    "source": "Mclean Hospital",
    "start_date": "2017-11-14",
    "start_date_type": "Actual",
    "start_month_year": "November 14 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041533.378501",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of Apatinib in Recurrent or Recurrent High-grade Glioma",
    "completion_date": "2020-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2020",
    "created_at": "2018-01-08T041356.889687",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390062",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An One Arm Open and Prospective Studyof Apatinib for the Treatment of Recurrent or Recurrent High-grade Glioma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 20 2019",
    "received_results_disposit_date": "",
    "source": "West China Hospital",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041356.889687",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction",
    "completion_date": "2026-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2026",
    "created_at": "2017-12-29T041549.758835",
    "enrollment": 70,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382665",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prospective Multi - Centre Clinical Evaluation of the Performance and Safety of the HYPERION Hip Endoprosthesis System in Defect Reconstruction",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 2017",
    "received_results_disposit_date": "",
    "source": "Zimmer Biomet",
    "start_date": "2010-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041549.758835",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "QUANTUM AF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation",
    "completion_date": "2020-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2020",
    "created_at": "2017-12-29T041550.575164",
    "enrollment": 20000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382613",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Quantify Use of Anticoagulation to Improve Management of AF",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2020",
    "received_results_disposit_date": "",
    "source": "Janssen Scientific Affairs LLC",
    "start_date": "2017-12-29",
    "start_date_type": "Anticipated",
    "start_month_year": "December 29 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041550.575164",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Retreatment With Epidermal Growth Factor ReceptorEGFR Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients",
    "completion_date": "2019-09-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 13 2019",
    "created_at": "2017-12-29T041547.033278",
    "enrollment": 69,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382795",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Retreatment With 1st Generation EGFR TKIs in Sensitizing EGFR Mutation Positive Non-Squamous Cell Carcinoma Patients Who Previously Treated With EGFR TKI and Cytotoxic Chemotherapy",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 13 2019",
    "received_results_disposit_date": "",
    "source": "Korea University Guro Hospital",
    "start_date": "2017-09-14",
    "start_date_type": "Actual",
    "start_month_year": "September 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041547.033278",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intrauterine Device Insertion a Step for High Satisfaction",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2017-12-29T041536.473517",
    "enrollment": 88,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383432",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Ultrasound-guided Approach Versus Uterine Sound-sparing Approach for Intrauterine Device Insertion a Randomized Clinical Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041536.473517",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cerebral and Renal Oxymetry and Anesthetic Techniques in Newborns",
    "completion_date": "2017-08-01",
    "completion_date_type": "Actual",
    "completion_month_year": "August 2017",
    "created_at": "2018-01-07T041856.041952",
    "enrollment": 60,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389139",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of the Effects of Anesthetic Techniques Used for Cesarean Delivery on Neonatal Cerebral and Renal Oxygenation",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 2017",
    "received_results_disposit_date": "",
    "source": "Antalya Training and Research Hospital",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041856.041952",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2Breast Cancer",
    "completion_date": "2022-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2022",
    "created_at": "2018-01-05T041725.540261",
    "enrollment": 24,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387553",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Pilot Study Utilizing a HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2 Breast Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2021",
    "received_results_disposit_date": "",
    "source": "H. Lee Moffitt Cancer Center and Research Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041725.540261",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives",
    "completion_date": "2015-01-01",
    "completion_date_type": "Actual",
    "completion_month_year": "January 1 2015",
    "created_at": "2017-12-29T041540.236314",
    "enrollment": 489,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383185",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives 5-year Follow-up",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-01-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 1 2015",
    "received_results_disposit_date": "",
    "source": "Federal University of So Paulo",
    "start_date": "2010-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041540.236314",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SOAP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study for Optimizing Anti-inflammatory Prophylaxis",
    "completion_date": "2019-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2019",
    "created_at": "2017-12-29T041538.014372",
    "enrollment": 470,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-19",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383328",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "Effect of Drop-less Surgery Compared to Topical NSAID Alone and Combination of Steroid and NSAID on Central Macular Thickness After Cataract Surgery a Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2019",
    "received_results_disposit_date": "",
    "source": "Rigshospitalet Denmark",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041538.014372",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Assess the Bioavailability Pharmacokinetics Safety and Tolerability of AVP-923 in Healthy Adult Participants",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2018",
    "created_at": "2018-01-09T041413.210016",
    "enrollment": 18,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381664",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Phase 1 Randomized Single-Dose 3-Way Crossover Study to Compare the Relative Bioavailability Pharmacokinetics Safety and Tolerability of AVP-923 Dextromethorphan Hydrobromide and Quinidine Sulfate Capsules Administered in Applesauce or Via a Nasogastric Feeding Tube With Administration of a Capsule in Healthy Adult Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "Avanir Pharmaceuticals",
    "start_date": "2017-11-28",
    "start_date_type": "Actual",
    "start_month_year": "November 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041413.210016",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of the Safety Tolerability Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants",
    "completion_date": "2018-09-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 5 2018",
    "created_at": "2017-12-25T041244.872783",
    "enrollment": 106,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381144",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 6,
    "number_of_groups": "",
    "official_title": "A Phase I Randomised Double-Blind Placebo-Controlled Single Centre 3-Part Study Designed to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 18 2018",
    "received_results_disposit_date": "",
    "source": "Genentech Inc.",
    "start_date": "2017-12-08",
    "start_date_type": "Actual",
    "start_month_year": "December 8 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041244.872783",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Haploidentical Lymphocytes With NivolumabAra-C as Consolidation in Elderly AML Patients",
    "completion_date": "2020-10-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 30 2020",
    "created_at": "2017-12-25T041245.248788",
    "enrollment": 52,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381118",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Study of Haploidentical Lymphocytes With Nivolumab and Intermediate Dose Cytarabine Versus Nivolumab and Intermediate Dose Cytarabine as Consolidation Treatment in Older Adults With Acute Myeloid Leukemia.",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 30 2019",
    "received_results_disposit_date": "",
    "source": "St. Petersburg State Pavlov Medical University",
    "start_date": "2017-06-30",
    "start_date_type": "Actual",
    "start_month_year": "June 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041245.248788",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Botox Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist",
    "completion_date": "2020-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2020",
    "created_at": "2018-01-09T041413.424869",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381261",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Novel Concepts for OnabotulinumtoxinA Botox Mechanisms of Action Role in Altering the Molecular Environment in Which Pain Fibers Exist",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Massachusetts General Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041413.424869",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cognitive Skills and Iconic Gestures",
    "completion_date": "2020-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2020",
    "created_at": "2018-01-05T041722.279300",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387748",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Role of Semantic Processing and Visuospatial Skills in Production of Iconic Gestures",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2020",
    "received_results_disposit_date": "",
    "source": "Universitaire Ziekenhuizen Leuven",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041722.279300",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Cypress 1",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2017-12-29T041545.253543",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382899",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line 1L Therapy in Patients With Stage IV  Metastatic Wild Type WT Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1  50",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "ARMO BioSciences",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041545.253543",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "IRX-2 Regimen Durvalumab Tremelimumab for Incurable Head and Neck Squamous Cell Carcinoma",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2021",
    "created_at": "2017-12-25T041244.362277",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381183",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 1b Trial of the IRX-2 Regimen Durvalumab MEDI4736 and Tremelimumab in Patients With Incurable Head and Neck Squamous Cell Carcinoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2020",
    "received_results_disposit_date": "",
    "source": "H. Lee Moffitt Cancer Center and Research Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041244.362277",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TEAMMATE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "TacrolimusEverolimus vs. TacrolimusMMF in Pediatric Heart Transplant Recipients Using the MATE Score",
    "completion_date": "2021-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2021",
    "created_at": "2018-01-02T182922.523142",
    "enrollment": 210,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386539",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2021",
    "received_results_disposit_date": "",
    "source": "Boston Childrens Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182922.523142",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PSA2STHLM31",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "From PSA to Stockholm3 Study Part 1",
    "completion_date": "2025-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2025",
    "created_at": "2017-12-25T041245.440317",
    "enrollment": 8000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381105",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "From PSA to Stockholm3 a Naturalistic Effectiveness Multipart Research Program Study Part 1",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Helse Stavanger HF",
    "start_date": "2017-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041245.440317",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent Adult and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications",
    "completion_date": "2019-10-29",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 29 2019",
    "created_at": "2017-12-25T041244.167402",
    "enrollment": 720,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381196",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 3 Randomized Double-blind Placebo-controlled Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent Adult and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-19",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 19 2019",
    "received_results_disposit_date": "",
    "source": "Janssen Research  Development LLC",
    "start_date": "2018-01-11",
    "start_date_type": "Anticipated",
    "start_month_year": "January 11 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041244.167402",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MEBIPAM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "MEthylene Blue In Patients With Acquired Methemoglobinemia",
    "completion_date": "2020-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2020",
    "created_at": "2018-01-11T042316.725500",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395223",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Open Label Clinical Study to Evaluate the Safety and Efficacy of ProvayBlueTM Methylene Blue for the Treatment of Acquired Methemoglobinemia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2020",
    "received_results_disposit_date": "",
    "source": "Provepharm SAS",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042316.725500",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "NB14",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Examination of a Weight Loss Formula on Health",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042316.142589",
    "enrollment": 80,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395262",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An Examination of a Novel Weight Loss Formula on Anthropometry and Indices of Cardiovascular Disease Risk",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Texas AM University",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042316.142589",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EMMIE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the Breast Augmentation and Reconstruction - EMMIE Study",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2018-01-02T182916.972504",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386682",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the Breast Augmentation and Reconstruction - EMMIE Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Symatese Aesthetics",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182916.972504",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Compare Pathologic Type NIH and WHO Criteriaand Mechanism of GIST Malignant Transformation",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2017-12-25T041246.316993",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381053",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Prospective Multicenter Cohort Study to Compare Pathologic Type NIH and WHO Criteria and Mechanism of GIST Malignant Transformation",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 1 2020",
    "received_results_disposit_date": "",
    "source": "Shanghai Zhongshan Hospital",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041246.316993",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Cypress 2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of AM0010 With Nivolumab Compared to Nivolumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2017-12-29T041545.047645",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382912",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV  Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "ARMO BioSciences",
    "start_date": "2018-06-01",
    "start_date_type": "Anticipated",
    "start_month_year": "June 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041545.047645",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PicoS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2019",
    "created_at": "2018-01-02T182912.637353",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386760",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2019",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Nice",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182912.637353",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage IV Breast Cancer",
    "completion_date": "2020-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2020",
    "created_at": "2017-12-23T042522.998084",
    "enrollment": 178,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377101",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Phase II Trial of Fulvestrant and Palbociclib in Combination With Copanlisib FPC Versus Fulvestrant and Palbociclib Alone FP for Endocrine Resistant Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer FPC vs FP",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2020",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute NCI",
    "start_date": "2018-10-12",
    "start_date_type": "Anticipated",
    "start_month_year": "October 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042522.998084",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2018",
    "created_at": "2018-01-09T041348.658879",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391609",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Peri-operative Dexmedetomidine Infusion in Mild Pre-eclamptic Patients Undergoing Elective Cesarean Section Under General Anesthesia",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-06-18",
    "start_date_type": "Actual",
    "start_month_year": "June 18 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041348.658879",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Microdialysis samples 6-10 times every day. Regularly standard blood samples. Daily samples\n      from pelvic drain. EDTA plasma 3 times a week.",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-11T042359.663698",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392584",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Oslo University Hospital",
    "start_date": "2016-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042359.663698",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Gala Treatment for Chronic Bronchitis in Canada",
    "completion_date": "2019-07-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 30 2019",
    "created_at": "2017-12-31T041319.469595",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": true,
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385616",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Feasibility Study A Safety Evaluation of the Gala Airway Treatment System on Patients With Chronic Bronchitis in Canada",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Gala Therapeutics Inc.",
    "start_date": "2017-08-24",
    "start_date_type": "Actual",
    "start_month_year": "August 24 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041319.469595",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "MEDI9447 EGFRm NSCLC Novel Combination Study",
    "completion_date": "2021-11-26",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 26 2021",
    "created_at": "2017-12-25T041243.137882",
    "enrollment": 98,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381274",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Multiarm Open-label Multicenter Phase 1b2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-11-26",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 26 2021",
    "received_results_disposit_date": "",
    "source": "MedImmune LLC",
    "start_date": "2018-02-09",
    "start_date_type": "Anticipated",
    "start_month_year": "February 9 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041243.137882",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Randomized Double-Blind Placebo-Controlled Safety and Tolerability Study of ITI-214 in Patients With Heart Failure",
    "completion_date": "2019-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2019",
    "created_at": "2018-01-05T041731.425619",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387215",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Randomized Double-Blind Placebo-Controlled Safety and Tolerability Study of Escalating Single Doses of ITI-214 in Patients With Systolic Heart Failure",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2019",
    "received_results_disposit_date": "",
    "source": "Intra-Cellular Therapies Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041731.425619",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PEN-LBP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pain Education for Patients With Low Back Pain in Nepal A Feasibility Study",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-05T041731.219952",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387228",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pain Education for Patients With Non-specific Low Back Pain in Nepal A Feasibility Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "Kathmandu University School of Medical Sciences",
    "start_date": "2018-02-05",
    "start_date_type": "Anticipated",
    "start_month_year": "February 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041731.219952",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "POST",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Postoperative Sore Throat in the Pediatric Population.",
    "completion_date": "2018-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2018",
    "created_at": "2018-01-08T041405.285606",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389776",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Incidence of Postoperative Sore Throat in the Pediatric Population. An Observational Cohort Prospective Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Istituto Giannina Gaslini",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041405.285606",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Naloxone Pharmacokinetics",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-05T041732.271144",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386591",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "Comparison of Naloxone Pharmacokinetics Using Marketed Naloxone Devices",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-08",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 8 2018",
    "received_results_disposit_date": "",
    "source": "National Institute on Drug Abuse NIDA",
    "start_date": "2018-01-03",
    "start_date_type": "Anticipated",
    "start_month_year": "January 3 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041732.271144",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Nerve Hydrodissection for Carpal Tunnel Syndrome",
    "completion_date": "2019-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2019",
    "created_at": "2017-12-26T040704.214060",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381521",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "The Clinical Efficacy of Nerve Hydrodissection in Patients With Carpal Tunnel Syndrome",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2019",
    "received_results_disposit_date": "",
    "source": "Tri-Service General Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040704.214060",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comprehensive Geriatric Assessment in Primary Care A Randomised Feasibility Trial",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2018-01-11T042327.606404",
    "enrollment": 160,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394534",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comprehensive Geriatric Assessment for Older Adults With Frailty Within Primary Care Setting A Randomised Feasibility Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "University of Derby",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042327.606404",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "VEIN-COLD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ecchymosis and Coldness in Patients With Varicose Vein",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-31T041345.464316",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384355",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 7,
    "official_title": "Ecchymosis and Coldness in Patients With Varicose Vein Multicenter Study of Modified VEIN-Sym QoL Assessment",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Vascular and Molecular Cardiology Society",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Day",
    "updated_at": "2017-12-31T041345.464316",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "UCSD Get Fit Be Fit Study",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2018-01-05T041722.866325",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387709",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects of Pistachio Consumption in a Weight Loss Intervention on Weight Change Dietary Intake and Metabolic Factors",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "University of California San Diego",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041722.866325",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD",
    "completion_date": "2018-10-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 30 2018",
    "created_at": "2018-01-07T041909.407364",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388385",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of a Single Intravenous Iron Upon Vascular Endothelium and Some Parameters of Oxidative Stress in Patients With Non-dialysis Chronic Kidney Disease",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 20 2018",
    "received_results_disposit_date": "",
    "source": "Carol Davila University of Medicine and Pharmacy",
    "start_date": "2017-09-20",
    "start_date_type": "Actual",
    "start_month_year": "September 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041909.407364",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "RCT for Evaluation of Online Social Networking Intervention in Smoking Cessations",
    "completion_date": "2018-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2018",
    "created_at": "2018-01-05T041721.455547",
    "enrollment": 408,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387800",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Controlled Trial Evaluating Efficacy of an Intervention Which Enhances Social Support and Positive Affect Through Online Social Networking in Smoking Cessations",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 31 2017",
    "received_results_disposit_date": "",
    "source": "Chinese University of Hong Kong",
    "start_date": "2015-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041721.455547",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Midfacial Product Selection",
    "completion_date": "2018-12-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 5 2018",
    "created_at": "2017-12-26T040722.119362",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381040",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Predictive Algorithm for Product Selection in the Management of Mid Facial Volume Correction Part I - A Pilot Validation of Patient Strata",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 5 2018",
    "received_results_disposit_date": "",
    "source": "Erevna Innovations Inc.",
    "start_date": "2017-12-05",
    "start_date_type": "Actual",
    "start_month_year": "December 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040722.119362",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain",
    "completion_date": "2019-10-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 31 2019",
    "created_at": "2017-12-26T040721.596514",
    "enrollment": 168,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381248",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Prospective Multi-center Randomized Clinical Trial Evaluating the Safety and Effectiveness of Using COOLIEF Cooled Radiofrequency Probe to Create Lesions of the Genicular Nerves and Comparing a Single Injection of Hyaluronic Acid in the Management of Knee Pain",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2019",
    "received_results_disposit_date": "",
    "source": "Halyard Health",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040721.596514",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Chinese Version of Fibromyalgia Criteria and Severity Scales Study",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2017-12-26T040721.783762",
    "enrollment": 590,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381131",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Chinese Version of the Modified American College of Rheumatology ACR Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Impact Questionnaire Reliability and Validity",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2019",
    "received_results_disposit_date": "",
    "source": "Guanganmen Hospital of China Academy of Chinese Medical Sciences",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Day",
    "updated_at": "2017-12-26T040721.783762",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Non-contact Intraoperative Optical Imaging During Neurosurgical Procedures",
    "completion_date": "2018-03-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 13 2018",
    "created_at": "2018-01-09T041358.123405",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391011",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Non-contact Intraoperative Optical Imaging During Neurosurgical Procedures",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 13 2018",
    "received_results_disposit_date": "",
    "source": "Sunnybrook Health Sciences Centre",
    "start_date": "2015-03-13",
    "start_date_type": "Actual",
    "start_month_year": "March 13 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041358.123405",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Powertoothbrushing for Treating Gingivitis",
    "completion_date": "2018-06-25",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 25 2018",
    "created_at": "2017-12-26T040720.946475",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381339",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Powertoothbrushing for Treating Gingivitis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-25",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 25 2018",
    "received_results_disposit_date": "",
    "source": "Marquette University",
    "start_date": "2017-12-05",
    "start_date_type": "Actual",
    "start_month_year": "December 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040720.946475",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pilot Study to Assess the Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening Curaseal AF as a Treatment for Perianal Fistula",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2017-12-26T040720.623720",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381365",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Pilot Study to Assess the Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening Curaseal AF as a Treatment for Perianal Fistula",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2017",
    "received_results_disposit_date": "",
    "source": "London North West Healthcare NHS Trust",
    "start_date": "2016-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040720.623720",
    "verification_date": "2017-09-01",
    "verification_month_year": "September 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer",
    "completion_date": "2024-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2024",
    "created_at": "2017-12-29T041541.672583",
    "enrollment": 122,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383094",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab Keytruda Versus Concurrent Chemotherapy in Patients With AdvancedIntermediate-Risk p16 Head and Neck Squamous Cell Carcinoma KEYCHAIN",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2021",
    "received_results_disposit_date": "",
    "source": "University of California San Diego",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041541.672583",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Participant Satisfaction With Two Different Summative Assessment Methods - a Mixed Method Questionnaire Study",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2017-12-26T040719.582278",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381443",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Participant Satisfaction With Two Different Summative Assessment Methods - a Mixed Method Questionnaire Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Inselspital Berne",
    "start_date": "2017-12-02",
    "start_date_type": "Actual",
    "start_month_year": "December 2 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040719.582278",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NBA-ICU",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Observational Study Examining Adverse Events and Effectiveness of the Nasal Bridle Securement Device in ICU Patients",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-05T041728.714553",
    "enrollment": 160,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387358",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Nasal Bridle Assessment in the Intensive Care Unit An Observational Study to Examine the Effectiveness and Adverse Events of the Nasal Bridle Securement Device in High Risk ICU Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of British Columbia",
    "start_date": "2018-01-20",
    "start_date_type": "Anticipated",
    "start_month_year": "January 20 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "4 Weeks",
    "updated_at": "2018-01-05T041728.714553",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ECTAUSOME",
    "baseline_population": "",
    "biospec_description": "blood and CSF sampling",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Ectosomes New Biomarkers of Tau Pathology",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-26T040718.555725",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381482",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 5,
    "official_title": "Ectosomes New Biomarkers of Tau Pathology",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Lille",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040718.555725",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SAS-leak-1",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Air Leakage Under Continuous Positive Airway Pressure",
    "completion_date": "2018-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2018",
    "created_at": "2017-12-26T040718.240058",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381508",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Retrospective Analysis of the Determinants of Air Leakage in a Population of Obstructive Sleep Apnea Syndrome Treated With Continuous Positive Airway Pressure",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital Montpellier",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040718.240058",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LICIdystonie",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Task-dependent Operation of a Mechanism Intracortical Inhibition in Dystonia",
    "completion_date": "2017-04-01",
    "completion_date_type": "Actual",
    "completion_month_year": "April 2017",
    "created_at": "2017-12-26T040718.892124",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381456",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Task-dependent Operation of a Mechanism Intracortical Inhibition in Dystonia",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-04-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "April 2017",
    "received_results_disposit_date": "",
    "source": "University Hospital Lille",
    "start_date": "2015-04-01",
    "start_date_type": "",
    "start_month_year": "April 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040718.892124",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "INDIAN",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Indigo System in Acute Lower Limb Malperfusion",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2018-01-02T182930.322575",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386370",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Indian Registry The INDigo System in Acute Lower Limb malperfusioN",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2019",
    "received_results_disposit_date": "",
    "source": "Azienda Ospedaliera Universitaria Senese",
    "start_date": "2017-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182930.322575",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Oral Propranolol for Reducing Pediatric Dental Patients Anxiety",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2019",
    "created_at": "2018-01-07T041858.970928",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388957",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Evaluating of Oral Propranolol Effect on Managing Anxiety of Dental Extractions in Children A Randomized Controlled Clinical Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2018",
    "received_results_disposit_date": "",
    "source": "Damascus University",
    "start_date": "2017-09-30",
    "start_date_type": "Actual",
    "start_month_year": "September 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041858.970928",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EVALDUO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of a Power Assistance Device for Wheelchair-DUO",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-02T182910.835378",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386799",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of a Power Assistance Device for Wheelchair-DUO",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Lille",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182910.835378",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "FLoCaMB",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "FLuorescence Cholangiography Using Methylene Blue",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2018",
    "created_at": "2018-01-02T182935.907317",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386201",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "FLuorescence Cholangiography Using Methylene Blue",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Oxford",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182935.907317",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Non-Contact Intraoperative Optical Imaging During Instrumentation Procedure",
    "completion_date": "2015-08-01",
    "completion_date_type": "Actual",
    "completion_month_year": "August 1 2015",
    "created_at": "2018-01-09T041357.927129",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391024",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Non-Contact Intraoperative Optical Imaging During Instrumentation Procedure",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-08-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 1 2015",
    "received_results_disposit_date": "",
    "source": "Sunnybrook Health Sciences Centre",
    "start_date": "2013-09-24",
    "start_date_type": "Actual",
    "start_month_year": "September 24 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041357.927129",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Willow II",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Pts After Dosing With AM0010",
    "completion_date": "2018-03-09",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 9 2018",
    "created_at": "2017-12-26T040717.624098",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381547",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An Open Label Randomized Single Dose 3-Way Crossover Study to Evaluate the Pharmacokinetics of Different Dose Levels and Dose Formulations of AM0010 in Healthy Adult Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-09",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 9 2018",
    "received_results_disposit_date": "",
    "source": "ARMO BioSciences",
    "start_date": "2018-01-12",
    "start_date_type": "Anticipated",
    "start_month_year": "January 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040717.624098",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Incidence of Ascending Aortic Atheromatous",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2019",
    "created_at": "2018-01-07T041925.199951",
    "enrollment": 196,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381222",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Incidence of Ascending Aortic Atheromatous Plaque in Thai Population",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Mahidol University",
    "start_date": "2018-07-01",
    "start_date_type": "Anticipated",
    "start_month_year": "July 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2018-01-07T041925.199951",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Association Between Dietary Pattern and Glycemic Control Among Type 2 Diabetes Patients in the Unites Arab Emirates",
    "completion_date": "2017-12-20",
    "completion_date_type": "Actual",
    "completion_month_year": "December 20 2017",
    "created_at": "2018-01-07T041914.093995",
    "enrollment": 850,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388229",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Association Between Dietary Pattern and Glycemic Control Among Type 2 Diabetes Patients in the United Arab Emirates A Retrospective Cross-sectional Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 10 2017",
    "received_results_disposit_date": "",
    "source": "Rashid Centre for Diabetes and Research",
    "start_date": "2017-08-08",
    "start_date_type": "Actual",
    "start_month_year": "August 8 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041914.093995",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ureter Identification With IRDye 800BK",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2018",
    "created_at": "2018-01-05T041727.896241",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387410",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Safety and Efficacy of IRDye 800BK in Ureter Identification Via Fluorescence Detection During Laparoscopic Abdominal Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "Oxford University Hospitals NHS Trust",
    "start_date": "2018-01-20",
    "start_date_type": "Anticipated",
    "start_month_year": "January 20 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041727.896241",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation",
    "completion_date": "2021-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2021",
    "created_at": "2018-01-05T041714.390181",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388008",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2021",
    "received_results_disposit_date": "",
    "source": "Washington University School of Medicine",
    "start_date": "2018-06-01",
    "start_date_type": "Anticipated",
    "start_month_year": "June 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041714.390181",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Non-contact Intraoperative Optical Imaging During Spinal Procedures",
    "completion_date": "2019-01-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 21 2019",
    "created_at": "2018-01-09T041356.372780",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391089",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Non-contact Intraoperative Optical Imaging During Spinal Procedures",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 21 2019",
    "received_results_disposit_date": "",
    "source": "Sunnybrook Health Sciences Centre",
    "start_date": "2016-01-21",
    "start_date_type": "Actual",
    "start_month_year": "January 21 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041356.372780",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fidgety Movements in Cystic Fibrosis",
    "completion_date": "2018-10-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2 2018",
    "created_at": "2017-12-31T041356.993685",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381157",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Fidgety Movements Analysis in Infants With Cystic Fibrosis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2 2018",
    "received_results_disposit_date": "",
    "source": "Hacettepe University",
    "start_date": "2017-10-02",
    "start_date_type": "Actual",
    "start_month_year": "October 2 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041356.993685",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2017-12-31T041357.206287",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381287",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Randomized Double Blind Placebo Controlled Multicenter Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2018",
    "received_results_disposit_date": "",
    "source": "HighTide Biopharma Pty Ltd",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041357.206287",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EXODYA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Exercise and Omega-3 on Metabolic Health in Elderly",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-02T182925.877158",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386461",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Exercise Training and Omega-3 Fatty Acids on Metabolic Health and Dysfunction of Adipose Tissue in Elderly",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Charles University Czech Republic",
    "start_date": "2017-01-05",
    "start_date_type": "Actual",
    "start_month_year": "January 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182925.877158",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "G551D",
    "baseline_population": "",
    "biospec_description": "sputum stool plasma",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor",
    "completion_date": "2017-07-26",
    "completion_date_type": "Actual",
    "completion_month_year": "July 26 2017",
    "created_at": "2018-01-09T041358.524621",
    "enrollment": 18,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390985",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-26",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 26 2017",
    "received_results_disposit_date": "",
    "source": "The Hospital for Sick Children",
    "start_date": "2013-04-23",
    "start_date_type": "Actual",
    "start_month_year": "April 23 2013",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041358.524621",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MAAP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role of Montelukast in Asthma and Allergic Rhinitis Patients",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-31T041357.611585",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380975",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Role of Montelukast in Asthma and Allergic Rhinitis Patients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2018",
    "received_results_disposit_date": "",
    "source": "Clinision",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041357.611585",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Long-term Observational Study of the Safety of Roflumilast",
    "completion_date": "2020-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2020",
    "created_at": "2017-12-26T040717.290287",
    "enrollment": 124080,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381573",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Long-Term Post-Marketing Observational Study of the Safety of Roflumilast",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2020",
    "received_results_disposit_date": "",
    "source": "AstraZeneca",
    "start_date": "2017-03-23",
    "start_date_type": "Actual",
    "start_month_year": "March 23 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040717.290287",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "iEAT 2.0 Open Trial",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2017-12-29T041543.145785",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383029",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of the Feasibility and Preliminary Efficacy of the Parent-Mediated Integrated Eating Aversion Treatment iEAT Manual",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "Emory University",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041543.145785",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Extension of the TG1101RMS201 Trial",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2017-12-29T041555.606925",
    "enrollment": 48,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381170",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open Label Extension of the TG1101RMS201 Trial for Subjects Currently Enrolled in TG1101RMS201Treated With Ublituximab for Relapsing Forms of Multiple Sclerosis",
    "overall_status": "Enrolling by invitation",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "TG Therapeutics Inc.",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041555.606925",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2017-12-31T041353.772070",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383237",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Clinical Study of Apatinib as the Second-line Therapy in Malignant MelanomaAn Open-Label Single-center Single-arm Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Henan Cancer Hospital",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041353.772070",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "eMERGE",
    "baseline_population": "",
    "biospec_description": "Blood samples are drawn from patients after consent in a CLIA certified manner. These samples\n      are processed DNA is extracted and sent to one of two sequencing centers Baylor College of\n      Medicine or Partners Healthcare with Broad Institute. DNA is then sequenced and clinical\n      reports along with sequencing results returned to sites.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Electronic Medical Records and Genomics eMERGE Phase III",
    "completion_date": "2019-05-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 31 2019",
    "created_at": "2018-01-11T042322.440561",
    "enrollment": 25000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394859",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Electronic Medical Records and Genomics eMERGE Phase III",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2019",
    "received_results_disposit_date": "",
    "source": "Vanderbilt University Medical Center",
    "start_date": "2015-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042322.440561",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluating the Pharmacokinetics Feasibility Acceptability and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2018-01-02T182921.241082",
    "enrollment": 390,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386578",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Pharmacokinetics Feasibility Acceptability and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention During Pregnancy and Postpartum in Adolescents and Young Women and Their Infants",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2021",
    "received_results_disposit_date": "",
    "source": "National Institute of Allergy and Infectious Diseases NIAID",
    "start_date": "2018-07-01",
    "start_date_type": "Anticipated",
    "start_month_year": "July 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182921.241082",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "IRSTB030",
    "baseline_population": "",
    "biospec_description": "blood samples and FFPE samples",
    "biospec_retention": "Samples With DNA",
    "brief_title": "CTC Free DNA Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2017-12-29T041554.982050",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381326",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Biomarkers Study Circulating Tumor Cells CTC Free DNA Stem Cells and Epithelial-mesenchymal-transition EMT Related Antigens as Biomarkers of Activity of Cabazitaxel in Castration-resistant Prostate Cancer CRPC a Proof of Concept.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2017",
    "received_results_disposit_date": "",
    "source": "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori",
    "start_date": "2014-12-15",
    "start_date_type": "Actual",
    "start_month_year": "December 15 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041554.982050",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LASSYC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC Study",
    "completion_date": "2018-10-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 5 2018",
    "created_at": "2017-12-26T040717.460327",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381560",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "An Observational Cross-sectional Study of Primary Data Collection to Describe Symptoms Over 24 Hours and Their Relationship With Adherence to Respiratory Treatment Direct Costs and PRO in Stable COPD Patients in Brazil.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 5 2018",
    "received_results_disposit_date": "",
    "source": "AstraZeneca",
    "start_date": "2017-11-07",
    "start_date_type": "Actual",
    "start_month_year": "November 7 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040717.460327",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Analgesic Value of Adductor Canal vs Femoral Block After Total Knee Arthroplasty",
    "completion_date": "2016-10-19",
    "completion_date_type": "Actual",
    "completion_month_year": "October 19 2016",
    "created_at": "2018-01-11T042306.432312",
    "enrollment": 16,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395990",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of the Comparative Analgesic Value of Adductor Canal Block Versus Femoral Block Following Total Knee Arthroplasty",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-10-19",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 19 2016",
    "received_results_disposit_date": "",
    "source": "Duke University",
    "start_date": "2016-03-27",
    "start_date_type": "Actual",
    "start_month_year": "March 27 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042306.432312",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "SENECA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2018-01-05T041724.899131",
    "enrollment": 112,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387592",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Phase II Trial of Capecitabine and Temozolomide CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas and Exploratory Analysis of Predictive Role of Positron Emission Tomography PET Imaging and Biological Markers",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori",
    "start_date": "2017-03-06",
    "start_date_type": "Actual",
    "start_month_year": "March 6 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041724.899131",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Classical Conditioning Training for Aphasia. A Telemedicine Approach.",
    "completion_date": "2017-11-01",
    "completion_date_type": "Actual",
    "completion_month_year": "November 2017",
    "created_at": "2017-12-29T041553.532811",
    "enrollment": 12,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381313",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Improving Word Repetition Training Using Classical Conditioning With a Computer Based Telemedicine Approach Evidence From a Study on 12 Person With Chronic Aphasia.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 2017",
    "received_results_disposit_date": "",
    "source": "I.R.C.C.S. Fondazione Santa Lucia",
    "start_date": "2014-04-01",
    "start_date_type": "Actual",
    "start_month_year": "April 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041553.532811",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea",
    "completion_date": "2018-05-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 6 2018",
    "created_at": "2017-12-25T041256.950773",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380390",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Multicenter Open-Label Interventional Study on the Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Subjects With Rosacea",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-06",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 6 2018",
    "received_results_disposit_date": "",
    "source": "Allergan",
    "start_date": "2017-12-04",
    "start_date_type": "Actual",
    "start_month_year": "December 4 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041256.950773",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Assess Persistence Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab HUMIRA",
    "completion_date": "2019-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2019",
    "created_at": "2017-12-29T041539.015152",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383263",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prospective Multi-Center Observational Study to Assess Persistence Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab HUMIRA in the Routine Clinical Settings in the Russian Federation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2019",
    "received_results_disposit_date": "",
    "source": "AbbVie",
    "start_date": "2017-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041539.015152",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients",
    "completion_date": "2017-09-30",
    "completion_date_type": "Actual",
    "completion_month_year": "September 30 2017",
    "created_at": "2017-12-29T041538.222094",
    "enrollment": 191,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383315",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients A Randomised Double Blind Placebo Controlled Trial",
    "overall_status": "Completed",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 30 2017",
    "received_results_disposit_date": "",
    "source": "University of Malaya",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041538.222094",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Adapting a Secondary Prevention Program for Nonstudent Emerging Adult Drinkers",
    "completion_date": "2015-12-02",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2 2015",
    "created_at": "2018-01-08T041419.503653",
    "enrollment": 164,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381391",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Adapting a Secondary Prevention Program for Nonstudent Emerging Adult Drinkers",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-12-02",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2 2015",
    "received_results_disposit_date": "",
    "source": "Old Dominion University",
    "start_date": "2013-07-10",
    "start_date_type": "Actual",
    "start_month_year": "July 10 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041419.503653",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "CLEAR-C4",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Trial to eLiminate HCV-infection in Treatment-nave Renally Impaired EgyptiAn Patients on Renal Dialysis With Chronic Hepatitis C Genotype 4",
    "completion_date": "2020-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2020",
    "created_at": "2017-12-26T040713.835800",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381859",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-site Open-label Non-comparator Clinical Trial to eLiminate HCV-infection in Treatment-nave EgyptiAn Patients With End-stage Renal Disease on Renal Dialysis With Chronic Hepatitis C Genotype 4 Infection Using a 12-week Course of Once-daily Single Oral Tablet of Elbasvir 50mgGrazoprevir 100 mg",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 1 2019",
    "received_results_disposit_date": "",
    "source": "University of Maryland",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040713.835800",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "FreeDom Innovative Strategy for the Management of COPD Exacerbations",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-11T042304.323050",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03396172",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "FreeDom  Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge Automated Oxygen Weaning at Home Telemedicine and Tele-rehabilitation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Laval University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042304.323050",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effectiveness of Thai Northeastern Folk Musical Therapy for Blood Pressure Control in Hypertensive Patients",
    "completion_date": "2017-12-17",
    "completion_date_type": "Actual",
    "completion_month_year": "December 17 2017",
    "created_at": "2017-12-26T040714.311396",
    "enrollment": 120,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381820",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Instrumental Folk Music Listening Reduced Home Blood Pressure in Stage-2 Hypertensive Patients a Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-05-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 31 2016",
    "received_results_disposit_date": "",
    "source": "Khon Kaen University",
    "start_date": "2015-11-23",
    "start_date_type": "Actual",
    "start_month_year": "November 23 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040714.311396",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "VITHGS",
    "baseline_population": "",
    "biospec_description": "Venous blood samples.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Vitamin D and Hand Grip Strength at 5 Years in Odense Child Cohort",
    "completion_date": "2017-06-30",
    "completion_date_type": "Actual",
    "completion_month_year": "June 30 2017",
    "created_at": "2017-12-29T041554.785313",
    "enrollment": 881,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381378",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Analysis of Associations Between s-25OHD and Hand Grip Strength at 5 Years in Odense Child Cohort",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 30 2017",
    "received_results_disposit_date": "",
    "source": "Odense University Hospital",
    "start_date": "2016-01-04",
    "start_date_type": "Actual",
    "start_month_year": "January 4 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041554.785313",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "LC-MSMS 25OHD Status in a Large Cohort",
    "completion_date": "2017-06-01",
    "completion_date_type": "Actual",
    "completion_month_year": "June 2017",
    "created_at": "2018-01-05T041711.171940",
    "enrollment": 74235,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-29",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388203",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "LC-MSMS Based 25OHD Status in a Large Central European Outpatient Cohort- Gender and Age Specific Differences",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2016",
    "received_results_disposit_date": "",
    "source": "Azienda Ospedaliera di Bolzano",
    "start_date": "2015-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2015",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-05T041711.171940",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Body Fat and Frequency of Resistance Training",
    "completion_date": "2015-07-24",
    "completion_date_type": "Actual",
    "completion_month_year": "July 24 2015",
    "created_at": "2017-12-26T040711.356148",
    "enrollment": 63,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381976",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Effects of Different Frequency Low-volume Resistance Training on Body Fat in Obese Older A Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-07-06",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 6 2015",
    "received_results_disposit_date": "",
    "source": "Universidade Estadual de Londrina",
    "start_date": "2015-03-02",
    "start_date_type": "Actual",
    "start_month_year": "March 2 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040711.356148",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EOLE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "End Of Life in the Critically Ill patiEnt",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2018",
    "created_at": "2018-01-11T042354.919587",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392857",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "End Of Life in the Critically Ill patiEnt",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "French Society for Intensive Care",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042354.919587",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "DAPACARD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work Heart Nutrient Uptake and Heart Muscle Efficiency in Type 2 Diabetes Patients.",
    "completion_date": "2019-01-21",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 21 2019",
    "created_at": "2018-01-05T041723.317390",
    "enrollment": 52,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387683",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Double-blind Randomized Parallel Group Phase IV Study to Investigate the Effects of DAPAgliflozin on CARDiac Substrate Uptake Myocardial Efficiency and Myocardial Contractile Work in Type 2 Diabetes Patients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 21 2019",
    "received_results_disposit_date": "",
    "source": "AstraZeneca",
    "start_date": "2018-03-15",
    "start_date_type": "Anticipated",
    "start_month_year": "March 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041723.317390",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LunSed",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Sedation on Pulmonary Aeration in Children",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-09T041342.507420",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392012",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Effect of Sedation on Pulmonary Aeration in Children",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "IRCCS San Raffaele",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041342.507420",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2017-12-31T041349.693311",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384095",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Single Center Placebo-Controlled Trial of Oral High-Molecular Weight Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "Indiana University",
    "start_date": "2018-06-30",
    "start_date_type": "Anticipated",
    "start_month_year": "June 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041349.693311",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2017-12-26T040716.348390",
    "enrollment": 290,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381651",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Different Radiation Dose of Neoadjuvant Chemoradiation Followed By Surgery in Treating Patients With Locally Advanced Resectable Thoracic Esophageal Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Zhejiang Cancer Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040716.348390",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimers Disease",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-31T041350.712878",
    "enrollment": 52,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384043",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Using Smartphone Personal Assistant Technology to Improve Prospective Memory in Alzheimers Disease",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Baylor University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041350.712878",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Trial to Investigate the Safety Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-29T041542.911321",
    "enrollment": 96,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-18",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383042",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 8,
    "number_of_groups": "",
    "official_title": "A Randomized Open-label Placebo- and Active- Controlled Single and Multiple Ascending Dose Phase I Clinical Trial to Investigate the Safety Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Jeil Pharmaceutical Co. Ltd.",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041542.911321",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Sugammadex Given Based on Ideal Actual or Adjusted Body Weight on Reversal of Rocuronium.",
    "completion_date": "2017-11-10",
    "completion_date_type": "Actual",
    "completion_month_year": "November 10 2017",
    "created_at": "2017-12-25T041244.002004",
    "enrollment": 60,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381209",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "The Effect of Sugammadex Given Based on Ideal Actual or Adjusted Body Weights on Reversal of Neuromuscular Blockade in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 10 2017",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2017-06-10",
    "start_date_type": "Actual",
    "start_month_year": "June 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041244.002004",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2018",
    "created_at": "2018-01-11T042329.231894",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-07",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394430",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Comparison of Intranasal Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction in Children",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "Shanghai 9th Peoples Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042329.231894",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Human fecal and gut mucosal samples for DNA extraction",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Gut Mucosal Microbiota is Associated With Colorectal Cancer Relapse",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2022",
    "created_at": "2018-01-02T182955.295182",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385213",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Structural of the Gut Mucosal Microbiota is Associated With Colorectal Cancer Relapses After Curative Surgery",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2019",
    "received_results_disposit_date": "",
    "source": "First Affiliated Hospital of Harbin Medical University",
    "start_date": "2017-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182955.295182",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Intraoperative Lidocaine Infusion on Intraoperative Isoflurane Requirements",
    "completion_date": "2017-12-15",
    "completion_date_type": "Actual",
    "completion_month_year": "December 15 2017",
    "created_at": "2018-01-02T182921.697535",
    "enrollment": 50,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386565",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Intraoperative IV Lidocaine Infusion on Intraoperative Isoflurane Requirements",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-02",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 2 2017",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2016-10-02",
    "start_date_type": "Actual",
    "start_month_year": "October 2 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182921.697535",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy",
    "completion_date": "2018-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 1 2018",
    "created_at": "2017-12-29T041543.570118",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383003",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy A Prospective Randomized Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2018",
    "received_results_disposit_date": "",
    "source": "Chang Gung Memorial Hospital",
    "start_date": "2016-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041543.570118",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Dexmedetomidine Wound Infiltration in Cesarean Section",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2017-12-29T041544.583812",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382938",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Wound Infiltration With Dexmedetomidine in Cesarean Section Effect on Postoperative Analgesia",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Attikon Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041544.583812",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NAFTI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reamed Nailing Versus Taylor Spatial Frame in Tibia Shaft Fractures",
    "completion_date": "2016-06-21",
    "completion_date_type": "Actual",
    "completion_month_year": "June 21 2016",
    "created_at": "2018-01-07T041900.281052",
    "enrollment": 65,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-30",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388879",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Reamed Nailing Versus Taylor Spatial Frame in Tibia Shaft Fractures",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-06-16",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 16 2015",
    "received_results_disposit_date": "",
    "source": "Oslo University Hospital",
    "start_date": "2010-10-31",
    "start_date_type": "Actual",
    "start_month_year": "October 31 2010",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041900.281052",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Articaine 4 Versus Mepivacaine 2 for Surgery of Molars Thirds Clinical Trial.",
    "completion_date": "2018-12-04",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 4 2018",
    "created_at": "2017-12-31T041348.661149",
    "enrollment": 7,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384160",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of Articaine 4 Versus Mepivacaine 2 for Surgery of Molars Thirds Splint-mouth Randomized Double Blind Controlled Clinical Trial.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 30 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Estadual Paulista Jlio de Mesquita Filho",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041348.661149",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role of Routine Hysteroscopy in Management of Cases of Unexplained Infertility",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2020",
    "created_at": "2017-12-31T041358.222839",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380364",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Role of Routine Hysteroscopy in Management of Cases of Unexplained Infertility",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Ain Shams University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041358.222839",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Analgesic Efficacy of Paravertebral Morphine",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2018",
    "created_at": "2017-12-29T041558.228589",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379987",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Analgesic Efficacy of Paravertebral Morphine for Acute Postoperative Pain Randomized Multicenter Clinical Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041558.228589",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Human fecal samples for DNA extraction",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Gut Microbiota Prediction of Metachronous Colorectal Neoplasms",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2017-12-31T041354.181589",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383159",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Gut Microbiota Prediction of Metachronous Colorectal Neoplasms in Patients With Colorectal Cancer",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "First Affiliated Hospital of Harbin Medical University",
    "start_date": "2017-10-30",
    "start_date_type": "Actual",
    "start_month_year": "October 30 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041354.181589",
    "verification_date": "2017-10-01",
    "verification_month_year": "October 2017",
    "why_stopped": ""
  },
  {
    "acronym": "IRIS Firehawk",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "IRIS-Firehawk Cohort in the IRIS-DES Registry",
    "completion_date": "2025-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2025",
    "created_at": "2017-12-25T041258.555339",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380286",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Evaluation of Effectiveness and Safety of Firehawk Stent in Routine Clinical Practice A Multicenter Prospective Observational Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "Asan Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041258.555339",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PRO-FIV",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Multidisciplinary Treatment of Obesity Prior to in Vitro Fertilization Impact on Global Reproductive Outcomes PRO-FIV Study",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2018-01-11T042319.409109",
    "enrollment": 104,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395067",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Multidisciplinary Treatment of Obesity Prior to In Vitro Fertilization Impact on Global Reproductive Outcomes",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "Hospital Clinic of Barcelona",
    "start_date": "2018-01-11",
    "start_date_type": "Anticipated",
    "start_month_year": "January 11 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042319.409109",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of the Thyroid Volume After Radiofrequency Ablation of Thyroid Nodules and Recurrent Thyroid",
    "completion_date": "2019-01-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 30 2019",
    "created_at": "2018-01-11T042307.290235",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395925",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of the Thyroid Volume After Radiofrequency Ablation of Thyroid Nodules and Recurrent Thyroid",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 30 2018",
    "received_results_disposit_date": "",
    "source": "Olympus Surgical Technologies Europe",
    "start_date": "2017-11-10",
    "start_date_type": "Actual",
    "start_month_year": "November 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042307.290235",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "VISCOTRAUMA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy a Pragmatic Randomized Clinical Trial.",
    "completion_date": "2021-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2021",
    "created_at": "2017-12-25T041251.525596",
    "enrollment": 118,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380767",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Use of Viscoelastic Tests in the Treatment of Trauma-induced Coagulopathy a Pragmatic Randomized Clinical Trial Comparing Viscoelastic Tests With Conventional Assays.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2021",
    "received_results_disposit_date": "",
    "source": "A.O. Ospedale Papa Giovanni XXIII",
    "start_date": "2018-06-01",
    "start_date_type": "Anticipated",
    "start_month_year": "June 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041251.525596",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SIRB2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer",
    "completion_date": "2019-01-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 5 2019",
    "created_at": "2017-12-25T041252.654038",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-17",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380689",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase I Study of Combination Therapy With S-1 Irinotecan and Bevacizumab as 1-line Chemotherapy in Patients With Advanced Colorectal Cancer.",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 5 2018",
    "received_results_disposit_date": "",
    "source": "Fujian Cancer Hospital",
    "start_date": "2018-01-05",
    "start_date_type": "Anticipated",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041252.654038",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Using Stable Isotopes to Assess the Effectiveness of Vitamin A Supplementation in Cameroon",
    "completion_date": "2016-07-29",
    "completion_date_type": "Actual",
    "completion_month_year": "July 29 2016",
    "created_at": "2017-12-29T041530.218897",
    "enrollment": 104,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383744",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-03-23",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 23 2016",
    "received_results_disposit_date": "",
    "source": "Centre for Food and Nutrition Research Yaounde",
    "start_date": "2015-10-05",
    "start_date_type": "Actual",
    "start_month_year": "October 5 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041530.218897",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Non-invasive Neurally Adjusted Ventilatory Assist Versus Nasal Intermittent Positive Pressure Ventilation for Preterm Infants After Extubation",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2018-01-07T041908.521051",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-24",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388437",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Non-invasive Neurally Adjusted Ventilatory Assist Versus Nasal Intermittent Positive Pressure Ventilation for Preterm Infants After Extubation A Randomised Control Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "King Fahad Armed Forces Hospital",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041908.521051",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Urinary and Anal Incontinence in Tunisian Women",
    "completion_date": "2017-09-30",
    "completion_date_type": "Actual",
    "completion_month_year": "September 30 2017",
    "created_at": "2018-01-02T182932.857919",
    "enrollment": 400,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386292",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prevalence and Risk Factors for Urinary and Anal Incontinence in Tunisian Middle Aged Women",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 30 2017",
    "received_results_disposit_date": "",
    "source": "University of Monastir",
    "start_date": "2017-06-16",
    "start_date_type": "Actual",
    "start_month_year": "June 16 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182932.857919",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Peripheral and Mesenteric Perfusion in Elective Surgical Patients",
    "completion_date": "2020-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2020",
    "created_at": "2018-01-11T042313.036665",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395483",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Investigating the Peripheral Perfusion Index Correlations Between Peripheral and Mesenteric Perfusion in Elective Surgical Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2020",
    "received_results_disposit_date": "",
    "source": "Hvidovre University Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042313.036665",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assessing an Educational Intervention Program on Knowledge Attitude and Behaviour Towards Pregnancy Prevention Based on Health Belief Model Amongst Adolescent Girls in Northern Ghana",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2018-01-07T041920.573898",
    "enrollment": 330,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384251",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Assessing an Educational Intervention Program on Knowledge Attitude and Behaviour Towards Pregnancy Prevention Based on Health Belief Model Amongst Adolescent Girls in Northern Ghana A Clustered Randomized Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Tehran University of Medical Sciences",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041920.573898",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Comparison the Intubation of a Left Sided Double Lumen Tube and Uniblocker",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042353.836947",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392922",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Comparison the Intubation of a Left Sided Double Lumen Tube and the Uniblocker Under the Guidence of Chest Computed Tomography Image",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "The First Hospital of Qinhuangdao",
    "start_date": "2018-01-06",
    "start_date_type": "Actual",
    "start_month_year": "January 6 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042353.836947",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TROJAN",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer",
    "completion_date": "2020-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2020",
    "created_at": "2017-12-24T041855.562730",
    "enrollment": 49,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-16",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379909",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041855.562730",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Central and Peripheral Venous Catheters Associated Blood Stream Infection in ICU in Assiut University",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2020",
    "created_at": "2017-12-31T041359.039919",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379948",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Central and Peripheral Venous Catheters Associated Blood Stream Infection in the Critically Ill Patients in Assiut University Hospital",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2017-12-31T041359.039919",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "OLGA and OLGIM Stage System for Gastric Cancer",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-25T041301.986809",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380052",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Laurens Classification",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Seoul National University Bundang Hospital",
    "start_date": "2006-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 2006",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041301.986809",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "RENOVATE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease",
    "completion_date": "2021-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2021",
    "created_at": "2017-12-26T040713.683487",
    "enrollment": 1620,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381872",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention RENOVATE-COMPLEX-PCI",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040713.683487",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms",
    "completion_date": "2020-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2020",
    "created_at": "2017-12-26T040723.523083",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-16",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379896",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "West China Hospital",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040723.523083",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Early Active Finger Exercises in Replanted Fingers",
    "completion_date": "2021-01-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 5 2021",
    "created_at": "2017-12-29T041531.727080",
    "enrollment": 42,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383640",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Will Early Active Finger Exercises in Replanted Fingers Improve Mobility A Prospective Randomized Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Oslo University Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041531.727080",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ibogaine in the Treatment of Alcoholism a Randomized Double-blind Placebo-controlled Escalating-dose Phase 2 Trial",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-09T041413.646745",
    "enrollment": 12,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380728",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Tolerability and Efficacy of Ibogaine in the Treatment of Alcoholism the First Randomized Double-blind Placebo-controlled Escalating-dose Phase 2 Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "University of Sao Paulo",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041413.646745",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Dried blood spot samples",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Evaluation of the Population-level Impact of PMTCT Option B in Zimbabwe",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2018-01-07T041909.192359",
    "enrollment": 30642,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388398",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 5,
    "official_title": "Evaluation of the Population-level Impact of Prevention of Mother-to-Child HIV Transmission Program Option B in Zimbabwe",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "University of California Berkeley",
    "start_date": "2012-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2012",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041909.192359",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Traumalert",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Implementation of New Trauma Triage Criteria and Implications on Under- and Overtriage.",
    "completion_date": "2017-11-01",
    "completion_date_type": "Actual",
    "completion_month_year": "November 1 2017",
    "created_at": "2018-01-11T042317.604527",
    "enrollment": 2200,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395158",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Implementation of New Trauma Triage Criteria and Implications on Under- and Overtriage",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 1 2017",
    "received_results_disposit_date": "",
    "source": "Uppsala University",
    "start_date": "2016-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2016",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2018-01-11T042317.604527",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Energy Cost of Posture Maintenance Ethnic Differences and the Influence of Metabolic State",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2018",
    "created_at": "2017-12-23T042500.581641",
    "enrollment": 30,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378115",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Energy Cost of Posture Maintenance Ethnic Differences and the Influence of Metabolic State",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "Clinical Nutrition Research Centre Singapore",
    "start_date": "2017-05-25",
    "start_date_type": "Actual",
    "start_month_year": "May 25 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042500.581641",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Music Therapy and Hematopoietic Stem Cell Transplant",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-23T042501.022349",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378089",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Pre-Transplant Music Therapy for Patients Undergoing Hematopoietic Stem Cell Transplant",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Case Comprehensive Cancer Center",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042501.022349",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Perioperative Management and Outcomes of Minimally Invasive Esophagectomy",
    "completion_date": "2017-09-15",
    "completion_date_type": "Actual",
    "completion_month_year": "September 15 2017",
    "created_at": "2017-12-24T041914.408153",
    "enrollment": 64,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378869",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Perioperative Management and Outcomes of Minimally Invasive Esophagectomy- Experience of a High-volume Tertiary Center in Taiwan",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 1 2017",
    "received_results_disposit_date": "",
    "source": "National Taiwan University Hospital",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041914.408153",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant",
    "completion_date": "2019-12-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 13 2019",
    "created_at": "2018-01-02T182932.452674",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386305",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Controlled Trial to Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 13 2019",
    "received_results_disposit_date": "",
    "source": "Albert Einstein Healthcare Network",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182932.452674",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase I Study of APX005M in Pediatric CNS Tumors",
    "completion_date": "2022-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2022",
    "created_at": "2018-01-09T041403.409224",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389802",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects With RecurrentRefractory Brain Tumors and Newly Diagnosed Brain Stem Glioma",
    "overall_status": "Active not recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "Pediatric Brain Tumor Consortium",
    "start_date": "2017-12-07",
    "start_date_type": "Actual",
    "start_month_year": "December 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041403.409224",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ADVICE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Randomized Study to Evaluate the Effect of Reminder Notifications and MotivationalAdaptive Messaging on Treatment Adherence",
    "completion_date": "2019-05-24",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 24 2019",
    "created_at": "2017-12-24T041908.004983",
    "enrollment": 146,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379233",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A 24-week Randomized Multicenter Single Blinded International Study to Evaluate the Effect of Reminder Notifications and MotivationalAdaptive Messaging on Treatment Adherence of COPD Subjects Receiving Ultibro Breezhaler Treatment Using the Concept2 Inhaler for Dose Tracking",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-24",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 24 2019",
    "received_results_disposit_date": "",
    "source": "Novartis",
    "start_date": "2018-03-23",
    "start_date_type": "Anticipated",
    "start_month_year": "March 23 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041908.004983",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MIID-SOC",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Debulking Surgery in Ovarian Cancer",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-23T042500.362470",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378128",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Minimally Invasive Interval Debulking Surgery in Ovarian Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2019",
    "received_results_disposit_date": "",
    "source": "Case Comprehensive Cancer Center",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042500.362470",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CHS DIET",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Childrens Health Study Diet and Air Pollution",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2017-12-24T041907.017102",
    "enrollment": 3142,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379298",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Regional and Traffic-related Air Pollutants Are Associated With Consumption of a High Fat Diet Among Adolescents",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2001-12-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 30 2001",
    "received_results_disposit_date": "",
    "source": "University of Southern California",
    "start_date": "1994-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 1994",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041907.017102",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "FIDDS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Family ICU Delirium Detection Study",
    "completion_date": "2019-05-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 6 2019",
    "created_at": "2017-12-24T041909.731089",
    "enrollment": 180,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379129",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Validation of Family-Administered Delirium Detection Tools for the Identification of Delirium in Critically Ill Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-06",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 6 2019",
    "received_results_disposit_date": "",
    "source": "University of Calgary",
    "start_date": "2017-11-06",
    "start_date_type": "Actual",
    "start_month_year": "November 6 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041909.731089",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Follow-Up Study Evaluating the Long Term Outcome of ChondroMimetic in the Treatment of Osteochondral Defects in the Knee",
    "completion_date": "2018-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2018",
    "created_at": "2017-12-31T041319.107845",
    "enrollment": 17,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385642",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Follow-Up Study Evaluating the Long-Term Outcomes of ChondroMimetic in the Treatment of Osteochondral Defects Extension Study of Protocol 0MCM0107",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "Collagen Solutions",
    "start_date": "2017-05-29",
    "start_date_type": "Actual",
    "start_month_year": "May 29 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041319.107845",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Olaparib in Treating Patients With Metastatic or Advanced Urothelial Cancer With DNA-Repair Defects",
    "completion_date": "2022-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2022",
    "created_at": "2017-12-22T042554.760926",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375307",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase II Study of Olaparib AZD2281 in Patients With MetastaticAdvanced Urothelial Carcinoma With DNA-Repair Defects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2022",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute NCI",
    "start_date": "2018-05-25",
    "start_date_type": "Anticipated",
    "start_month_year": "May 25 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042554.760926",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Glycaemic Control Using GlucoTab With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2018-01-05T041721.657687",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387787",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Pilot Study to Evaluate Glycaemic Control Using GlucoTab With Insulin Degludec and Aspart in Hospitalized Patients With Diabetes Mellitus Type 2",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Inselspital Berne",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041721.657687",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Oral Imaging for Porphyrin Biomarkers",
    "completion_date": "2016-08-01",
    "completion_date_type": "Actual",
    "completion_month_year": "August 2016",
    "created_at": "2017-12-24T041906.390269",
    "enrollment": 28,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379337",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Pilot Study of a Modular Fluorescent Device With Interchangeable Heads to Identify Oral Diseases",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 2016",
    "received_results_disposit_date": "",
    "source": "Massachusetts Institute of Technology",
    "start_date": "2016-04-01",
    "start_date_type": "",
    "start_month_year": "April 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041906.390269",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SENTICOLIII",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer",
    "completion_date": "2026-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2026",
    "created_at": "2018-01-02T182914.020691",
    "enrollment": 950,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386734",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire de Besancon",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182914.020691",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Periodontal Regeneration Using Dental Pulp Stem Cells DPSCs",
    "completion_date": "2017-04-28",
    "completion_date_type": "Actual",
    "completion_month_year": "April 28 2017",
    "created_at": "2018-01-02T182907.757581",
    "enrollment": 29,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386877",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Human Intrabony Defect Regeneration With Micro-grafts Containing Dental Pulp Stem Cells a Randomized Controlled Clinical Trial.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-04-28",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "April 28 2017",
    "received_results_disposit_date": "",
    "source": "University of Turin Italy",
    "start_date": "2016-01-25",
    "start_date_type": "Actual",
    "start_month_year": "January 25 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182907.757581",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ImpactTextureO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prognostic Value of 18FDG PETCT Textural Indices in HNSCC",
    "completion_date": "2018-03-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 30 2018",
    "created_at": "2017-12-23T042459.229777",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378193",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prognostic Value of Textural Indices Extracted From Pre-therapeutic 18-F FDG PETCT in Head and Neck Squamous Cell Carcinoma.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital Brest",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042459.229777",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effects of Kinesiotaping on Muscular Activity Mobility Strength and Pain After Rotator Cuff Surgery",
    "completion_date": "2017-01-04",
    "completion_date_type": "Actual",
    "completion_month_year": "January 4 2017",
    "created_at": "2017-12-26T040723.844143",
    "enrollment": 39,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379636",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Immediate and Short-term Effects of Kinesiotaping on Muscular Activity Mobility Strength and Pain After Rotator Cuff Surgery A Cross-over Clinical Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-01-04",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 4 2017",
    "received_results_disposit_date": "",
    "source": "Clinique Romande de Readaptation",
    "start_date": "2013-01-07",
    "start_date_type": "Actual",
    "start_month_year": "January 7 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040723.844143",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Individualized Exercise Program Plus Behavioral Change Enhancement Strategies for Managing Fatigue in Frail Older People",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2019",
    "created_at": "2018-01-11T042328.230631",
    "enrollment": 285,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394495",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Evaluation of an Individualized Exercise Programme Plus Behavioural Change Enhancement Strategies for Managing General Fatigue in Community-dwelling Frail Older People A Cluster-randomized Controlled Trial.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2019",
    "received_results_disposit_date": "",
    "source": "The Hong Kong Polytechnic University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042328.230631",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ImPACT",
    "baseline_population": "",
    "biospec_description": "Blood samples for all participants Tracheal aspirations for invasively ventilated patients\n      Broncho alveolar lavage fluid when available indication left at the discretion of the\n      investigator",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Innate Immune Response During Community Acquired Pneumonia",
    "completion_date": "2021-06-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 15 2021",
    "created_at": "2018-01-07T041927.524282",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379207",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Innate Immunity During Community Acquired Pneumonia A Translational Approach",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2021",
    "received_results_disposit_date": "",
    "source": "University Hospital Tours",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-07T041927.524282",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2017-12-23T042500.797279",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378102",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Antigen Specific Adoptive T Cell Therapy for Refractory Opportunistic Adenovirus Infection After a Related Donor Hematopoietic Stem Cell Transplantation",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Case Comprehensive Cancer Center",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042500.797279",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Observational Study on Sarilumab-exposed Pregnancies",
    "completion_date": "2027-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2027",
    "created_at": "2017-12-23T042458.769819",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378219",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Kevzara Sarilumab Pregnancy Exposure Registry An OTIS Pregnancy Surveillance Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2027-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2027",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042458.769819",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Evaluation of Low Level Laser Light Therapy for Autistic Disorder",
    "completion_date": "2017-11-28",
    "completion_date_type": "Actual",
    "completion_month_year": "November 28 2017",
    "created_at": "2017-12-26T040723.675205",
    "enrollment": 40,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": true,
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379662",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Double-blind Placebo-controlled Randomized Evaluation of the Effect of the Erchonia EAL Laser Device on Children and Adolescents With Autistic Disorder",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-28",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 28 2017",
    "received_results_disposit_date": "",
    "source": "Erchonia Corporation",
    "start_date": "2017-07-02",
    "start_date_type": "Actual",
    "start_month_year": "July 2 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040723.675205",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "FinnValve",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis FinnValve Registry",
    "completion_date": "2018-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2018",
    "created_at": "2018-01-02T182948.614320",
    "enrollment": 7000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385915",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Nationwide Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis FinnValve Registry",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "Turku University Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182948.614320",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Praluent Alirocumab Pregnancy Exposure Registry An OTIS Pregnancy Surveillance Study",
    "completion_date": "2028-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2028",
    "created_at": "2018-01-11T042422.946868",
    "enrollment": 375,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379558",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Praluent Alirocumab Pregnancy Exposure Registry An OTIS Pregnancy Surveillance Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2028-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2028",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042422.946868",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference Tablet",
    "completion_date": "2018-02-08",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 8 2018",
    "created_at": "2017-12-23T042457.118183",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378310",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Open-Label Study to Evaluate the Bioavailability of a BMS-986205 Tablet Containing Free Base Relative to a Reference Tablet in Healthy Participants",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-08",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 8 2018",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2017-12-21",
    "start_date_type": "Anticipated",
    "start_month_year": "December 21 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042457.118183",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "8-Week Atopic Dermatitis AD Treatment Study",
    "completion_date": "2018-06-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 15 2018",
    "created_at": "2018-01-02T182943.415755",
    "enrollment": 62,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386032",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "8-Week Atopic Dermatitis AD Treatment Study",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 15 2018",
    "received_results_disposit_date": "",
    "source": "Procter and Gamble",
    "start_date": "2017-11-27",
    "start_date_type": "Actual",
    "start_month_year": "November 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182943.415755",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Bromocriptine Metoprolol and Tamsulosin in Eyes With Non-Central DME",
    "completion_date": "2019-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2019",
    "created_at": "2017-12-31T041342.968525",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384524",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase III Evaluation of Bromocriptine Metoprolol and Tamsulosin Combination Therapy in Eyes With Non-Central Diabetic Macular Edema",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2019",
    "received_results_disposit_date": "",
    "source": "University of Southern California",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041342.968525",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced Metastatic or Cannot Be Removed by Surgery",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2021",
    "created_at": "2017-12-22T042554.515670",
    "enrollment": 395,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375320",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Randomized Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients With Advanced Neuroendocrine Tumors After Progression on Everolimus CABINET",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2021",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute NCI",
    "start_date": "2018-06-12",
    "start_date_type": "Anticipated",
    "start_month_year": "June 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042554.515670",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SATYAM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2019",
    "created_at": "2017-12-24T041903.152929",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379480",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "National Institute of Mental Health and Neuro Sciences India",
    "start_date": "2016-11-11",
    "start_date_type": "Actual",
    "start_month_year": "November 11 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041903.152929",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Explore the Antiviral Activity Clinical Outcomes Safety Tolerability and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus",
    "completion_date": "2019-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 1 2019",
    "created_at": "2018-01-07T041927.189306",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379675",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Pilot Phase 2a Randomized Double-blind Placebo-controlled Study to Explore the Antiviral Activity Clinical Outcomes Safety Tolerability and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Subjects Infected With Respiratory Syncytial Virus",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 18 2019",
    "received_results_disposit_date": "",
    "source": "Janssen Research  Development LLC",
    "start_date": "2018-01-26",
    "start_date_type": "Anticipated",
    "start_month_year": "January 26 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041927.189306",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Outcomes in Children With Pre-operative Residual Hearing",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2017-12-24T041856.140268",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379870",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Outcomes in Children With Cochlear Implants and Pre-Operative Residual Hearing Electric Only and Electric-Acoustic Stimulation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "University of North Carolina Chapel Hill",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041856.140268",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The VetSeq Study a Pilot Study of Genome Sequencing in Veteran Care",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-26T040721.265071",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380819",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Clinical Safety and Efficacy of Pharmacogenetics in Veteran Care",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "VA Boston Healthcare System",
    "start_date": "2017-12-29",
    "start_date_type": "Anticipated",
    "start_month_year": "December 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040721.265071",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "nNIRS-AKI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "NIRS for AKI in Preterm Infants",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2017-12-31T041348.453809",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384173",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Use of NIRS to Detect Acute Kidney Injury in Preterm Infants",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Wisconsin Madison",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041348.453809",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Interprofessional Intervention to Reduce Smoking Rates in the Latino Population",
    "completion_date": "2018-01-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 5 2018",
    "created_at": "2017-12-26T040722.476731",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380910",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "An Interprofessional Intervention With Behavioral Health and Pharmacy Trainees to Reduce Smoking Rates in the Latino Population of a Free Health Clinic in Richmond",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 5 2018",
    "received_results_disposit_date": "",
    "source": "Virginia Commonwealth University",
    "start_date": "2018-01-05",
    "start_date_type": "Anticipated",
    "start_month_year": "January 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040722.476731",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy",
    "completion_date": "2017-10-30",
    "completion_date_type": "Actual",
    "completion_month_year": "October 30 2017",
    "created_at": "2018-01-02T182926.793192",
    "enrollment": 148,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386435",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of Remote Ischemic Preconditioning on the Postoperative Liver Function in Living Donor Hepatectomy a Randomized Clinical Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 31 2017",
    "received_results_disposit_date": "",
    "source": "Asan Medical Center",
    "start_date": "2016-08-22",
    "start_date_type": "Actual",
    "start_month_year": "August 22 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182926.793192",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Incidence of Pancreatic Fistula After Radical Gastrectomy",
    "completion_date": "2018-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2018",
    "created_at": "2018-01-09T041347.371666",
    "enrollment": 2100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391687",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Investigation of Incidence of Pancreatic Fistula After Radical Gastrectomy in Gastric Cancer Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Shanghai Zhongshan Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041347.371666",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Postoperative Pain and PTN and Reciproc",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2018",
    "created_at": "2017-12-26T040722.814696",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380585",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Postoperative Pain Assessment After Foraminal Enlargement Using Protaper Next and Reciproc File Systems.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2018",
    "received_results_disposit_date": "",
    "source": "Isparta Military Hospital",
    "start_date": "2017-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040722.814696",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Efficacy of Lymphatic Massage on Lower Extremity Edema and Performance After Treadmill Exercise in Sprinter Compare to Static Stretching and Cold Water Immersion",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 1 2017",
    "created_at": "2018-01-02T182944.001612",
    "enrollment": 14,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386019",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Efficacy of Lymphatic Massage on Lower Extremity Edema and Performance After Treadmill Exercise in Sprinter Compare to Static Stretching and Cold Water Immersion",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-11-28",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 28 2017",
    "received_results_disposit_date": "",
    "source": "National Taiwan University Hospital",
    "start_date": "2017-11-06",
    "start_date_type": "Actual",
    "start_month_year": "November 6 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182944.001612",
    "verification_date": "2017-10-01",
    "verification_month_year": "October 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Genicular Nerve and Intra-articular Radiofrequency Versus Platelet Rich Plasma Injection for Knee Osteoarthritis",
    "completion_date": "2019-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2019",
    "created_at": "2017-12-24T041855.942480",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379883",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Combined Ultrasound Guided Genicular Nerve and Intra-articular Pulsed Radiofrequency Versus Intra-articular Platelet Rich Plasma Injection for Chronic Knee Osteoarthritis A Comparative Study",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 31 2018",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2017-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041855.942480",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study on Nutrition Support in Adult Patients With Severe Burns",
    "completion_date": "2014-10-02",
    "completion_date_type": "Actual",
    "completion_month_year": "October 2 2014",
    "created_at": "2017-12-25T041304.191071",
    "enrollment": 100,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379116",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-09-24",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 24 2014",
    "received_results_disposit_date": "",
    "source": "Southeast University China",
    "start_date": "2014-06-02",
    "start_date_type": "Actual",
    "start_month_year": "June 2 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041304.191071",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Promoting Partnership and Improving Self-Management for Children With Persistent Asthma",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-08T041348.405086",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390556",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Promoting Partnership and Improving Self-Management for Children With Persistent Asthma A Pilot Program of Clinic-Based Asthma Education and Medication Labeling",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "University of Rochester",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041348.405086",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role Of Physical Therapy In Relieving Constipation In Children With Spastic Cerebral Palsy",
    "completion_date": "2016-12-13",
    "completion_date_type": "Actual",
    "completion_month_year": "December 13 2016",
    "created_at": "2017-12-31T041358.434606",
    "enrollment": 35,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379038",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Role Of Physical Therapy In Relieving Constipation In Children With Spastic Cerebral Palsy",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-20",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 20 2016",
    "received_results_disposit_date": "",
    "source": "Isra University",
    "start_date": "2015-09-20",
    "start_date_type": "Actual",
    "start_month_year": "September 20 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041358.434606",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "VAPS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Video Assisted Pericardioscopic Surgery Minimal-invasive Implantation of Epimyocardial Pacemaker Leads in Humans",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2019",
    "created_at": "2018-01-05T041726.610052",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387488",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Video Assisted Pericardioscopic Surgery Minimal-invasive Implantation of Epimyocardial Pacemaker Leads in Humans VAPS - A Pilot Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2018",
    "received_results_disposit_date": "",
    "source": "RWTH Aachen University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041726.610052",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "GOAL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cognitive and Physical Home-rehabilitation by Information and Communications Technology. Games for Older Adults Active Life GOAL",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2017-12-29T041533.190366",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383549",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Home-rehabilitation Protocol in Elderly Subjects With Mild Cognitive Impairment MCI Based on Information and Communications Technology ICT and Serious Games for Cognitive and Physical Training. Games for Older Adults Active Life GOAL",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Fondazione Don Carlo Gnocchi Onlus",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041533.190366",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Patients",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-05T041720.320191",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387852",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Randomized Double-blind Placebo-controlled Parallel-group 12-week Proof-of-Concept PoC Study to Assess the Efficacy Safety and Tolerability of SAR440340 and the Coadministration of SAR440340 and Dupilumab in Patients With Moderate-to-severe Asthma Who Are Not Well Controlled on Inhaled Corticosteroid ICS Plus Long-acting 2 Adrenergic Agonist LABA Therapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2019",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2018-03-26",
    "start_date_type": "Anticipated",
    "start_month_year": "March 26 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041720.320191",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Platelet Rich Plasma for Patients With Recurrent Implantation Failure",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-25T041302.562279",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379649",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Platelet Rich Plasma for Patients With Recurrent Implantation Failure A Prospective Randomized Pilot Study",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Stanford University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041302.562279",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prognostic and Predictive Factors for Small Breast Tumors",
    "completion_date": "2016-07-30",
    "completion_date_type": "Actual",
    "completion_month_year": "July 30 2016",
    "created_at": "2018-01-08T041347.338050",
    "enrollment": 35002,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390608",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prognosis Prognostic Factors and Predictive Factors in Centimeter or Subcentimeter Node-negative Breast Cancer",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2014",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "1977-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 1977",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041347.338050",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DONUM",
    "baseline_population": "",
    "biospec_description": "Primary and metastatic tissues and peripheal blood samples",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Donation of Post Mortem Tumor Tissues",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-02T182945.450347",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385980",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Donation of Post Mortem Tumor Tissues to Unravel Cancer Heterogeneity",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Niguarda Hospital",
    "start_date": "2016-02-11",
    "start_date_type": "Actual",
    "start_month_year": "February 11 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182945.450347",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CIRN PCV 1 vs 2 Dose Priming Study",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2017-12-31T041341.927808",
    "enrollment": 248,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384589",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Controlled Trial to Compare a 1-dose vs. 2-dose Priming Schedule of 13-valent Pneumococcal Conjugate Vaccine in Canadian Infants a Canadian Immunization Research Network CIRN Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "University of British Columbia",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041341.927808",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "IMX-110 in Patients With Advanced Solid Tumors",
    "completion_date": "2019-12-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 15 2019",
    "created_at": "2017-12-29T041553.332127",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382340",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 12a Open-Label Dose-EscalationDose-Expansion Safety Tolerability and Pharmacokinetic Study of IMX-110 in Patients With Advanced Solid Tumors",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 15 2019",
    "received_results_disposit_date": "",
    "source": "Immix Biopharma Inc.",
    "start_date": "2018-01-29",
    "start_date_type": "Anticipated",
    "start_month_year": "January 29 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041553.332127",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Study to Evaluate the Effect of the Connected Inhaler System CIS on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects",
    "completion_date": "2019-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2019",
    "created_at": "2017-12-25T041256.392274",
    "enrollment": 432,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380429",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "An Open Label Randomised Parallel Group Clinical Study to Evaluate the Effect of the Connected Inhaler System CIS on Adherence to RelvarBreo ELLIPTA Therapy in Asthmatic Subjects With Poor Control",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2019",
    "received_results_disposit_date": "",
    "source": "GlaxoSmithKline",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041256.392274",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Ivabradine in Stage D HFCardiogenic Shock Patients on Dobutamine",
    "completion_date": "2020-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2020",
    "created_at": "2018-01-05T041724.673380",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387605",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Ivabradine on Heart Rate and Hemodynamics in Patients With Stage D Heart Failure HFCardiogenic Shock on Dobutamine Treatment",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Loyola University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041724.673380",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects",
    "completion_date": "2018-02-05",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 5 2018",
    "created_at": "2017-12-25T041256.028450",
    "enrollment": 14,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380455",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-center Open-label Study to Investigate the Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Male Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 5 2018",
    "received_results_disposit_date": "",
    "source": "Idorsia Pharmaceuticals Ltd.",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041256.028450",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pregabalin Premedication for Conscious Sedation",
    "completion_date": "2017-05-16",
    "completion_date_type": "Actual",
    "completion_month_year": "May 16 2017",
    "created_at": "2018-01-05T041723.948249",
    "enrollment": 70,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387644",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Pregabalin Premedication for Conscious Sedation for Flexible Bronchoscopy A Randomized Double Blind Controlled Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-11-24",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 24 2016",
    "received_results_disposit_date": "",
    "source": "Menoufia University",
    "start_date": "2015-04-15",
    "start_date_type": "Actual",
    "start_month_year": "April 15 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041723.948249",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "AOPOSSI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "AO Multicenter Intervention Trial for Prevention of Surgical Site Infection",
    "completion_date": "2023-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2023",
    "created_at": "2017-12-25T041258.749841",
    "enrollment": 8476,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380273",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "AO Multicenter Intervention Trial to Evaluate the Impact of a Bundle of Measures for the Prevention of Surgical Site Infection in Fracture Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2023",
    "received_results_disposit_date": "",
    "source": "AO Clinical Investigation and Documentation",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041258.749841",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MINDD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Metformin Vitamin D and Depression in Polycystic Ovary Syndrome PCOS Trial",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-24T041852.117636",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380091",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Metformin Vitamin D and Depression in Polycystic Ovary Syndrome PCOS Trial The MINDD Trial",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2019",
    "received_results_disposit_date": "",
    "source": "University of California San Francisco",
    "start_date": "2017-12-12",
    "start_date_type": "Actual",
    "start_month_year": "December 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041852.117636",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ultrasound for Comparison of Gastric Antral Volume in Pregnants and Non-pregnants",
    "completion_date": "2017-10-10",
    "completion_date_type": "Actual",
    "completion_month_year": "October 10 2017",
    "created_at": "2017-12-25T041253.382418",
    "enrollment": 63,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380637",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Ultrasound for Comparison of Gastric Volume in Pregnant Females Posted for Elective Lower Segment Cesarean Section With Non-pregnant Females Undergoing Elective Surgeries.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 10 2017",
    "received_results_disposit_date": "",
    "source": "Postgraduate Institute of Medical Education and Research",
    "start_date": "2016-10-13",
    "start_date_type": "Actual",
    "start_month_year": "October 13 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041253.382418",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Motion Perception in Individuals With Type 2 Diabetes",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2018",
    "created_at": "2017-12-25T041250.621259",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380832",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Vestibular Perception and Action",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "Massachusetts Eye and Ear Infirmary",
    "start_date": "2017-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041250.621259",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Cardiac Rehab for Patients With Peripheral Artery Disease Versus Patients With Coronary Artery Disease",
    "completion_date": "2019-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2019",
    "created_at": "2018-01-11T042333.105649",
    "enrollment": 56,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394183",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparing the Efficacy of Cardiac Rehabilitation for Patients With Peripheral Artery Disease to Patients With Coronary Artery Disease",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2018",
    "received_results_disposit_date": "",
    "source": "University Health Network Toronto",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042333.105649",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "MODULAR",
    "baseline_population": "",
    "biospec_description": "Cervicalvaginal cytology swab",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Lab-on-a-chip Detection of Cervical Cancer Tumour Markers",
    "completion_date": "2019-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2019",
    "created_at": "2017-12-25T041251.902769",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380741",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 5,
    "official_title": "Molecular Diagnostics Using a Novel Lab-on-a-chip and MRI for Detecting Cervical Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2019",
    "received_results_disposit_date": "",
    "source": "Royal Marsden NHS Foundation Trust",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041251.902769",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "LaGRA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "LaGRA Trial in Laparoscopic Cholecystectomy",
    "completion_date": "2017-08-30",
    "completion_date_type": "Actual",
    "completion_month_year": "August 30 2017",
    "created_at": "2018-01-11T042323.295839",
    "enrollment": 76,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394807",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Laparoscopic Guided Regional Analgesia LaGRA Reduces Post Operative Pain After Laparoscopic Cholecystectomy - a Randomised Controlled Trial.",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-07-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 30 2017",
    "received_results_disposit_date": "",
    "source": "Health Service Executive Ireland",
    "start_date": "2016-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042323.295839",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Personalized Cancer Vaccine NEO-PV-01 With Pembrolizumab and Chemotherapy for Patients With Lung Cancer",
    "completion_date": "2021-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2021",
    "created_at": "2017-12-25T041249.981621",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380871",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open-Label Phase 1B Study of NEO-PV-01 With Pembrolizumab Plus Chemotherapy in Patients With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2020",
    "received_results_disposit_date": "",
    "source": "Neon Therapeutics Inc.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041249.981621",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ANASTOSEAL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "REINFORCEMENT ANASTOMOSIS IN ONCOLOGIC COLORECTAL SURGERY COLORETTALE ONCOLOGICA",
    "completion_date": "2019-05-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2 2019",
    "created_at": "2017-12-25T041250.271282",
    "enrollment": 390,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-15",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380858",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "REINFORCEMENT ANASTOMOSIS IN ONCOLOGIC COLORECTAL SURGERY",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-02",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2 2017",
    "received_results_disposit_date": "",
    "source": "National Cancer Institute Naples",
    "start_date": "2017-11-02",
    "start_date_type": "Actual",
    "start_month_year": "November 2 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041250.271282",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "IRAC",
    "baseline_population": "",
    "biospec_description": "Blood samples to asses serological status rheumatoid arthritis antibodies",
    "biospec_retention": "Samples With DNA",
    "brief_title": "INCMNSZ - Rheumatoid Arthritis Cohort",
    "completion_date": "2024-02-04",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 4 2024",
    "created_at": "2018-01-08T041341.100151",
    "enrollment": 210,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389711",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "INCMNSZ Early Rheumatoid Arthritis Cohort",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-04",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 4 2019",
    "received_results_disposit_date": "",
    "source": "National Institute of Medical Sciences and Nutrition Salvador Zubiran",
    "start_date": "2004-02-04",
    "start_date_type": "Actual",
    "start_month_year": "February 4 2004",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041341.100151",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Dual Guidance in Regional Anesthesia",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2019",
    "created_at": "2017-12-29T041529.812710",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383770",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Dual Guidance in Regional Anesthesia - Prospective Randomized Study of Needle-nerve Distance in Different Cannulas for Regional Nerve Blockade",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "Charite University Berlin Germany",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041529.812710",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "VFI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prevalidation of the First German Version of the Vocal Fatigue Index VFI",
    "completion_date": "2018-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2018",
    "created_at": "2017-12-24T041919.246781",
    "enrollment": 190,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378609",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Prevalidation of the First German Version of the Vocal Fatigue Index VFI",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Zurich",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041919.246781",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "SPOON Sustained Program for Improving Nutrition - Colombia",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2017-12-24T041917.268852",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378726",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "SPOON Sustained Program for Improving Nutrition - Colombia",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Inter-American Development Bank",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041917.268852",
    "verification_date": "2017-02-01",
    "verification_month_year": "February 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prevention of Gastric Insufflation During Positive Pressure Ventilation",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2018",
    "created_at": "2017-12-24T041919.670586",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378583",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Is Ultrasound-guided Left Paratracheal Esophagus Pressure More Effective Than Cricoid Pressure to Prevent Gastric Insufflation During Positive Pressure Ventilation",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "University Hospital of Liege",
    "start_date": "2017-03-22",
    "start_date_type": "Actual",
    "start_month_year": "March 22 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041919.670586",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CORTEX",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role of the Posterior Parietal Cortex in the Processing of Sensory Information",
    "completion_date": "2019-07-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 18 2019",
    "created_at": "2018-01-02T182936.496697",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386188",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Role of the Posterior Parietal Cortex in the Processing of Sensory Information Modulating the Excitability of the Primary Motor Cortex in Humans",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 18 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Lille",
    "start_date": "2016-01-01",
    "start_date_type": "",
    "start_month_year": "January 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182936.496697",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Th17Treg Cells and IL-23IL-17 Axis and Early Enteral Nutrition in Sepsis",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2018-01-02T182952.438877",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385850",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Roles of Th17Treg Cells and IL-23IL-17 Axis in the Mechanisms of Early Enteral Nutrition Improving Immune Function of Sepsis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Nanjing First Hospital Nanjing Medical University",
    "start_date": "2017-12-15",
    "start_date_type": "Actual",
    "start_month_year": "December 15 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182952.438877",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia",
    "completion_date": "2020-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2020",
    "created_at": "2017-12-23T042501.713349",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378050",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy and Feasibility of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia in China Study Protocol of a Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Yale University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042501.713349",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CheckMate9N9",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread",
    "completion_date": "2022-12-17",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 17 2022",
    "created_at": "2017-12-23T042518.116497",
    "enrollment": 345,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377361",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Metastatic Colorectal Cancers",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 15 2021",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2018-01-12",
    "start_date_type": "Anticipated",
    "start_month_year": "January 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042518.116497",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy During Pterygium Excision",
    "completion_date": "2021-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2021",
    "created_at": "2017-12-23T042518.408482",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377348",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Evaluation of the Use of Intraoperative Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy During Bare Scleral Pterygium Excision",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042518.408482",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Respiration and The Airway With Supraglottic Airway Devices",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042418.815228",
    "enrollment": 80,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384056",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparison of the Self Pressurized Airway Device With Blocker and the Proseal Laryngeal Mask Airway in Anaesthetized Paralyzed Adult Female Patients Undergoing Gynecological Operations",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 30 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2016-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042418.815228",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-23T042516.673162",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377439",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP Patients a Prospective Multicenter Double-blind Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Shandong University",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042516.673162",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Spermidine Intake and All-cause Mortality",
    "completion_date": "2015-10-01",
    "completion_date_type": "Actual",
    "completion_month_year": "October 2015",
    "created_at": "2017-12-24T041914.806556",
    "enrollment": 829,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378843",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Association Between Dietary Spermidine Intake and Mortality in the Population-based Bruneck Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-10-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 2015",
    "received_results_disposit_date": "",
    "source": "Medical University Innsbruck",
    "start_date": "1995-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1995",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041914.806556",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "LYS228 PK Clinical Response Safety and Tolerability in Patients With Complicated Urinary Tract Infection cUTI",
    "completion_date": "2018-12-23",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 23 2018",
    "created_at": "2017-12-23T042516.916877",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377426",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Controlled Evaluator-blinded Multi-center Study to Evaluate LYS228 Pharmacokinetics Clinical Response Safety and Tolerability in Patients With Complicated Urinary Tract Infection",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-23",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 23 2018",
    "received_results_disposit_date": "",
    "source": "Novartis",
    "start_date": "2018-01-18",
    "start_date_type": "Anticipated",
    "start_month_year": "January 18 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042516.916877",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Capecitabine 77 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-23T042517.588525",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377387",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase IbII Study of Capecitabine 77 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Memorial Sloan Kettering Cancer Center",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042517.588525",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reduction of Shear Forces Using Semi-flexible Sockets on Transtibial Amputees",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-08T041355.516553",
    "enrollment": 5,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390153",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Reduction of Shear Forces Using Semi-flexible Sockets on Transtibial Amputees",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Loma Linda University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041355.516553",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer",
    "completion_date": "2019-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2019",
    "created_at": "2017-12-23T042517.361655",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377400",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Trial of Durvalumab MEDI4736 Tremelimumab Combined With Definitive Concurrent Chemo-radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2019",
    "received_results_disposit_date": "",
    "source": "Samsung Medical Center",
    "start_date": "2017-12-14",
    "start_date_type": "Actual",
    "start_month_year": "December 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042517.361655",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SPRING",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Survival Prolongation by Rationale Innovative Genomics",
    "completion_date": "2022-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2022",
    "created_at": "2018-01-09T041407.431326",
    "enrollment": 130,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386929",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Proof of Concept Study to Explore Safety and Efficacy of Tri-therapy Approach in AdvancedMetastatic NSCLC and Retrospectively Assess the Ability of Integrated Genomics and Transcriptomics to Match Patients to the Combination",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "Worldwide Innovative Networking Association",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041407.431326",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "APLABE-PCI",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Anti-platelet Effect of Berberine in Patients After Elective Percutaneous Coronary interventionCoronary Intervention",
    "completion_date": "2020-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2020",
    "created_at": "2017-12-24T041913.340030",
    "enrollment": 64,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378934",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Single-center Randomized Open-label Controlled Dose-escalating Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients on Aspirin and Clopidogrel After Elective Percutaneous Coronary Intervention for Stable Coronary Artery Disease or Unstable Angina",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2020",
    "received_results_disposit_date": "",
    "source": "Peking Union Medical College Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041913.340030",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women",
    "completion_date": "2017-10-31",
    "completion_date_type": "Actual",
    "completion_month_year": "October 31 2017",
    "created_at": "2017-12-24T041915.735994",
    "enrollment": 120,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378791",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Iron Bisglycinate Chelate or Ferrous Fumarate in Treatment of Iron Deficiency Anemia in Pregnant Women",
    "overall_status": "Completed",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 31 2017",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2015-12-31",
    "start_date_type": "Actual",
    "start_month_year": "December 31 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041915.735994",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ALLIENCE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Allopurinol and Endothelial Function in Diabetic CAD Patients",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2017-12-31T041329.441086",
    "enrollment": 58,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385135",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of ALLopurInol on Endothelial fuNCtion in diabEtic Patients Affected With Coronary Artery Disease",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "University Tunis El Manar",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041329.441086",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pharmacokinetic PK Study of ACH-0144471 Modified Release Prototype Formulations in Healthy Subjects",
    "completion_date": "2018-04-17",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 17 2018",
    "created_at": "2017-12-31T041348.259006",
    "enrollment": 14,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384186",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Study to Evaluate the Pharmacokinetic Profile of ACH-0144471 Following Administration of Modified Release Prototype Formulations in Healthy Subjects",
    "overall_status": "Active not recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-04",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 4 2018",
    "received_results_disposit_date": "",
    "source": "Achillion Pharmaceuticals",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041348.259006",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "rTMS for MDD 5.5cm Rule vs. F3 Targeting",
    "completion_date": "2020-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2020",
    "created_at": "2017-12-24T041919.877738",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378570",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Repetitive Transcranial Magnetic Stimulation Prefrontal Target Location on Outcomes for Major Depressive Disorder",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2020",
    "received_results_disposit_date": "",
    "source": "University of Iowa",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041919.877738",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Remifentanil and Stress Hormones Response",
    "completion_date": "2012-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 2012",
    "created_at": "2018-01-11T042423.175027",
    "enrollment": 50,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378674",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Different Doses of Remifentanil on Stress Response During Laparoscopic Cholecystectomy",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2012-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 2012",
    "received_results_disposit_date": "",
    "source": "Catholic University of the Sacred Heart",
    "start_date": "2008-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2008",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042423.175027",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "BACILLUS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Description of the Pathogenicity and Incriminated Modes of Contamination of Neonatal Bacillus Species Sepsis.",
    "completion_date": "2016-08-31",
    "completion_date_type": "Actual",
    "completion_month_year": "August 31 2016",
    "created_at": "2017-12-23T042515.037976",
    "enrollment": 11,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377530",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Description of the Pathogenicity and Incriminated Modes of Contamination of Neonatal Bacillus Species Sepsis.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-08-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 31 2016",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Ren Dubos",
    "start_date": "2008-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2008",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042515.037976",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reporting Patient Generated Health Data and Patient Reported Outcomes With Health Information Technology",
    "completion_date": "2019-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2019",
    "created_at": "2018-01-05T041732.057700",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386773",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Engaging Disadvantaged Patients in Sharing Patient Generated Health Data and Patient Reported Outcomes Through Health Information Technology",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "Denver Health and Hospital Authority",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041732.057700",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "POInT",
    "baseline_population": "",
    "biospec_description": "blood and urine",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Prostatic Obstruction Investigation Team Multicenter Study",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2018-01-11T042325.848049",
    "enrollment": 11500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394651",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Current Status and Progression of Symptoms and Comorbidities Among Male Lower Urinary Tract Symptoms Patients in China a Multicenter Study From Prostatic Obstruction Investigation Team POInT",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Changhai Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042325.848049",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "KRONOS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of AK002 in Patients With Atopic Keratoconjunctivitis Vernal Keratoconjunctivitis and Perennial Allergic Conjunctivitis",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2017-12-24T041906.812427",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379311",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1b Open-Label Multiple Dose Proof-of-Concept Study to Evaluate the Safety Tolerability and Pharmacodynamics of AK002 in Patients With Atopic Keratoconjunctivitis Vernal Keratoconjunctivitis and Perennial Allergic Conjunctivitis",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2019",
    "received_results_disposit_date": "",
    "source": "Allakos Inc.",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041906.812427",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Apical Support During Hysterectomy for Pelvic Organ Prolapse",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-24T041907.804258",
    "enrollment": 250,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379246",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Are we Supporting the Apex During Hysterectomy for Pelvic Organ Prolapse",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "TriHealth Inc.",
    "start_date": "2017-12-05",
    "start_date_type": "Actual",
    "start_month_year": "December 5 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041907.804258",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-26T040725.850707",
    "enrollment": 1150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374215",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2017-12-14",
    "start_date_type": "Actual",
    "start_month_year": "December 14 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040725.850707",
    "verification_date": "2017-12-08",
    "verification_month_year": "December 8 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PIE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of a Novel Intervention for Infants At Risk for Neurodevelopmental Disorders",
    "completion_date": "2022-07-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 15 2022",
    "created_at": "2018-01-11T042413.076966",
    "enrollment": 44,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388294",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of a Novel Intervention for Infants At Risk for Neurodevelopmental Disorders",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 15 2019",
    "received_results_disposit_date": "",
    "source": "University of North Carolina Chapel Hill",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042413.076966",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "ZIEL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Internet-based Self-help for Negative Life Events",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2018-01-11T042423.407465",
    "enrollment": 128,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379155",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "ZIEL - Zurck Ins Eigene Leben - Internet-based Self-help for Negative Life Events",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Bern",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042423.407465",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "BCI-controlled NMES in Subacute Stroke",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-24T041902.328096",
    "enrollment": 32,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379532",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Brain-computer Interface Controlled Neuromuscular Electrical Stimulation in Subacute Stroke",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "University Hospital Geneva",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041902.328096",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Expanding the Pool in Lung Transplantation",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 1 2020",
    "created_at": "2017-12-23T042515.973642",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377478",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Expanding the Pool in Lung Transplantation The Use of Hepatitis C Positive Donor Lungs in Hepatitis C Negative Recipients",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2020",
    "received_results_disposit_date": "",
    "source": "University of Pittsburgh",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042515.973642",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pain at Home After Tonsillectomy With or Without Adenoidectomy",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2017-12-26T040724.003897",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378830",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Pain at Home After Tonsillectomy With or Without Adenoidectomy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "McGill University Health Center",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040724.003897",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Regisry of the Stroke Patients in Assiut University Hospital",
    "completion_date": "2018-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2018",
    "created_at": "2018-01-11T042356.000192",
    "enrollment": 1,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392792",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Regisry of the Stroke Patients in Assiut University Hospital",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2018-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042356.000192",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Treating Sleep Apnea in Women Veterans",
    "completion_date": "2022-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2022",
    "created_at": "2018-01-11T042423.642582",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377452",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Diagnosis and Treatment of Sleep Apnea in Women Veterans",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "VA Office of Research and Development",
    "start_date": "2018-06-01",
    "start_date_type": "Anticipated",
    "start_month_year": "June 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042423.642582",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Can a Smartphone App That Includes a Chatbot-based Coaching and Incentives Increase Physical Activity in Healthy Adults",
    "completion_date": "2018-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2018",
    "created_at": "2017-12-31T041342.560209",
    "enrollment": 274,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384550",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Investigating Different Intervention Components of a Smartphone App to Promote Physical Activity A Longitudinal Factorial Experiment",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-17",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 17 2017",
    "received_results_disposit_date": "",
    "source": "University of St.Gallen",
    "start_date": "2017-10-24",
    "start_date_type": "Actual",
    "start_month_year": "October 24 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041342.560209",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Bleeding in Knee Arthroplasty After Preconditioning With Sevoflurane",
    "completion_date": "2020-01-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 30 2020",
    "created_at": "2017-12-26T040724.378463",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379103",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects on Bleeding in Knee Arthroplasty After Ischemic Preconditioning With Sevoflurane",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "University of Sao Paulo General Hospital",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040724.378463",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "Papillon",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Vaccination Against Human Papillomavirus HPV With the 9-valent Vaccine in HIV-positive Women the Papillon Study",
    "completion_date": "2021-01-08",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 8 2021",
    "created_at": "2018-01-09T041343.811252",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-31",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391921",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Prospective Longitudinal Study on Immunogenicity Induction of Cellular Immune Responses and Safety of Vaccination Against HPV With the 9-valent Vaccine in HIV-positive Women The Papillon Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-08",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 8 2020",
    "received_results_disposit_date": "",
    "source": "Centre Hospitalier Universitaire Saint Pierre",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041343.811252",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mindfulness-Based Cognitive Therapy and Compassion-Focused Therapy for Prolonged Grief Symptoms",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2017-12-31T041341.489438",
    "enrollment": 192,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384615",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "The Aarhus Bereavement Study TABs A Three-armed Randomized Controlled Trial of the Efficacy of Mindfulness-Based Cognitive Therapy and Compassion-Focused Therapy for Prolonged Grief Symptoms in Bereaved Adults",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "University of Aarhus",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041341.489438",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 1 2018",
    "created_at": "2017-12-25T041307.006073",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377309",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 1 2018",
    "received_results_disposit_date": "",
    "source": "American University of Beirut Medical Center",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041307.006073",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Blood sample obtained for cytokines detection",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure",
    "completion_date": "2019-12-19",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 19 2019",
    "created_at": "2017-12-24T041858.058779",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379779",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Department of Critical Care Medicine Taichung Veterans General Hospital",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 20 2018",
    "received_results_disposit_date": "",
    "source": "Taichung Veterans General Hospital",
    "start_date": "2017-08-28",
    "start_date_type": "Actual",
    "start_month_year": "August 28 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2017-12-24T041858.058779",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Antiplatelet Effects of Low-dose Ticagrelor and Standard-dose Clopidogrel in Chinese ACS Patients",
    "completion_date": "2020-02-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 13 2020",
    "created_at": "2017-12-26T040715.225797",
    "enrollment": 2000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381742",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Real-World Comparison of the Antiplatelet Effects of Low-dose Ticagrelor and Standard-dose Clopidogrel in Chinese ACS Patients",
    "overall_status": "Recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 13 2019",
    "received_results_disposit_date": "",
    "source": "First Affiliated Hospital of Harbin Medical University",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040715.225797",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Gut Microbiota Short Chain Fatty Acids and Adiposity Across The Epidemiological Transition",
    "completion_date": "2022-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2022",
    "created_at": "2018-01-08T041421.513893",
    "enrollment": 2500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378765",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Gut Microbiota Short Chain Fatty Acids and Adiposity Across The Epidemiological Transition",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2022",
    "received_results_disposit_date": "",
    "source": "Loyola University",
    "start_date": "2018-01-02",
    "start_date_type": "Actual",
    "start_month_year": "January 2 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041421.513893",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Investigate Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366",
    "completion_date": "2018-08-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 28 2018",
    "created_at": "2018-01-08T041421.281094",
    "enrollment": 96,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378648",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A First In Human Randomised Double-Blind Placebo-Controlled Study Of Single Ascending Doses In Healthy Male Volunteers And Repeated Ascending Dose In Asthmatic Patients Followed By A 3-Way Cross-Over Placebo-Controlled Single-Dose In Copd Patients To Investigate The Safety Tolerability Pharmacokinetics And Pharmacodynamics Of CHF6366",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 28 2018",
    "received_results_disposit_date": "",
    "source": "Chiesi Farmaceutici S.p.A.",
    "start_date": "2017-12-28",
    "start_date_type": "Actual",
    "start_month_year": "December 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041421.281094",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Mobile Intervention to Reduce Pain and Improve Health MORPH",
    "completion_date": "2019-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2019",
    "created_at": "2017-12-23T042509.895043",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377634",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Mobile Intervention to Reduce Pain and Improve Health MORPH in Obese Older Adults",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2019",
    "received_results_disposit_date": "",
    "source": "Wake Forest University Health Sciences",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042509.895043",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PEH",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Citrulline and Arginine Supplementation on the Post-exercise Hypotension PEH",
    "completion_date": "2018-02-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 28 2018",
    "created_at": "2017-12-31T041401.038029",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378596",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Impact of L-citrulline Associated With L-arginine Supplementation on the Post-exercise Hypotension in Normotensives and Hypertensives",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2018",
    "received_results_disposit_date": "",
    "source": "Universidade Norte do Paran",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041401.038029",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Stem Cells After Peripheral Mobilization and Harvest",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-26T040716.973247",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381599",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Quantification and Qualification of Stem Cells After Peripheral Mobilization and Harvest for Orthopaedic Point of Care Application",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Andrews Research  Education Foundation",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040716.973247",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "microbiota DNA are extracted from human feces",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Gut Microbiota is Associated With Autoimmune Thyroid Disease",
    "completion_date": "2021-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2021",
    "created_at": "2018-01-08T041347.991423",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390582",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Gut Microbiota is Associated With Autoimmune Thyroid DiseaseGD and HT",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-24",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 24 2018",
    "received_results_disposit_date": "",
    "source": "First Affiliated Hospital of Harbin Medical University",
    "start_date": "2017-04-20",
    "start_date_type": "Actual",
    "start_month_year": "April 20 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-08T041347.991423",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Spreading Depolarizations in Traumatic Brain Injury",
    "completion_date": "2020-07-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 14 2020",
    "created_at": "2017-12-25T041304.008427",
    "enrollment": 189,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379220",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Development and Validation of Spreading Depolarization Monitoring for TBI Management",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "University of Cincinnati",
    "start_date": "2017-03-28",
    "start_date_type": "Actual",
    "start_month_year": "March 28 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041304.008427",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome CRPS Type 1",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2018",
    "created_at": "2017-12-29T041600.768025",
    "enrollment": 36,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377504",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome CRPS Type 1Prospective Randomized Single Blind Controlled Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "Ankara University",
    "start_date": "2017-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041600.768025",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage",
    "completion_date": "2014-03-08",
    "completion_date_type": "Actual",
    "completion_month_year": "March 8 2014",
    "created_at": "2017-12-25T041302.951551",
    "enrollment": 655,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379467",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage A Randomized Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-03-08",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 8 2014",
    "received_results_disposit_date": "",
    "source": "Interactive Research and Development",
    "start_date": "2011-05-23",
    "start_date_type": "Actual",
    "start_month_year": "May 23 2011",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041302.951551",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Venetoclax in Combination With Ublituximab and Umbralisib TGR-1202 in Patients With Relapsed or Refractory CLLSLL",
    "completion_date": "2020-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2020",
    "created_at": "2017-12-25T041301.554306",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379051",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Venetoclax in Combination With Ublituximab and Umbralisib TGR-1202 in Patients With Relapsed or Refractory CLLSLL",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2019",
    "received_results_disposit_date": "",
    "source": "TG Therapeutics Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041301.554306",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Postoperative Environment on Pain Following Pelvic Reconstructive Surgery",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-24T041858.485808",
    "enrollment": 102,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379753",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Influence of Postoperative Environment on Patient Satisfaction and Perception of Care Following Pelvic Reconstructive Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "TriHealth Inc.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041858.485808",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "EBV-associated Diffuse Large B Cell Lymphoma",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2018",
    "created_at": "2017-12-26T040723.168642",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378947",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "EBV-associated Diffuse Large B Cell Lymphoma NOS in Non Immunocompromised Patients  a French Retrospective Case Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2018",
    "received_results_disposit_date": "",
    "source": "Hospices Civils de Lyon",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040723.168642",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reverse Total Shoulder Arthroplasty Versus Hemiarthroplasty for Displaced 3- and 4-part Proximal Humeral Fractures",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2017-12-31T041351.526578",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383991",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Reverse Total Shoulder Arthroplasty Versus Hemiarthroplasty for Displaced 3- and 4-part Proximal Humeral Fractures in Patients Older Than 70 Years. A Multicenter Randomized Controlled Trial",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2 2018",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "2013-09-10",
    "start_date_type": "Actual",
    "start_month_year": "September 10 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041351.526578",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "VRC 603 A Phase I Dose-Escalation Study of the Safety of AAV8-VRC07 VRC-HIVAAV070-00-GT Recombinant AAV Vector Expressing VRC07 HIV-1 Neutralizing Antibody in Antiretroviral -Treated HIV-1 Infected Adults With Controlled Viremia.",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2019",
    "created_at": "2018-01-11T042425.515262",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374202",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "VRC 603 A Phase I Dose-Escalation Study of the Safety of AAV8-VRC07 VRC-HIVAAV070-00-GT Recombinant AAV Vector Expressing VRC07 HIV-1 Neutralizing Antibody in Antiretroviral -Treated HIV-1 Infected Adults With Controlled Viremia.",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 1 2019",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042425.515262",
    "verification_date": "2017-12-08",
    "verification_month_year": "December 8 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Apical Negative Pressure Irrigation System at Cleaning Lateral Canals and Reduction of Periapical Lesions After Endodontic Therapy",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2017-12-31T041351.319174",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": true,
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384004",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Apical Negative Pressure Irrigation System at Cleaning Lateral Canals and Reduction of Periapical Lesions After Endodontic Therapy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "KaVo Kerr",
    "start_date": "2017-11-20",
    "start_date_type": "Actual",
    "start_month_year": "November 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041351.319174",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI",
    "completion_date": "2020-12-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 14 2020",
    "created_at": "2017-12-26T040715.054070",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381755",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Comparative Effectiveness and Safety Analysis of Low-dose and Standard-dose Ticagrelor in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-14",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 14 2019",
    "received_results_disposit_date": "",
    "source": "First Affiliated Hospital of Harbin Medical University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040715.054070",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "KEPOBA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ketamine for Postoperative Pain in Bariatric Surgery",
    "completion_date": "2017-06-06",
    "completion_date_type": "Actual",
    "completion_month_year": "June 6 2017",
    "created_at": "2018-01-07T041857.930771",
    "enrollment": 32,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-01",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389022",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Ketamine on Postoperative Pain After Intraoperative Remifentanil Infusions in Bariatric Surgery",
    "overall_status": "Completed",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-03-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 30 2017",
    "received_results_disposit_date": "",
    "source": "Lithuanian University of Health Sciences",
    "start_date": "2015-07-22",
    "start_date_type": "Actual",
    "start_month_year": "July 22 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041857.930771",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "XELOXmFOLFOX Plus Vitamin D3 vs. XELOXmFOLFOX as Firstline Chemotherapy in mCRC",
    "completion_date": "2022-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2022",
    "created_at": "2018-01-07T041841.864412",
    "enrollment": 750,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389659",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Multicenter Double-blinded Phase III Study of Vitamin D3 in Combination With Oxaliplatin Plus Fluoropyrimidine Versus Oxaliplatin Plus Fluoropyrimidine as First-line Chemotherapy in Previously Untreated Advanced or Metastatic Colorectal Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2021",
    "received_results_disposit_date": "",
    "source": "Tianjin Medical University Cancer Institute and Hospital",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041841.864412",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Different Spinal Needles Sizes and Dural Puncture Epidural For Labor Analgesia",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-08T041358.745367",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389945",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Dural Puncture Epidural For Early Labor Analgesia A Randomized Comparison Between 27- and 25-Gauge Pencil Point Spinal Needles.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "University of Chile",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041358.745367",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2017-12-29T041532.608791",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383588",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Addition of Subcutaneous Bupivacaine to Patients Undergoing Cesarean Section for Post-op Pain Relief Receiving Intrathecal Morphine",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Montefiore Medical Center",
    "start_date": "2018-01-02",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041532.608791",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "DexSwallow",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Dexmedetomidine and Swallowing Function",
    "completion_date": "2018-04-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 11 2018",
    "created_at": "2018-01-09T041358.724989",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390972",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effects of Dexmedetomidine on Swallowing Function a Randomized Double-Blind Study in Healthy Volunteers",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 11 2018",
    "received_results_disposit_date": "",
    "source": "Region rebro County",
    "start_date": "2018-01-22",
    "start_date_type": "Anticipated",
    "start_month_year": "January 22 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041358.724989",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "M01",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Educational Intervention in Patients With Migraine",
    "completion_date": "2016-05-30",
    "completion_date_type": "Actual",
    "completion_month_year": "May 30 2016",
    "created_at": "2017-12-26T040711.977488",
    "enrollment": 116,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381924",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of a Group Educational Intervention in Patients With Migraine a Randomised Controlled Trial",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-05-30",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 30 2016",
    "received_results_disposit_date": "",
    "source": "Basque Health Service",
    "start_date": "2013-08-01",
    "start_date_type": "Actual",
    "start_month_year": "August 1 2013",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040711.977488",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "RESIST-2",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "RESIST-2 2nd-line ART for HIV-2 Infection",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2018-01-11T042332.886781",
    "enrollment": 150,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03394196",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Implementation and Evaluation of an HIV-2 Viral Load and ARV Resistance Informed Algorithm for 2nd-line ART in HIV-2 Infected Patients in the Initiative Sngalaise dAccs Aux Antirtroviraux ISAARV Program",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "University of Washington",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042332.886781",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "HOP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Whats Hopping Cricket Protein and Human Gut Microbiota",
    "completion_date": "2017-05-10",
    "completion_date_type": "Actual",
    "completion_month_year": "May 10 2017",
    "created_at": "2017-12-29T041537.815093",
    "enrollment": 20,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383341",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Whats Hopping Cricket Powder and the Human Microbiota",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-05-10",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 10 2017",
    "received_results_disposit_date": "",
    "source": "Colorado State University",
    "start_date": "2017-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041537.815093",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Computer-based Treatment of Dysfunctional Beliefs in Depressive Inpatients",
    "completion_date": "2018-04-27",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 27 2018",
    "created_at": "2018-01-07T041850.140551",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389464",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Computer-based Treatment of Dysfunctional Beliefs in Depressive Inpatients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 27 2018",
    "received_results_disposit_date": "",
    "source": "University of Regensburg",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041850.140551",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Novel Equation for Estimating Resting Energy Expenditure",
    "completion_date": "2019-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2019",
    "created_at": "2017-12-24T041921.713480",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377413",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Novel Equation for Estimating Resting EnergyREE Expenditure in Chronic Kidney DiseaseCKD 3-5 Stages Patients",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 30 2019",
    "received_results_disposit_date": "",
    "source": "Peking University First Hospital",
    "start_date": "2017-09-01",
    "start_date_type": "Actual",
    "start_month_year": "September 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041921.713480",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Assess the Safety and Efficacy of Midostaurin PKC412 in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Monotherapy in Patients With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia.",
    "completion_date": "2021-08-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 15 2021",
    "created_at": "2017-12-24T041858.909072",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-14",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379727",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "An Open-label Multi-Center Phase IIIb Study to Assess the Safety and Efficacy of Midostaurin PKC412 in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia Who Are Eligible for 73 or 52 Chemotherapy",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-08-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 15 2021",
    "received_results_disposit_date": "",
    "source": "Novartis",
    "start_date": "2017-12-31",
    "start_date_type": "Anticipated",
    "start_month_year": "December 31 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041858.909072",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia",
    "completion_date": "2021-02-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 14 2021",
    "created_at": "2018-01-08T041340.716441",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389724",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-11-14",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 14 2020",
    "received_results_disposit_date": "",
    "source": "Childrens Cancer Hospital Egypt 57357",
    "start_date": "2017-11-14",
    "start_date_type": "Actual",
    "start_month_year": "November 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041340.716441",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2018",
    "created_at": "2017-12-23T042524.929841",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376997",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An Open-Label Randomized Crossover Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "Eisai Inc.",
    "start_date": "2017-11-08",
    "start_date_type": "Actual",
    "start_month_year": "November 8 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042524.929841",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk",
    "completion_date": "2023-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2023",
    "created_at": "2017-12-23T042531.775580",
    "enrollment": 76,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375788",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-10-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 31 2022",
    "received_results_disposit_date": "",
    "source": "Massachusetts General Hospital",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042531.775580",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hypermetabolism in ALS Using Six REE Formulas",
    "completion_date": "2014-11-01",
    "completion_date_type": "Actual",
    "completion_month_year": "November 2014",
    "created_at": "2017-12-26T040705.016015",
    "enrollment": 449,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382392",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Increased Resting Energy Expenditure Compared to Six Predictive Theoretical Equations in Amyotrophic Lateral Sclerosis a Study Versus Controls",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 2014",
    "received_results_disposit_date": "",
    "source": "University Hospital Limoges",
    "start_date": "1996-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1996",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040705.016015",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy",
    "completion_date": "2021-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2021",
    "created_at": "2017-12-23T042525.415873",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376971",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Real-Time Optical Biopsy for Improved Lung Cancer Diagnosis",
    "overall_status": "Recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2021",
    "received_results_disposit_date": "",
    "source": "University of Arizona",
    "start_date": "2017-07-26",
    "start_date_type": "Actual",
    "start_month_year": "July 26 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042525.415873",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes",
    "completion_date": "2018-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2018",
    "created_at": "2018-01-11T042402.237577",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392441",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Pilot Study to Evaluate the Effects of Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "Mayo Clinic",
    "start_date": "2017-11-30",
    "start_date_type": "Actual",
    "start_month_year": "November 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042402.237577",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Raindrop Near Vision Inlay Under Flap or Within Pocket",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2017-12-22T042534.617400",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376412",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopes Implanted Under a Corneal Flap or Within a Small-Incision Pocket",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "Whitten Laser Eye",
    "start_date": "2017-12-08",
    "start_date_type": "Actual",
    "start_month_year": "December 8 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042534.617400",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Phase III Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer",
    "completion_date": "2021-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2021",
    "created_at": "2017-12-23T042524.441166",
    "enrollment": 98,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377023",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Phase III Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2020",
    "received_results_disposit_date": "",
    "source": "H. Lee Moffitt Cancer Center and Research Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042524.441166",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "DNA and RNA from blood and skin",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Biomarkers and Validation of Selected Outcome Measures CMTNSmod",
    "completion_date": "2019-09-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 30 2019",
    "created_at": "2018-01-02T182933.725351",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386266",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Biomarkers and Validation of Selected Outcome Measures CMTNSmod",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2019",
    "received_results_disposit_date": "",
    "source": "University Medical Center Goettingen",
    "start_date": "2017-08-11",
    "start_date_type": "Actual",
    "start_month_year": "August 11 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182933.725351",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Exercise and RP AVAMC and Emory",
    "completion_date": "2018-08-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 28 2018",
    "created_at": "2017-12-25T041243.682526",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381235",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Exercise on Progression of Disease and Quality of Life in Patients With Retinitis Pigmentosa - a Small Pilot Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 28 2018",
    "received_results_disposit_date": "",
    "source": "Emory University",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041243.682526",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "STBV",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Survive and Thrive Boa Vista Early Childhood Program",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2020",
    "created_at": "2018-01-02T182913.379782",
    "enrollment": 15000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386747",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Survive and Thrive in Brazil Boa Vista Early Childhood Program",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2019",
    "received_results_disposit_date": "",
    "source": "University of Sao Paulo",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182913.379782",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of LY3298176 in Healthy Participants",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2018-01-11T042424.816604",
    "enrollment": 46,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375463",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "Pharmacokinetics Safety and Tolerability of a Solution Formulation of LY3298176 in Healthy Subjects",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Eli Lilly and Company",
    "start_date": "2017-12-19",
    "start_date_type": "Actual",
    "start_month_year": "December 19 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042424.816604",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "CicloSAAR",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Ciclosporin A Preconditioning for Renal Artery Stenosis",
    "completion_date": "2020-04-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 15 2020",
    "created_at": "2017-12-26T040706.638388",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382301",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Impact of a Ciclosporin A Preconditioning for Prevention of Ischemia-reperfusion Injury After Renal Artery Stenosis Dilation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-04-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 15 2020",
    "received_results_disposit_date": "",
    "source": "Hospices Civils de Lyon",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040706.638388",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Utility of Platelet Rich Plasma in Hair Loss",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2018-01-11T042424.100941",
    "enrollment": 30,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376581",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Utility of Platelet Rich Plasma in Hair Loss",
    "overall_status": "Active not recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "University of California Irvine",
    "start_date": "2017-11-28",
    "start_date_type": "Actual",
    "start_month_year": "November 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042424.100941",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder A Feasibility Study",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2019",
    "created_at": "2017-12-31T041322.004404",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385460",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder A Feasibility Study",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2019",
    "received_results_disposit_date": "",
    "source": "Mansoura University",
    "start_date": "2017-01-24",
    "start_date_type": "Actual",
    "start_month_year": "January 24 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041322.004404",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "STRONG",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Intrathecal Administration of AVXS-101 for Spinal Muscular Atrophy",
    "completion_date": "2019-08-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 30 2019",
    "created_at": "2017-12-26T040715.391004",
    "enrollment": 27,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381729",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Phase I Open-Label Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-08-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 30 2019",
    "received_results_disposit_date": "",
    "source": "AveXis Inc.",
    "start_date": "2017-12-14",
    "start_date_type": "Actual",
    "start_month_year": "December 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040715.391004",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CVA in Patients Suffering From Decreased Consciousness Confusion or Headaches to an Emergency Room",
    "completion_date": "2020-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2020",
    "created_at": "2017-12-23T042523.723695",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377062",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Cerebrovascular Accident CVA in Patients Suffering From Decreased Consciousness Confusion or Headaches to an Emergency Room",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Rambam Health Care Campus",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042523.723695",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Two Onabotulinum Toxin Doses",
    "completion_date": "2019-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2019",
    "created_at": "2018-01-11T042413.602566",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388086",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2018",
    "received_results_disposit_date": "",
    "source": "Swiss Paraplegic Centre Nottwil",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042413.602566",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Massage on Pain Levels Range of Motion and Muscle Strength in Unilateral Lower Limb Amputees",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-09T041403.858198",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389334",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Effects of Myofascial Release Massage on Pain Levels Range of Motion and Muscle Strength in Unilateral Lower Limb Amputees",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2018",
    "received_results_disposit_date": "",
    "source": "Loma Linda University",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041403.858198",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "TOSYMA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Breast Cancer Screening Digital Breast Tomosynthesis Versus Digital 2D Mammography",
    "completion_date": "2023-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2023",
    "created_at": "2017-12-23T042524.186643",
    "enrollment": 80000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377036",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prospective Randomized Comparison of Digital Breast Tomosynthesis Plus Synthesized Images Versus Standard Full-field Digital Mammography in Population-based Screening TOSYMA",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2023",
    "received_results_disposit_date": "",
    "source": "University Hospital Muenster",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042524.186643",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pharmacokinetics Efficacy Safety and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A",
    "completion_date": "2018-08-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 2018",
    "created_at": "2017-12-22T042532.814413",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376516",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Clinical Study to Investigate the Pharmacokinetics Efficacy Safety and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2018",
    "received_results_disposit_date": "",
    "source": "Octapharma",
    "start_date": "2017-11-22",
    "start_date_type": "Actual",
    "start_month_year": "November 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042532.814413",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Safety Study of SGN-CD48A in Patients With Multiple Myeloma",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2017-12-24T041901.395414",
    "enrollment": 75,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379584",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Study of SGN-CD48A in Patients With Relapsed or Refractory Multiple Myeloma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-08-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 2020",
    "received_results_disposit_date": "",
    "source": "Seattle Genetics Inc.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041901.395414",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of ET190L1-ARTEMIS T Cells in Relapsed and Refractory CD19 Non-Hodgkins Lymphoma",
    "completion_date": "2024-12-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 10 2024",
    "created_at": "2017-12-24T041902.932803",
    "enrollment": 54,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379493",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Open-label Phase I Study of ET190L1-ARTEMIS T Cells in Relapsed and Refractory CD19 Non-Hodgkins Lymphoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2024-12-10",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 10 2024",
    "received_results_disposit_date": "",
    "source": "Eureka Therapeutics Inc.",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041902.932803",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "UF-BMT-HSCT-001 A Non-Interventional Study Evaluating Diet in HSCT Survivors",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2022",
    "created_at": "2018-01-09T041414.291664",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377010",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "UF-BMT-HSCT-001 A Non-Interventional Study Evaluating the Quality of Diet in Allogeneic and Autologous Hematopoietic Stem Cell Transplant Survivors",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2021",
    "received_results_disposit_date": "",
    "source": "University of Florida",
    "start_date": "2017-12-14",
    "start_date_type": "Actual",
    "start_month_year": "December 14 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041414.291664",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate Safety Tolerability and PD of Tegoprazan on Healthy Male Volunteers",
    "completion_date": "2018-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2018",
    "created_at": "2017-12-23T042457.615683",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378284",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Open-label Active-controlled Multiple Dose Phase 1 Clinical Trial to Evaluate Safety Tolerability and Pharmacodynamics of Tegoprazan After Oral Administration in Healthy Male Volunteers",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "CJ HealthCare Corporation",
    "start_date": "2017-12-10",
    "start_date_type": "Actual",
    "start_month_year": "December 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042457.615683",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mid-term Data Collection of the Treatment of Intracranial Aneurysms With the WEB Aneurysm Embolization System",
    "completion_date": "2022-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2022",
    "created_at": "2017-12-24T041859.119186",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379714",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Data Collection of the Treatment of Intracranial Aneurysms With the WEB Aneurysm Embolization System a Monocentric Post-market Observational Study",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2021",
    "received_results_disposit_date": "",
    "source": "Medical Therapy Solutions",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "24 Months",
    "updated_at": "2017-12-24T041859.119186",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "STOP-AUST Ambulance Stopping Haemorrhage With Tranexamic Acid cOmmenced Prehospital - AUSTralia in a Mobile Stroke Ambulance.",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2021",
    "created_at": "2018-01-11T042414.528273",
    "enrollment": 62,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385928",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "STOP-AUST Ambulance Stopping Haemorrhage With Tranexamic Acid cOmmenced Prehospital - AUSTralia in a Mobile Stroke Ambulance. A Phase II Randomised Placebo-controlled Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage Using a Mobile Stroke Unit",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2020",
    "received_results_disposit_date": "",
    "source": "Neuroscience Trials Australia",
    "start_date": "2018-01-12",
    "start_date_type": "Anticipated",
    "start_month_year": "January 12 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042414.528273",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Tele-rehabilitation Intervention for People Post Hip Fracture - Randomized Controlled Trial RCT",
    "completion_date": "2019-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2019",
    "created_at": "2017-12-22T042527.927141",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376750",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Effectiveness of a Tele-rehabilitation Intervention to Improve Performance and Reduce Morbidity for People Post Hip Fracture - Randomized Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Herzog Hospital",
    "start_date": "2017-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042527.927141",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain",
    "completion_date": "2021-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2021",
    "created_at": "2017-12-22T042550.734380",
    "enrollment": 210,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375515",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Prospective Multi-center Randomized Controlled Study Comparing Patient-controlled Analgesia PCA Versus Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Fujian Cancer Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042550.734380",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PROGRO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Milk Protein vs Blends of Milk and Plant Protein on Growth Markers in 7-8 Year Old Healthy Danish Children",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-31T041339.655257",
    "enrollment": 129,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384719",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "The Effect of Milk Protein vs. Blends of Milk and Plant Protein on Growth Markers in 7-8 Year Old Healthy Danish Children",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2019",
    "received_results_disposit_date": "",
    "source": "University of Copenhagen",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041339.655257",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis Creation of a ALS-specific Equation",
    "completion_date": "2014-11-01",
    "completion_date_type": "Actual",
    "completion_month_year": "November 2014",
    "created_at": "2017-12-23T042456.024793",
    "enrollment": 315,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378375",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis Creation of a ALS-specific Equation",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-11-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "November 2014",
    "received_results_disposit_date": "",
    "source": "University Hospital Limoges",
    "start_date": "1996-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1996",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042456.024793",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-26T040720.788104",
    "enrollment": 27,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381352",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2018",
    "received_results_disposit_date": "",
    "source": "Chinese Academy of Medical Sciences",
    "start_date": "2015-12-02",
    "start_date_type": "Actual",
    "start_month_year": "December 2 2015",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040720.788104",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults",
    "completion_date": "2018-12-22",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 22 2018",
    "created_at": "2017-12-22T042549.143018",
    "enrollment": 48,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375606",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 1 Randomized Double-blind Placebo-controlled Single Ascending Dose Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intravenous CSL730 in Healthy Caucasian and Japanese Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 22 2018",
    "received_results_disposit_date": "",
    "source": "CSL Behring",
    "start_date": "2018-01-22",
    "start_date_type": "Anticipated",
    "start_month_year": "January 22 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042549.143018",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Decitabine and Arsenic Trioxide for Myelodysplastic SyndromeMDS",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2020",
    "created_at": "2018-01-08T041422.000039",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377725",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Decitabine and Arsenic TrioxideATO in the Treatment of Myelodysplasic Syndrome",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2019",
    "received_results_disposit_date": "",
    "source": "Ruijin Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041422.000039",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "SCAD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Angiographic and Psychosocial Evaluation of Peripartum vs. Non SCAD",
    "completion_date": "2018-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2018",
    "created_at": "2018-01-09T041358.324322",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03390998",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Angiographic and Psychosocial Evaluation of Peripartum vs. Non Peripartum Spontaneous Coronary Artery Dissection SCAD A Collaborative Study",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 31 2018",
    "received_results_disposit_date": "",
    "source": "Stanford University",
    "start_date": "2017-11-28",
    "start_date_type": "Actual",
    "start_month_year": "November 28 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-09T041358.324322",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Pain Relief and Functional Outcome After Partial Denervation of the Wrist",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2020",
    "created_at": "2017-12-23T042456.230976",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378362",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Prospective Study on Pain Relief and Functional Outcome After Partial Denervation of the Wrist",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Karolinska Institutet",
    "start_date": "2017-12-31",
    "start_date_type": "Anticipated",
    "start_month_year": "December 31 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042456.230976",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Quality Control of CE-Certified Phonak Hearing Aids - 2017_37",
    "completion_date": "2018-02-02",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2 2018",
    "created_at": "2017-12-24T041858.281331",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379766",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Quality Control of CE-Certified Phonak Hearing Aids - 2017_37",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-02",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2 2018",
    "received_results_disposit_date": "",
    "source": "Sonova AG",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041858.281331",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effect of Esophageal Temperature Probe Insertion on Tracheal Cuff Pressure",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2018",
    "created_at": "2017-12-22T042550.074832",
    "enrollment": 112,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375554",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "The Effect of Esophageal Temperature Probe Insertion on Tracheal Cuff Pressure",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 2018",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042550.074832",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Safety and Efficacy of VP-102 in Subjects With Molluscum",
    "completion_date": "2018-10-19",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 19 2018",
    "created_at": "2017-12-23T042506.108838",
    "enrollment": 250,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377803",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 3 Randomized Double-Blind Placebo-Controlled Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution 0.7 wv Cantharidin in Subjects 2 Years and Older With Molluscum Contagiosum",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 21 2018",
    "received_results_disposit_date": "",
    "source": "Verrica Pharmaceuticals Inc.",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042506.108838",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms",
    "completion_date": "2019-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2019",
    "created_at": "2017-12-29T041602.584591",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376399",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Do Sleeve Gastrectomies Result in Improved Gastric Emptying and Thus Improved Symptoms in Patients With Diabetic Gastroparesis",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Baylor Research Institute",
    "start_date": "2017-10-25",
    "start_date_type": "Actual",
    "start_month_year": "October 25 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041602.584591",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MAESTRO",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics",
    "completion_date": "2019-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2019",
    "created_at": "2017-12-29T041602.809374",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376763",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics",
    "overall_status": "Recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2019",
    "received_results_disposit_date": "",
    "source": "Korea Otsuka Pharmaceutical Co. Ltd.",
    "start_date": "2017-11-21",
    "start_date_type": "Actual",
    "start_month_year": "November 21 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041602.809374",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Elbasvir EBRGrazoprevir GZR in Pediatric Participants With Chronic Hepatitis C Infection MK-5172-079",
    "completion_date": "2020-05-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 6 2020",
    "created_at": "2017-12-31T041359.481240",
    "enrollment": 56,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379506",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase IIb Clinical Study to Assess the Pharmacokinetics Safety and Efficacy of the Combination Regimen of Elbasvir EBRGrazoprevir GZR in Participants Aged 3 to Less Than 18 Years With Chronic Hepatitis C Infection",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-05-06",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 6 2020",
    "received_results_disposit_date": "",
    "source": "Merck Sharp  Dohme Corp.",
    "start_date": "2018-01-24",
    "start_date_type": "Anticipated",
    "start_month_year": "January 24 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041359.481240",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PONTOS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PDMS Outcome After Intensive Care Organdysfunction and Monitoring",
    "completion_date": "2014-07-01",
    "completion_date_type": "Actual",
    "completion_month_year": "July 1 2014",
    "created_at": "2017-12-31T041359.260348",
    "enrollment": 6909,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379688",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Patient Data Management System Monitored Outcome After Intensive Care Organdysfunction and Monitoring",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2013-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2013",
    "received_results_disposit_date": "",
    "source": "Charite University Berlin Germany",
    "start_date": "2006-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2006",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041359.260348",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "AROMA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Aromatherapy Randomization of Pain Management in Adults",
    "completion_date": "2018-05-17",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 17 2018",
    "created_at": "2017-12-31T041402.553648",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377088",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Aromatherapy for Management of Back Pain in the Emergency Department",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2018",
    "received_results_disposit_date": "",
    "source": "Stony Brook University",
    "start_date": "2017-12-11",
    "start_date_type": "Actual",
    "start_month_year": "December 11 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041402.553648",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Investigate the Pharmacokinetics Safety and Tolerability of Emicizumab in Healthy Chinese Volunteers",
    "completion_date": "2018-07-18",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 18 2018",
    "created_at": "2017-12-31T041357.806269",
    "enrollment": 16,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380780",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-Center Open-Label Single Dose Study to Investigate the Pharmacokinetics Safety and Tolerability of Emicizumab in Healthy Chinese Volunteers",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-18",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 18 2018",
    "received_results_disposit_date": "",
    "source": "Hoffmann-La Roche",
    "start_date": "2018-01-11",
    "start_date_type": "Anticipated",
    "start_month_year": "January 11 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041357.806269",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Treatment and Exacerbation in COPD Subjects",
    "completion_date": "2017-08-25",
    "completion_date_type": "Actual",
    "completion_month_year": "August 25 2017",
    "created_at": "2017-12-22T042551.922947",
    "enrollment": 60243,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375450",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Retrospective Comparative Effectiveness Study Assessing Treatment and Rates of Exacerbation Among Chronic Obstructive Pulmonary Disease Subjects in England",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-25",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 25 2017",
    "received_results_disposit_date": "",
    "source": "AstraZeneca",
    "start_date": "2017-08-25",
    "start_date_type": "Actual",
    "start_month_year": "August 25 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042551.922947",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Investigate Safety and Tolerability Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimers Disease",
    "completion_date": "2019-02-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 15 2019",
    "created_at": "2017-12-22T042547.220120",
    "enrollment": 64,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375697",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A 2-Part Randomized Placebo-Controlled Double-Blind Single and Multiple Ascending Dose Study to Investigate Safety and Tolerability Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimers Disease",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 15 2019",
    "received_results_disposit_date": "",
    "source": "Janssen Research  Development LLC",
    "start_date": "2017-12-14",
    "start_date_type": "Anticipated",
    "start_month_year": "December 14 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042547.220120",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Lung-MAP Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer",
    "completion_date": "2024-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2024",
    "created_at": "2017-12-23T042511.741562",
    "enrollment": 64,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377556",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase II Study of Talazoparib BMN 673 in Patients With Homologous Recombination Repair Deficiency Positive Stage IV Squamous Cell Lung Cancer Lung-Map Sub-Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2022",
    "received_results_disposit_date": "",
    "source": "Southwest Oncology Group",
    "start_date": "2017-02-07",
    "start_date_type": "Actual",
    "start_month_year": "February 7 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042511.741562",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm",
    "completion_date": "2021-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2021",
    "created_at": "2017-12-31T041402.784702",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377049",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage Evaluating Predictability for Early Ischemia in Cerebral Vasospasm",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2021",
    "received_results_disposit_date": "",
    "source": "University of Wisconsin Madison",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2017-12-31T041402.784702",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Safety and Efficacy of VP-102 in Subjects With Molluscum",
    "completion_date": "2018-10-19",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 19 2018",
    "created_at": "2017-12-23T042506.377595",
    "enrollment": 250,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377790",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 3 Randomized Double-Blind Placebo-Controlled Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution 0.7 wv Cantharidin in Subjects 2 Years and Older With Molluscum Contagiosum",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-21",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 21 2018",
    "received_results_disposit_date": "",
    "source": "Verrica Pharmaceuticals Inc.",
    "start_date": "2018-01-04",
    "start_date_type": "Anticipated",
    "start_month_year": "January 4 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042506.377595",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Functional Exercises for Chronic Low Back Pain",
    "completion_date": "2018-11-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 10 2018",
    "created_at": "2017-12-29T041602.114276",
    "enrollment": 84,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376724",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effectiveness of the Functional Exercises in Young Adults Chronic Low Back Pain a Randomized Controlled Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-10",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 10 2018",
    "received_results_disposit_date": "",
    "source": "Federal University of So Paulo",
    "start_date": "2017-11-10",
    "start_date_type": "Actual",
    "start_month_year": "November 10 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041602.114276",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "VDIAMETER",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response",
    "completion_date": "2017-10-01",
    "completion_date_type": "Actual",
    "completion_month_year": "October 1 2017",
    "created_at": "2017-12-23T042530.604246",
    "enrollment": 145,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-16",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376308",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 1 2017",
    "received_results_disposit_date": "",
    "source": "Adnan Menderes University",
    "start_date": "2017-06-01",
    "start_date_type": "Actual",
    "start_month_year": "June 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-23T042530.604246",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Blood specimens will be collected prospectively from consented patients at baseline during\n      radiation therapy at completion of radiation therapy and during 3-4 month follow up visit.",
    "biospec_retention": "Samples Without DNA",
    "brief_title": "Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome",
    "completion_date": "2025-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2025",
    "created_at": "2017-12-29T041541.476179",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383107",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 4,
    "official_title": "Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2021",
    "received_results_disposit_date": "",
    "source": "Weill Medical College of Cornell University",
    "start_date": "2017-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041541.476179",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "OSAstimD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "DAW1033D in Obstructive Sleep Apnea",
    "completion_date": "2018-12-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 13 2018",
    "created_at": "2017-12-31T041352.754114",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-26",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383887",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of DAW1033D on Obstructive Sleep Apnea and Its Phenotypic Traits",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 13 2018",
    "received_results_disposit_date": "",
    "source": "Brigham and Womens Hospital",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041352.754114",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PBS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prostate Boost Irradiation With Stereotactic Body RT SBRT",
    "completion_date": "2022-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 1 2022",
    "created_at": "2017-12-29T041556.263432",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380806",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Phase II Trial Investigating Stereotactic Body RadioTherapy SBRT for Prostate Boost Irradiation in the Treatment of High Risk Prostate Cancer PrCa",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 1 2020",
    "received_results_disposit_date": "",
    "source": "Juravinski Cancer Center",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041556.263432",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Assesment of the Accuracy of Surgical Guide Designed From CBCT With Different Voxel Sizes",
    "completion_date": "2018-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2018",
    "created_at": "2018-01-07T041844.502921",
    "enrollment": 8,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03389594",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Assesment of the Accuracy of Surgical Guide Designed From CBCT With Different Voxel Size in Computer Guided Implantology Randomized Clinical Trial",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 15 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2017-07-01",
    "start_date_type": "Actual",
    "start_month_year": "July 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041844.502921",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Generation of Induced Pluripotent Stem iPS Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration",
    "completion_date": "2018-12-14",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 14 2018",
    "created_at": "2018-01-11T042426.500622",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03372746",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Generation of Induced Pluripotent Stem iPS Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-14",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 14 2018",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042426.500622",
    "verification_date": "2017-12-05",
    "verification_month_year": "December 5 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH",
    "completion_date": "2019-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2019",
    "created_at": "2017-12-31T041349.278561",
    "enrollment": 5,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384121",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "The Hospital for Sick Children",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041349.278561",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Understanding ConcussionMild Traumatic Brain Injury",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2018",
    "created_at": "2017-12-26T040716.512773",
    "enrollment": 200,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381638",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Understanding ConcussionMild Traumatic Brain Injury",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 1 2018",
    "received_results_disposit_date": "",
    "source": "Blinktbi Inc.",
    "start_date": "2016-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2016",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-26T040716.512773",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "NDGX",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy",
    "completion_date": "2020-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2020",
    "created_at": "2017-12-25T041305.922741",
    "enrollment": 54,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": true,
    "is_us_export": true,
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376984",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Nanodiamonds and Antibiotics Modified Gutta-percha NDGX for Non-surgical Root Canal Therapy RCT Filler Material",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2020",
    "received_results_disposit_date": "",
    "source": "University of California Los Angeles",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041305.922741",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies",
    "completion_date": "2019-12-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 11 2019",
    "created_at": "2018-01-02T182923.708648",
    "enrollment": 90,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386526",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase I Study of the Safety Tolerability Pharmacokinetic and Pharmacodynamic Properties of APG-1387 as A Single Agent or in Combination With Systemic Anti-Cancer Agents in Patients With Advanced Solid Tumors or Hematologic Malignancies",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 11 2019",
    "received_results_disposit_date": "",
    "source": "Ascentage Pharma Group Inc.",
    "start_date": "2017-12-12",
    "start_date_type": "Actual",
    "start_month_year": "December 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182923.708648",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults",
    "completion_date": "2020-07-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 31 2020",
    "created_at": "2018-01-11T042425.759988",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": true,
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-09",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03372733",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-07-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 31 2020",
    "received_results_disposit_date": "",
    "source": "National Institutes of Health Clinical Center CC",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042425.759988",
    "verification_date": "2017-11-22",
    "verification_month_year": "November 22 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Epiretinal Proliferation in Eyes With Full Thickness Macular Hole",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2017",
    "created_at": "2017-12-22T042527.471657",
    "enrollment": 390,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376776",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "Epiretinal Proliferation in Eyes With Full Thickness Macular Hole",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-01-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "January 2017",
    "received_results_disposit_date": "",
    "source": "Kyorin University",
    "start_date": "2013-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 2013",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042527.471657",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Head Tilting During Nasotracheal Intubation",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2017-12-23T042522.756784",
    "enrollment": 66,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377114",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effect of Head Tilting on the Passing of Tracheal Tube Through Nasopharynx During Nasotracheal Intubation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 2018",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042522.756784",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes",
    "completion_date": "2018-04-10",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 10 2018",
    "created_at": "2017-12-18T041348.474294",
    "enrollment": 84,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375138",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Open-label Parallel-group Single-dose Biocomparability Study of the Pharmacokinetics of Belatacept Drug Products Using Active Pharmaceutical Ingredient Manufactured by Process E PPQ Relative to Active Pharmaceutical Ingredient Manufactured by Process C in Healthy Participants",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-04-10",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 10 2018",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2017-12-04",
    "start_date_type": "Actual",
    "start_month_year": "December 4 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041348.474294",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2017-12-23T042505.126486",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377855",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Weill Medical College of Cornell University",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042505.126486",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment",
    "completion_date": "2019-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2019",
    "created_at": "2017-12-18T041348.339530",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375151",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2019",
    "received_results_disposit_date": "",
    "source": "Brainmarc Ltd.",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041348.339530",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of DALDD in the Treatment of Femoropopliteal Occlusive Disease",
    "completion_date": "2019-12-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 30 2019",
    "created_at": "2017-12-25T041253.200154",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380650",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Study of Combined Use of Directional Atherectomy and Local Drug Delivery With Balloon Catheter System in the Treatment of Femoropopliteal Occlusive Disease",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 30 2018",
    "received_results_disposit_date": "",
    "source": "RenJi Hospital",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041253.200154",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mylan Insulin Glargine Study",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2017-12-22T042527.247229",
    "enrollment": 202,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376789",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Multi-center Double-Blind Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2018",
    "received_results_disposit_date": "",
    "source": "Mylan Inc.",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042527.247229",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "SECRETS-TCM",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "SouthErn China REgisTry for Stroke on Traditional Chinese Medicine",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-25T041255.654628",
    "enrollment": 10000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380481",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "SouthErn China REgisTry for Stroke on Traditional Chinese Medicine",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2020",
    "received_results_disposit_date": "",
    "source": "Guangzhou University of Traditional Chinese Medicine",
    "start_date": "2017-12-25",
    "start_date_type": "Anticipated",
    "start_month_year": "December 25 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "24 Months",
    "updated_at": "2017-12-25T041255.654628",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Phase II Study of the Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2017-12-22T042543.704152",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375892",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase II Study of the Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "Medical College of Wisconsin",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042543.704152",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Role of Topical Putrescine Fibrostat for Prevention of Hypertrophic Scars in Mammoplasty Patients",
    "completion_date": "2016-07-15",
    "completion_date_type": "Actual",
    "completion_month_year": "July 15 2016",
    "created_at": "2017-12-24T041924.911996",
    "enrollment": 56,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376620",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Role of Topical Putrescine Fibrostat in 10Urea TFU for Prevention of Hypertrophic Scars in Mammoplasty Patients",
    "overall_status": "Completed",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2013-08-13",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 13 2013",
    "received_results_disposit_date": "",
    "source": "University of Manitoba",
    "start_date": "2011-09-02",
    "start_date_type": "Actual",
    "start_month_year": "September 2 2011",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041924.911996",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cheese Consumption and Human Microvascular Function",
    "completion_date": "2018-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2018",
    "created_at": "2017-12-24T041925.241699",
    "enrollment": 15,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376555",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "Cheese Consumption and Human Microvascular Function",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2018",
    "received_results_disposit_date": "",
    "source": "Penn State University",
    "start_date": "2016-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041925.241699",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Pathology samples",
    "biospec_retention": "None Retained",
    "brief_title": "Lanugo Hair Loss as a Marker for Peri-ocular Malignancy",
    "completion_date": "2018-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2018",
    "created_at": "2017-12-29T041549.158645",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382704",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Lanugo Hair Loss as a Marker for Peri-ocular Malignancy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "NHS Lothian",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-29T041549.158645",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CBT for African Americans With Cognitive Impairment",
    "completion_date": "2020-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2020",
    "created_at": "2017-12-31T041350.306690",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384069",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Cognitive Behavioral Therapy for African Americans With Mild Cognitive Impairment",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-03-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 31 2020",
    "received_results_disposit_date": "",
    "source": "Emory University",
    "start_date": "2018-01-10",
    "start_date_type": "Anticipated",
    "start_month_year": "January 10 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041350.306690",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "momHealth",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "momHealth Multiple Health Behavior Change Intervention in Teen Pregnancy  Parenting Using Mobile Technology",
    "completion_date": "2019-05-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 30 2019",
    "created_at": "2017-12-26T040709.526704",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382132",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "momHealth Multiple Health Behavior Change Intervention in Teen Pregnancy  Parenting Using Mobile Technology",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2019",
    "received_results_disposit_date": "",
    "source": "University of Kansas Medical Center",
    "start_date": "2017-11-20",
    "start_date_type": "Actual",
    "start_month_year": "November 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040709.526704",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Increased Liver Stiffness A Study of Acoustic Radiation Force Impulse ARFI Elastography",
    "completion_date": "2019-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 1 2019",
    "created_at": "2017-12-26T040709.676389",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382119",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Increased Liver Stiffness A Study of Acoustic Radiation Force Impulse ARFI Elastography",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2019",
    "received_results_disposit_date": "",
    "source": "University of Michigan",
    "start_date": "2017-12-22",
    "start_date_type": "Anticipated",
    "start_month_year": "December 22 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040709.676389",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PROFILE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Assess the Patterns of Use of REKOVELLE in Nave Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures",
    "completion_date": "2020-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2020",
    "created_at": "2018-01-11T042334.740647",
    "enrollment": 1300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393780",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Ferring Pharmaceuticals",
    "start_date": "2018-01-31",
    "start_date_type": "Anticipated",
    "start_month_year": "January 31 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042334.740647",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "rWGS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Rapid Whole Genome Sequencing Study",
    "completion_date": "2050-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2050",
    "created_at": "2018-01-02T182951.124696",
    "enrollment": 100000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385876",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Rapid Whole Genome Sequencing rWGS Rapid Genomic Sequencing for Acutely Ill Patients and the Collection Storage Analysis and Distribution of Biological Samples Genomic and Clinical Data",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2050-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2050",
    "received_results_disposit_date": "",
    "source": "Rady Pediatric Genomics  Systems Medicine Institute",
    "start_date": "2017-08-29",
    "start_date_type": "Actual",
    "start_month_year": "August 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182951.124696",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PharmaMD",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Impact of Pharmacy Clinic on Diabetes Management",
    "completion_date": "2020-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2020",
    "created_at": "2017-12-24T041923.378204",
    "enrollment": 86,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377127",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluating the Impact of a Pharmacist Managed Diabetes Clinic on a High-Risk Diabetes Population a Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2019",
    "received_results_disposit_date": "",
    "source": "William Beaumont Hospitals",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041923.378204",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "APG-1252 in Patients With SCLC or Advanced Solid Tumors",
    "completion_date": "2019-12-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 28 2019",
    "created_at": "2018-01-05T041729.281719",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387332",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase I Study of the Safety Pharmacokinetic and Pharmacodynamic Properties of Intravenously Administered APG-1252 in Patients With Small Cell Lung Cancer SCLC or Advanced Solid Tumors.",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-28",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 28 2019",
    "received_results_disposit_date": "",
    "source": "Ascentage Pharma Group Inc.",
    "start_date": "2017-12-28",
    "start_date_type": "Anticipated",
    "start_month_year": "December 28 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041729.281719",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CHORAL",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of the Choroidal and Retinal Thickness in Relation to Axial Length.",
    "completion_date": "2018-03-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 31 2018",
    "created_at": "2017-12-24T041923.597643",
    "enrollment": 65,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03377075",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Study of the Choroidal and Retinal Thickness in Relation to Axial Length in Healthy Young Subjects With Swept-source Optical Coherence Tomography.",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-08-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "August 31 2017",
    "received_results_disposit_date": "",
    "source": "Semmelweis University",
    "start_date": "2017-02-06",
    "start_date_type": "Actual",
    "start_month_year": "February 6 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041923.597643",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Fractional Photothermolysis for Hair Loss",
    "completion_date": "2019-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 1 2019",
    "created_at": "2017-12-26T040708.941848",
    "enrollment": 50,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382184",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Fractional Photothermolysis for the Treatment of Hair Loss",
    "overall_status": "Recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2019",
    "received_results_disposit_date": "",
    "source": "University of California Irvine",
    "start_date": "2017-10-20",
    "start_date_type": "Actual",
    "start_month_year": "October 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040708.941848",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2017-12-22T042528.148463",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-13",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376737",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single-Arm Phase II Clinical Trial of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Henan Cancer Hospital",
    "start_date": "2017-10-12",
    "start_date_type": "Actual",
    "start_month_year": "October 12 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042528.148463",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Reproductive Prognosis After Therapies for Uterus Arcuatus Following Recurrent Miscarriage Women",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-31T041349.913103",
    "enrollment": 82,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-13",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384082",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Prospective and Randomized Trial on Reproductive Prognosis After Therapies for Uterus Arcuatus on Women With Recurrent Miscarriage Women",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Fu Xing Hospital Capital Medical University",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041349.913103",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery",
    "completion_date": "2020-10-11",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 11 2020",
    "created_at": "2018-01-08T041416.387989",
    "enrollment": 47,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384836",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase IbII Study of Propranolol With Fixed-Dose Pembrolizumab in Patients With Unresectable Stage III and Stage IV Melanoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-10-11",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 11 2019",
    "received_results_disposit_date": "",
    "source": "Roswell Park Cancer Institute",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-08T041416.387989",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects",
    "completion_date": "2018-07-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "July 2018",
    "created_at": "2017-12-23T042524.687707",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376802",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Double-blind Placebo-controlled Study to Assess the Effect of Repeated Subcutaneous Doses of SAR425899 on Energy Expenditure and Safety in Overweight to Obese Male and Female Subjects",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-07-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "July 2018",
    "received_results_disposit_date": "",
    "source": "Sanofi",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042524.687707",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Bioavailability of BMS-986205",
    "completion_date": "2018-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2018",
    "created_at": "2017-12-18T041400.573024",
    "enrollment": 8,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374228",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Study to Evaluate the Absolute Bioavailability of BMS-986205 Tablet Formulation",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "Bristol-Myers Squibb",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041400.573024",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "EXPLAIN-IRON",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "EXPLorative Data Collection for Patient chAracterIzation treatmeNt Pathways and Outcomes of IRON Preparations",
    "completion_date": "2021-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2021",
    "created_at": "2017-12-26T040706.926283",
    "enrollment": 3000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382275",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "EXPLorative Data Collection for Patient chAracterIzation treatmeNt Pathways and Outcomes of IRON Preparations",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "GWT-TUD GmbH",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "2 Years",
    "updated_at": "2017-12-26T040706.926283",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "stasfa",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer  Contribution in Pathology Diagnosis and Molecular Biology",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2018-01-02T182905.519211",
    "enrollment": 80,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386916",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer  Pathology Diagnosis and Molecular Biology",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 2017",
    "received_results_disposit_date": "",
    "source": "University Hospital Grenoble",
    "start_date": "2010-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182905.519211",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 1 2019",
    "created_at": "2018-01-09T041410.438311",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384537",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash - Randomized Clinical Trail",
    "overall_status": "Not yet recruiting",
    "phase": "Early Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "Cairo University",
    "start_date": "2018-06-01",
    "start_date_type": "Anticipated",
    "start_month_year": "June 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041410.438311",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Public Health Messages to Address Vaccine Hesitancy",
    "completion_date": "2018-03-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 15 2018",
    "created_at": "2018-01-11T042318.852976",
    "enrollment": 788,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395106",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Developing and Evaluating Public Health Messages to Address Vaccine Hesitancy",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 15 2018",
    "received_results_disposit_date": "",
    "source": "University of Manitoba",
    "start_date": "2018-01-08",
    "start_date_type": "Anticipated",
    "start_month_year": "January 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042318.852976",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Efficacy of Pembrolizumab MK-3475 Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer mCRC Participants MK-3475-651",
    "completion_date": "2021-11-26",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 26 2021",
    "created_at": "2017-12-18T041400.247617",
    "enrollment": 220,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374254",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "A Phase 1b Multi-cohort Study of the Combination of Pembrolizumab MK-3475 Plus Binimetinib Alone or the Combination of Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Participants With Metastatic Colorectal Cancer KEYNOTE-651",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-11-26",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 26 2021",
    "received_results_disposit_date": "",
    "source": "Merck Sharp  Dohme Corp.",
    "start_date": "2018-03-05",
    "start_date_type": "Anticipated",
    "start_month_year": "March 5 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041400.247617",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Safety and Efficacy of Xalkori ROS1",
    "completion_date": "2021-08-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 30 2021",
    "created_at": "2017-12-22T042530.079289",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375242",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Xalkori Ros1Nsclc Drug Use Investigation",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-08-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 30 2021",
    "received_results_disposit_date": "",
    "source": "Pfizer",
    "start_date": "2017-10-25",
    "start_date_type": "Actual",
    "start_month_year": "October 25 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042530.079289",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "INOVASHOCK",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Inova Cardiogenic Shock Registry INOVA SHOCK",
    "completion_date": "2018-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2018",
    "created_at": "2017-12-24T041916.963327",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378739",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Implementation of a Cardiogenic Shock Team and Clinical Outcomes INOVA-SHOCK Registry",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Inova Health Care Services",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2017-12-24T041916.963327",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ReFaPo02",
    "baseline_population": "",
    "biospec_description": "blood samples",
    "biospec_retention": "Samples With DNA",
    "brief_title": "First Trimester Screening for Trisomy 21 18 13 and 22q11.2 Deletion Syndrome",
    "completion_date": "2019-04-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 30 2019",
    "created_at": "2018-01-11T042425.049832",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375359",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "First Trimester Screening for Trisomy 21 18 13 and 22q11.2 Deletion Syndrome - ReFaPo02",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-03-29",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 29 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Tuebingen",
    "start_date": "2018-01-08",
    "start_date_type": "Actual",
    "start_month_year": "January 8 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042425.049832",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PERA",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Technological Innovation in Radiotherapy",
    "completion_date": "2021-10-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 2021",
    "created_at": "2017-12-24T041914.608040",
    "enrollment": 400,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378856",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2021",
    "received_results_disposit_date": "",
    "source": "Centre hospitalier de lUniversit de Montral CHUM",
    "start_date": "2017-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "2 Years",
    "updated_at": "2017-12-24T041914.608040",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Pilot Study to Investigate the Effect of Motor Imagery on Dynamic Balance of Asymptomatic Students",
    "completion_date": "2015-05-25",
    "completion_date_type": "Actual",
    "completion_month_year": "May 25 2015",
    "created_at": "2017-12-22T042535.935032",
    "enrollment": 25,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376334",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Pilot Study to Investigate the Effect of Motor Imagery on Dynamic Balance of Asymptomatic University Students An Experimental Study",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-05-25",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 25 2015",
    "received_results_disposit_date": "",
    "source": "Universiti Tunku Abdul Rahman",
    "start_date": "2014-10-02",
    "start_date_type": "Actual",
    "start_month_year": "October 2 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042535.935032",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "the SafetyEfficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Healing Poor After Uterus Injury",
    "completion_date": "2019-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2019",
    "created_at": "2018-01-02T182915.795767",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386708",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "A Clinical Research on the SafetyEfficacy of Human Umbilical Cord Mesenchymal Stem Cell hUC-MSC Therapy for Patients With Healing Poor After Uterus Injury",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Sclnow Biotechnology Co. Ltd.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-02T182915.795767",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "completion_date": "",
    "completion_date_type": "",
    "completion_month_year": "",
    "created_at": "2018-01-11T042419.461809",
    "enrollment": "",
    "enrollment_type": "",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-08",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383666",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": "",
    "official_title": "Trial of device that is not approved or cleared by the U.S. FDA",
    "overall_status": "Withheld",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "",
    "primary_completion_date_type": "",
    "primary_completion_month_year": "",
    "received_results_disposit_date": "",
    "source": "Redacted",
    "start_date": "",
    "start_date_type": "",
    "start_month_year": "",
    "study_type": "NA",
    "target_duration": "",
    "updated_at": "2018-01-11T042419.461809",
    "verification_date": "",
    "verification_month_year": "",
    "why_stopped": ""
  },
  {
    "acronym": "PORT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed Refractory Specified Stages of Cutaneous T-cell Lymphoma CTCL Mycosis Fungoides MFSezary Syndrome SS",
    "completion_date": "2023-05-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "May 2023",
    "created_at": "2017-12-31T041327.820767",
    "enrollment": 46,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-27",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385226",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T-cell Lymphoma",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2021-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2021",
    "received_results_disposit_date": "",
    "source": "University College London",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041327.820767",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Effects of Dexmedetomidine Dose on Motor Evoked Potentials",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2017-12-24T041912.687676",
    "enrollment": 68,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378973",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Effects of Dexmedetomidine Dose on Motor Evoked Potentials During Spine Surgery A Randomized Single-blind Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2020",
    "received_results_disposit_date": "",
    "source": "Hospital for Special Surgery New York",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041912.687676",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "How Point-of-Care Ultrasound Affects the Diagnostic Process in General Practice.",
    "completion_date": "2019-06-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 15 2019",
    "created_at": "2018-01-11T042423.880081",
    "enrollment": 940,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-06",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375333",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "How Point-of-Care Ultrasound Affects the Diagnostic Process in General Practice. A Prospective Follow-up Study.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2019",
    "received_results_disposit_date": "",
    "source": "Aalborg University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042423.880081",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Transthoracic Shear-wave Ultrasound Elastography",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-22T042534.398352",
    "enrollment": 300,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376425",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Application of Transthoracic Shear-wave Ultrasound Elastography in the Diagnosis of Pulmonary Lesions",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2020",
    "received_results_disposit_date": "",
    "source": "National Taiwan University Hospital",
    "start_date": "2017-12-08",
    "start_date_type": "Actual",
    "start_month_year": "December 8 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042534.398352",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes",
    "completion_date": "2017-09-01",
    "completion_date_type": "Actual",
    "completion_month_year": "September 2017",
    "created_at": "2017-12-22T042558.311261",
    "enrollment": 42,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374176",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in the Treatment of Periodontitis in Patients With Diabetes",
    "overall_status": "Completed",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2016-07-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "July 2016",
    "received_results_disposit_date": "",
    "source": "Centro Universitario de Tonal",
    "start_date": "2014-03-01",
    "start_date_type": "Actual",
    "start_month_year": "March 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042558.311261",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "PediCRaFT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "PediCRaFT Pediatric Crohns Disease Fecal Transplant Trial",
    "completion_date": "2019-03-28",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 28 2019",
    "created_at": "2017-12-23T042459.668539",
    "enrollment": 28,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378167",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "PediCRaFT Pediatric Crohns Disease Fecal Microbiota Transplant Pilot Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 30 2018",
    "received_results_disposit_date": "",
    "source": "McMaster Childrens Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042459.668539",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CareACT",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Internet-based Intervention for Enhancing the Psychological Well-being of Elderly Caregivers",
    "completion_date": "2018-10-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "October 15 2018",
    "created_at": "2018-01-09T041348.850367",
    "enrollment": 160,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-04",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03391596",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 08 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "CareACT - Internet-based Intervention for Enhancing the Psychological Well-being of Elderly Caregivers",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 15 2018",
    "received_results_disposit_date": "",
    "source": "The Gerocenter Foundation for Research and Development",
    "start_date": "2016-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-09T041348.850367",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Predictive Model for Postoperative Complications in Hemi-hip Arthroplasty",
    "completion_date": "2018-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2018",
    "created_at": "2017-12-22T042555.455434",
    "enrollment": 460,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375268",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Predictive Model for Postoperative Complications in Elderly Patients With Hip Arthroplasty Retrospective Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2015-12-31",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 31 2015",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2011-01-01",
    "start_date_type": "Actual",
    "start_month_year": "January 1 2011",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042555.455434",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of the DentalVibe Injection System on Pain During Local Anesthesia Injections in Children",
    "completion_date": "2018-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2018",
    "created_at": "2017-12-22T042557.106916",
    "enrollment": 38,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374982",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of the DentalVibe Injections System on Pain During Local Anesthesia Injections in Children",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "University of Nebraska",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042557.106916",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "tN2O",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder PTSD",
    "completion_date": "2021-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2021",
    "created_at": "2017-12-22T042554.995495",
    "enrollment": 5,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375294",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder PTSD",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-01-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 15 2020",
    "received_results_disposit_date": "",
    "source": "Stanford University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042554.995495",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown",
    "completion_date": "2014-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2014",
    "created_at": "2017-12-18T041356.874268",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374501",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Determination of the Glycemic and Insulinemic Index Values of Soft Drink and Two Test Meals Containing Soft Drink Consumed With Sugardown",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2014-12-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 2014",
    "received_results_disposit_date": "",
    "source": "Boston Therapeutics",
    "start_date": "2014-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041356.874268",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Prostate Cancer Biomarker Enrichment and Treatment Selection",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-31T041318.929591",
    "enrollment": 500,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03385655",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Prostate Cancer Biomarker Enrichment and Treatment Selection PC-BETS Study",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 31 2019",
    "received_results_disposit_date": "",
    "source": "Canadian Cancer Trials Group",
    "start_date": "2017-12-30",
    "start_date_type": "Anticipated",
    "start_month_year": "December 30 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041318.929591",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique",
    "completion_date": "2019-11-20",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 20 2019",
    "created_at": "2017-12-22T042555.222982",
    "enrollment": 140,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375281",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique A Prospective Single Arm Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-20",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 20 2018",
    "received_results_disposit_date": "",
    "source": "Seoul National University Hospital",
    "start_date": "2017-11-20",
    "start_date_type": "Actual",
    "start_month_year": "November 20 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042555.222982",
    "verification_date": "2017-11-01",
    "verification_month_year": "November 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Neighborhood Influence on Parenting Practices Regarding Youth Outdoor Play",
    "completion_date": "2019-08-06",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 6 2019",
    "created_at": "2017-12-24T041910.659213",
    "enrollment": 32,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379090",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Using In-depth Interviews to Examine Neighborhood Influence on Parenting Practices Regarding Youth Outdoor Play and Physical Activity.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-07",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 7 2018",
    "received_results_disposit_date": "",
    "source": "Pennington Biomedical Research Center",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041910.659213",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "ICF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Development of an ICF Core Set for Geriatric Patients in Primary Care",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2018-01-11T042417.688125",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-05",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384732",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Development of a Core Set of the International Classification of Functioning Disability and Health ICF for Geriatric Patients in Primary Care",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2019",
    "received_results_disposit_date": "",
    "source": "University of Erlangen-Nrnberg Medical School",
    "start_date": "2017-06-30",
    "start_date_type": "Actual",
    "start_month_year": "June 30 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-11T042417.688125",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate VLA1553 in Healthy Volunteers",
    "completion_date": "2019-06-24",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 24 2019",
    "created_at": "2017-12-29T041544.186937",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03382964",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Randomized Observer-Blinded Dose-Escalation Phase 1 Study to Assess the Safety and Immunogenicity of Three Different Dose Levels of a Live-Attenuated Chikungunya Virus Vaccine Candidate VLA1553 in Healthy Volunteers Aged 18 To 45 Years",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-05-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "May 30 2018",
    "received_results_disposit_date": "",
    "source": "Valneva Austria GmbH",
    "start_date": "2018-02-26",
    "start_date_type": "Anticipated",
    "start_month_year": "February 26 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041544.186937",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Rapamycin Treatment for Activated Phosphoinositide 3-Kinase  Syndrome",
    "completion_date": "2022-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2022",
    "created_at": "2017-12-29T041537.239146",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383380",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety of Rapamycin Therapy for Patients With Activated Phosphoinositide 3-Kinase  Syndrome",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2022",
    "received_results_disposit_date": "",
    "source": "Childrens Hospital of Fudan University",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041537.239146",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Safety and Efficacy Study of Cryopreserved GSK2696274 for Treatment of Metachromatic Leukodystrophy MLD",
    "completion_date": "2028-08-23",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 23 2028",
    "created_at": "2018-01-11T042352.646584",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03392987",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Single Arm Open Label Clinical Study of Cryopreserved Autologous CD34 Cells Transduced With Lentiviral Vector Containing Human ARSA cDNA GSK2696274 for the Treatment of Early Onset Metachromatic Leukodystrophy MLD",
    "overall_status": "Recruiting",
    "phase": "Phase 3",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-08-22",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 22 2022",
    "received_results_disposit_date": "",
    "source": "GlaxoSmithKline",
    "start_date": "2017-12-15",
    "start_date_type": "Actual",
    "start_month_year": "December 15 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042352.646584",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents",
    "completion_date": "2017-05-01",
    "completion_date_type": "Actual",
    "completion_month_year": "May 1 2017",
    "created_at": "2018-01-05T041729.921480",
    "enrollment": 22,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-28",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387293",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-03-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "March 1 2017",
    "received_results_disposit_date": "",
    "source": "TC Erciyes University",
    "start_date": "2016-11-01",
    "start_date_type": "Actual",
    "start_month_year": "November 1 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041729.921480",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TGIF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids",
    "completion_date": "2017-05-30",
    "completion_date_type": "Actual",
    "completion_month_year": "May 30 2017",
    "created_at": "2017-12-23T042458.540324",
    "enrollment": 90,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378232",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "EPA and DHA Regulation of Blood Triglycerides Resting Metabolic Rate and Blood Markers of Cardiometabolic Health.",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-05-26",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "May 26 2017",
    "received_results_disposit_date": "",
    "source": "University of Guelph",
    "start_date": "2017-01-05",
    "start_date_type": "Actual",
    "start_month_year": "January 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042458.540324",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Use of Osteopathic Principles for Nonpharmacologic Therapeutic Interventions in Women With Polycystic Ovary Syndrome",
    "completion_date": "2017-12-01",
    "completion_date_type": "Actual",
    "completion_month_year": "December 2017",
    "created_at": "2017-12-29T041535.641140",
    "enrollment": 45,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383484",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Use of Osteopathic Principles for Nonpharmacologic Therapeutic Interventions in Women With Polycystic Ovary Syndrome",
    "overall_status": "Completed",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-09-01",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "September 2017",
    "received_results_disposit_date": "",
    "source": "Lake Erie College of Osteopathic Medicine",
    "start_date": "2016-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041535.641140",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Pattern of Pediatric Seizures at Al-Arish Central Hospital - North Sinai",
    "completion_date": "2019-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2019",
    "created_at": "2017-12-22T042600.240029",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374384",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Pattern of Pediatric Seizures at Al-Arish Central Hospital - North Sinai",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2018",
    "received_results_disposit_date": "",
    "source": "Assiut University",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Observational Patient Registry",
    "target_duration": "1 Year",
    "updated_at": "2017-12-22T042600.240029",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "StandUP UBC Reducing Workplace Sitting",
    "completion_date": "2018-12-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 15 2018",
    "created_at": "2017-12-23T042532.476693",
    "enrollment": 46,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375749",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "StandUP UBC Impact of a Low-cost Standing Desk on Reducing Workplace Sitting",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-15",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 15 2018",
    "received_results_disposit_date": "",
    "source": "University of British Columbia",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042532.476693",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "GUIDE-HF",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Hemodynamic-GUIDEd Management of Heart Failure",
    "completion_date": "2023-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 2023",
    "created_at": "2018-01-05T041721.249459",
    "enrollment": 3600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03387813",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 04 2018",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Hemodynamic-GUIDEd Management of Heart Failure",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2023-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 2023",
    "received_results_disposit_date": "",
    "source": "St. Jude Medical",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-05T041721.249459",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer",
    "completion_date": "2018-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2018",
    "created_at": "2018-01-02T182910.469848",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03386812",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 02 2018",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer Treated With Androgen Deprivation Therapy.",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Texas Southwestern Medical Center",
    "start_date": "2017-10-01",
    "start_date_type": "Actual",
    "start_month_year": "October 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2018-01-02T182910.469848",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "Heparinized peripheral blood is obtained from patients with severe EBV infections. Samples is\n      performed after parents information and consent.",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Immunodeficiency for Severe Epstein-Barr Virus Infection",
    "completion_date": "2022-11-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 30 2022",
    "created_at": "2017-12-25T041308.242608",
    "enrollment": 100,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374566",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Screening for Immunodeficiency Diseases in Patients With Severe Epstein-Barr Virus Infection",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-11-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 30 2022",
    "received_results_disposit_date": "",
    "source": "Childrens Hospital of Fudan University",
    "start_date": "2017-12-01",
    "start_date_type": "Actual",
    "start_month_year": "December 1 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-25T041308.242608",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Lymphatic Function in Patients With a Fontan-Kreutzer Circulation",
    "completion_date": "2018-08-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "August 31 2018",
    "created_at": "2017-12-24T041857.630561",
    "enrollment": 10,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379805",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": "",
    "number_of_groups": 2,
    "official_title": "The Lymphatic Morphology and Function of Fontan-Kreutzer Operated Patients",
    "overall_status": "Active not recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-06-20",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "June 20 2017",
    "received_results_disposit_date": "",
    "source": "University of Aarhus",
    "start_date": "2014-04-25",
    "start_date_type": "Actual",
    "start_month_year": "April 25 2014",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-24T041857.630561",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia",
    "completion_date": "2020-12-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 31 2020",
    "created_at": "2017-12-26T040721.937808",
    "enrollment": 120,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-20",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03381079",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Posterior Scleral Reinforcement for Adults With High Myopia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2020-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 1 2020",
    "received_results_disposit_date": "",
    "source": "Beijing Tongren Hospital",
    "start_date": "2018-04-01",
    "start_date_type": "Anticipated",
    "start_month_year": "April 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-26T040721.937808",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Modulating Context Generalization Through Transcranial Direct Current Stimulation",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-18T041355.647210",
    "enrollment": 40,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374605",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Modulating Context Generalization Through Transcranial Direct Current Stimulation",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "Butler Hospital",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041355.647210",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CHIMICI",
    "baseline_population": "",
    "biospec_description": "Intestinal mucosal biopsies Blood",
    "biospec_retention": "Samples With DNA",
    "brief_title": "Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease",
    "completion_date": "2019-01-24",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 24 2019",
    "created_at": "2017-12-22T042537.733483",
    "enrollment": 600,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376230",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 3,
    "official_title": "Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-24",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 24 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Lille",
    "start_date": "2010-02-01",
    "start_date_type": "Actual",
    "start_month_year": "February 2010",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042537.733483",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Nanogen Pegfilgrastim Pegcyte PKPD Clinical Study in Breast Cancer Patients",
    "completion_date": "2017-11-06",
    "completion_date_type": "Actual",
    "completion_month_year": "November 6 2017",
    "created_at": "2017-12-23T042530.074168",
    "enrollment": 24,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376503",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Randomized Double-blind Parallel Study Comparing Pharmacokinetic PK and Pharmacodynamic PD Parameters of Pegcyte Nanogen and Reference Product Neulastim Roche for Chemotherapy-induced Neutropenia in Breast-cancer Patients",
    "overall_status": "Completed",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-10-09",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "October 9 2017",
    "received_results_disposit_date": "",
    "source": "Nanogen Pharmaceutical Biotechnology Joint Stock Company",
    "start_date": "2016-05-25",
    "start_date_type": "Actual",
    "start_month_year": "May 25 2016",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042530.074168",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis",
    "completion_date": "2018-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2018",
    "created_at": "2018-01-11T042310.232142",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-03",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03395704",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase 2 Multi-Center Randomized Placebo Controlled Double-Blind Study With LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-10-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "October 2018",
    "received_results_disposit_date": "",
    "source": "La Jolla Pharmaceutical Company",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042310.232142",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Efficacy and Safety Study of AcetylcysteineDoxofylline 1200400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2018-01-07T041900.762113",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-25",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03388853",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 05 2018",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Efficacy and Safety Study of AcetylcysteineDoxofylline 1200400 mg Effervescent Tablet in the Treatment of Moderate-Severe Chronic Obstructive Pulmonary Disease COPD",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 4",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Neutec Ar-Ge San ve Tic A.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-07T041900.762113",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain",
    "completion_date": "2018-02-16",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 16 2018",
    "created_at": "2017-12-25T041308.022114",
    "enrollment": 73,
    "enrollment_type": "Actual",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374592",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "A Phase II Randomized Controlled Trial of Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain",
    "overall_status": "Active not recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2017-12-20",
    "primary_completion_date_type": "Actual",
    "primary_completion_month_year": "December 20 2017",
    "received_results_disposit_date": "",
    "source": "Centre hospitalier de lUniversit de Montral CHUM",
    "start_date": "2014-07-07",
    "start_date_type": "Actual",
    "start_month_year": "July 7 2014",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041308.022114",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Strategies to Maximise Patient Comfort During ESWL",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 2018",
    "created_at": "2017-12-24T041855.370242",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-17",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379922",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Randomised Control Trial of Strategies to Maximise Patient Comfort During Extracorporeal Shockwave Lithotripsy",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-03-27",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "March 27 2018",
    "received_results_disposit_date": "",
    "source": "University College Hospital Galway",
    "start_date": "2017-03-27",
    "start_date_type": "Actual",
    "start_month_year": "March 27 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041855.370242",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone CRD",
    "completion_date": "2020-01-15",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 15 2020",
    "created_at": "2017-12-22T042549.851064",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375567",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone CRD",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2019",
    "received_results_disposit_date": "",
    "source": "Yale University",
    "start_date": "2018-01-15",
    "start_date_type": "Anticipated",
    "start_month_year": "January 15 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042549.851064",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2019",
    "created_at": "2017-12-31T041337.506250",
    "enrollment": 110,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384758",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus.",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 1 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Erlangen",
    "start_date": "2018-02-01",
    "start_date_type": "Anticipated",
    "start_month_year": "February 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041337.506250",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "A Study to Evaluate the Safety Tolerability and Pharmacokinetics of a Single Dose of SRP-5051 in Participants With Duchenne Muscular Dystrophy DMD",
    "completion_date": "2019-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2019",
    "created_at": "2017-12-31T041404.325801",
    "enrollment": 30,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-22",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375255",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Phase 1 Trial to Evaluate the Safety Tolerability and Pharmacokinetics of a Single Dose of SRP-5051 in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Treatment",
    "overall_status": "Recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Sarepta Therapeutics",
    "start_date": "2017-12-01",
    "start_date_type": "Anticipated",
    "start_month_year": "December 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041404.325801",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Opioid Withdrawal Symptoms in Critically Ill Patients",
    "completion_date": "2018-09-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "September 1 2018",
    "created_at": "2017-12-31T041404.527921",
    "enrollment": 364,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-23",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374722",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Opioid Withdrawal Symptoms in Critically Ill Patients",
    "overall_status": "Enrolling by invitation",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-08-25",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "August 25 2018",
    "received_results_disposit_date": "",
    "source": "Mahidol University",
    "start_date": "2017-12-25",
    "start_date_type": "Anticipated",
    "start_month_year": "December 25 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-31T041404.527921",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The SafetyEfficacy of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Osteoarthritis",
    "completion_date": "2020-01-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 2020",
    "created_at": "2017-12-29T041541.879528",
    "enrollment": 60,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-21",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03383081",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 28 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Clinical Research on the SafetyEfficacy of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Osteoarthritis",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Sclnow Biotechnology Co. Ltd.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-29T041541.879528",
    "verification_date": "2017-09-01",
    "verification_month_year": "September 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Compuflo Instrument for Thoracic ES Identification",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 1 2019",
    "created_at": "2017-12-22T042537.273264",
    "enrollment": 20,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03376256",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Evaluation of the Compuflo Epidural Instrument for Thoracic Epidural Space Identification",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 1 2018",
    "received_results_disposit_date": "",
    "source": "University of Miami",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042537.273264",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-23T042455.356311",
    "enrollment": 45,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378414",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Clinical Research on the SafetyEfficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2019",
    "received_results_disposit_date": "",
    "source": "Sclnow Biotechnology Co. Ltd.",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042455.356311",
    "verification_date": "2017-09-01",
    "verification_month_year": "September 2017",
    "why_stopped": ""
  },
  {
    "acronym": "me15Schaefer",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Recipient Site Pre-conditioning in Fat Grafting",
    "completion_date": "2019-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2019",
    "created_at": "2018-01-11T042342.516622",
    "enrollment": 56,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2018-01-02",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03393598",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on January 10 2018",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Randomized Multi-centered Study on Enhancement of Autologous Fat Graft Survival by Recipient Site Preparation",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-06-30",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 30 2019",
    "received_results_disposit_date": "",
    "source": "University Hospital Basel Switzerland",
    "start_date": "2018-02-08",
    "start_date_type": "Anticipated",
    "start_month_year": "February 8 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2018-01-11T042342.516622",
    "verification_date": "2018-01-01",
    "verification_month_year": "January 2018",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Influence of Oesophageal Contractile Reserve in High Resolution Manometry on Post Operative Dysphagia After Anti-reflux Surgery",
    "completion_date": "2018-06-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 2018",
    "created_at": "2017-12-18T041351.023462",
    "enrollment": 70,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374930",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "Influence of Oesophageal Contractile Reserve in High Resolution Manometry on Post Operative Dysphagia After Anti-reflux Surgery",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-06-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "June 2018",
    "received_results_disposit_date": "",
    "source": "Poitiers University Hospital",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041351.023462",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "RACKED",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Rapid Agitation Control With Ketamine in the Emergency Department",
    "completion_date": "2020-04-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "April 1 2020",
    "created_at": "2017-12-22T042547.697219",
    "enrollment": 184,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-12",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375671",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Rapid Agitation Control With Ketamine in the Emergency Department RACKED a Randomized Controlled Trial",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-04-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "April 1 2019",
    "received_results_disposit_date": "",
    "source": "University of British Columbia",
    "start_date": "2018-03-01",
    "start_date_type": "Anticipated",
    "start_month_year": "March 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042547.697219",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MOPS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Montefiore Opioid and Pain Study",
    "completion_date": "2019-03-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "March 2019",
    "created_at": "2017-12-22T042548.187774",
    "enrollment": 462,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375645",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": "",
    "number_of_groups": 1,
    "official_title": "Montefiore Opioid and Pain Study",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-09-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "September 2018",
    "received_results_disposit_date": "",
    "source": "Montefiore Medical Center",
    "start_date": "2017-11-08",
    "start_date_type": "Actual",
    "start_month_year": "November 8 2017",
    "study_type": "Observational",
    "target_duration": "",
    "updated_at": "2017-12-22T042548.187774",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications",
    "completion_date": "2020-06-30",
    "completion_date_type": "Anticipated",
    "completion_month_year": "June 30 2020",
    "created_at": "2017-12-18T041356.250549",
    "enrollment": 25,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03374553",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 15 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "A Prospective Open Multicentre Clinical Trial Analysing the Effectiveness and Safety of MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 1 2018",
    "received_results_disposit_date": "",
    "source": "iSTAR Medical",
    "start_date": "2017-11-25",
    "start_date_type": "Actual",
    "start_month_year": "November 25 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-18T041356.250549",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "MIDAS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Mechlorethamine Induced Contact Dermatitis Avoidance Study",
    "completion_date": "2019-12-13",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 13 2019",
    "created_at": "2017-12-24T041853.127218",
    "enrollment": 28,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03380026",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Valchlor Therapy in Conjunction With Triamcinolone 0.1 Ointment for the Treatment of Contact Dermatitis in Patients With Early Stage Cutaneous T-cell Lymphoma Mechlorethamine Induced Dermatitis Avoidance Study",
    "overall_status": "Recruiting",
    "phase": "Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-13",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 13 2019",
    "received_results_disposit_date": "",
    "source": "Rochester Skin Lymphoma Medical Group PLLC",
    "start_date": "2017-12-13",
    "start_date_type": "Actual",
    "start_month_year": "December 13 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-24T041853.127218",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Utilizing Ultrasound for Residents as an Aid in Epidural Placement",
    "completion_date": "2020-11-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "November 2020",
    "created_at": "2017-12-23T042453.941191",
    "enrollment": 190,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": true,
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": true,
    "last_changed_date": "2017-12-18",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03378492",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "Utilizing Ultrasound for Residents as an Aid in Epidural Placement",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-11-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "November 2019",
    "received_results_disposit_date": "",
    "source": "Yale University",
    "start_date": "2017-12-31",
    "start_date_type": "Anticipated",
    "start_month_year": "December 31 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-23T042453.941191",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer",
    "completion_date": "2021-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2021",
    "created_at": "2017-12-25T041303.607789",
    "enrollment": 51,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03379428",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 22 2017",
    "number_of_arms": 4,
    "number_of_groups": "",
    "official_title": "Phase III Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer",
    "overall_status": "Recruiting",
    "phase": "Phase 1Phase 2",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-12-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "December 2019",
    "received_results_disposit_date": "",
    "source": "US Oncology Research",
    "start_date": "2017-11-29",
    "start_date_type": "Actual",
    "start_month_year": "November 29 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-25T041303.607789",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "Sensitization Study of ATx201 in Healthy Volunteers",
    "completion_date": "2018-02-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "February 2018",
    "created_at": "2017-12-22T042542.575210",
    "enrollment": 240,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": true,
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375957",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 3,
    "number_of_groups": "",
    "official_title": "A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers",
    "overall_status": "Not yet recruiting",
    "phase": "Phase 1",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-02-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "February 2018",
    "received_results_disposit_date": "",
    "source": "AntibioTx AS",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042542.575210",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "RESTORE",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Use of Telemedicine in Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 2019",
    "created_at": "2017-12-22T042542.802254",
    "enrollment": 1000,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-15",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375944",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 2,
    "number_of_groups": "",
    "official_title": "The Use of Modern Telemedicine Technologies in an Innovative Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2018-01-01",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 2018",
    "received_results_disposit_date": "",
    "source": "American Heart of Poland",
    "start_date": "2018-01-01",
    "start_date_type": "Anticipated",
    "start_month_year": "January 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042542.802254",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "TSCS",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "The Impact of Transcutaneous Spinal Cord Stimulation TSCS and Gait Training on Walking Function in Patients With Spinal Cord Injury",
    "completion_date": "2019-12-01",
    "completion_date_type": "Anticipated",
    "completion_month_year": "December 1 2019",
    "created_at": "2017-12-31T041351.108405",
    "enrollment": 10,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": true,
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-19",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03384017",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 29 2017",
    "number_of_arms": 1,
    "number_of_groups": "",
    "official_title": "The Impact of Transcutaneous Spinal Cord Stimulation TSCS and Gait Training on Walking Function in Patients With Spinal Cord Injury",
    "overall_status": "Recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2019-01-05",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 5 2019",
    "received_results_disposit_date": "",
    "source": "Hugo W. Moser Research Institute at Kennedy Krieger Inc.",
    "start_date": "2017-01-05",
    "start_date_type": "Actual",
    "start_month_year": "January 5 2017",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-31T041351.108405",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  },
  {
    "acronym": "CONSULT-BP",
    "baseline_population": "",
    "biospec_description": "",
    "biospec_retention": "",
    "brief_title": "COmmuNity-engaged SimULation Training for Blood Pressure Control",
    "completion_date": "2022-01-31",
    "completion_date_type": "Anticipated",
    "completion_month_year": "January 31 2022",
    "created_at": "2017-12-22T042543.253134",
    "enrollment": 205,
    "enrollment_type": "Anticipated",
    "expanded_access_type_individual": "",
    "expanded_access_type_intermediate": "",
    "expanded_access_type_treatment": "",
    "first_received_date": "2017-12-12",
    "first_received_results_date": "",
    "has_dmc": "",
    "has_expanded_access": "",
    "is_fda_regulated_device": "",
    "is_fda_regulated_drug": "",
    "is_ppsd": "",
    "is_unapproved_device": "",
    "is_us_export": "",
    "last_changed_date": "2017-12-14",
    "last_known_status": "",
    "limitations_and_caveats": "",
    "nct_id": "NCT03375918",
    "nlm_download_date_description": "ClinicalTrials.gov processed this data on December 21 2017",
    "number_of_arms": 5,
    "number_of_groups": "",
    "official_title": "COmmuNity-engaged SimULation Training for Blood Pressure Control",
    "overall_status": "Not yet recruiting",
    "phase": "NA",
    "plan_to_share_ipd": "",
    "plan_to_share_ipd_description": "",
    "primary_completion_date": "2022-01-31",
    "primary_completion_date_type": "Anticipated",
    "primary_completion_month_year": "January 31 2022",
    "received_results_disposit_date": "",
    "source": "University of Massachusetts Worcester",
    "start_date": "2018-07-01",
    "start_date_type": "Anticipated",
    "start_month_year": "July 1 2018",
    "study_type": "Interventional",
    "target_duration": "",
    "updated_at": "2017-12-22T042543.253134",
    "verification_date": "2017-12-01",
    "verification_month_year": "December 2017",
    "why_stopped": ""
  }
]